Sentence,class,file
Bacteria  are  estimated  to  occupy  between  7% http://dx.doi.org/10.1016/j.bjm.2016.09.003 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,OADS,/arxiv_data1/oa_pdf/ba/d6/main.PMC5220633.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/d6/main.PMC5220633.pdf
http://dx.doi.org/10.1016/j.bjm.2016.07.025 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/ce/4e/main.PMC5220634.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/4e/main.PMC5220634.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/4e/main.PMC5220634.pdf
"The  sequences  were  edited using the  Bioedit  program16and  Mega  version  4.017and  com- pared with  other  sequences  in  the  NCBU  database  (GenBank: http://www.ncbi.nlm.nih.gov/ )  using  the  BLAST  algorithm.18 Statistics The  biochemical  tests  and  MALDI–TOF  MS  association  were evaluated  by  Chi-Square  test  (/US2)  and  Fisher’s  test  with  95% conﬁdence interval, considering wrong  identiﬁcation  in  gen- era or  at  a  specie  level.",OADS,/arxiv_data1/oa_pdf/ce/4e/main.PMC5220634.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/f1/main.PMC5220635.pdf
http://dx.doi.org/10.1016/j.bjm.2016.09.002 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/6c/f1/main.PMC5220635.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/f1/main.PMC5220635.pdf
Available at:  http://faostat3.fao.org/download/Q/QC/E .,Non-OADS,/arxiv_data1/oa_pdf/6c/f1/main.PMC5220635.pdf
Available  at:  http://www.conab.gov.br/OlalaCMS/ uploads/arquivos/13 07  09  09  04  53  boletim  graos  junho 2013.pdf .,OADS,/arxiv_data1/oa_pdf/6c/f1/main.PMC5220635.pdf
Available at:  http://extranet.agricultura.gov.br/sislegis/ .,Non-OADS,/arxiv_data1/oa_pdf/6c/f1/main.PMC5220635.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/45/main.PMC5220636.pdf
http://dx.doi.org/10.1016/j.bjm.2016.04.031 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/5c/45/main.PMC5220636.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/45/main.PMC5220636.pdf
We used  the  Rapid  Annotation  using  Subsystem Technology8and  National  Centre  for  Biotechnology  Infor- mation’s Prokaryotic Genomes  Annotation  Pipeline  v2.6 (http://www.ncbi.nlm.nih.gov/genome/annotation  prok )  for gene  prediction  and  annotation.,OADS,/arxiv_data1/oa_pdf/5c/45/main.PMC5220636.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/cb/main.PMC5220637.pdf
"E-mails: wshws68@126.com  (L.  Tian),  jhguo@njau.edu.cn  (J.  Guo).pollution  can  lead  to  severe  changes  in  the  composition  of microbial communities  that  inhabit  these  zones.2,3Micro- bial  communities  present  in  marine  sediments  primarily decompose  organic  matter  derived  from  plant  litter  but  also play a  vital  role  in  the  transformation  of  pollutants.4,5They can  also  inﬂuence  the  availability  of  heavy  metals  and  are http://dx.doi.org/10.1016/j.bjm.2016.09.007 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/c8/cb/main.PMC5220637.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/cb/main.PMC5220637.pdf
This  is an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/0a/main.PMC5220638.pdf
http://dx.doi.org/10.1016/j.bjm.2016.08.001 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/0d/0a/main.PMC5220638.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/0a/main.PMC5220638.pdf
"Material  and  methods The  ﬁrst  step  on  this  process,  was  to  make  electronic searches in  the  Scopus  (http://www.scopus.com/ ),  Sci- enceDirect  (http://www.sciencedirect.com/ ),  ISI  Web of  Science  (http://apps.isiknowledge.com )  and  PubMed (http://www.ncbi.nlm.nih.gov/pubmed )  databases,  using  the following  keywords:  (collagenolytic  OR  collagenase)  AND (fungi OR  fungus  OR  fungal)  AND  (production  OR  synthesis OR synthesize)  AND  (characterization).",OADS,/arxiv_data1/oa_pdf/0d/0a/main.PMC5220638.pdf
http://www.ncbi.nlm.nih.gov/pubmed/12470591 .,Non-OADS,/arxiv_data1/oa_pdf/0d/0a/main.PMC5220638.pdf
"ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?ascbin=8&maxaln=10&seltype=2&uid=301352&query=VFLGREPKPDAFY&aln=1,1,622,12http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?ascbin=8&maxaln=10&seltype=2&uid=301352&query=VFLGREPKPDAFY&aln=1,1,622,12 [Accessed 28.06.16].",OADS,/arxiv_data1/oa_pdf/0d/0a/main.PMC5220638.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/d2/main.PMC5220639.pdf
Discovery  of  microorganisms for use  as  a  source  of  commercially  exploitable  products may support  programs  focused  on  the  application  of  biosyn- http://dx.doi.org/10.1016/j.bjm.2016.09.004 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/71/d2/main.PMC5220639.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/d2/main.PMC5220639.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/8a/cvw231.PMC5220676.pdf
Available from: https://www.med.unc.edu/ ibs/files/educational‑gi handouts.,Non-OADS,/arxiv_data1/oa_pdf/c6/5f/ABR-5-196.PMC5220688.pdf
Available from: http://www.idf.org/guideline‑diabetes‑ childhood.,Non-OADS,/arxiv_data1/oa_pdf/3c/4b/CMJ-130-39.PMC5221109.pdf
"[13] The estimated glomerular filtration rate  (eGFR) was calculated by CKD‑EPI (CKD Epidemiology  Collaboration) equation:[14,15] eGFR (ml∙min‑1∙1.73 m‑2) = 141  × min (Scr/k, 1)a × max (Scr/k, 1)−1.209 × 0.993Age × 1.018  (if female) × 1.159 (if black) where k is 0.7 for females  and 0.9 for males, a is −0.329 for females and −0.411 for  males, min indicates the minimum of Scr/k or 1, and max  indicates the maximum of Scr/k or 1, which was performed  by a CKD‑EPI calculator on the website (http://www.qxmd.",OADS,/arxiv_data1/oa_pdf/3d/35/CMJ-130-45.PMC5221111.pdf
"[7] The data used to calculate the UKPDS risk  scores (available at http://www.dtu.ox.ac.uk/riskengine/ download.php) included HbA1c, systolic blood pressure,  serum total cholesterol and HDL‑C, atrial fibrillation, sex,  age, ethnicity, smoking status, and diabetes duration.",OADS,/arxiv_data1/oa_pdf/ee/65/CMJ-130-57.PMC5221113.pdf
Available from: http://www.health.gov.au/internet/ main/publishing.nsf/content/cda ‑surveil ‑nndss‑casedefs‑cd_qfev.,Non-OADS,/arxiv_data1/oa_pdf/64/e9/CMJ-130-64.PMC5221114.pdf
"Two independent searches were performed  using TargetScan 6.2 (http://www.targetscan.org/) and  miRDB (http://mirdb.org/miRDB/), and the results were  compared.",OADS,/arxiv_data1/oa_pdf/d8/30/CMJ-130-93.PMC5221119.pdf
"To determine the functions of the predicted target  genes, the gene ontology (GO) of the target pool was  analyzed using CapitalBio Molecule Annotation System  3.0 (MAS, http://bioinfo.capitalbio.com/mas3/).",OADS,/arxiv_data1/oa_pdf/d8/30/CMJ-130-93.PMC5221119.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/a1/main.PMC5221347.pdf
"New  micro- bial  species  and  rhizobia  plant  infection  mechanisms  were discovered through  studying  this  bacterial  diversity.5,6Certain http://dx.doi.org/10.1016/j.bjm.2016.10.013 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",OADS,/arxiv_data1/oa_pdf/0f/a1/main.PMC5221347.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/a1/main.PMC5221347.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/6c/main.PMC5221349.pdf
"Berbara).The  AM  enhances  the  absorption  of  water  and  nutrients, mainly  P.1It  also  increases  the  tolerance  of  plants  to  biotic  and abiotic stresses,  as  pathogens,  drought  and  high  salinity.3,4 Besides that, the  AM  plays  a  critical  role  in  the  functional  and successional  processes  of  plant  communities  as  soil  forma- tion, management  and  nutrient  cycling.5–7 In  Cuba  the  production  of  previously  selected  AMF  for their use  as  biofertilizers  began  in  the  decade  of  1990  with http://dx.doi.org/10.1016/j.bjm.2016.10.012 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/25/6c/main.PMC5221349.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/6c/main.PMC5221349.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/05/main.PMC5221351.pdf
"Monteiro).not  particularly  toxic.1Nevertheless,  their  persistence  and resulting long  exposure  time  is  of  particular  concern  for  the discharge  of  waste  dye  efﬂuent,  since  these  substances  may exhibit  chronic  effects  such  as  mutagenic  damage  and  car- cinogenicity towards  biota.2,3Several  authors  reported  that dye  discharges  from  textile  processing  plants  were  the  major http://dx.doi.org/10.1016/j.bjm.2016.09.012 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/ba/05/main.PMC5221351.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/05/main.PMC5221351.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/ee/main.PMC5221353.pdf
http://dx.doi.org/10.1016/j.bjm.2016.10.011 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/56/ee/main.PMC5221353.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/ee/main.PMC5221353.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/92/main.PMC5221355.pdf
"Dalitz).Actinobacteria  from  intertidal  regions  produce  unique metabolites  and  carry  out  unique  physiological  processes  due to extreme  environmental  conditions,  such  as  salinity,  tem- perature,  and  humidity.4Actinobacteria  from  the  intertidal region of  Ilha  do  Mel,  Paraná,  Brazil,  have  already  shown promising  results  in  inhibition  of  pathogenic  organisms  and production  of  substances  with  antimicrobial  potential.5Other http://dx.doi.org/10.1016/j.bjm.2016.09.010 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/bd/92/main.PMC5221355.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/92/main.PMC5221355.pdf
"16S  rDNA  sequencing The  16S  rDNA  sequences  were  edited  using  the  Staden  soft- ware, and  the  BLAST  algorithm  (http://blast.ncbi.nlm.nih.gov ) was used  to  compare the sequences  with  other  sequences  pre- viously  deposited  in  the  GenBank  database.",OADS,/arxiv_data1/oa_pdf/bd/92/main.PMC5221355.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/ad/main.PMC5221356.pdf
http://dx.doi.org/10.1016/j.bjm.2016.09.013 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/20/ad/main.PMC5221356.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/ad/main.PMC5221356.pdf
2012ZX10004-201-002  and 2012ZX10004215 of  the  National  Science  and  Technology Major  Project  of  China  (http://www.nmp.gov.cn ).,Non-OADS,/arxiv_data1/oa_pdf/20/ad/main.PMC5221356.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/86/main.PMC5221357.pdf
"These lentiviruses cause  persistent  infections,  including http://dx.doi.org/10.1016/j.bjm.2016.11.002 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/2c/86/main.PMC5221357.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/86/main.PMC5221357.pdf
http://dx.doi.org/10.1016/j.bjm.2016.10.001 1517-8382/©  2016  Published  by  Elsevier  Editora  Ltda.,Non-OADS,/arxiv_data1/oa_pdf/81/d0/main.PMC5221365.pdf
This  is  an  open  access  article under the  CC  BY -NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/d0/main.PMC5221365.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/77/main.PMC5221367.pdf
"E-mail: htakiff@gmail.com  (H.  Takiff).have  recently  become  notorious  as  contaminant  infections after major  and  minor  surgery,  particularly  NTM  of  the  M. abscessus complex.4,5Although  these  low  virulence  bacte- ria  are  generally  regarded  as  opportunistic  agents  requiring direct  inoculation  into  a  wound  site,  treating  them  is  often difﬁcult and  requires  prolonged  multi-drug  therapy,  as  they are intrinsically  resistant  to  most  antibiotics,6,7including http://dx.doi.org/10.1016/j.bjm.2016.09.009 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/6e/77/main.PMC5221367.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/77/main.PMC5221367.pdf
"Disinfectants The  disinfectants  evaluated were: cetyltrimethyl  ammonium bromide  (CTAB),  dodecyl  trimethyl  ammonium  bromide (DTAB),  cetylpyridinium  chloride  (HPC)  and  dimethyl  benzyl lauryl ammonium  bromide  (DBLAB  –  marketed  under  a  com- mercial product  name  http://www.pharmcast.com/Patents/ Yr2002/August2002/082702/6441045  Disinfectant082702.htm ).",Non-OADS,/arxiv_data1/oa_pdf/6e/77/main.PMC5221367.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/66/main.PMC5221368.pdf
and  meroplank- tonic  organisms  (larval  stages  of  benthic  invertebrates: http://dx.doi.org/10.1016/j.bjm.2016.10.009 1517-8382/© 2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/2b/66/main.PMC5221368.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/66/main.PMC5221368.pdf
"Albuquerque).Paratuberculosis  has  been  previously  investigated  in  sev- eral studies  in  Brazil.3Its  occurrence  in  Pernambuco  has  been described  in  dairy  cattle  based  on  clinical  signs,  histopatho- logy, and  results  from  enzyme-linked  immune  sorbent  assay (ELISA)  serology (32.3%  positive  samples),  isolation  (50%  pos- itive  samples),  and  polymerase  chain  reaction  (PCR)  studies.4 Additionally, a  prevalence  rate  of  2.7%  (11/408)  has  been http://dx.doi.org/10.1016/j.bjm.2016.10.010 1517-8382/©  2016  Published  by  Elsevier  Editora  Ltda.",Non-OADS,/arxiv_data1/oa_pdf/39/e1/main.PMC5221396.pdf
This  is  an  open  access  article under the  CC  BY -NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/e1/main.PMC5221396.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/0d/main.PMC5221399.pdf
"The  sequence  reads  were  trimmed  for  adapters  using Trimmomatic,8ﬁltered  for  quality  using  the  FASTX-Toolkit http://dx.doi.org/10.1016/j.bjm.2016.06.016 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",OADS,/arxiv_data1/oa_pdf/64/0d/main.PMC5221399.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/0d/main.PMC5221399.pdf
12  b  r  a  z  i  l  i  a  n  j  o  u  r  n  a  l  o  f  m  i  c  r  o  b  i  o  l  o  g  y  4  8  (2  0  1  7)  11–12 suite  of  tools  (http://hannonlab.cshl.edu/fastx  toolkit/ )  and the de  novo  assembly  was  performed  using  Velvet  v.  1.2.08.9 The  assembly  gave  an  average  coverage  across  the  genome  of 117X.,OADS,/arxiv_data1/oa_pdf/64/0d/main.PMC5221399.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/d3/main.PMC5221400.pdf
"1Chao  An  and  Sai-jian  Ma  contributed  equally  to  this  work.usually  biosynthesized  by  strains  of  the  yeast-like  polymor- phic fungus  Aureobasidium  pullulans .3–5Because  of  its  strictly linear  structure,  pullulan  has  been  used  in  applications  such as blood  plasma  substitutes  and  as  an  additive  for  food,  adhe- sives,  and  cosmetics.1,6Despite  these  applications,  pullulan  is more costly  ($25  kg−1)  than  other  exopolysaccharides,  which is  a  major  limiting  factor  for  its  effective  application.7 http://dx.doi.org/10.1016/j.bjm.2016.11.001 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/b8/d3/main.PMC5221400.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/d3/main.PMC5221400.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/e9/main.PMC5221401.pdf
"E-mail: kineto.magnetic@gmail.com  (R.K.  Sinha).archipelago,  Spitsbergen  79◦N–12◦E,  is  a  key  site  for  the monitoring  of  Arctic  biodiversity  and  also  considered  for modeling  in  climate  change  studies.1The  marine  ecosystem of Kongsfjorden  is  well  explored  with  regards  to  hydrogra- phy,  mesozooplankton,  and  higher  trophic  levels,  while  the knowledge on  its  bacterial  diversity  still  remains  insufﬁcient.2 http://dx.doi.org/10.1016/j.bjm.2016.09.011 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/8b/e9/main.PMC5221401.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/e9/main.PMC5221401.pdf
"The  obtained sequences  were  checked  for  chimera  with  the  CHIMERA  detec- tion  program  (http://rdp8.cme.msu.edu/cgis/chimera.cgi ).19 The 16S  rDNA  sequences  of  the  isolates  (∼1200  bp)  were compared  with  the  type  strains  belonging  to  the  same phylogenetic group,  using  the  Seqmatch  tool  of  Ribo- somal  Database  Project  (http://rdp.cme.msu.edu/ ).19SINA v1.2.1120software was  used  to  align  the  16S  rRNA  gene sequences.",OADS,/arxiv_data1/oa_pdf/8b/e9/main.PMC5221401.pdf
"2005;110, http://dx.doi.org/10.1029/2004JC00275 .",Non-OADS,/arxiv_data1/oa_pdf/8b/e9/main.PMC5221401.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
"The Israeli curriculum for biotechnology majors shares many topics with the Australian one [ 54] and the online teach- ing resources for biotechnology teachers in Australia (http:// archive.industry.gov.au/Biotechnologyonline.gov.au/topitems/ resources.html) and New Zealand (http://biotechlearn.org.nz/).Noteworthy, the level of the 12th-grade senior high-school bio-technology curriculum is in a way similar to the advancedplacement biology in the United States.",Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
The bioinformatics learning environment The bioinformatics learning environment (http://stwww.weizmann.ac.il/g-bio/bioinfo/) was described in detail elsewhere [47].,Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
"Methods Population The study population consisted of 11th-grade high-school bio- technology majors ( n¼44, 16–17 years of age, 21 males and 23 females) from four different schools who were introduced toone of two ‘in-depth’ activities of the bioinformatics learningenvironment (http://stwww.weizmann.ac.il/g-bio/bioinfo/).",Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
Supplementary data Supplementary data are available online at http://bib.oxford journals.org/.,Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
http://www.bisti.nih.gov (17 July 2000 date last accessed).,Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
http://www.ncbi.nlm.nih.gov/ About/primer/bioinformatics.html (15 June 2011 date lastaccessed).,OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
"http://visionandchange.org/ﬁles/2011/03/Revised-Vision-and-Change-Final-Report.pdf, 2011.",Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
http://www.iscb.org/ archive/conferences/iscb/ismb2010-program/ismb2010-tutor ials.html#AM1.,Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
http://www.iscb.org/archive/conferences/iscb/ismb2010-program/ismb2010-tutorials.html#AM1 (3May 2015 date last accessed).37.Global Organisation for Bioinformatics Learning ETG.,Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
http://mygoblet.org/about-us/ goblet-events/goblet-agm-2014-stao-conference.,Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
"Rehovot, Israel: The Amos de-Shalit Center for Science Teaching, 2001. http://stwww.weizmann.ac.il/ bioinformatics 57.Chinn CA, Malhotra BA.",Non-OADS,/arxiv_data1/oa_pdf/3c/f3/bbv113.PMC5221422.pdf
The MTD is freely accessible at http://mtd.cbi.ac.cn.,Non-OADS,/arxiv_data1/oa_pdf/3d/f1/bbv117.PMC5221423.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/bbv117.PMC5221423.pdf
"All raw RNA-seq data and the corresponding experiment metadata (.xml format) of four model mammals (human, pig, ratand mouse) were collected from healthy samples without any spe-cial treatment in Sequence Read Archive (SRA) (http://www.ncbi.nlm.nih.gov/sra) by considering the five criteria mentioned as fol- lows: (1) only selecting samples under normal conditions and removing tissues/cell lines with special treatments to avoid differ-ent regulation mechanisms under di verse physiological conditions, (2) removing all mixed tissue/cell line samples that might mask thereal differences among samples, (3) filtering severe unsaturated data sets that might increase the false-negative rate of gene ex- pression and the HK genes, (4) selecting the most saturated andhighest sequencing quality experiment as representative data foreach tissue/cell line and (5) selecting samples from the IlluminaGenome Analyzer and Illumina HiSeq 2000/2500 to reduce the dif- ferences resulting from the use of different sequencing instru- ments ( Table 1 ).",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/bbv117.PMC5221423.pdf
"We arranged our transcriptomic data to fit into our designed relational database schema and stored the data in the MySQL database (http://www.mysql.org; a free andpopular relational database management system; version 5.1.69).The MTD was built using HyperText Markup Language (HTML and HTML5), HyperText Preprocessor (PHP) (http://php.net; a widely used general-purpose scripting language; version 5.2.17),JavaScript, jQuery, Cascading Style Sheets (CSS, CSS3), ScalableVector Graphics (SVG) and Asynchronous JavaScript and XML(AJAX).",OADS,/arxiv_data1/oa_pdf/3d/f1/bbv117.PMC5221423.pdf
"The structure images andcoverage plots of genes were supported by embedding GBrowse [22], and KEGG [ 23] pathway graphs were provided by KEGG API (http://www.kegg.jp/kegg/rest/).",OADS,/arxiv_data1/oa_pdf/3d/f1/bbv117.PMC5221423.pdf
JPGraph (http://jpgraph.net) wasalso used to offer an overview of gene expression levels acrosstissues/cell lines for each expressed gene/isoform.,OADS,/arxiv_data1/oa_pdf/3d/f1/bbv117.PMC5221423.pdf
The MTD isfreely available at http://mtd.cbi.ac.cn.,Non-OADS,/arxiv_data1/oa_pdf/3d/f1/bbv117.PMC5221423.pdf
"Discussion and future directions The MTD focuses on characterization and comparative analysis ofRNA-seq data in most available tissues of humans, mice, rats and pigs, and can be accessed through a user-friendly Web interface (http://mtd.cbi.ac.cn).",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/bbv117.PMC5221423.pdf
Supplementary data Supplementary data are available online at http://bib.oxford journals.org/.,Non-OADS,/arxiv_data1/oa_pdf/3d/f1/bbv117.PMC5221423.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Genome- and phenome-wide studies are effectively using clinical data from EMRs linked to patient samples from clinical repositories or biobanks including studies from eMERGE (elec-tronic MEdical Records and Genomics; http://www.gwas.net) network, Clinical Implementation of Personalized Medicine through Electronic Health Records and Genomics (CLIPMERGE PGx) program [ 7] and Informatics for Integrating Biology and the Bedside (i2b2; https://www.i2b2.org/) [ 8–15].",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"On the other hand, integrated appli-cation development frameworks like Apple ResearchKit (http://www.apple.com/researchkit/) and Google Fit (https://developers.google.com/fit/?hl ¼en) offer a convenient option for wellness data gathering.",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Biomedical and health care data aggregation resources Data resource Description Example Example URL Biobank Biorepository that stores biological samples from volunteers for research useBioMe BioBank Program https://icahn.mssm.edu/research/institutes/ ipm/programs/biome-biobank Biorepository Biological materials repository that collects, processes, stores and distributes biospecimens to support future scientiﬁc investigationMount Sinai Cancer Institute Biorepository https://biospecimens.ordr.info.nih.gov/ AllRepositories.aspx Clinical data warehouse Data aggregation system that collects data from diverse data-capturing system as part of health care delivery and clinical trialsMount Sinai Data Warehouse http://icahn.mssm.edu/about-us/services- and-resources/computer-services/resources/ research-information-technology/mount-sinai-data-warehouse Clinical trials database Disease-, therapy- or intervention-speciﬁc database that collects data during a clinical trialCardiovascular Health Study https://clinicaltrials.gov/ Disease registries Specialized database that contains information about patients diagnosed with a speciﬁc type of diseasehttps://www.nih.gov/health-information/ nih-clinical-research-trials-you/list-registries Electronic medical record (EMR) or electronic health record (EHR)Longitudinal record of patient care as documented by care provider and maintained by hospitalsEpic, Cerner https://www.cms.gov/Medicare/E-Health/ EHealthRecords/index.html?redirect ¼/ ehealthrecords/ Health care survey databases Large-scale health care survey database maintained organizations like center for disease and infection control (CDC), AHRQ, NCI, etc.Surveillance, Epidemiology and End Results (SEER)http://www.cdc.gov/nchs/dhcs.htm Patient Health Record (PHR) A compendium of health care information maintained by a patientMicrosoft HealthVault https://www.healthit.gov/providers- professionals/faqs/what-personal-health-record Patient portal A web-based data aggregation system to collect demographic data, enable patient-provider interactions and help patients to coordinate health care servicesMy Mount Sinai chart https://www.healthit.gov/providers- professionals/faqs/what-patient-portal Payer databases Database managed by government or non-government organizations or insurance companiesDatabase maintained by health insurance companies, state or other federal health agencies.",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
Payer databases are also available as products from data vendorshttps://www.health.ny.gov/technology/ all_payer_database/108 | Shameer et al.,OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Initiatives and organ- izations like Human API, Aqua.io, Vivametrica (http://www.viva metrica.com) and ‘Here is My Data’ (http://www.hereismydata.com) address unification of data from such diverse resources.",OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Features of consumer health-monitoring devices Consumer device Health features monitored Medical field(s) Source Basis B1 wrist band Heart rate, accelerometer, body temperature, ambient temperature, skin conductance,caloric burnCV, Endo, Psych https://www.mybasis.com/ BodyMedia Link ArmbandHeat ﬂux, body temperature, motion and skin conductance, activity level, calorie burn and sleepCV, Endo http://www.bodymedia.com/ Fitbit Aria Weight, body fat %, BMI CV, Endo https://www.ﬁtbit.com/aria Fitbit Surge GPS, altimiter, heart rate, accelerometer, activity, caloric burn and sleepCV https://www.ﬁtbit.com/surge Hexoskin smart shirt ECG, respiratory rate, tidal volume, acceleromter, position, sleepCV, Pulm http://www.hexoskin.com/ iHealth BP5 Blood pressure CV, Renal http://www.ihealthlabs.com/ iHealth Glucometer Blood glucose Endo http://www.ihealthlabs.com/ Jawbone UP3 Accelerometer, heart rate, respiratory rate, skin conductance, skin temperature andambient temperature, activity, sleep and caloric intakeCV, Endo, Pulm, Psych http://jawbone.com/store/buy/up3 MapMyFitness Record activity, food intake CV http://www.mapmyﬁtness.com/ Melon Headband Three-channel EEG, infer concentration, relaxationNeuro, Psych, Devel http://www.thinkmelon.com/ Muse headband Seven-channel EEG, infer concentration, relaxationNeuro, Psych, Devel http://www.choosemuse.com/ Nike Fuelband Activity CV http://www.nike.com Scanadu Scanaﬂo Urinalysis Renal, Endo https://www.scanadu.com/scanaﬂo Scanadu Scout Temperature, blood pressure, heart rate, blood oxygenation and ECGCV, Pulm https://www.scanadu.com/scout Sensimed Triggerﬁsh Eye shape and blinking, infer intraocular pressureOphtho http://www.sensimed.ch/ Withings BP Monitor Blood pressure, heart rate CV, Renal http://www.withings.com/ Withings Pulse Accelerometer, heart rate, blood oxygenation, activity, sleep and caloric burnCV, Pulm http://www.withings.com/ Zephyr BioPatch Heart rate, respiratory rate, accelerometer, ECG, activityCV, Pulm http://zephyranywhere.com/ CV, cardiovascular; Devel, development; Pulm, pulmonary medicine; Endo, endocrinology; Neuro, neurology; Ophtho, ophthalmology.Translational bioinformatics using real-time data streams |109",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
Efforts are underway to connect ResearchKit and HealthKit health data streams into intuitional EMRs or PHRs.Medicare and Medicaid services provide meaningful use (MU;http://www.cms.gov/Regulation s-and-Guidance/Legislation/ EHRIncentivePrograms/Meaningful_Use.html) guidelines for health care providers to receive incentive payments.,Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
One of therecommendations for the next stage of MU is to engage patientsand families in their care by enabling patients to access and trans- mit patient-generated health information (http://www.healthit.,Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
Existing standardsbased on Health Level 7 (HL7; https://www.hl7.org/) and healthinformation exchanges (HIE; http://www.healthit.gov/providers-professionals/health-information-exchange/what-hie) could pro- vide a basis for such an integration of a consumer device and clinical data.,Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Standards in health and clinical informatics that can leverage integration of health monitoring data to EMRs Name Description URL CDISC Clinical Data Interchange Standards Consortium is a standards development collaboration to streamline medical researchand health carehttp://www.cdisc.org/standards-and- implementations Health IT at NIST StandardsProvides various information regarding Health IT Standards and details for implementing high-quality health information technology applications and projectshttp://healthcare.nist.gov/ HIE Data interoperability guidelines provided to implement health system, state or national level health information exchangeshttps://www.healthit.gov/HIE HIPAA The Health Insurance Portability and Accountability Act, a federal act that provides national standards for EHR transactions andidentiﬁers for providers and payors and aid in protecting patient informationhttp://www.hhs.gov/ocr/privacy/ HITSP Health care Information Technology Standards designed by public and private partnership to develop health information technology systems that allow better interoperabilityhttp://www.hitsp.org/ HL7 Standards and framework for the exchange, integration, sharing and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health serviceshttp://www.hl7.org/ MU The Medicare and Medicaid EHR Incentive Programs and associated guidelines provide ﬁnancial incentives for the ‘meaningful use’of certiﬁed EHR technology to improve patient carehttps://www.healthit.gov/policy- researchers-implementers/meaningful-use-regulations OMOP Observational Medical Outcomes Partnership informs the appropriate use of observational health care data setshttp://omop.org/ PHI Protected health information standard is any patient-related information, including information about the provider or payer and other data thatcan be linked to an individual.",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
PHI standards and guidelines are designed by institutions to protect patient identifyhttp://www.hhs.gov/ocr/privacy/Translational bioinformatics using real-time data streams |111,Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Theinsight on the individual’s longitudinal health and holistic con-siderations meets the Patient-Centered Outcomes Research Institute (http://www.pcori.org) mission to improve the ability to discern which health care options are best for a particular pa-tient and potentiates informed individualized health decisions.Ontology for home-based care [ 56] has been proposed, but its in- tegration with existing medical or clinical terminologies are limited; hence, an additional set of ontologies or new terms related to pertinent health monitoring data elements needs tobe designed for effective integration of such health monitoringdata into the EMR.",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Resource for extraction, integration, storage or reference of clinically relevant data elements from health care monitoring devices and digital applications to EMRs Name Description Reference Apache cTAKES Tools and APIs for unstructured data http://uima.apache.org/ Apache UIMA Tools and APIs for unstructured data http://uima.apache.org/ Aqua.io Medical vocabulary APIs http://aqua.io/ CDT Current dental terminology http://www.ada.org/en/publications/cdt/ CPT Current procedural terminology http://www.ama-assn.org/ama/pub/physician- resources/solutions-managing-your-practice/ coding-billing-insurance/cpt.page CVX HL7 standard code set for vaccines administered http://www2a.cdc.gov/vaccines/iis/iisstandards/ vaccines.asp?rpt ¼cvx FHIR Fast Health care Interoperability Resources https://www.hl7.org/fhir/HCPCS Health care Common Procedure Coding System http://www.cms.gov/Medicare/Coding/ MedHCPCSGenInfo/index.html?redirect ¼/ MedHCPCSGeninfo/ HealthData.gov Provides diverse health care data sets http://healthdata.gov/dataset/search HealthData.gov API Diverse set of APIs to access HealthData.gov data http://healthdata.gov/data-api HealthData.gov Hub 1339 health care data sets (as of May 2014) http://hub.healthdata.gov/ HumanAPI An integrated API service http://humanapi.co/ LOINC A universal code system for tests, measurements and observations http://loinc.org/MedTagger Text mining tool with options for indexing based on dictionaries, information extraction based on patterns and machine learning-based named entity recognitionhttp://sourceforge.net/projects /ohnlp/ ﬁles/MedTagger/ MetaMap Map biomedical text to the UMLS Metathesaurus or, equivalently, to discover Metathesaurus concepts referred to in texthttp://metamap.nlm.nih.gov/#MetaMapJavaApi OHNLP Open-source consortium to promote past and current development efforts and to encourage participation in advancing future effortshttp://ohnlp.org/index.php/Main_Page OpenCDS Collaborative effort to develop open-source, standards- based CDS tools and resourceshttp://www.opencds.org/ OpenICE Open-Source Integrated Clinical Environment is designed as a framework for integrating apps and devices into the Medical Internet of Thingshttps://www.openice.info/ OpenNLP Text mining https://opennlp.apache.org/ PheKB Knowledgebase for discovering phenotypes from EMRs http://phekb.org/ RxNORM Normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction softwarehttps://www.nlm.nih.gov/research/umls/rxnorm/ SMART Appstore for health http://smarthealthit.org/about/ SNOMED CT Comprehensive, multilingual clinical health care terminology http://www.ihtsdo.org/snomed-ct/ SPHINX Web-based tool for exploring drug response implications of genetic variation across the eMERGE PGx project cohorthttp://www.emergesphinx.org/112 | Shameer et al.",OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
Platforms for health outcome research such as the Observational Medical Outcomes Partnership (OMOP; http://omop.org) can already ac- commodate these additional patient features to improve data utilization in large-scale studies.,Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Scalable technologies that can be used for computation, integration and analytics of health monitoring data integrated with EMRs Type Name Reference Distributed computing for batch and streaming data processingApache Hadoop http://hadoop.apache.org/ Apache Storm http://storm.incubator.apache.org/ Apache Spark https://spark.apache.org/Apache Fink https://ﬂink.apache.org/ Apache Samza http://samza.apache.org/ Data storage Apache Cassandra http://cassandra.apache.org/ MongoDb http://www.mongodb.org/ Neo4j http://www.neo4j.org/Elastic https://www.elastic.co/ Data visualization Gephi http://gephi.github.io/ EHDViz http://ehdviz.dudleylab.org Kibana https://www.elastic.co/products/kibana Deep learning Theano https://pypi.python.org/pypi/Theano Tensor Flow http://www.tensorﬂow.org/ Graph processing Pregel https://kowshik.github.io/JPregel/pregel_paper.pdf Apache Giraph https://giraph.apache.org/ Machine learning Apache Mahout http://mahout.apache.org/ Spark MLlib https://spark.apache.org/mllib/ Weka http://www.cs.waikato.ac.nz/ml/weka/index.html Amazon Machine Learning http://aws.amazon.com/machine-learning/ Microsoft Azure http://azure.microsoft.com/Ayasdi http://www.ayasdi.com/Translational bioinformatics using real-time data streams |113",OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
The introduction of the Sensible Oversight For Technology Which Advances RegulatoryEfficiency (http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM263366.pdf) (SOFTWARE) Act of 2013 provides regulatoryguidelines for development and implementation clinicalsoftware and health software along with existing regulations recommended by FDA for mobile app [ 136] and CDS [ 137].,Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Twenty-first Century Cures Act (https://www.congress.gov/bill/114th-congress/house-bill/6) further enhances the promise ofimproving the medical innovation for drug discovery by con-verging multiple streams of medicine, engineering and science[138].",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
ClinicalTrials.gov lists 113 studies that use wearable devices (https://clinicaltrials.gov/ct2/results?term ¼%22wearable%22).,OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"For example,patients can be assessed for a variety of health risks hospital-ization including hospital-acquired conditions like falls or air embolism (HAC, https://www.cms.gov/medicare/medicare-fee-for- service-payment/hospitalacqcond/hospital-acquired_conditions.html) and hospital-acquired infections like sepsis or pneumonia(HAI; see http://www.cdc.gov/hai/), and necessary stratification measures can be taken.",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
Data-driven clinical trials A recent FDA guideline for clinical trials and investigations de-tails the importance of the risk-based approach and implemen- tation of monitoring systems as part of clinical trials (See:http://www.fda.gov/downloads/Drugs/ .../Guidances/ UCM269919.pdf).,Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
"Acknowledgements Authors would like to thank Harris Center For Precision Wellness (http://www.precisionwellness.org/) and Icahn Institute for Genomics and Multiscale Biology (http://icahn.mssm.edu/departments-and-institutes/genomics), of MountSinai Health System for infrastructural support.",Non-OADS,/arxiv_data1/oa_pdf/94/6d/bbv118.PMC5221424.pdf
We provide SGA-Iteratively Correcting Errors (https://github.com/hillerlab/IterativeErrorCorrection/) that implements iterative error correction by using modules from SGA.,OADS,/arxiv_data1/oa_pdf/4a/85/bbw003.PMC5221426.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/85/bbw003.PMC5221426.pdf
All simulated data sets and the error-profile are available at http://bds.mpi-cbg.de/hillerlab/IterativeErrorCorrection/.,OADS,/arxiv_data1/oa_pdf/4a/85/bbw003.PMC5221426.pdf
"Real data To test our error correction strategy on real data sets, we down- loaded 2 /C2250 bp MiSeq reads for the rice strains IR64, DJ123 and Nipponbare (SRX180591, SRX186093 and SRX179262, re-spectively; http://schatzlab.cshl.edu/data/rice/).",Non-OADS,/arxiv_data1/oa_pdf/4a/85/bbw003.PMC5221426.pdf
We also down-loaded a human 2 /C2100 bp HiSeq read data set (Library 1 from http://gage.cbcb.umd.edu/data/).,OADS,/arxiv_data1/oa_pdf/4a/85/bbw003.PMC5221426.pdf
SGA-ICE is available at https://github.com/hillerlab/Iterative ErrorCorrection/.,OADS,/arxiv_data1/oa_pdf/4a/85/bbw003.PMC5221426.pdf
Supplementary data Supplementary data are available online at http://bib.oxford journals.org/.,Non-OADS,/arxiv_data1/oa_pdf/4a/85/bbw003.PMC5221426.pdf
"Technical challenges include the low abundance of membrane-boundTable of Links TARGETS Catalytic receptors Integrin α4β7 This Table lists key protein targets in this article that are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the com mon portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016), and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 (Alexander et al., 2015).Physiologically relevant K Dmeasurements using BSI BJP British Journal of Pharmacology (2017) 174 70–81 71",Non-OADS,/arxiv_data1/oa_pdf/64/a3/BPH-174-70.PMC5221447.pdf
Supporting Information Additional Supporting Information may be found in the on- line version of this article at the publisher ’s web-site: http://dx.doi.org/10.1111/bph.13654Figure S1 Characterization of CHO cell vesicles.,Non-OADS,/arxiv_data1/oa_pdf/64/a3/BPH-174-70.PMC5221447.pdf
"In addition to its lack of S1P 3receptor agonist activity, amiselimod was designed to be converted to the active metabolite in human cells (in vitro )m o r es l o w l yt h a n ﬁngolimod, because it was thought that its effect on the heart rate of humans maybe ameliorated by the gradua l increase in concentrationTables of Links TARGETS GPCRsaVoltage-gated ion channelsb S1P 1receptorG-protein-activated inward- rectiﬁer K channel (K ir3.1) S1P 2receptorG-protein-activated inward- rectiﬁer K channel (K ir3.2) S1P 3receptorG-protein-activated inward- rectiﬁer K channel (K ir3.3) S1P 4receptorG-protein-activated inward- rectiﬁer K channel (K ir3.4) S1P 5receptorLIGANDS Amiselimod Sphingosine 1-phosphate FingolimodFingolimod phosphate These Tables list key protein targets and ligands in this article which are hyperlinked to corresponding entries in http://www.guidetopharmacolog y.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 (a,bAlexander et al., 2015a,b).",Non-OADS,/arxiv_data1/oa_pdf/d8/17/BPH-174-15.PMC5221453.pdf
[Online] Available at: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/d8/17/BPH-174-15.PMC5221453.pdf
"Supporting Information Additional Supporting Information may be found in the on- line version of this article at the publisher ’s web-site: http://dx.doi.org/10.1111/bph.13641 Figure S1 Effects of amiselimod-P, ﬁngolimod-P, and S1P on human GIRK currents.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/BPH-174-15.PMC5221453.pdf
"Analysis of eQTL effects and LD structure at theSNCA locus To determine whether rs356182 or other PD-associated variants are located in predicted gene regulatory regions,we visualized the regulatory histone mark histone h3 lysine27 acetylation (H3K27ac) 27–29in all available brain regions on the WashU Epigenome Browser (http://epigenomegate-way.wustl.edu/).",OADS,/arxiv_data1/oa_pdf/64/d2/ACN3-4-15.PMC5221454.pdf
NeuroImage 2015; http://dx.doi.org/10.1016/ j.neuroimage.2015.11.059.,OADS,/arxiv_data1/oa_pdf/42/5e/ACN3-4-61.PMC5221458.pdf
"These variants were annotated usingan in-house script in conjunction with the software,ANNOVAR [http://www.openbioinformatics.org/annovar/] to produce an annotated variant list with the mostrecent available information from a number of referenceWebsites.",OADS,/arxiv_data1/oa_pdf/ab/f2/ACN3-4-26.PMC5221474.pdf
Filtered variants were anno-tated with CADD score using online tools[http://cadd.gs.washington.edu/score].,OADS,/arxiv_data1/oa_pdf/ab/f2/ACN3-4-26.PMC5221474.pdf
"This patient is a member of the UCSFMS EPIC cohort (http://msepicstudy.com); many mem-bers of the UCSF MS EPIC Team were involved inpatient visit logistics, MR imaging, acquisition of clini-cal data, and lumbar punctures; the authors acknowl-edge in particular Refujia Gomez, Pamela Qualley, and William Stern.",Non-OADS,/arxiv_data1/oa_pdf/dd/5d/ACN3-4-46.PMC5221476.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 31–38ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  31 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S121093Costs of adverse events associated with erlotinib  or afatinib in first-line treatment of advanced  EGFR-positive non-small cell lung cancer Dolores Isla1 Javier De Castro2 Oscar Juan3 Santiago Grau4 Javier Orofino5 Rocío Gordo5 Carlos Rubio-T errés6 Darío Rubio-Rodríguez6 1Medical Oncology Department,   Clinical Universitary Hospital Lozano  Blesa, Zaragoza, 2Medical Oncology  Department, Universitary Hospital La Paz, Madrid,  3Medical Oncology  Department, Universitary and Polytechnic Hospital La Fe, Valencia,   4Pharmacy Department, Del Mar  Hospital, Barcelona, 5Roche Farma,   S.A., Health Economics, 6Health Value,   Health Economics, Madrid, SpainObjectives:  Epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKIs) are an  established treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutation.",Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
"8–10 Erlotinib and gefitinib are EGFR–TKIs  that reversibly inhibit EGFR.11,12 Afatinib is an irreversible EGFR–TKI that inhibits vari - ous ERBB receptor family members (including EGFR, HER2, ERBB3, and ERBB4).13Correspondence: Darío Rubio Rodríguez Health Value, C/Virgen de Aránzazu, 21, 28034 Madrid, SpainEmail drubiorodriguez@healthvalue.orgJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Isla et alRunning head recto: Adverse events costs associated with erlotinib or afatinib in first-line treatmentDOI: http://dx.doi.org/10.2147/CEOR.S121093",Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
Available from: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-epidemiologia-ambiental-y-cancer/mortalidad-cancer-en-espana.shtml.,Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
Available from: http://ci5.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
Available from: http://www.ema.europa.eu/ema/index.jsp?curl= pages/medicines/human/medicines/000618/human_ med_001077.jsp&mid= WC0b01ac058001d124.,Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
Available from: https://clinicaltrials.gov/ct2/show/results/NCT00949650.,Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
Available from: https://clinicaltrials.gov/ct2/show/results/NCT01121393?sect= X3n0156#evnt.,Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
Available from: https://botplusweb.portalfarma.com/.,Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 38 Isla et al 32.,Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
Available from: https://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/b4/ceor-9-031.PMC5221482.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/90/94/opth-11-127.PMC5221483.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 127–133Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  127Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12757 9 interactive navigation-guided ophthalmic plastic  surgery: the utility of 3D CT -DCg-guided  dacryolocalization in secondary acquired lacrimal  duct obstructions Mohammad Javed ali1 swati singh1 Milind n naik1 swathi Kaliki2 Tarjani Vivek Dave1 1govindram seksaria institute of  Dacryology, 2The Operation eyesight  Universal institute for eye Cancer,   l V Prasad eye institute, hyderabad,   T elangana, indiaAim:  The aim of this study was to report the preliminary experience with the techniques and  utility of navigation-guided, 3D, computed tomography–dacryocystography (CT-DCG) in the  management of secondary acquired lacrimal drainage obstructions.",Non-OADS,/arxiv_data1/oa_pdf/90/94/opth-11-127.PMC5221483.pdf
"Computed tomography  (CT)–dacryocystography (DCG) is a well-established modality of lacrimal imaging  and is useful in delineating the lacrimal drainage system from the surrounding tissues Correspondence: Mohammad Javed ali govindram seksaria institute of  Dacryology, l V Prasad eye institute,  road no 2, Banjara hills, hyderabad  500034, Telangana, india email drjaved007@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Ali et al Running head recto: 3D CT-DCG-guided stereotactic surgeries DOI: http://dx.doi.org/10.2147/OPTH.S127579",Non-OADS,/arxiv_data1/oa_pdf/90/94/opth-11-127.PMC5221483.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/90/94/opth-11-127.PMC5221483.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/94/opth-11-127.PMC5221483.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 39–47ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  39 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S122177Cost-effectiveness analysis of combination  antifungal therapy with voriconazole and  anidulafungin versus voriconazole monotherapy for  primary treatment of invasive aspergillosis in Spain Santiago Grau1 Jose Ramon Azanza2 Isabel Ruiz3 Carlos Vallejo4 Josep Mensa5 Johan Maertens6 Werner J Heinz7 Jon Andoni Barrueta8 Carmen Peral9 Francisco Jesús Mesa8 Miguel Barrado10 Claudie Charbonneau11 Darío Rubio-Rodríguez12 Carlos Rubio-T errés12 1Pharmacy Department, Hospital del  Mar, Universitat Autònoma de Barcelona,  Barcelona, 2Clinical Pharmacology  Department, Clínica Universidad de Navarra, Pamplona,  3Infectious Diseases Department,  Hospital Universitari Vall d’Hebron, Barcelona,  4Hematology Department,  Hospital Universitario Donostia, San Sebastián,  5Infectious Diseases Department,  Hospital Clínic de Barcelona, Barcelona, Spain;  6Hematology Department, University  Hospital Gasthuisberg, Leuven, Belgium;  7Hematology/Oncology Department,   Medizinische Klinik und Poliklinik II, Universitätsklinikum, Würzburg, Germany;  8Medical Department, 9Economics  and Outcomes Research Department, Pfizer S.L.U, Alcobendas,  10Clinical Trials  Department, Trial Form Support, Madrid, Spain;  11Pharmacoeconomics Department,  Pfizer International Operations, Paris, France;  12Pharmacoeconomics Department, Health  Value, Madrid, SpainObjective: According to a recent randomized, double-blind clinical trial comparing the com- bination of voriconazole and anidulafungin (VOR+ANI) with VOR monotherapy for invasive  aspergillosis (IA) in patients with hematologic disease or with hematopoietic stem cell transplant,  mortality was lower after 6 weeks with VOR+ANI than with VOR monotherapy in a post hoc  analysis of patients with galactomannan-based IA.",Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
"1 Although survival has increased in recent years due to advances in  diagnosis and new antifungal drugs,2 prognosis of IA continues to be suboptimal, Journal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Grau et alRunning head recto: Cost-effectiveness of VOR+ANI versus VOR for invasive aspergillosis in SpainDOI: http://dx.doi.org/10.2147/CEOR.S122177 Correspondence: Darío Rubio-Rodríguez Health Value, C/Virgen de Aránzazu, 21.",Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: http://www.madrid.org/wleg/servlet/Servidor?opcion= VerHtml&nmnorma= 8275&cdestado= P#_ftn1.,OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
"Available from: http://www.boletinesoficiales.com/documentacion/legislacion/documento/RESOLUCION-626-2014-5-ju-nio-Director-Gerente-Servicio-Navarro-Salud-Osasunbidea-actualizan-tarifas-servicios-prestados,50,20140709,10/.",Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: https://www.epa.gov/sites/production/files/2014-11/documents/montecar.pdf.,OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm.,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 47 Cost-effectiveness of VOR+ANI versus VOR for invasive aspergillosis in Spain  13.,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: https://botplusweb.portalfarma.com/.,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: https://www.medicines.org.uk/emc/medicine/22690.,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: https://www.medicines.org.uk/emc/medicine/10059.,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: http://www.msssi.gob.es/estadEstudios/estadisticas/inforRecopilacio-nes/atlas/atlasDatos.htm.,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: http://www.isciii.es/ISCIII/es/contenidos/fd-el-insti-tuto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-servicios-aplicados-formacion-investigacion/fd-centros-unidades/fd-investen-isciii-2/docus/2006_X_encuentro_Investen_Albacete.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: http://www.saludcastil-layleon.es/institucion/es/recopilacion-normativa/asistencia-sanitaria/prestaciones-derechos/resolucion-1-julio-2008-presidente-gerencia-regional-salud-.,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Available from: http://www.msps.es/estadEstudios/estadisticas/docs/NormaGRD2009/NORMA_2009_AP_GRD_V23_CLUSTER.xls.,OADS,/arxiv_data1/oa_pdf/cd/8f/ceor-9-039.PMC5221484.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d1/64/41.PMC5221518.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fd/c3/3436.PMC5221537.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e1/9e/ccid-10-003.PMC5221538.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e1/9e/ccid-10-003.PMC5221538.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 3–9Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 3 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S125438 Efficacy of a twice-daily, 3-step, over-the-counter  skincare regimen for the treatment of acne  vulgaris Katie Rodan Kathy Fields Timothy J Falla Rodan + Fields, San Francisco,   CA, USABackground: Acne vulgaris (acne) is the most common skin disorder producing physical and  emotional scars that can persist for years.",Non-OADS,/arxiv_data1/oa_pdf/e1/9e/ccid-10-003.PMC5221538.pdf
"1,4,5 Those suffering from acne tend to have feelings  of isolation and loneliness with an increased risk for anxiety and depression.1,4,5 Correspondence: Timothy J Falla Rodan + Fields, 60 Spear Street, San  Francisco, CA 94105, USATel +1 415 597 6328Email tfalla@rodanandfields.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Rodan et alRunning head recto: OTC acne treatment efficacyDOI: http://dx.doi.org/10.2147/CCID.S125438",Non-OADS,/arxiv_data1/oa_pdf/e1/9e/ccid-10-003.PMC5221538.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/e1/9e/ccid-10-003.PMC5221538.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 9 OTC acne treatment efficacy Supplementary material S1: Subject instructions on the use of test materials Instructions: Dates and times of use must be included in this diary: 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/9e/ccid-10-003.PMC5221538.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/27/copd-12-169.PMC5221539.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 169–176International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  169OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11859 6 Increased brachial intima-media thickness is  associated with circulating levels of asymmetric  dimethylarginine in patients with COPD Matthias helmut Urban1 Philipp eickhoff2 georg-Christian Funk1 Otto Chris Burghuber1 Michael Wolzt3 arschang Valipour1 1Department of respiratory and  Critical Care Medicine, ludwig- Boltzmann Institute for COPD and  respiratory epidemiology, Otto  Wagner hospital, Vienna, austria;   2Department of Obstetrics and  gynecology, st. Josef hospital, Vienna,   austria; 3Department of Clinical  Pharmacology, Medical University  Vienna, Vienna, austriaBackground:  Chronic obstructive pulmonary disease (COPD) is associated with an increased  cardiovascular risk.",Non-OADS,/arxiv_data1/oa_pdf/44/27/copd-12-169.PMC5221539.pdf
"For this purpose, several markers of subclinical atherosclerosis have been iden - tified as predictors of cardiovascular risk.4–6 Intima-media thickness of the brachial  artery (B-IMT)7 is a novel and easily accessible parameter for the quantification of Correspondence: arschang Valipour Department of respiratory and Critical  Care Medicine, ludwig-Boltzmann- Institute for COPD and respiratory  epidemiology, Otto Wagner hospital,  sanatoriumstrasse 2, a-1140 Vienna,  austria Tel +43 1 910 60 41008 Fax +43 1 910 60 49823 email arschang.valipour@wienkav.a tJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Urban et al Running head recto: B-IMT in COPD DOI: http://dx.doi.org/10.2147/COPD.S118596",Non-OADS,/arxiv_data1/oa_pdf/44/27/copd-12-169.PMC5221539.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/44/27/copd-12-169.PMC5221539.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/27/copd-12-169.PMC5221539.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ff/5d/rru-9-001.PMC5221540.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ff/5d/rru-9-001.PMC5221540.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2017:9 1–4Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  1 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S125996Using central venous catheter for suprapubic  catheterization in cardiac surgery Eissa Bilehjani1 Solmaz Fakhari2 1Department of Cardiovascular  Anesthesia, Tabriz University  of Medical Sciences, Madani Heart Hospital,  2Department of  Anesthesiology, Tabriz University of Medical Sciences, Madani Heart Hospital, Tabriz, IranAbstract:  Suprapubic catheterization is an alternative method for urinary drainage that is used  when transurethral catheterization fails.",Non-OADS,/arxiv_data1/oa_pdf/ff/5d/rru-9-001.PMC5221540.pdf
"Correspondence: Solmaz Fakhari Cardiovascular Research Center, Madani Heart Hospital, Daneshqhah Street, Tabriz 5166615573, IranTell +98 914 402 4929 Fax +98 411 337 3950Email Solmaz_fakhari@yahoo.comJournal name: Research and Reports in Urology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Bilehjani and FakhariRunning head recto: Suprapubic catheterization in cardiac surgeryDOI: http://dx.doi.org/10.2147/RRU.S125996",Non-OADS,/arxiv_data1/oa_pdf/ff/5d/rru-9-001.PMC5221540.pdf
"Research and Reports in Urology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/ff/5d/rru-9-001.PMC5221540.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 4 Bilehjani and Fakhari  5.,Non-OADS,/arxiv_data1/oa_pdf/ff/5d/rru-9-001.PMC5221540.pdf
Available from: https://www2.rcn.org.uk/__data/assets/pdf_file/0018/157410/003237.pdf.,OADS,/arxiv_data1/oa_pdf/ff/5d/rru-9-001.PMC5221540.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/23/copd-12-199.PMC5221541.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 199–208International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  199OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11842 4 serum CCl-18 level is a risk factor for COPD  exacerbations requiring hospitalization asli gorek Dilektasli1 ezgi Demirdogen  Cetinoglu1 esra Uzaslan1 Ferah Budak2 Funda Coskun1 ahmet Ursavas1 Ilker ercan3 ercument ege1 1Department of Pulmonary Disesaes,   2Department of Immunology,   3Department of Biostatistics, Uludag  University Faculty of Medicine,   Bursa, T urkeyIntroduction:  Chemokine (C-C motif) ligand 18 (CCL-18) has been shown to be elevated in  chronic obstructive pulmonary disease (COPD) patients.",Non-OADS,/arxiv_data1/oa_pdf/75/23/copd-12-199.PMC5221541.pdf
"It is a chronic and progressive disease often associated with  periods of exacerbation that are related with reduced health-related quality of life,  accelerated forced expiratory volume in 1 s (FEV1) decline, increased health resource  utilization and increased mortality.1,2 Acute exacerbations of COPD requiring hos - pitalization are particularly important because they lead to an increased economical  burden, and each has the potential for a fatal outcome.3 Current knowledge of factors  associated with exacerbations requiring hospitalization is limited.4,5 It is suggested that  COPD patients suffering from frequent exacerbations belong to a distinct phenotype,  as demonstrated in the Evaluation of COPD Longitudinally to Identify Predictive  Surrogate Endpoints (ECLIPSE) study.6,7Correspondence: asli gorek Dilektasli Department of Pulmonary Medicine,  Uludag University Faculty of Medicine,  nilüfer 16059, Bursa, Turkey Tel +90 224 295 0911 email asligorekd@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Dilektasli et al Running head recto: CCL-18: a promising marker for COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S118424",Non-OADS,/arxiv_data1/oa_pdf/75/23/copd-12-199.PMC5221541.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/75/23/copd-12-199.PMC5221541.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/23/copd-12-199.PMC5221541.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/78/2e/ppa-11-071.PMC5221542.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 71–74Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  71Comment Aryopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S12007 0 Collaborative care in real-world settings: barriers  and opportunities for sustainability Katherine Sanchez1,2 1School of Social Work, the University  of texas at Arlington, Arlington,   2Department of Psychiatry, University  of texas Southwestern medical  Center, Dallas, tX, USAAbstract:  Patient-centered care and self-management of chronic disease are optimally  characterized by distinct adjunct services such as education, and support for the behavioral and  psychosocial elements of managing disease.",Non-OADS,/arxiv_data1/oa_pdf/78/2e/ppa-11-071.PMC5221542.pdf
"Keywords:  collaborative care, barriers, depression, anxiety, patient preferences Background In primary care, the persistent presentation of patients with depression and anxiety,  especially in the context of chronic disease, has led to the evolution of providers as the  “de facto” specialty mental health providers.1 However, access to care, dissatisfaction  with quality, and noncompliance with prescribed medications are common.2,3 Stigma  about mental illness and myths about the effects of medication often fuel the lack of  adherence, especially if prescribed without the full buy-in of the patient and, many  times, the support system.4 Patient-centered care and self-management of chronic disease are optimally  characterized by distinct adjunct services such as education, and support for the  behavioral and psychosocial elements of managing disease.5 The collaborative care  model for the treatment of depression and anxiety in primary care was adapted  from Wagner’s Chronic Care Model of disease management,6 and it includes the  integration of a behavioral health specialist, in collaboration with the primary care  provider, and psychiatric consultation to effectively screen and treat common mental  health problems.7  The essential components of collaborative care include: 1) mental health services  located in the primary care setting; 2) systematic care management provided by a social  worker, nurse, or other behaviorist; 3) symptom measurement and outcome monitoring  by care managers during clinic visits or by telephone; and, optimally, 4) brief evidence- based interventions, such as behavioral activation and problem-solving therapy.8 With systematic care management, the care manager functions as a depression  specialist working in conjunction with the primary care provider, offering supportive  counseling and education to patients about the disorder, systematically following  up with patients for symptom assessment, and tracking patient progress, preferably Correspondence: Katherine Sanchez School of Social Work, the University  of texas at Arlington, 211 South Cooper  Street, Arlington, tX 76019, USA tel +1 512 415 8349 email ks anchez@uta.ed u Journal name: Patient Preference and Adherence Article Designation: Commentary Y ear: 2017 Volume: 11 Running head verso: Sanchez Running head recto: Barriers to collaborative care DOI: http://dx.doi.org/10.2147/PPA.S120070",Non-OADS,/arxiv_data1/oa_pdf/78/2e/ppa-11-071.PMC5221542.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/78/2e/ppa-11-071.PMC5221542.pdf
"Washington, DC;  Available from: https://www.cms.gov/regulations-and-guidance/health- insurance-reform/healthinsreformforconsume/downloads/mhpaea.pdf.",Non-OADS,/arxiv_data1/oa_pdf/78/2e/ppa-11-071.PMC5221542.pdf
Available from: http://housedocs.house.,Non-OADS,/arxiv_data1/oa_pdf/78/2e/ppa-11-071.PMC5221542.pdf
Available from: http://www.cms.gov/ Regulations-and Guidance/Legislation/EHRIncentivePrograms/Basics.,Non-OADS,/arxiv_data1/oa_pdf/78/2e/ppa-11-071.PMC5221542.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/e6/cia-12-065.PMC5221543.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2017:12 65–73Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  65OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8756 4Potentially inappropriate medications use in  community-based aged patients: a cross-sectional  study using 2012 Beers criteria rony Zeenny samira Wakim Yara-Mary Kuyumjian Department of Pharmacy Practice,   school of Pharmacy, lebanese  American University, Byblos, lebanonBackground:  Potentially inappropriate medications (PIMs) should be avoided by the aged popula - tion.",Non-OADS,/arxiv_data1/oa_pdf/98/e6/cia-12-065.PMC5221543.pdf
"Between 2000 and 2050, the proportion of the world’s population aged  more than 60 years will double from approximately 11% to 22%.1 In Lebanon, the  proportion of the aged population has been increasing since 1990, where it stood at  5.2% to reach 9.2% in 2013, and is expected to reach 21% in 2050.2,3 The presence  of many comorbidities, polypharmacy, physiological changes, and socioeconomic  status constitute risk factors for the occurence of adverse drug events (ADEs) in this  high risk population.4,5 Furthermore, while polypharmacy is a common phenomenon in aged populations  because of multimorbidity, it is associated with inappropriate drug use and drug inter - actions leading to an increased risk of adverse drug reactions/events and indices of  morbidity and mortality, especially among the very old.6–8 Potentially inappropriate  medication (PIM) is defined as: Correspondence: rony Zeenny Department of Pharmacy Practice,  school of Pharmacy, lebanese American  University, PO Box 36 (F-46) Byblos,  lebanon Tel +961 9 54 7254 ext 2864 Fax +961 9 54 7256 email rony.zeenny@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zeenny et al Running head recto: 2012 Beers Criteria in Lebanese elderly DOI: http://dx.doi.org/10.2147/CIA.S87564",Non-OADS,/arxiv_data1/oa_pdf/98/e6/cia-12-065.PMC5221543.pdf
Available from: http://www.who.int/ageing/en /.,Non-OADS,/arxiv_data1/oa_pdf/98/e6/cia-12-065.PMC5221543.pdf
"Available from: http://www.escwa.un.org/popin/ members/lebanon.pd f. Accessed April 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/98/e6/cia-12-065.PMC5221543.pdf
Available  from: http://www.indexmundi.com/lebanon/demographics_profile.,Non-OADS,/arxiv_data1/oa_pdf/98/e6/cia-12-065.PMC5221543.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/98/e6/cia-12-065.PMC5221543.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/98/e6/cia-12-065.PMC5221543.pdf
"Available from: http://www.who.int/classifications/ icd/ICD10Volume2_en_2010.pd f. Accessed April 28, 2015.",OADS,/arxiv_data1/oa_pdf/98/e6/cia-12-065.PMC5221543.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 59–63ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  59 ORiginal REsEaRCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S114416improving outpatient primary medication  adherence with physician guided, automated  dispensing Jacob g Moroshek1,2 1Bioinformatics and Computational  Biology, 2Carlson school of  Management, University of Minnesota,   Minneapolis, M n, UsaBackground: Physician dispensing, different from pharmacist dispensing, is a way for practi- tioners to supply their patients with medications, at the point of care.",Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
"4 The focus of this paper is on primary Correspondence: Jacob g Moroshek Carlson school of Management, University of Minnesota, Minneapolis, 321 19th ave s, Minneapolis, Mn 55455, UsaTel +1 919 724 4529Email moro0027@umn.eduJournal name: ClinicoEconomics and Outcomes Research Article Designation: Original researchY ear: 2017V olume: 9Running head verso: MoroshekRunning head recto: Improving adherence via automated dispensingDOI: http://dx.doi.org/10.2147/CEOR.S114416",Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 63 improving adherence via automated dispensing  6.,Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
Available  from: http://www.imshealth.com/deployedfies/imshealth/Global/Content/Corporate/IMS%20Institute/RUOM-2013/IHII_Respon-sible_Use_Medicines_2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
Available from: http://www.InstyMeds.com.,Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
Available from: http://drugtopics.modernmedicine.com/ drug-topics/content/tags/controlled-substances/physician-office-dis   pensing-rx-drugs.,Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
Available from: http://www.asteres.com/script   center-mx/.,Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
Available from: http://www.medvantx.com/medvantx-for-you/healthcare-providers.,Non-OADS,/arxiv_data1/oa_pdf/0a/f8/ceor-9-059.PMC5221544.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/01/cb/ppa-11-063.PMC5221545.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 63–70Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  63OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12294 8 sublingual versus subcutaneous immunotherapy:  patient adherence at a large german allergy  center Marie-luise lemberg1 Till Berk2 Kija shah-hosseini1 elena-Manja Kasche1,3 ralph Mösges1 1Faculty of Medicine, institute of  Medical statistics, informatics and  epidemiology, University of cologne,   cologne, germany; 2Department of  Trauma surgery, University hospital  Zurich, Zurich, switzerland; 3center  for Dermatology, specific Allergology  and environmental Medicine,   hamburg, germanyBackground:  Many placebo-controlled studies have demonstrated that allergen immunotherapy  (AIT) is an effective therapy for treating allergies.",Non-OADS,/arxiv_data1/oa_pdf/01/cb/ppa-11-063.PMC5221545.pdf
"SLIT adherence rates are reported to be between 7%  and 82%, whereas SCIT adherence rates range from 23% to 55%.5–8 Reasons for  nonadherence vary with the most commonly cited reasons for nonadherence to SLIT  being nonperception of efficacy, costs, and side effects.9–11correspondence: ralph Mösges Faculty of Medicine, institute of Medical  statistics, informatics and epidemiology,  University of cologne, lindenburger  Allee 42, cologne 50931, germany Tel +49 221 478 82929 Fax +49 221 478 82940 email ralph@moesges.d e Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Lemberg et al Running head recto: SLIT versus SCIT DOI: http://dx.doi.org/10.2147/PPA.S122948",Non-OADS,/arxiv_data1/oa_pdf/01/cb/ppa-11-063.PMC5221545.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/01/cb/ppa-11-063.PMC5221545.pdf
Available from: http://www.pei.de/DE/arzneimit - tel/allergene/therapie-allergene/sublingual/sublinguale-therapie-node.,OADS,/arxiv_data1/oa_pdf/01/cb/ppa-11-063.PMC5221545.pdf
"html or http://www.pei.de/EN/medicinal-products/allergens/therapy- allergens/sublingual/sublingual-therapy-node.htm l. Accessed July,  2016.",Non-OADS,/arxiv_data1/oa_pdf/01/cb/ppa-11-063.PMC5221545.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c1/44/ceor-9-049.PMC5221546.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c1/44/ceor-9-049.PMC5221546.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 49–57ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  49 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S122462Relative cost-effectiveness of using a liquid human  milk fortifier in preterm infants in the US Julian F Guest1,2 Fernando Moya3 Paula M Sisk4 Mark L Hudak5 Devon Kuehn6 1Catalyst Health Economics  Consultants, Northwood, Middlesex,   UK; 2Faculty of Life Sciences and  Medicine, King’s College, London,  UK;  3Coastal Carolina Neonatology,   Wilmington, NC, USA; 4Novant Health  Forsyth Medical Center, Winston Salem, NC, USA;  5Department of  Pediatrics, University of Florida College of Medicine, Jacksonville,  FL, USA;  6Department of Pediatrics,   East Carolina University, Greenville,  NC, USAObjective: To estimate the cost-effectiveness of using a liquid human milk fortifier (LHMF)  compared to a powdered human milk fortifier (PHMF) in preterm infants in the US from the  perspective of third-party payers and parents.",Non-OADS,/arxiv_data1/oa_pdf/c1/44/ceor-9-049.PMC5221546.pdf
"A recent multicenter, third-party-blinded, randomized controlled study, in which  the clinical investigators, all NICU personnel and sponsor personnel who were Correspondence: Julian F Guest Catalyst Health Economics Consultants, 34b High Street, Northwood, Middlesex HA6 1BN, UKTel +44 1923 450 045Email julian.guest@catalyst-health.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Guest et alRunning head recto: Cost-effectiveness of a liquid human milk fortifierDOI: http://dx.doi.org/10.2147/CEOR.S122462",Non-OADS,/arxiv_data1/oa_pdf/c1/44/ceor-9-049.PMC5221546.pdf
Available from: http://www.uichildrens.org/iowa-neonatology-handbook/feeding/human-milk.,Non-OADS,/arxiv_data1/oa_pdf/c1/44/ceor-9-049.PMC5221546.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/c1/44/ceor-9-049.PMC5221546.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 57 Cost-effectiveness of a liquid human milk fortifier  2.,Non-OADS,/arxiv_data1/oa_pdf/c1/44/ceor-9-049.PMC5221546.pdf
Available from: http://www.fda.gov/Food/RecallsOutbreaksEmergen-cies/SafetyAlertsAdvisories/ucm111299.htm.,Non-OADS,/arxiv_data1/oa_pdf/c1/44/ceor-9-049.PMC5221546.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/58/tcrm-13-049.PMC5221547.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 49–58Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  49ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12468 9 Prognostic role of copeptin with all-cause  mortality after heart failure: a systematic review   and meta-analysis Peng Zhang Xiaomei Wu guangxiao li hao sun Jingpu shi Department of Clinical epidemiology,   Center of evidence-Based Medicine,   institute of Cardiovascular Disease,   The First hospital of China Medical  University, shenyang, People’s  Republic of ChinaBackground:  As the C-terminal section of vasopressin precursor, copeptin has been recently  suggested as a new prognostic biomarker after heart failure (HF).",Non-OADS,/arxiv_data1/oa_pdf/29/58/tcrm-13-049.PMC5221547.pdf
"AVP is widely known as a vital hormone with numerous  effects in the human body, such as central nervous, hemodynamic, hemostatic and  endocrinologic effects.5 Plasma AVP levels increase apparently during the process  of some acute and chronic diseases, and the measurement of AVP would be useful Correspondence: Jingpu shi Department of Clinical epidemiology,  Center of evidence-Based Medicine,  institute of Cardiovascular Disease,  The First hospital of China Medical  University, no 155, north nanjing  street, shenyang 110001, People’s  Republic of China email sjp562013@126.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Zhang et al Running head recto: Prognostic role of copeptin with all-cause mortality after heart failure DOI: http://dx.doi.org/10.2147/TCRM.S124689",Non-OADS,/arxiv_data1/oa_pdf/29/58/tcrm-13-049.PMC5221547.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/29/58/tcrm-13-049.PMC5221547.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/58/tcrm-13-049.PMC5221547.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/2a/dddt-11-135.PMC5221548.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 135–141Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  135Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12163 3 Pharmacokinetic and pharmacodynamic evaluation  according to absorption differences in three  formulations of ibuprofen Dongseong shin1 sook Joung lee2 Yu-Mi ha3 Y oung-sim choi3 Jae-Won Kim3 se-rin Park3 Min Kyu Park3 1clinical Trials center, gachon  University gil Medical center,   incheon, 2Department of  rehabilitation Medicine, 3Department  of clinical Pharmacology and  Therapeutics, Dong- a University  college of Medicine and hospital,   Busan, south KoreaObjective:  Prostaglandin E2 (PGE2) synthesis is modulated by COX2.",Non-OADS,/arxiv_data1/oa_pdf/17/2a/dddt-11-135.PMC5221548.pdf
"Nonsteroidal anti-inflammatory drugs (NSAIDs) have generally been  effective for musculoskeletal pain.2,3 For pain control, earlier absorption of ibuprofen  could lead to early pain relief with a similar adverse-event profile as occurs upon  later absorption.4,5correspondence: Min Kyu Park Department of clinical Pharmacology  and Therapeutics, Dong-a University  college of Medicine and hospital, 26  Daesingongwon-ro, seo-gu, Busan 49201,  south Korea Tel +82 51 240 5180 Fax +82 51 257 2616 email mkparkdau@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Shin et al Running head recto: Absorption differences in three ibuprofen formulations DOI: http://dx.doi.org/10.2147/DDDT.S121633",Non-OADS,/arxiv_data1/oa_pdf/17/2a/dddt-11-135.PMC5221548.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/17/2a/dddt-11-135.PMC5221548.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/2a/dddt-11-135.PMC5221548.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/99/4c/ceg-10-001.PMC5221549.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/99/4c/ceg-10-001.PMC5221549.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2017:10 1–7Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  1 OriG inal rEsEarCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S120544Correlation between obesity and metabolic  syndrome-related factors and cecal intubation  time during colonoscopy ryo Kawasato1 shinichi hashimoto1 T omohiro shirasawa1 atsushi Goto1 Takeshi Okamoto1 Jun nishikawa2 isao sakaida1 1Department of Gastroenterology  and hepatology, 2Department of  laboratory science, Yamaguchi  University Graduate school of  Medicine, Yamaguchi, JapanPurpose: To investigate which colonoscopy (CS) cases should be presided over by endoscopists  in training, using factors including obesity and metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/99/4c/ceg-10-001.PMC5221549.pdf
Tel +81 836 22 2239   Fax +81 836 22 2303Email has-333@yamaguchi-u.ac.jpJournal name: Clinical and Experimental Gastroenterology Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Kawasato et alRunning head recto: Obesity and metabolic syndrome factors and colonoscopyDOI: http://dx.doi.org/10.2147/CEG.S120544,Non-OADS,/arxiv_data1/oa_pdf/99/4c/ceg-10-001.PMC5221549.pdf
"Clinical and Experimental Gastroenterology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/99/4c/ceg-10-001.PMC5221549.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 7 Obesity and metabolic syndrome factors and colonoscopy Disclosure All authors report no conflict of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/99/4c/ceg-10-001.PMC5221549.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/79/ppa-11-055.PMC5221550.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 55–62Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  55OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11810 7 An evaluation of adherence in patients with  multiple sclerosis newly initiating treatment with  a self-injectable or an oral disease-modifying drug Michael Munsell1 Molly Frean1 Joseph Menzin1 Amy l Phillips2 1Boston health economics, inc.,   Waltham, MA, UsA; 2health  economics & Outcomes research,   eMD serono inc., rockland, MA, UsAObjective:  As the multiple sclerosis (MS) disease-modifying drug (DMD) treatment options  have expanded to include oral therapies, it is important to understand whether route of  administration is associated with DMD adherence.",Non-OADS,/arxiv_data1/oa_pdf/69/79/ppa-11-055.PMC5221550.pdf
"Keywords:  multiple sclerosis, adherence, disease-modifying drugs, self-injectable, oral, mode  of administration Introduction Multiple sclerosis (MS) is an inflammatory-mediated chronic neurodegenerative  disease characterized by a range of symptoms including fatigue, impaired motor skills,  blurred vision, bladder and bowel dysfunction, and cognitive impairment.1 More than  2.3 million people are affected by MS worldwide.1 The economic and humanistic  burden of this chronic disease is substantial, particularly because patients with MS are  affected at a young age, resulting in a greater loss of productivity and quality of life correspondence: Joseph Menzin Boston health economics, inc., 20 Fox  road, Waltham, MA 02451, UsA Tel +1 781 290 0808 Fax +1 781 290 0029 email jmenzin@bhei.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Munsell et al Running head recto: Adherence to self-injectables versus orals in multiple sclerosis DOI: http://dx.doi.org/10.2147/PPA.S118107",Non-OADS,/arxiv_data1/oa_pdf/69/79/ppa-11-055.PMC5221550.pdf
"Available  from: http://www.nationalmssociety.org/What-is-MS/MS-FAQ- s.  Accessed March 18, 2016.",OADS,/arxiv_data1/oa_pdf/69/79/ppa-11-055.PMC5221550.pdf
"Available from: http://calmain.nationalmssociety.org/site/ PageNavigator / CAL_Exercise_MS1_Treate d. Accessed March 21, 2016.",OADS,/arxiv_data1/oa_pdf/69/79/ppa-11-055.PMC5221550.pdf
"Available from:  http://www.nationalmssociety.org/Treating-MS/Medication s. Accessed  March 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/69/79/ppa-11-055.PMC5221550.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/69/79/ppa-11-055.PMC5221550.pdf
Available  from: https://www.r-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/69/79/ppa-11-055.PMC5221550.pdf
"Available from:  http://www.rand.org/content/dam/rand/pubs/technical_reports/2009/ RAND_TR765.pd f. Accessed March 16, 2016.",OADS,/arxiv_data1/oa_pdf/69/79/ppa-11-055.PMC5221550.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/67/4c/clep-9-009.PMC5221551.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/67/4c/clep-9-009.PMC5221551.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 9–18Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 9 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S121023 Causal inference as an emerging statistical  approach in neurology: an example for epilepsy in  the elderly Lidia MVR Moura1,2 M Brandon Westover1,2 David Kwasnik1 Andrew J Cole1,2 John Hsu3–5 1Massachusetts General Hospital,   Department of Neurology, Epilepsy  Service, Boston, MA, USA; 2Harvard  Medical School, Boston, MA, USA;   3Massachusetts General Hospital,   Mongan Institute, Boston, MA, USA;   4Harvard Medical School, Department  of Medicine, Boston, MA, USA;   5Harvard Medical School, Department  of Health Care Policy, Boston,    MA, USAAbstract:  The elderly population faces an increasing number of cases of chronic neurological  conditions, such as epilepsy and Alzheimer’ s disease.",Non-OADS,/arxiv_data1/oa_pdf/67/4c/clep-9-009.PMC5221551.pdf
"We then sought Correspondence: Lidia MVR Moura Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USAEmail lidia.moura@mgh.harvard.eduJournal name: Clinical Epidemiology Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Moura et alRunning head recto: Causal inference framework in geriatric epilepsyDOI: http://dx.doi.org/10.2147/CLEP .S121023",Non-OADS,/arxiv_data1/oa_pdf/67/4c/clep-9-009.PMC5221551.pdf
Available from: http://www.cdc.gov/chronicdisease/resources/publications/aag/pdf/2015/epilepsy-2015-aag-rev.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/4c/clep-9-009.PMC5221551.pdf
Available from: https://www.effectivehealthcare.ahrq.gov/ehc/products/159/868/Epi-lepsy_FinalReport_20120802.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/4c/clep-9-009.PMC5221551.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/67/4c/clep-9-009.PMC5221551.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dc/62/cia-12-085.PMC5221552.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 85–96Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  85OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12460 4 effects of tai chi qigong on psychosocial well-being  among hidden elderly, using elderly neighborhood  volunteer approach: a pilot randomized  controlled trial Aileen WK Chan Doris sF Yu KC Choi The nethersole school of n ursing,   Faculty of Medicine, The Chinese  University of hong Kong, shatin,   nT, hong Kong sArPurpose:  To test the feasibility and preliminary effectiveness of a tai chi qigong program  with the assistance of elderly neighborhood volunteers in strengthening social networks and  enhancing the psychosocial well-being of hidden elderly.",Non-OADS,/arxiv_data1/oa_pdf/dc/62/cia-12-085.PMC5221552.pdf
"Keywords:  group-based activity, social isolation, social network, social support Clinical trial regis try Clinical trial regis try: CUHK_CCRB00489 ( https://www2.ccrb.cuhk.edu.hk/registry/ public/34 3).",OADS,/arxiv_data1/oa_pdf/dc/62/cia-12-085.PMC5221552.pdf
"Introduction With the life expectancy of older people rising, the world population aged 60 and older  is expected to increase from 900 million in 2015 to 2 billion by 2050, with 400 million  aged 80 and over.1 Projections indicate that nearly one-third of the local population will Correspondence: Aileen WK Chan The nethersole school of nursing,  Faculty of Medicine, 7/F, esther lee  Building, The Chinese University of hong  Kong, shatin, nT, hong Kong sAr Tel +852 3943 4290 Fax +852 2603 5269 email aileenchan@cuhk.edu.h k Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Chan et al Running head recto: Tai chi qigong improves psychosocial health of hidden elderly DOI: http://dx.doi.org/10.2147/CIA.S124604",Non-OADS,/arxiv_data1/oa_pdf/dc/62/cia-12-085.PMC5221552.pdf
Available from: http://www.who.int/ features /factfiles/ageing/en /.,OADS,/arxiv_data1/oa_pdf/dc/62/cia-12-085.PMC5221552.pdf
Available  from: http://www.info.gov.hk/gia/general/200703/28/P200703280174.,Non-OADS,/arxiv_data1/oa_pdf/dc/62/cia-12-085.PMC5221552.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/dc/62/cia-12-085.PMC5221552.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/dc/62/cia-12-085.PMC5221552.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/cia-12-075.PMC5221554.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 75–83Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  75OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12146 7 relationship between lower limb position and  pelvic floor muscle surface electromyography  activity in menopausal women: a prospective  observational study T omasz halski1 Kuba Ptaszkowski2 Lucyna Słupska1 Robert Dymarek3 Małgorzata Paprocka- Borowicz2 1Department of Physiotherapy,   Opole Medical School, Opole,   2Department of Clinical Biomechanics  and Physiotherapy in Motor System  Disorders, 3Department of Nervous  System Diseases, Faculty of Health  Science, Wroclaw Medical University,   Wroclaw, PolandObjectives:  In physiotherapeutic practice, special attention is being given to the reciprocal  anatomical, physiological, and biomechanical relationship of the pelvis and the structures con - nected to it.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/cia-12-075.PMC5221554.pdf
"Among the Correspondence: Tomasz halski Department of Physiotherapy,  Opole Medical School, Katowicka 68,  45-060 Opole, Poland Tel +48 77 442 3524 Fax +48 77 442 3517 email tomhalski@wp.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Halski et al Running head recto: Relationship between lower limb position and pelvic floor muscles DOI: http://dx.doi.org/10.2147/CIA.S121467",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/cia-12-075.PMC5221554.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/cia-12-075.PMC5221554.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6d/6f/cia-12-075.PMC5221554.pdf
Avail - able from: https://www.anzctr.org.au/Trial/Registration/TrialReview.,Non-OADS,/arxiv_data1/oa_pdf/6d/6f/cia-12-075.PMC5221554.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/13/88/cia-12-045.PMC5221555.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 45–53Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  45OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11759 7 effects of Chinese herbal formula erxian decoction  for treating osteoporosis: a systematic review Jin-Yu li1,* Yu-song Jia1,* li-Min Chai1 Xiao-hong Mu1 sheng Ma1 lin Xu1 Xu Wei2 1Department of Orthopaedics,   Dongzhimen hospital, Beijing  University of Chinese Medicine,   Beijing, People’s republic of China;   2Department of scientific research,   Wangjing hospital, China Academy  of Chinese Medical sciences, Beijing,   People’s republic of China *These authors contributed equally   to this workPurpose:  The aim is to systematically assess the effectiveness and safety of Chinese herbal  formula Erxian decoction (EXD) for treating osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/13/88/cia-12-045.PMC5221555.pdf
"However, the  pathogenesis of osteoporosis is still complex and multifactorial, which makes us put  more emphasis on preventing and treating this “silent disease”.4,5 Furthermore, a grow - ing body of research evidence has fostered the development of clinical practice guide - lines to monitor and provide appropriate choices for osteoporosis intervention.Correspondence: lin Xu Department of Orthopaedics,  Dongzhimen hospital, Beijing University  of Chinese Medicine, no 5 haiyuncang  street, Dongcheng District, Beijing  100700, People’s republic of China  Tel +86 10 8401 5571 email xulinguke2002@163.co m  Xu Wei  Department of Scientific Research,  Wangjing hospital, China Academy  of Chinese Medical sciences, huajiadi  street, Chaoyang District, Beijing 100102,  People’s republic of China Tel +86 13 4887 16557 email weixu.007@163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Li et al Running head recto: Erxian decoction for treating osteoporosis DOI: http://dx.doi.org/10.2147/CIA.S117597",Non-OADS,/arxiv_data1/oa_pdf/13/88/cia-12-045.PMC5221555.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/13/88/cia-12-045.PMC5221555.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/13/88/cia-12-045.PMC5221555.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/dmso-10-013.PMC5221556.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5b/95/dmso-10-013.PMC5221556.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 13–17Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 13 Original reSearch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S118437 role of glycemic control on hospital-related  outcomes in patients with diabetes mellitus  undergoing renal transplantation elizabeth M lamos1 Marniker a Wijesinha2 Seba ramhmdani1 laurence S Magder2 Kristi D Silver1 1Division of endocrinology, Diabetes  and nutrition, 2Department of  epidemiology, University of Maryland  School of Medicine, Baltimore,  MD, USa Objective: To compare length of stay (LOS) and incidence of hypoglycemic events and infec- tions in hospitalized patients with diabetes mellitus (DM) undergoing renal transplantation,  among groups of patients defined by admission glucose and mean inpatient daily glucose.",Non-OADS,/arxiv_data1/oa_pdf/5b/95/dmso-10-013.PMC5221556.pdf
"This is in contrast to the many studies evaluating glycemic control in cardiac, trauma, and intensive care unit correspondence: Kristi D Silver Division of endocrinology, Diabetes and nutrition, University of Maryland School of Medicine, 660 West redwood Street, hh 494, Baltimore, MD 21201, USaTel +1 410 706 1628Fax +1 410 706 1622email ksilver@medicine.umaryland.eduJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Lamos et alRunning head recto: Glycemic control in renal transplantationDOI: http://dx.doi.org/10.2147/DMSO.S118437",Non-OADS,/arxiv_data1/oa_pdf/5b/95/dmso-10-013.PMC5221556.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/5b/95/dmso-10-013.PMC5221556.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 17 glycemic control in renal transplantation when balancing variables like renal function and steroid/immu - nosuppressive regimens in this population.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/dmso-10-013.PMC5221556.pdf
Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5b/95/dmso-10-013.PMC5221556.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/c9/copd-12-141.PMC5221557.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 141–168International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  141RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S11671 9 Dual bronchodilation in COPD: lung function and  patient-reported outcomes – a review David Price1,2 Anders Østrem3 Mike Thomas4 T obias welte5 1Department of Primary Care  Respiratory Medicine, Division  of Applied Health Sciences,   University of Aberdeen, Aberdeen,   UK; 2Observational and Pragmatic  Research Institute, Singapore;   3Gransdalen Legesenter, Oslo,   Norway; 4Department of Primary  Care Research, University of  Southampton, Southampton,   UK; 5Department of Pulmonary  Medicine, Hannover Medical School,   Hannover, GermanyAbstract:  Several fixed-dose combinations (FDCs) of long-acting bronchodilators (a long-acting  muscarinic antagonist [LAMA] plus a long-acting β2-agonist [LABA]) are available for the  treatment of COPD.",Non-OADS,/arxiv_data1/oa_pdf/74/c9/copd-12-141.PMC5221557.pdf
"Beta agonists (BAs) and muscarinic  antagonists (MAs) target different pathways to promote smooth-muscle relaxation and Correspondence: David Price Department of Primary Care Respiratory  Medicine, Academic Primary Care,  Division of Applied Health Sciences,  Polwarth Building, University of  Aberdeen, Aberdeen AB25 2ZD, UK Tel +44 1223 967 855 email dprice@opri.s g Journal name: International Journal of COPD Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Price et al Running head recto: LAMA–LABA FEV1 and patient-reported outcomes DOI: http://dx.doi.org/10.2147/COPD.S116719",Non-OADS,/arxiv_data1/oa_pdf/74/c9/copd-12-141.PMC5221557.pdf
"Available from: http://www.fda.gov/ downloads/advisorycommittees/committeesmeetingmaterials/drugs/ pulmonary-allergydrugsadvisorycommittee/ucm367411.pd f. Accessed  October 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/74/c9/copd-12-141.PMC5221557.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/74/c9/copd-12-141.PMC5221557.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/c9/copd-12-141.PMC5221557.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/bc/copd-12-177.PMC5221558.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 177–187International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  177OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11957 5 Flexible bronchoscopy with moderate sedation  in COPD: a case–control study Peter grendelmeier Michael Tamm Kathleen Jahn eric Pflimlin Daiana stolz Clinic of Pulmonary Medicine  and respiratory Cell research,   University hospital Basel,   Petersgraben, Basel, switzerlandBackground:  Flexible bronchoscopy is increasingly used for diagnostic and therapeutic  purposes.",Non-OADS,/arxiv_data1/oa_pdf/d1/bc/copd-12-177.PMC5221558.pdf
"They have been typically exposed to cigarette smoking, thus sharing a major  risk factor for malignancy and infection.2,3 In addition, interventional bronchoscopy  has evolved as a treatment option for the disease itself (eg, bronchoscopic lung volume  reduction) and its comorbidities (eg, laser and stenting placement).4 In addition, airway Correspondence: Daiana stolz Clinic of Pulmonary Medicine and  respiratory Cell research, University  hospital Basel, Petersgraben 4,  4031 Basel, switzerland Tel +41 61 265 5193 Fax +41 61 265 4587 email daiana.stolz@usb.c h Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Grendelmeier et al Running head recto: Flexible bronchoscopy with moderate sedation in COPD DOI: http://dx.doi.org/10.2147/COPD.S119575",Non-OADS,/arxiv_data1/oa_pdf/d1/bc/copd-12-177.PMC5221558.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d1/bc/copd-12-177.PMC5221558.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/bc/copd-12-177.PMC5221558.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/05/c1/copd-12-135.PMC5221559.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 135–140International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  135RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S11427 3 Spotlight on fluticasone furoate/umeclidinium/ vilanterol in COPD: design, development, and  potential place in therapy Chitra Lal Charlie Strange Division of Pulmonary, Critical  Care, Allergy and Sleep Medicine,   Medical University of South Carolina,   Charleston, SC, USAAbstract:  COPD is characterized by persistent airflow obstruction caused by exposure to  irritants including cigarette smoke, dust, and fumes.",Non-OADS,/arxiv_data1/oa_pdf/05/c1/copd-12-135.PMC5221559.pdf
"Thus, while “open” triple-combination  therapies such as tiotropium added to salmeterol/fluticasone and glycopyrronium added Correspondence: Chitra Lal Division of Pulmonary, Critical Care,  Allergy and Sleep Medicine, Medical  University of South Carolina,  96 Jonathan Lucas Street, CSB Suite 816,  Msc 630, Charleston, SC 29425, USA Tel +1 843 792 7776 Fax +1 843 876 2057 email lalch@musc.ed u Journal name: International Journal of COPD Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Lal and Strange Running head recto: Fluticasone furoate/umeclidinium/vilanterol in COPD DOI: http://dx.doi.org/10.2147/COPD.S114273",Non-OADS,/arxiv_data1/oa_pdf/05/c1/copd-12-135.PMC5221559.pdf
Available from:  http://www.gsk.com/en-gb/media/press-releases/2016/ regulatory - update-on-us-filing-plans-for-closed-triple-combination-therapy- ffumecvi-in-patients-with-copd /.,Non-OADS,/arxiv_data1/oa_pdf/05/c1/copd-12-135.PMC5221559.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/05/c1/copd-12-135.PMC5221559.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/c1/copd-12-135.PMC5221559.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/f6/main.PMC5221561.pdf
"http://dx.doi.org/10.1016/j.gendis.2016.03.004 2352-3042/Copyright ª2016, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/86/f6/main.PMC5221561.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2016) 3, 130e143",Non-OADS,/arxiv_data1/oa_pdf/86/f6/main.PMC5221561.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.gendis.2016.03.004 .,OADS,/arxiv_data1/oa_pdf/86/f6/main.PMC5221561.pdf
"2014; based on November 2014 SEER Data Submission, Posted to the SEER Web Site: ; 2015. http://seer.cancer.gov/csr/1975_2011/ .",OADS,/arxiv_data1/oa_pdf/86/f6/main.PMC5221561.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4a/9d/3377.PMC5221573.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cf/dd/3379.PMC5221574.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4e/da/3385.PMC5221575.pdf
Data were collected and  digitized from a range of published fluorophore spectra using the  WebPlotDigitizer software package (http://arohatgi.info/Web - PlotDigitizer/).,OADS,/arxiv_data1/oa_pdf/4e/da/3385.PMC5221575.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6a/64/3395.PMC5221576.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4f/a9/3405.PMC5221577.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/73/d6/3449.PMC5221579.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0d/ef/3459.PMC5221580.pdf
Stocks are de - scribed in FlyBase (http://flybase.org/).,OADS,/arxiv_data1/oa_pdf/0d/ef/3459.PMC5221580.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0f/50/3471.PMC5221581.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d8/da/3480.PMC5221582.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/3490.PMC5221583.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/17/1b/3515.PMC5221584.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/72/a0/3526.PMC5221585.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/3537.PMC5221586.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7a/f9/3550.PMC5221587.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b7/23/3563.PMC5221588.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6d/ac/3574.PMC5221589.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a3/da/3583.PMC5221590.pdf
Available at http://digitalcommons.calpoly.edu/ aerosp/78/.,Non-OADS,/arxiv_data1/oa_pdf/a3/da/3583.PMC5221590.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d3/f1/3591.PMC5221591.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/43/51/3601.PMC5221592.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fe/c5/3616.PMC5221593.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a7/f0/3627.PMC5221594.pdf
Available at http://user.uni-frankfurt.de/ ∼malkusch/lama.html  (accessed 1 July 2016).,Non-OADS,/arxiv_data1/oa_pdf/a7/f0/3627.PMC5221594.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ce/7e/3637.PMC5221595.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a5/71/3645.PMC5221596.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/03/9a/3659.PMC5221597.pdf
Available at http://seer.cancer.gov   /archive/csr/1975_2011/ (accessed 25 January 2016).,Non-OADS,/arxiv_data1/oa_pdf/03/9a/3659.PMC5221597.pdf
"11, 773 –779 http://dx.doi.org/10.1080/15592294.2016.1233091",Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
ORCID Andres Cardenas http://orcid.org/0000-0003-2284-3298 Kelly M. Bakulski http://orcid.org/0000-0002-9605-6337 References 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
BMC Bioinformatics2012; 13:1; PMID:22214541; http://dx.doi.org/10.1186/1471-2105- 13-86 2.,OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
PloS One 2012; 7:e41361; PMID: 22848472; http://dx.doi.org/10.1371/journal.pone.0041361 3.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
Epige- netics 2016; 11:354-62; PMID:27019159; http://dx.doi.org/10.1080/15592294.2016.1161875 4.,OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
Arch Dis Child Fetal Neonatal Ed 2001; 84:F211-F5; PMID:11320052; http://dx.doi.org/10.1136/fn.84.3.F211 5.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
Environ Mol Mutagen 2015; 56:751-8; PMID:26332589; http://dx.doi.org/10.1002/em.21966 6.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
J Perinatol 2015; 35:469-75; PMID:25634517; http://dx.doi.org/10.1038/jp.2014.241778 A. CARDENAS ET AL.,OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
Genome Biol 2014; 15:1; PMID:24598480; http://dx.doi.org/ 10.1186/gb-2014-15-3-r50 10.,OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
Epigenetics 2013; 8:816-26; PMID:23903776;http://dx.doi.org/10.4161/epi.25430 11.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
"Bone Marrow Transplant 1997; 19:1023-8; PMID:9169647; http://dx.doi.org/10.1038/sj.bmt.1700788 12. de Goede OM, Razzaghian HR, Price EM, Jones MJ, Kobor MS, Rob- inson WP, Lavoie PM.",Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
Clin Epigenetics 2015; 7:1; PMID:25628764; http://dx.doi.org/10.1186/ s13148-015-0129-6 13.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
Apoptosis in fetal nucleated erythrocytes circulating in maternal blood.Prenat Diagn 2000; 20:886-9; PMID:11113889; http://dx.doi.org/ 10.1002/1097-0223(200011)20:11 <886::AID-PD942 >3.0.CO;2-4 14.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
N Engl J Med 2014; 370:2534-6; PMID:24963574; http://dx.doi.org/10.1056/ NEJMcibr1404324 15.,OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
J Exp Med 2004; 200:123-35; PMID:15263023; http://dx.doi.org/10.1084/jem.20040440 16.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
Am J Clin Pathol 2011; 136:309-16; PMID:21757605; http://dx.doi.org/ 10.1309/AJCPDLR4KGKAFW4W 18.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
"Bruegel M, Nagel D, Funk M, Fuhrmann P, Zander J, Teupser D. Comparison of ﬁve automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-5000, and Sysmex XN-2000.Clin Chem Lab Med 2015; 53:1057-71; PMID:25720071; http://dx.doi.org/10.1515/cclm-2014-0945EPIGENETICS 779",OADS,/arxiv_data1/oa_pdf/6f/e6/kepi-11-11-1233091.PMC5221601.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/0e/rjw195.PMC5221604.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/e8/rjw193.PMC5221606.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/21/e2/1.PMC5221613.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/89/fa/111.PMC5221614.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c9/4e/12.PMC5221615.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/2d/33/120.PMC5221616.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a1/0b/128.PMC5221617.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/73/eb/141.PMC5221618.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/90/23/152.PMC5221619.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9a/7b/161.PMC5221620.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/73/6f/173.PMC5221621.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License(http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/de/f4/182.PMC5221622.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3d/f5/192.PMC5221623.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/ licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d0/4c/201.PMC5221624.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/41/00/21.PMC5221625.pdf
"bioRxiv 054908, doi: http://dx.doi   .org/10.1101/054908.",Non-OADS,/arxiv_data1/oa_pdf/41/00/21.PMC5221625.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1a/3e/210.PMC5221626.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/90/ea/30.PMC5221628.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/78/29/54.PMC5221629.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f0/55/76.PMC5221631.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/91/dc/85.PMC5221632.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8d/84/9.PMC5221633.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/92/b6/98.PMC5221634.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/19/ndt-13-109.PMC5221650.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 109–116Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  109OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12153 6 Cognitive profiles in bilingual children born to  immigrant parents and italian monolingual native  children with specific learning disorders anna riva renata Nacinovich Nadia Bertuletti Valentina Montrasi sara Marchetti Francesca Neri Monica Bomba child and adolescent Mental health  Department, University of Milan  Bicocca, san gerardo hospital,   Monza,  italyPurpose:  The aim of this study is to compare the Wechsler Intelligence Scale for Children® –  fourth edition IV (WISC IV) intellectual profile of two groups of children with specific learning  disorder, a group of bilingual children and a group of monolingual Italian children, in order to  identify possible significant differences between them.",Non-OADS,/arxiv_data1/oa_pdf/d1/19/ndt-13-109.PMC5221650.pdf
"Concerning cognitive functions and bilingualism, if previous studies were oriented  to cognitive disadvantages of bilingualism, more recent studies instead support the  hypothesis of positive effects of bilingualism.1 The discrepancy of the results obtained in these studies is related to the strong  different typology of the bilingual populations examined: earlier studies considered  bilingual individuals as belonging to immigrant ethnic minorities with socioeconomic  disadvantages, whereas the most recent studies recruited populations with a high level  of bilingualism (eg, American residents in Canada, typically Francophone bilinguals).1  Another interpretation of the contradictory findings arising from the studies about correspondence: renata Nacinovich clinica di Neuropsichiatria dell’infanzia e  dell’adolescenza, Ospedale san gerardo,  assT Monza, Ospedale Nuovo, scala a,  Piano 11, Via Pergolesi, 33, 20900  Monza, italy Tel +39 3 9233 3579 Fax +39 3 9233 3321 email renata.nacinovich@unimib.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Riva et al Running head recto: WISC IV in bilingual with SLD DOI: http://dx.doi.org/10.2147/NDT.S121536",Non-OADS,/arxiv_data1/oa_pdf/d1/19/ndt-13-109.PMC5221650.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d1/19/ndt-13-109.PMC5221650.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/19/ndt-13-109.PMC5221650.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cf/a5/opth-11-149.PMC5221651.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 149–152Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  149Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S12593 5 Sometimes new does not mean safer Constantin-Dan Bordeianu Private Practice, Ploiesti,   Prahova, romaniaDear editor I was extremely interested in an article by Masuda et al,1 recently published in your  Clinical Ophthalmology  journal, especially after reading in the abstract that the  phaco tip is the only surgical instrument required “for lens cleavage and removal”.1  The authors assert that this new technique maintains a stable intraocular pressure  during hydrodissection and lens removal, whereas the existing techniques induce  anterior chamber instability because three instruments are successively inserted and  withdrawn.",Non-OADS,/arxiv_data1/oa_pdf/cf/a5/opth-11-149.PMC5221651.pdf
"In my work, I named the Correspondence: Constantin-Dan  Bordeianu email bordmail3@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Letter Y ear: 2017 Volume: 11 Running head verso: Bordeianu Running head recto: Sometimes new does not mean safer DOI: http://dx.doi.org/10.2147/OPTH.S125935",Non-OADS,/arxiv_data1/oa_pdf/cf/a5/opth-11-149.PMC5221651.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/cf/a5/opth-11-149.PMC5221651.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/a5/opth-11-149.PMC5221651.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3a/d1/opth-11-153.PMC5221652.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 153–160Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  153Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12053 0 Ocular melanoma-when you have seen one, you  have not seen them all: a clinical outcome study  from the surveillance, epidemiology and end  results (seer) database (1973–2012) Krishnaraj Mahendraraj1 sneha shrestha1 Christine sM lau1,2 ronald s Chamberlain1–4 1Department of surgery, saint  Barnabas Medical Center, livingston,   nJ, Usa; 2saint george’s University  school of Medicine, grenada, West  indies; 3Department of surgery,   Banner MD anderson Cancer Center,   gilbert, aZ, Usa; 4Department of  surgery, rutgers University, new  Jersey Medical school, newark,   nJ, UsaBackground:  Ocular melanoma (OM) comprises ,5% of all melanomas.",Non-OADS,/arxiv_data1/oa_pdf/3a/d1/opth-11-153.PMC5221652.pdf
"UM is the most common primary intraocular malignancy among adults, and  accounts for up to 85% of all cases of OM.4,5 The incidence of UM in the US is  4.9 per million and has remained stable over the last three decades.6 Although UM  patients typically present with symptoms including blurred vision, visual field defect,  metamorphopsia, or photopsia, 30% patients may be asymptomatic and upon routine  eye examination, they are detected incidentally.7,8 Diagnosis is accurately established  by clinical examination in over 99% cases.9 Modern diagnostic tools such as A and  B ultrasonography, fluorescein angiography, and optical coherence tomography can Correspondence: ronald s Chamberlain Department of surgery, Banner MD  anderson Cancer Center, 2940 east  Banner gateway Dr, gilbert, aZ, 85234 Tel +1 480 256 4737 Fax +1 480 256 4734 email ronald.chamberlain@ bannerhealth.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Mahendraraj et al Running head recto: Ocular melanoma DOI: http://dx.doi.org/10.2147/OPTH.S120530",Non-OADS,/arxiv_data1/oa_pdf/3a/d1/opth-11-153.PMC5221652.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3a/d1/opth-11-153.PMC5221652.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/d1/opth-11-153.PMC5221652.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/38/ott-10-205.PMC5221653.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 205–216OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  205Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11617 8 long noncoding rna CRNDE  functions as  a competing endogenous rna to promote  metastasis and oxaliplatin resistance by sponging  mir-136 in colorectal cancer hongyan gao,1 Xiaodi  song,2 Ting Kang,3 Baohong  Yan,4 li Feng,5 li gao,6  liang ai,6 Xiaoni liu,7,*  Jie Yu,8,* huiqi li9,* 1Department of gastroenterology,   The First affiliated hospital of Xi’an  Medical University, 2Department of  Pharmacy, Xi’an central hospital,   Xi’an, 3Department of Oncology,   Yan’an University affiliated hospital,   Yan’an, 4Department of Pharmacy,   hong-hui hospital, Xi’an Jiaotong  University Medical college, Xi’an,   5Department of anorectal surgery,   ankang city central hospital,   ankang, 6Department of Pharmacy,   Yan’an University affiliated hospital,   7Department of endocrinology, Yan’an  People’s hospital, Yan’an, 8Department  of general surgery, nuclear industry  215 hospital of shaanxi Province,   Xianyang, 9Department of general  surgery, The People’s hospital of Baoji  city, Baoji, People’s republic of china *These authors contributed equally  to this workAbstract:  Colorectal neoplasia differentially expressed ( CRNDE ) is a novel gene recog - nized as a long noncoding RNA (lncRNA) that is highly elevated in colorectal cancer and  many other solid tumors but its functions on metastasis and oxaliplatin (OXA) resistance  are unknown.",Non-OADS,/arxiv_data1/oa_pdf/c8/38/ott-10-205.PMC5221653.pdf
"The understanding of the  molecular mechanisms underlying resistance to OXA is important to improve predic - tion of treatment response and guide treatment decisions in patients with metastatic  colorectal cancer.correspondence: huiqi li Department of general surgery, Xinjian  road, Weibin District, Baoji, 721000,  shaanxi, People’s republic of china Tel +86 156 1971 9058 email lihuiqi1971@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Gao et al Running head recto: CRNDE  functions as a competing endogenous RNA DOI: http://dx.doi.org/10.2147/OTT.S116178",Non-OADS,/arxiv_data1/oa_pdf/c8/38/ott-10-205.PMC5221653.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c8/38/ott-10-205.PMC5221653.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/38/ott-10-205.PMC5221653.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/42/ee/ott-10-195.PMC5221654.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 195–203OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  195Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11883 4 Multivoxel magnetic resonance spectroscopy  identifies enriched foci of cancer stem-like cells  in high-grade gliomas Tao he1–3,* Tianming Qiu4,* Xiaodong Wang5 hongxing gui6 Xilong Wang2 Qikuan Hu3,7 hechun Xia2 gaoyang Qi1,2 Jinsong Wu4 hui Ma2 1clinical Medicine college, ningxia  Medical University, 2Department of  Neurosurgery, General Hospital of  ningxia Medical University, 3ningxia  Key Laboratory of Cerebrocranial  Diseases, The national Key  laboratory incubation Base, Yinchuan,   4Department of Neurosurgery,   huashan hospital, shanghai Medical  college, Fudan University, shanghai,   5Department of Radiology, General  Hospital of Ningxia Medical University,   Yinchuan, People’s Republic of China;   6Department of Neuroscience and  cell Biology, robert Wood Johnson  Medical School of Rutgers University,   Piscataway, NJ, USA; 7Department of  Physiology, ningxia Medical University,   Yinchuan, People’s Republic of China *These authors contributed equally  to this workObjective:  This study investigated the correlation between choline/creatine (Cho/Cr) ratios  determined by multivoxel proton magnetic resonance spectroscopy (1H-MRS) and the distribu - tion of cancer stem-like cells (CSLCs) in high-grade gliomas.",Non-OADS,/arxiv_data1/oa_pdf/42/ee/ott-10-195.PMC5221654.pdf
"Keywords:  high-grade glioma, 1H-MRS, cancer stem-like cells, choline, creatine, Cho/Cr Introduction Gliomas are the most prevalent primary brain tumors and are of various histological  types and grades, according to the World Health Organization (WHO) classification  criteria.1 Among them, grade III anaplastic astrocytoma and grade IV glioblastoma  are the most common, with the latter comprising 15% of all intracranial neoplasms  and 60%–75% of astrocytic tumors.2 Conventional treatment for high-grade gliomas  (grades III and IV) involves neurosurgery, chemotherapy, and radiotherapy; however,  therapy is almost inevitably followed by therapeutic resistance and recurrence, which  are due largely to the propagation of residual glioma cancer stem cells (CSCs).3,4  CSCs isolated from high-grade gliomas are capable of self-renewal and formation of  neurospheres in serum-free medium.5 Cancer stem cells within the same tumor are correspondence: hui Ma Department of Neurosurgery, General  Hospital of Ningxia Medical University,  804 shengli street, Yinchuan 750004,  Ningxia, People’s Republic of China Tel +86 951 674 3247 Fax +86 951 408 2981 email mahui0528@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: He et al Running head recto: 1H-MRS identifies glioma stem-like cell foci DOI: http://dx.doi.org/10.2147/OTT.S118834",Non-OADS,/arxiv_data1/oa_pdf/42/ee/ott-10-195.PMC5221654.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/42/ee/ott-10-195.PMC5221654.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/ee/ott-10-195.PMC5221654.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/64/opth-11-135.PMC5221655.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 135–147Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  135Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11527 0 Comparison and analysis of FD a reported visual  outcomes of the three latest platforms for lasiK:  wavefront guided Visx iDesign, topography guided  Wavelight allegro Contoura, and topography  guided nidek eC-5000 C aTz Majid Moshirfar1,2 Tirth J shah3 David Franklin skanchy4 steven h linn1 Paul Kang3 Daniel s Durrie5 1hDr research Center, hoopes  Vision, salt lake City, UT,   2Department of Ophthalmology and  Visual sciences, John a Moran eye  Center, University of Utah school  of Medicine, salt lake City, UT,   3University of arizona College of  Medicine – Phoenix, Phoenix, aZ,   4Mcgovern Medical school, The  University of Texas health science  Center at houston, TX, 5Durrie  Vision,  Kansas City, K s, UsaPurpose:  To compare and analyze the differences in visual outcomes between Visx iDesign  Advanced WaveScan Studio™ System, Alcon Wavelight Allegro Topolyzer and Nidek EC-5000  using Final Fit™ Custom Ablation Treatment Software from the submitted summary of safety  and effectiveness of the US Food and Drug Administration (FDA) data.",Non-OADS,/arxiv_data1/oa_pdf/f3/64/opth-11-135.PMC5221655.pdf
"With approximately  620,000 to 720,000 procedures performed annually in the last 5 years, laser-assisted  in situ keratomileusis (LASIK) remains the predominant surgical procedure in the  US to correct refractive error.2,3 LASIK has among the highest satisfaction rates of  surgical procedures, ranging from 82%–98%.3 Y et recently there has been a growing Correspondence: Majid Moshirfar hDr research Center, hoopes Vision,  11820 south state street, Draper,  salt lake City, UT 84020, Usa Tel +1 801 568 0200 Fax +1 801 565 0200 email cornea2020@me.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Moshirfar et al Running head recto: FDA reported visual outcomes of latest platforms for LASIK DOI: http://dx.doi.org/10.2147/OPTH.S115270",Non-OADS,/arxiv_data1/oa_pdf/f3/64/opth-11-135.PMC5221655.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f3/64/opth-11-135.PMC5221655.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/64/opth-11-135.PMC5221655.pdf
Available at http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/f3/64/opth-11-135.PMC5221655.pdf
Available at http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/f3/64/opth-11-135.PMC5221655.pdf
Available at http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/f3/64/opth-11-135.PMC5221655.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ .,Non-OADS,/arxiv_data1/oa_pdf/bf/df/nihms777631.PMC5221657.pdf
2010; 753A http://dx.doi.org/10.1016/j.bpj.2009.12.4129 .,OADS,/arxiv_data1/oa_pdf/bf/df/nihms777631.PMC5221657.pdf
"Neuropsy- chopharmacology ,30, 1154–1162, doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"1747, doi:http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"Cognition ,108, 687–701, doi:http://dx.doi.org/10.1016/j.cognition.2008.05.010.",OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"Attention, Perception, & Psychophysics ,72, 179– 186, doi:http://dx.doi.org/10.3758/APP.72.1.179 .",Non-OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"Current Biology ,20, 1464–1469, doi:http://dx.doi.org/10.1016/j.cub.2010.06.057 .",OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"Journal of Neuroscience ,31, 10293–10301, doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"Neural correlates of perceptual rivalry in the human brain.Science ,280, 1930–1934, doi:http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"Current Biology ,25, 1496–1501, doi:http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"Retrieved from https://CRAN.R-project.org/package ¼BayesFactor Nagamine, M., Yoshino, A., Miyazaki, M., Takahashi, Y., & Nomura, S. (2008).",OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"Journal of Neurosci- ence,33, 16983–16991, doi:http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"Current Biology ,23, 823–827, doi: http://dx.doi.org/10.1016/j.cub.2013.03.067 .",OADS,/arxiv_data1/oa_pdf/d4/18/i1534-7362-16-15-22.PMC5221672.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/93/rjw192.PMC5221691.pdf
See http://creativecommons.org/licenses/by-nc/2.0/de/ HHS Public Access Author manuscript Demogr Res .,Non-OADS,/arxiv_data1/oa_pdf/2d/59/nihms838018.PMC5221702.pdf
< http://www.equator-network.org/ >.,Non-OADS,/arxiv_data1/oa_pdf/52/f3/policy-12-008.PMC5221706.pdf
< http://www.equator-network.org/ >.,Non-OADS,/arxiv_data1/oa_pdf/34/b8/policy-12-010.PMC5221707.pdf
< http://angusreidglobal.com/ wp-content/uploads/2008/11/2013.04.08_CityAge.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/e8/6a/policy-12-019.PMC5221709.pdf
< https://smith.queensu.ca/centres/monieson/knowledge_articles/toward-a- coordinated-electronic-health-record-ehr-strategy-for-canada.php >.,Non-OADS,/arxiv_data1/oa_pdf/e8/6a/policy-12-019.PMC5221709.pdf
"Public reports  and interactive  website.Primary care specific: clinical,  public health, quality and  productivity (previously  organizational), patient  experience.<http://qof.hscic.gov.uk/ > Care Quality  Commission (CQC)Monitoring system for general  practices to help monitor the  quality of care (e.g., used to  plan inspection activities and  also publicly available).Public reports  and interactive  website.Primary care specific:  effectiveness, responsiveness  and care.<www.cqc.org.uk/ > NHS Choices Launched to support the  public become active  consumers of healthcare and  to make healthcare decisions.Interactive  website.Whole of health system: user  ratings, online facilities, patient  experiences of care and quality  of services, patients with  long-term conditions, age of  patients and use of hospitals.<www.nhs.uk/pages/home.",Non-OADS,/arxiv_data1/oa_pdf/b2/cd/policy-12-033.PMC5221710.pdf
"Questions are in relation to  access and experiences with  primary care and dental care.<https://gp-patient.co.uk/ about > New Zealand Atlas of Variation in  Health Care, Health  Quality and Safety  CommissionNational and local-level  reporting.",Non-OADS,/arxiv_data1/oa_pdf/b2/cd/policy-12-033.PMC5221710.pdf
Results not  publicly reported;  direct to  physicians.Primary care: Indicators in 47  clinical areas.<https://www.ama-assn.,Non-OADS,/arxiv_data1/oa_pdf/b2/cd/policy-12-033.PMC5221710.pdf
< http://ovidsp.ovid.com/ovidweb.cgi?T =JS&C SC=Y&NEWS=N&PAGE=fulltext&D=med4&AN=12886178 >.,Non-OADS,/arxiv_data1/oa_pdf/b2/cd/policy-12-033.PMC5221710.pdf
< https://secure.cihi.ca/estore/productFamily.htm?locale=en&pf=PFC2000&lang=en >.,OADS,/arxiv_data1/oa_pdf/b2/cd/policy-12-033.PMC5221710.pdf
< https://secure.cihi.ca/free_products/HSP-Framework-ENweb.pdf >.,OADS,/arxiv_data1/oa_pdf/78/1f/policy-12-052.PMC5221711.pdf
< http://siteresources.worldbank.org/ INTHSD/Resources/376278-1202320704235/GuidingPrivHospitalsDeberetal.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/78/1f/policy-12-052.PMC5221711.pdf
< http://search.oecd.org/ officialdocuments/publicdisplaydocumentpdf/?cote=DEELSA/ELSA/WD(2000)8&docLanguage=En >.,Non-OADS,/arxiv_data1/oa_pdf/78/1f/policy-12-052.PMC5221711.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/jpr-10-053.PMC5221717.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4e/c5/jpr-10-053.PMC5221717.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 53–64Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  53 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S125074A 9-year follow-up of a self-management group  intervention for persistent neck pain in primary  health care: a randomized controlled trial Catharina Gustavsson1,2 Lena von Koch1,3,4 1Center for Clinical Research Dalarna,   Department of Public Health and  Caring Science, Uppsala University,  Uppsala,  2School of Education, Health  and Social Studies, Dalarna University,  Falun,  3Department of Neurobiology,   Care Science and Society, Karolinska Institutet,  4Department of Neurology,   Karolinska University Hospital,  Stockholm, SwedenBackground and objective: In previous short-term and 2-year follow-ups, a pain and stress  self-management group intervention (PASS) had better effect on pain-related disability, self- efficacy, catastrophizing, and perceived pain control than individually administered physio- therapy (IAPT) for patients with persistent tension-type neck pain.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/jpr-10-053.PMC5221717.pdf
"5,6 Rehabilitation strategies that address cognitive and behav- ioral factors involved in the maintenance of musculoskeletal pain by promoting active Correspondence: Catharina Gustavsson Center for Clinical Research Dalarna, Nissers vag 3, S-79182 Falun, SwedenTel +46 73 081 8201Fax +46 23 183 75Email catharina.gustavsson@ltdalarna.seJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Gustavsson and von KochRunning head recto: A 9-year follow-up of a pain self-management RCTDOI: http://dx.doi.org/10.2147/JPR.S125074",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/jpr-10-053.PMC5221717.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/jpr-10-053.PMC5221717.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 64 Gustavsson and von Koch  58.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/jpr-10-053.PMC5221717.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b2/90/jpr-10-121.PMC5221718.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b2/90/jpr-10-121.PMC5221718.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 121–128Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  121 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S116997A cross-cultural adaptation and validation of the  short-form McGill Pain Questionnaire-2: Chinese  version in patients with chronic visceral pain Jiang-Lin Wang1* Wei-Jun Zhang2* Min Gao2 Shengfa Zhang2 Dong-Hua Tian2* Jun Chen1,3,4* 1Institute for Biomedical Sciences  of Pain, Tangdu Hospital, The Fourth  Military Medical University, Xi’an,   2School of Social Development and  Public policy, China Institute of Health, Beijing Normal University,  Beijing,  3Key Laboratory of Brain  Stress and Behavior, People’s Liberation Army, Xi’an,  4Beijing  Institute for Brain Disorders, Beijing,  Peoples’ Republic of China * These authors contributed equally  to this work Objective: The present study aimed to develop a culturally appropriate and functional Standard  Mandarin Chinese translation of the short-form McGill Pain Questionnaire-2 (SF-MPQ-2) and  to assess its reliability and validity for characterizing chronic visceral pain in Chinese patients.",Non-OADS,/arxiv_data1/oa_pdf/b2/90/jpr-10-121.PMC5221718.pdf
"569 Xinsi Road, Baqiao, Xi’an 710038, People’s Republic of ChinaTel +86 29 8477 7942Fax +86 29 8477 7945Email junchen@fmmu.edu.cn Dong-Hua Tian School of Social Development and Public Policy, China Institute of Health, Beijing Normal University, 19, Xinjiekou Wai Street, Beijing 100875, People’s Republic of ChinaTel +86 10 5880 5031Fax +86 10 5880 0366Email tian65216@hotmail.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Wang et alRunning head recto: Chinese short-form McGill Pain Questionnaire-2 for patients with chronic visceral painDOI: http://dx.doi.org/10.2147/JPR.S116997",Non-OADS,/arxiv_data1/oa_pdf/b2/90/jpr-10-121.PMC5221718.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/b2/90/jpr-10-121.PMC5221718.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 128 Wang et al  27.,Non-OADS,/arxiv_data1/oa_pdf/b2/90/jpr-10-121.PMC5221718.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4f/dd/jpr-10-105.PMC5221719.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4f/dd/jpr-10-105.PMC5221719.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 105–112Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  105 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S120463Analysis of the clinical effects of transforaminal  endoscopic discectomy on lumbar disk  herniation combined with common peroneal  nerve paralysis: a 2-year follow-up retrospective study on 32 patients Ya-peng Wang* Wei Zhang Jian Zhang Ya-peng Sun*Ji-long AnWen-yuan Ding Department of Spinal Surgery, The  Third Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China *These authors contributed equally to  this workBackground: Very few studies have discussed transforaminal endoscopic discectomy (TED)  in the treatment of common peroneal nerve paralysis induced by lumbar disk herniation (LDH).",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/jpr-10-105.PMC5221719.pdf
"139, Ziqiang Road, Shijiazhuang City 050000, Hebei Province, People’s Republic of ChinaTel/fax +86 311 8860 2082Email wypsmile866@163.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Wang et alRunning head recto: TED for LDH with common peroneal nerve paralysisDOI: http://dx.doi.org/10.2147/JPR.S120463",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/jpr-10-105.PMC5221719.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/jpr-10-105.PMC5221719.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 112 Wang et al complications, and thus, it is a safe, effective, and minimally  invasive treatment for patients with LDH-induced common peroneal nerve paralysis.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/jpr-10-105.PMC5221719.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/68/ee/jpr-10-113.PMC5221720.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/68/ee/jpr-10-113.PMC5221720.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 113–120Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  113 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S121590Pain extent and function in youth with   physical disabilities Jordi Miró1–4 Rocío de la Vega1,5  Catarina T omé-Pires1–3 Elisabet  Sánchez-Rodríguez1–3  Elena Castarlenas1–3  Mark P Jensen5  Joyce M Engel6 1Unit for the Study and Treatment of  Pain – ALGOS, Universitat Rovira i  Virgili, Catalonia, Spain; 2Research  Center for Behavior Assessment (CRAMC), Department of Psychology,  Universitat Rovira i Virgili, Catalonia,  Spain;  3Institut d’Investigació  Sanitària Pere Virgili, Catalonia,  Spain; Universitat Rovira i Virgili,  Catalonia, Spain;  4Chair in Pediatric  Pain, Universitat Rovira i Virgili-Fundación Grünenthal, Catalonia,  Spain;  5Department of Rehabilitation  Medicine, University of Washington,  Seattle, WA, USA;  6Department of  Occupational Science and T echnology,  University of Wisconsin-Milwaukee,  Milwaukee, WI, USABackground: The aim of this study was to increase our understanding of the role that spatial  qualities of pain (location and extent) play in functioning, among youths with disabilities and  chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/68/ee/jpr-10-113.PMC5221720.pdf
"Research has shown that function, at least in adults with physical disabilities, is influenced by some of these other pain characteristics over Correspondence: Jordi Miró Departament de Psicologia, Universitat Rovira i Virgili, Carretera de Valls s/n, 43007 Tarragona, SpainTelephone: +34 9 775 5179Email jordi.miro@urv.catJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Miró et alRunning head recto: Pain extent and functionDOI: http://dx.doi.org/10.2147/JPR.S121590",Non-OADS,/arxiv_data1/oa_pdf/68/ee/jpr-10-113.PMC5221720.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/68/ee/jpr-10-113.PMC5221720.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 120 Miró et al 48.,Non-OADS,/arxiv_data1/oa_pdf/68/ee/jpr-10-113.PMC5221720.pdf
Supplemental Material The online data supplements are available at http://journals.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/d1/7d/10.1177_1948550616663803.PMC5221722.pdf
"Retrieved from https://www.R-project.org/ Resnick, P. (2001).",Non-OADS,/arxiv_data1/oa_pdf/d1/7d/10.1177_1948550616663803.PMC5221722.pdf
"Human-Computer Interaction in the New Millenium ,77, 247–272.Retrieved from http://presnick.pe ople.si.umich.edu/papers/stk/ ResnickSTK.pdf Rim, S., Uleman, J. S., & Trope, Y.",OADS,/arxiv_data1/oa_pdf/d1/7d/10.1177_1948550616663803.PMC5221722.pdf
"Retrieved from http://www.nytimes.com/2008/ 09/07/magazine/07awareness-t.html Todd, A. R., Molden, D. C., Ham, J., & Vonk, R. (2011).",Non-OADS,/arxiv_data1/oa_pdf/d1/7d/10.1177_1948550616663803.PMC5221722.pdf
"Random forests for survival, regression and classification (RF-SRC), Rpackage version 1.6.1. https://cran.r-project.org/web/packages/randomForestSRC/randomForestSRC.pdf (2015, accessed 16 November 2015).",Non-OADS,/arxiv_data1/oa_pdf/77/66/10.1177_1357633X15618810.PMC5221726.pdf
Available at: https://www.hindawi.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/10.1177_2055102916681759.PMC5221737.pdf
Keywords Clubroot; FISH (fluorescence in-situ hybridisation); LSU rDNA; pathotyping; phytomyxea;  plasmodiophorids This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/de/emss-70675.PMC5221739.pdf
"The original, unprocessed images  were deposited at Figshare ( http://dx.doi.org/10.6084/m9.figshare.3184399.v1 ).Schwelm et al.",OADS,/arxiv_data1/oa_pdf/e9/de/emss-70675.PMC5221739.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/70/main.PMC5221745.pdf
http://dx.doi.org/10.1016/j.bbamcr.2015.10.014 0167-4889/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/37/70/main.PMC5221745.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/70/main.PMC5221745.pdf
"Baillie, Targeted disruption of the heat shock protein 20-phosphodiesterase 4D (PDE4D) interaction protects against pathological cardiac re modelling in a mouse model of hypertrophy, FEBS Open Bio 4 (2014) 923 –927, http://dx.doi.org/10.1016/j.fob.2014.10.011 eCollection 2014.1748 C. Denning et al.",OADS,/arxiv_data1/oa_pdf/37/70/main.PMC5221745.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.BACTERIOPHAGE 2016, VOL.",Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"4, e1268664 (6 pages)http://dx.doi.org/10.1080/21597081.2016.1268664",Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
Biophys J 2014;25:1844-58; http://dx.doi.org/10.1016/j.bpj.2014.03.029 [2] Howard J.,OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Rep Prog Phys 2013; 76:016601; PMID:23249673;http://dx.doi.org/10.1088/0034-4885/76/1/016601 [4] Serwer P, Jiang W. Dualities in the analysis of phage DNA packaging motors.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Bacteriophage 2012; 2:1-17;PMID:22666651; http://dx.doi.org/10.4161/bact.23829 [5] Liu S, Chistol G, Hetherington CL, Tafoya S, Aathavan K, Schnitzbauer J, Grimes S, Jardine P, Bustamante C. A viral packaging motor varies its DNA rotation and step size to preserve subunit coordination as the capsid ﬁlls.",Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Cell 2014; 157:702-13; PMID:24766813; http://dx.doi.org/10.1016/j.cell.2014.02.034 [6] Cao S, Saha M, Zhao W, Jardine PJ, Zhang W, Grimes S, Morais MC.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
J Virol 2014; 88:3986-96; PMID:24403593; http://dx.doi.org/10.1128/JVI.03203-13[7] Serwer P. The XXIIIrd phage/virus assembly meeting.,Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
Bacte- riophage 2014; 4:e27272: Citation of the abstract of Dai et al;PMID:24498537; http://dx.doi.org/10.4161/bact.27272 [8] Casjens SR.,Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Nature Rev Microbiol 2011; 9:647-57;http://dx.doi.org/10.1038/nrmicro2632 [9] Rao VB, Feiss M. Mechanisms of DNA packaging by large double-stranded DNA viruses.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
Annu Rev Virol 2015; 2:351-78; PMID:26958920; http://dx.doi.org/10.1146/annurev-virology-100114-055212 [10] Black LW.,Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Virology 2015; 479-80:650-6; PMID:25728298; http://dx.doi.org/10.1016/j.virol.2015.01.015 [11] Bjornsti MA, Reilly BE, Anderson DL.",Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"J Mol Biol 2008; 384:1384-99; PMID:18952096; http://dx.doi.org/10.1016/j.jmb.2008.10.012 [13] Khan SA, Hayes SJ, Watson RH, Serwer P. Speci ﬁc non- productive cleavage of packaged bacteriophage T7 DNAin vivo .",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
Virology 1995; 210:409-20; PMID:7618276; http://dx.doi.org/10.1006/viro.1995.1357 [14] Serwer P. Proposed Ancestors of Phage Nucleic Acid Packaging Motors (and Cells).,Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Viruses 2011; 3:1249-80;PMID:21994778; http://dx.doi.org/10.3390/v3071249 [15] Frazer JCW, Myrick RT.",Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
J Am Chem Soc 1916; 38:1907-22; http://dx.doi.org/10.1021/ja02267a001 [16] Koch AL.,OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"J Mol Recognit 2004; 17:488-96; PMID:15362109; http://dx.doi.org/10.1002/jmr.695 [19] Serwer P, Wright ET, Liu Z, Jiang W. Length quantization of DNA partially expelled from heads of a bacteriophage T3mutant.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Virology 2014; 456-7:157-70; PMID:24889235; http://dx.doi.org/10.1016/j.virol.2014.03.016 [20] Deatherage DE, Barrick JE.",Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Meth Mol Biol 2014;1151:165-88; http://dx.doi.org/10.1007/978-1-4939-0554-6_12 [21] Serwer P, Wright ET, Chang JT, Liu X.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
Bacteriophage 2014; 4: e961869; PMID:26713220; http://dx.doi.org/10.4161/ 21597073.2014.961869BACTERIOPHAGE e1268664-5,Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"J Mol Biol1980; 138:65-91; PMID:7411607; http://dx.doi.org/10.1016/S0022-2836(80)80005-2 [23] Bancroft FC, Freifelder D. Molecular weights of coli- phages and coliphage DNA.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"J Mol Biol 1970; 54:537-546; PMID:4923668; http://dx.doi.org/10.1016/0022-2836(70)90124-5 [24] Guo F, Liu Z, Fang PA, Zhang Q, Wright ET, Wu W, Zhang C, Vago F, Ren Y, Jakana J, Chiu W, Serwer P,Jiang W. Capsid expansion mechanism of bacteriophageT7 revealed by multistate atomic models derived fromcryo-EM reconstructions.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Proc Natl Acad Sci USA 2014; 111:E4606-14; PMID:25313071; http://dx.doi.org/ 10.1073/pnas.1407020111 [25] Ye QL, Yoshikawa H, Bandow S, Awaga K. Green mag- netite (Fe 3O4): Unusual optical Mie scattering and mag- netic isotropy of submicron-size hollow spheres.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
ApplPhys Lett 2009; 94:063114; http://dx.doi.org/10.1063/1.3079407 [26] Serwer P. Buoyant density centrifugation of macromole- cules in sodium iothalamate density gradients.,OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
J Mol Biol1974; 92:433-48; PMID:167175; http://dx.doi.org/ 10.1016/0022-2836(75)90290-9 [27] Serwer P. Flattening and shrinkage of bacteriophage T7 after preparation for electron microscopy by negativestaining.,Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
J Ultrastruct Res 1977; 58:235-43; PMID:66322;http://dx.doi.org/10.1016/S0022-5320(77)90015-6 [28] Serwer P. Fibrous projections from the core of a bacterio- phage T7 procapsid.,OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
J Supramol Struct 1979; 11:321-6; PMID:544920; http://dx.doi.org/10.1002/jss.400110307 [29] Walsby AE.,Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Environ Microbiol 2016;18:1264-76; PMID:26743231; http://dx.doi.org/ 10.1111/1462-2920.13203 [31] Aggelli A, Bell M, Boden N, Keen JN, Knowles PF, McLe- ish TCB, Pitkeathly M, Radford SE.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"Nature 1997; 386:259-62; PMID:9069283; http://dx.doi.org/10.1038/386259a0 [32] Aksyuk AA, Rossmann MG. Bacteriophage assembly.",OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
Viruses 2011; 3:172-203; PMID:21994726; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/40/kbac-06-04-1268664.PMC5221748.pdf
"4, e1251381 (9 pages)http://dx.doi.org/10.1080/21597081.2016.1251381",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
Proc Soc Exp Biol Med1927; 24(7):635-9; http://dx.doi.org/10.3181/00379727-24-3498 [2] Evans AC.,OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Available from: http://www.ncbi.nlm.nih.gov/books/NBK190419/ [ 4 ] J a r v i sA W ,C o l l i n sL J ,A c k e r m a n nH - W .As t u d yo f ﬁve bacteriophages of the Myoviridae family which replicate ondifferent gram-positive bacteria.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Arch Virol 1993; 133:75-84; PMID:8340019; http://dx.doi.org/10.1007/BF01309745 [5] Yang H-Y, Kim Y-W, Chang H-I.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Bacteriol 2002; 184 (7):1859-64; PMID:11889091; http://dx.doi.org/10.1128/JB.184.7.1859-1864.2002 [6] Vinodkumar C, Srinivasa H, Basavarajappa KGeethalakshmi S, Bandekar N. Isolation of bacteriophages to multi-drugresistant Enterococci obtained from diabetic foot: A novelantimicrobial agent waiting in the shelf?",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Ind J Pathol Micro- biol 2011; 54.1:90; PMID:21393885; http://dx.doi.org/ 10.4103/0377-4929.77333 [7] Rigvava S, Tchgkonia I, Jgenti D, Dvalidze T, Caprino J, Goderdzishvili M. Comparative analysis of the biologicaland physical properties of Enterococcus faecalis bacterio-phage vB_SmM_GEC-SmitisM_2.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Can J Microbiol 2012;59:18-21; PMID:23391224; http://dx.doi.org/10.1139/cjm-2012-0385 [8] Zhang W, Mi Z, Yin X, Fan H, An W, Zhang Z, Chen J, Tong Y.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Arch Virol 2015; 160:601-4; PMID:25359106;http://dx.doi.org/10.1007/s00705-014-2263-4 [10] Lee Y-D, Park J-H.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Virol 2012; 86(9):5402-5403;PMID:22492926; http://dx.doi.org/10.1128/JVI.00321-12 [11] Horiuchi T, Sakka M, Hayashi A, Shimada T, Kimura T, Sakka K. Complete genome sequence of bacteriophageBC-611 specifcially infecting Enterococcus faecalis strainNP-10011.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J. Virol 2012; 86(17):9538-9; PMID:22870611;http://dx.doi.org/10.1128/JVI.01424-12 [12] Fard RMN, Barton MD, Arthur JL, Heuzenroeder MW.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"ArchVirol 2010; 155:1887-91; PMID:20844906; http://dx.doi.org/10.1007/s00705-010-0800-3 [13] Nigutova K, Styriak I, Javorsky P, Prestas P. Partial char- acterization of Enterococcus faecalis bacteriophage F4.Folia Microbiol 2008; 53(3):234-6; PMID:18661299; http://dx.doi.org/10.1007/s12223-008-0033-y[14] Duerkop BA, Clements CV, Rollins D, Rodrigues JLM, Hooper LV.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Bacteriol 2010; 192(4):1122-30;PMID:20008075; http://dx.doi.org/10.1128/JB.01293-09 [17] Stevens RH, Ektefaie MR, Fouts DE.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"FEMS Microbiol Lett 2011;317:9-26; PMID:21204936; http://dx.doi.org/10.1111/j.1574-6968.2010.02203.x [18] Uchiyama J, Rashel M, Takemura I, Wakiguchi H, Matsuzaki S. In Silico and In vitro evaluation of bac- teriophage fEf24C, a candidate for treatment of Enterococcus faecalis infections.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Appl Environ Micro-biol 2008; 74(13):4149-63; PMID:18456848; http://dx.doi.org/10.1128/AEM.02371-07 [19] Khalifa L, Brosh Y, Gelman D, Coppenhagen-Glazer S, Beyth S, Poradosu-Cohen R, Que Y-A, Beyth N, Hazan R.Targeting Enteococcus faecalis bio ﬁlms with phage ther- apy.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Microbiol 2015; 81:2696-705; PMID:25662974. http://dx.doi.org/10.1128/AEM.00096-15 [20] Stevens RH, Porras O, Delisle A. Bacteriophages induced from lysogenic root canal isolates of Enterococcus faeca-lis.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Oral Microbiol Immunol 2009; 24:278-84;PMID:19572888; http://dx.doi.org/10.1111/j.1399-302X.2009.00506.x [21] McGrath S, Neve H, Seegers JFML, Eijlander R, Vegg CS, Brøndsted L, Heller KJ, Fitzgerald GF, Vogensen FK, van Sinderen D. Anatomy of a Lactococcal phage tail.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Bac- teriol 2006; 188(11):3972-82; PMID:16707689; http://dx.doi.org/10.1128/JB.00024-06 [22] Auzat I, Dr €oge A, Weise F, Lurz R, Tavares P. Origin and function of the two major tail proteins of bacteri-ophage SPP1.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Mol Microbiol 2008; 70(3):557-69;PMID:18786146; http://dx.doi.org/10.1111/j.1365-2958.2008.06435.x [23] Zimmer M, Sattelberger E, Inman RB, Calendar R, Loessner MJ.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Genome and proteome of Listeria monocy-togenes phage PSA: an unusual case for programmed C1 translational frameshifting in structural protein synthesis.Mol Microbiol 2003; 50(1):303-17; PMID:14507382;http://dx.doi.org/10.1046/j.1365-2958.2003.03684.x [24] Fortier LC, Bransi A, Moineau S. Genome sequence and global gene expression of Q54, a new phage species link- ing the 936 and c2 phage species of Lactococcus lactis.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Mol Biol 2000; 298:167-85;PMID:10764589; http://dx.doi.org/10.1006/jmbi.2000.3668 [26] Levin ME, Hendrix RW, Casjens SR. A programmed translational frameshift is required for the synthesis of bacteriophage λtail assembly protein.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Mol Biol 1993; 234:124-39; PMID:8230192; http://dx.doi.org/10.1006/jmbi.1993.1568 [27] Jacks T, Madhani HD, Masiarz FRT, Varmus HE.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Cell 1988; 55:447-58; PMID:2846182;http://dx.doi.org/10.1016/0092-8674(88)90031-1 [28] Xu J, Hendrix RW, Duda RL.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Conserved translational frameshift in dsDNA bacteriophage tail assembly genes.Molecular Cell 2004; 16:11-21; PMID:15469818; http://dx.doi.org/10.1016/j.molcel.2004.09.006 [29] Fraser JS, Yu Z, Maxwell KL, Davidson AR.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Mol Biol 2006; 359:496-507; PMID:16631788;http://dx.doi.org/10.1016/j.jmb.2006.03.043 [30] Rodriguez I, Garcia P, Suarez JE.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Bacteriol 2005;187(23):8201-4; PMID:16291695; http://dx.doi.org/10.1128/JB.187.23.8201-8204.2005 [31] Garcia P, Rodriguez I, Suarez JE.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Bacteriol 2004; 186(6):1714-9; PMID:14996802; http://dx.doi.org/10.1128/JB.186.6.1714-1719.2004 [32] Alam SL, Atkins JF, Gesteland RF.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Nuc Acid Res 2003; 31 (13):3406-15; PMID:12824337. http://mfold.rna.albany.edu; http://dx.doi.org/10.1093/nar/gkg595[34] Seegers JFML, McGrath S, O ’Connell-Motherway M, Arendt EK, van de Guchte M, Creaven M, Fitzgerald GF,van Sinderen D. Molecular and transcriptional analysisof the temperate lactococcal bacteriophage Tuc2009.Virology 2004; 329:40-52; PMID:15476873; http://dx.doi.org/10.1016/j.virol.2004.07.003 [35] Johnsen MG, Appel KF, Madsen PL, Vogensen FK, Ham- mer K, Arnau J.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
Virology 1996; 218:306-16; PMID:8610457;http://dx.doi.org/10.1006/viro.1996.0199 [36] Dokland T. Scaffolding proteins and their role in viral assembly.,Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Cell Mol Life Sci 1999; 56:580-603;PMID:11212308; http://dx.doi.org/10.1007/s000180050455 [37] Chang JR, Polakov A, Prevelige PE, Mobley JA, Dokland T. Incorporation of scaffolding protein gpO in bacteriophages P2 and P4.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Virology 2008; 370(2):352-61; PMID:17931675; http://dx.doi.org/10.1016/j.virol.2007.08.039 [38] H €auser R, Sabri M, Moineau S, Uetz P. The proteome and interactome of Streptococcus pneumoniae phageCp-1.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"J Bacteriol 2011; 193(12):3135-8; PMID:21515781;http://dx.doi.org/10.1128/JB.01481-10 [39] Zhang H, Fouts DE, DePew J, Stevens RH.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Microbiol2013; 159(6):1023-35; PMID:23579685; http://dx.doi.org/10.1099/mic.0.067116-0 [40] Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Nature 1970;227:680-5; PMID:5432063; http://dx.doi.org/10.1038/227680a0 [42] Tibrewal N, Liu T, LI H, Birge RB.",OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
Mol Cell Biochem 2007; 304:119-25; PMID:17534701; http://dx.doi.org/10.1007/s11010-007-9492-8BACTERIOPHAGE e1251381-9,Non-OADS,/arxiv_data1/oa_pdf/45/d7/kbac-06-04-1251381.PMC5221750.pdf
"Stroke 46: 3020–3035, 2015  7) The Japan stroke society, the Japan Neurosurgical society, and the Japanese society for Neuroen-dovascular Therapy: guideline of proper use of embolectomy devices for acute ischemic stroke  (version 2) http://www.jsts.gr.jp/img/noukessen.pdf   8) hyogo T, Taki w , Negoro m, Takahashi a, edura m,  hyodo a, Kobayashi s, Komiyama m, Kuwayama  N, matsumaru y , miyachi s, murao K, murayama  y, Nakahara i, Nemoto s, sakai N, satoh K, sonobe  m, sugiu K, Terada T, y oshimura s, abe T, itoh y ,  Kiyosue h , Nagashima h , Nakamura m, m atsushima  s, Japanese society of neuro-endovascular treatment specialist qualification system.",Non-OADS,/arxiv_data1/oa_pdf/6f/fd/nmc-56-737.PMC5221771.pdf
https://blogs.gartner.,Non-OADS,/arxiv_data1/oa_pdf/75/3d/nmc-56-655.PMC5221776.pdf
http://www.hcup-us.ahrq.gov/nisoverview.jsp.,Non-OADS,/arxiv_data1/oa_pdf/75/3d/nmc-56-655.PMC5221776.pdf
"http://healthcaredelivery.cancer.gov/seer - medicare/ Address reprint requests to: Koji iihara, md, Phd,  department of Neurosurgery, Graduate school of medical sciences, Kyushu university, 3-1-1 maidashi,  higashi-ku, Fukuoka 812-8582, Japan.",Non-OADS,/arxiv_data1/oa_pdf/75/3d/nmc-56-655.PMC5221776.pdf
"Bethesda, md, http://seer.cancer.gov/stattacts/html/brain.html  5) stupp R, hegi me, mason WP, van den Bent mJ,  taphoorn mJ, Janzer Rc, Ludwin sK, Allgeier A,  Fisher B, Belanger K, hau P, Brandes AA, gijtenbeek J, marosi c, Vecht cJ, mokhtari K, Wesseling P, Villa s, eisenhauer e, gorlia t , Weller m, Lacombe d,  cairncross Jg, mirimanoff Ro: european organisa- tion for Research and t reatment of cancer Brain  tumour and Radiation oncology groups; National  cancer institute of canada clinical trials group.",Non-OADS,/arxiv_data1/oa_pdf/b4/80/nmc-56-664.PMC5221777.pdf
"http://www.mhlw.go.jp/toukei/ saikin/hw/kanja/11/index.html, 2011 18) Ray s, Bonafede mm, mohile NA: t reatment patterns,  survival, and healthcare costs of patients with malig-nant gliomas in a large us commercially insured population.",Non-OADS,/arxiv_data1/oa_pdf/b4/80/nmc-56-664.PMC5221777.pdf
available at https://www.jpeds.or.jp/uploads/files/ saisin_1109062.pdf  2) japan association of obstetricians and gynecologists.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/nmc-56-704.PMC5221781.pdf
a vailable at http://www.jaog.or.jp/ all/document/83_150114.pdf  3) japan association of w omen Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/nmc-56-704.PMC5221781.pdf
a vailable at http://dl.med.or.jp/ dl-med/teireikaiken/20090408_2.pdf  5) nakamura m: The determinants of working hours of  japanese female physicians: the effects of family structures and transitions into part-time status.,Non-OADS,/arxiv_data1/oa_pdf/d0/d4/nmc-56-704.PMC5221781.pdf
Retrieved from http://www.neuronproject.,OADS,/arxiv_data1/oa_pdf/f3/19/nmc-56-709.PMC5221782.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5b/05/ijn-12-317.PMC5221794.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 317–325International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  317OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11444 6 Potential inhibition of hIV-1 encapsidation by  oligoribonucleotide–dendrimer nanoparticle  complexes raveen Parboosing1,2 louis chonco1,2 Francisco Javier de la  Mata3,4 Thavendran govender5 glenn eM Maguire5 hendrik g Kruger5 1Department of Virology, University  of KwaZulu-Natal, 2National health  laboratory service, Durban, south  africa; 3Organic and Inorganic  chemistry Department, University  of alcalá, alcalá de henares,   4Networking research center on  Bioengineering, Biomaterials and  Nanomedicine (cIBer-BBN), Madrid,   spain; 5catalysis and Peptide research  Unit, University of KwaZulu-Natal,   Durban, south africaBackground:  Encapsidation, the process during which the genomic RNA of HIV is packaged  into viral particles, is an attractive target for antiviral therapy.",Non-OADS,/arxiv_data1/oa_pdf/5b/05/ijn-12-317.PMC5221794.pdf
"For example, vectors that express Ψ-containing transcripts, correspondence: raveen Parboosing Department of Virology, University of  KwaZulu-Natal, 5th Floor laboratory  Building, Inkosi albert luthuli central  hospital, 800 Bellair (Vusi Mzimele) road,  Mayville, Durban 4091, south africa Tel +27 31 240 2816 Fax +27 31 240 2797 email parboosingr@ukzn.ac.z a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Parboosing et al Running head recto: Anti-HIV RNA-dendrimer nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S114446",Non-OADS,/arxiv_data1/oa_pdf/5b/05/ijn-12-317.PMC5221794.pdf
"Available from: http://dharmacon.gelifesciences.com/ uploadedFiles /Products/Custom_Synthesis/Single-stranded_RNA_ Synthesis/deprotection-protocol.pd f. Accessed May 8, 2014.",OADS,/arxiv_data1/oa_pdf/5b/05/ijn-12-317.PMC5221794.pdf
Available from:  http://www.who.int/ csr/resources/publications/biosafety/WHO_CDS_CSR_LYO_2004_11/ en/.,OADS,/arxiv_data1/oa_pdf/5b/05/ijn-12-317.PMC5221794.pdf
Available from: http://www.cdc.gov/biosafety/publications/bmbl5 /.,OADS,/arxiv_data1/oa_pdf/5b/05/ijn-12-317.PMC5221794.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5b/05/ijn-12-317.PMC5221794.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/05/ijn-12-317.PMC5221794.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/41/f9/jaa-10-001.PMC5221795.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/41/f9/jaa-10-001.PMC5221795.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 1–7Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 1 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S123053Anaphylaxis across two Canadian pediatric  centers: evaluating management disparities Alison YM Lee1  Paul Enarson2  Ann E Clarke3  Sébastien La Vieille4  Harley Eisman5,6  Edmond S Chan7  Christopher Mill7  Lawrence Joseph8  Moshe Ben-Shoshan9 1Pediatric Residency Program,   Department of Pediatrics,   University of British Columbia, BC Children’s Hospital,  2Division of  Emergency Medicine, Department of Pediatrics, University of British Columbia, Vancouver, BC,  3Division  of Rheumatology, Department of Medicine, Cumming School of Medicine, University of Calgary,  Calgary, AB,  4Food Directorate, Health  Canada, Ottawa, ON, 5Emergency  Department, 6Department of  Pediatrics, Montreal Children’s Hospital, Montreal, QC,  7Division of  Allergy and Immunology, Department of Pediatrics, BC Children’s Hospital,  University of British Columbia,  Vancouver, BC,  8Department of  Epidemiology and Biostatistics, McGill University,  9Division of Allergy and  Clinical Immunology, Department of Pediatrics, Montreal Children’s Hospital, Montreal, QC, CanadaBackground: There are no data on the percentage of visits due to anaphylaxis in the emergency  department (ED), triggers, and management of anaphylaxis across different provinces in Canada.",Non-OADS,/arxiv_data1/oa_pdf/41/f9/jaa-10-001.PMC5221795.pdf
"8,9 However, it is not clear if this high rate of anaphylaxis is reflective Correspondence: Moshe Ben-Shoshan Division of Allergy and Clinical Immunology, Department of Pediatrics, Montreal Children’s Hospital, 1001 Decarie, Montreal, QC H4A 3J1, Canada   Tel +1 514 412 4400 ext 24470   Fax +1 514 228 1197   Email moshebenshoshan@gmail.comJournal name: Journal of Asthma and Allergy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Lee et alRunning head recto: Anaphylaxis across two Canadian pediatric centersDOI: http://dx.doi.org/10.2147/JAA.S123053",Non-OADS,/arxiv_data1/oa_pdf/41/f9/jaa-10-001.PMC5221795.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/41/f9/jaa-10-001.PMC5221795.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fc/ed/imcrj-10-007.PMC5221797.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fc/ed/imcrj-10-007.PMC5221797.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 7–9International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 7 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S123524Pediatric endogenous Haemophilus influenzae   endophthalmitis with presumed hyposplenism Masatoshi Haruta Yumiko Y oshida Ryoji Yamakawa Department of Ophthalmology,   Kurume University School of Medicine, Kurume, JapanBackground: Endogenous bacterial endophthalmitis is a rare but potentially devastating  intraocular infection that can have severe sight-threatening complications.",Non-OADS,/arxiv_data1/oa_pdf/fc/ed/imcrj-10-007.PMC5221797.pdf
"Because the spleen is critical Correspondence: Masatoshi Haruta Department of Ophthalmology, Kurume University School of Medicine, 67 Asahi‑machi, Kurume, Fukuoka 830‑0011, JapanTel +81 942 31 7574Fax +81 942 37 0324Email haruta_masatoshi@med.kurume‑u.ac.jpJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Haruta et alRunning head recto: Pediatric endophthalmitis with presumed hyposplenismDOI: http://dx.doi.org/10.2147/IMCRJ.S123524",Non-OADS,/arxiv_data1/oa_pdf/fc/ed/imcrj-10-007.PMC5221797.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international‑medical‑case‑reports‑journal‑journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/fc/ed/imcrj-10-007.PMC5221797.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 9 Pediatric endophthalmitis with presumed hyposplenism light perception.4 Gupta et al reported that infection with  H. influenzae was associated strongly with a final outcome  of enucleation or evisceration.5 However, in studies that  focused only on endogenous H. influenzae endophthalmitis involving children younger than 3 years of age, the prognosis with antibiotic treatment was more favorable, and enucleation was necessary in only one of seven eyes.",Non-OADS,/arxiv_data1/oa_pdf/fc/ed/imcrj-10-007.PMC5221797.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/67/ijn-12-295.PMC5221798.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 295–304International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  295OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12235 7 low molecular weight chitosan-coated silver  nanoparticles are effective for the treatment of  Mrsa-infected wounds Yinbo Peng1 chenlu song1 chuanfeng Yang1 Qige guo1 Min Yao1,2 1Department of Burns and Plastic  surgery, shanghai Ninth People’s  hospital, Institute of Traumatic  Medicine, shanghai Jiao T ong  University school of Medicine,   shanghai, People’s republic of  china; 2Department of Dermatology,   Wellman center for Photomedicine,   harvard Medical school,   Massachusetts general hospital,   Boston, M a, UsaAbstract:  Silver nanoparticles (AgNPs) are being widely applied as topical wound materials;  however, accumulated deposition of silver in the liver, spleen, and other main organs may lead  to organ damage and dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/69/67/ijn-12-295.PMC5221798.pdf
"Keywords:  silver nanoparticles, LMWC-AgNPs, MRSA, PVP-AgNPs, PVP, biocompatibility Introduction Silver nanoparticles (AgNPs) are increasingly being used as various types of external  trauma materials due to their effective antimicrobial and good release properties.1–4  However, the toxicology of AgNPs remains largely unknown.5,6 Moreover, AgNPs  can be absorbed into the bloodstream via different routes of administration, leading  to deposition of silver in many organs, including the liver and spleen, and potential  organ damage after a certain amount of accumulation.1,7–9 Therefore, in the actual correspondence: Min Yao Department of Burns and Plastic surgery,  shanghai Ninth People’s hospital,  Institute of Traumatic Medicine,  shanghai Jiao Tong University school  of Medicine, 280 Mohe road, Baoshan  District, shanghai 201900, People’s  republic of china Tel +86 21 5669 1101 ext 6186 Fax +86 21 6131 3990 email my058@vip.sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Peng et al Running head recto: Low molecular weight chitosan-coated silver nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S122357",Non-OADS,/arxiv_data1/oa_pdf/69/67/ijn-12-295.PMC5221798.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/69/67/ijn-12-295.PMC5221798.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/67/ijn-12-295.PMC5221798.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/fb/ijn-12-217.PMC5221799.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 217–237International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  217OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12217 1 simultaneous delivery of anti-mir21 with  doxorubicin prodrug by mimetic lipoprotein  nanoparticles for synergistic effect against drug  resistance in cancer cells Mengjie rui Yang Qu T ong gao Yanru ge chunlai Feng Ximing Xu Department of Pharmaceutics, school  of Pharmacy, Jiangsu University,   Zhenjiang, People’s republic of chinaAbstract:  The development of drug resistance in cancer cells is one of the major obstacles  to achieving effective chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/ad/fb/ijn-12-217.PMC5221799.pdf
"The emergence of drug  resistance mainly arises from the overexpression of membrane proteins that activate  the efflux pump, thereby exporting drugs before they reach their intracellular sites  of action.3–5 Pgp, a typical drug-efflux transporter, has received increasing attention, correspondence: Ximing Xu;   chunlai Feng school of Pharmacy, Jiangsu University,  301 Xuefu road, Zhenjiang, Jiangsu  212013, People’s republic of china Tel +86 0511 8503 8170 Fax +86 0511 8879 5939 email xmxu@ujs.edu.c n;  feng@ujs.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Rui et al Running head recto: Dox–anti-miR21 codelivery to overcome drug resistance DOI: http://dx.doi.org/10.2147/IJN.S122171",Non-OADS,/arxiv_data1/oa_pdf/ad/fb/ijn-12-217.PMC5221799.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ad/fb/ijn-12-217.PMC5221799.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/fb/ijn-12-217.PMC5221799.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/b6/ijn-12-305.PMC5221800.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 305–315International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  305OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12306 2 achieving long-term stability of lipid nanoparticles:  examining the effect of ph, temperature, and  lyophilization rebecca l Ball1 Palak Bajaj1,2 Kathryn a Whitehead1,2 1Department of chemical engineering,   2Department of Biomedical  engineering, carnegie Mellon  University, Pittsburgh, P a, UsaAbstract:  The broadest clinical application of siRNA therapeutics will be facilitated by  drug-loaded delivery systems that maintain stability and potency for long times under ambient  conditions.",Non-OADS,/arxiv_data1/oa_pdf/7f/b6/ijn-12-305.PMC5221800.pdf
"Generic LNPs are formulated by combining lipidoids, cholesterol, distearoyl- sn-glycerol-3-phosphocholine (DSPC), polyethylene glycol (PEG), and siRNA.8 correspondence: Kathryn a Whitehead Department of chemical engineering,  carnegie Mellon University, 5000 Forbes  avenue, Pittsburgh, Pa 15217, Usa Tel +1 412 268 9836 Fax +1 412 268 7139 email kawhite@cmu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ball et al Running head recto: Achieving long-term stability of lipid nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S123062",Non-OADS,/arxiv_data1/oa_pdf/7f/b6/ijn-12-305.PMC5221800.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7f/b6/ijn-12-305.PMC5221800.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/b6/ijn-12-305.PMC5221800.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ed/81/jmdh-10-013.PMC5221801.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ed/81/jmdh-10-013.PMC5221801.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 13–27Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 13 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S111369The role and structure of the multidisciplinary  team in the management of advanced Parkinson’s  disease with a focus on the use of levodopa– carbidopa intestinal gel Stephen W Pedersen1, Martin  Suedmeyer2, Louis W C Liu3,  Dirk Domagk4, Alison Forbes5,  Lars Bergmann6, Koray Onuk6,  Ashley Yegin6, T eus van Laar7 1Department of Neurology, Glostrup Hospital,   University of Copenhagen, Glostrup, Copenhagen,   Denmark; 2Department of Neurology, University  of Düesseldorf, Düesseldorf, Germany; 3Division  of Gastroenterology, Department of Medicine,  University of T oronto, University Health Network,   T oronto, ON, Canada;  4Department of Medicine  I, Josephs-Hospital Warendorf, Academic T eaching  Hospital, University of Muenster, Warendorf,   Germany; 5PDNS consultant, AbbVie Inc.,   Roswell, GA, USA; 6Global Medical Affairs, AbbVie  Inc., North Chicago, IL, USA; 7Department of  Neurology, University Medical Center Groningen,   Groningen, The NetherlandsAbstract:  A multidisciplinary team (MDT) approach is increasingly recommended in Parkin- son’ s disease (PD) treatment guidelines, but no standard of care exists for such an approach,  and the guidelines do not provide clarification on how it should be implemented.",Non-OADS,/arxiv_data1/oa_pdf/ed/81/jmdh-10-013.PMC5221801.pdf
"Furthermore, people who have been identified as having advanced PD are often not referred for advanced therapies, 17 which can improve their motor function and  QoL.18 These therapies – deep brain stimulation (DBS),19 subcutaneous apomorphine  pump,20 and levodopa–carbidopa intestinal gel (LCIG; carbidopa–levodopa enteral Correspondence: Stephen W Pedersen Department of Neurology, Copenhagen University  Hospital Glostrup, Nordre Ringvej 57, 2600 Glostrup,  DenmarkTel +45 2089 0056 Fax +45 3331 0248 Email stephen.w.pedersen@gmail.comJournal name: Journal of Multidisciplinary Healthcare Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Pedersen et alRunning head recto: MDT management for advanced PDDOI: http://dx.doi.org/10.2147/JMDH.S111369 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/ed/81/jmdh-10-013.PMC5221801.pdf
Or use: http://youtu.be/ddAvX-IUNIM,Non-OADS,/arxiv_data1/oa_pdf/ed/81/jmdh-10-013.PMC5221801.pdf
Available from: http://alt.kompetenznetz-parkinson.de/EPDA_Parkinson_s_standard_nsus_Statement_V ol_I.pdf.,OADS,/arxiv_data1/oa_pdf/ed/81/jmdh-10-013.PMC5221801.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/ed/81/jmdh-10-013.PMC5221801.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 27 MDT management for advanced PD  37.,Non-OADS,/arxiv_data1/oa_pdf/ed/81/jmdh-10-013.PMC5221801.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/db/ijn-12-263.PMC5221802.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 263–277International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  263OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12383 9 long-term intravenous administration of  carboxylated single-walled carbon nanotubes  induces persistent accumulation in the lungs and  pulmonary fibrosis via the nuclear factor-kappa B  pathway Yue Qin1,* suning li2,* gan Zhao2,* Xuanhao Fu1 Xueping Xie1 Yiyi huang1 Xiaojing cheng3 Jinbin Wei1 huagang liu1 Zefeng lai1 1Pharmaceutical college, guangxi  Medical University, 2Department of  Pharmacy, The Maternal and child  health hospital of guangxi Zhuang  autonomous region, 3life sciences  Institute, guangxi Medical University,   Nanning, guangxi, People’s republic  of china *These authors contributed equally  to this workAbstract:  Numerous studies have demonstrated promising application of single-walled carbon  nanotubes (SWNTs) in drug delivery, diagnosis, and targeted therapy.",Non-OADS,/arxiv_data1/oa_pdf/ec/db/ijn-12-263.PMC5221802.pdf
"CNTs are promising candidates for biomedical  applications, such as delivery of therapeutic agents,3,4 diagnosis using near-infrared  imaging, and photothermal treatment.5,6 Commercial products made from CNTs are  now part of daily life, and global production of CNTs has increased at least tenfold  since 2006 to .4.5 kilotons per year.7 Large-scale production and research interest in  CNTs have raised concerns about their potential adverse effects on human health and correspondence: Zefeng lai; huagang liu Pharmaceutical college, guangxi  Medical University, 22 shuangyong road,  Nanning 530021, guangxi, People’s  republic of china Tel +86 771 535 0441 Fax +86 771 535 8272 email laizefeng@foxmail.co m;  46669073@qq.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Qin et al Running head recto: SWNTs cause lung disorders via NF- κB DOI: http://dx.doi.org/10.2147/IJN.S123839",Non-OADS,/arxiv_data1/oa_pdf/ec/db/ijn-12-263.PMC5221802.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ec/db/ijn-12-263.PMC5221802.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/db/ijn-12-263.PMC5221802.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1d/41/jbm-8-001.PMC5221806.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1d/41/jbm-8-001.PMC5221806.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2017:8 1–4Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  1 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S96465Management of psychiatric complications in  unrelated donor before unrelated peripheral  hematopoietic stem cell collections Olivier Hequet1,2  Valerie Mialou2  Francoise Audat3  Eric Wattel4  Valerie Chapel4  Damiela Revesz1  Jean-Piere Jouet3  Brigitte Fisseaux5  Mohamed Saoud6  Mauricette Michallet4 1Apheresis Unit, 2Cell Therapy  Laboratory, Etablissement Français  du Sang (EFS) Rhône Alpes, Centre Hospitalier Lyon Sud, Pierre Bénite,   3Biomedicine Agency, Saint-Denis,   4Hematological Unit, Hospices  Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite,  5Psychiatric  Unit, Hospices Civils de Lyon,  Centre Hospitalier, Bourgoin Jallieu,  6Psychiatric Unit, Hospices  Civils de Lyon, Centre Hospitalier P Wertheimer, Lyon, FranceAbstract: Allogeneic hematopoietic stem cell transplantation can efficiently treat patients with  severe hematological diseases.",Non-OADS,/arxiv_data1/oa_pdf/1d/41/jbm-8-001.PMC5221806.pdf
"Other Correspondence: Olivier Hequet  Centre de santé, Banque de cellules et tissus, Etablissement Français du Sang (EFS), Pavillon Marcel Bérard 1G, Centre Hospitalier Lyon Sud, Chemin du Grand Revoyet, 69495 Pierre Bénite, France Tel +33 4 7886 2273   Fax + 33 4 7886 2297   Email olivier.hequet@efs.sante.frJournal name: Journal of Blood Medicine Article Designation: CASE REPORTY ear: 2017V olume: 8Running head verso: Hequet et alRunning head recto: Management of psychiatric complications in donorDOI: http://dx.doi.org/10.2147/JBM.S96465",Non-OADS,/arxiv_data1/oa_pdf/1d/41/jbm-8-001.PMC5221806.pdf
"Journal of Blood Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/1d/41/jbm-8-001.PMC5221806.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 4 Hequet et al the different teams can be assisted by ethical committees  to define the medical rules that must be followed in these particular situations.,Non-OADS,/arxiv_data1/oa_pdf/1d/41/jbm-8-001.PMC5221806.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/57/1e/jhc-4-011.PMC5221808.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/57/1e/jhc-4-011.PMC5221808.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Hepatocellular Carcinoma 2017:4 11–13Journal of Hepatocellular Carcinoma Dovepress submit your manuscript | www.dovepress.com Dovepress 11 Commentary open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JHC.S122807 Strengthening the case that elevated levels of  programmed death ligand 1 predict poor  prognosis in hepatocellular carcinoma patients Jian-Hong Zhong1,*  Cheng-Piao Luo2,*  Chun-y an Zhang2  Le-Qun Li1 1Hepatobiliary Surgery Department,   2experimental Department, affiliated  tumor Hospital of Guangxi medical  University, nanning, People’s republic  of China *these authors contributed equally to  this workAbstract: Immunotherapy targeting programmed death receptor 1 and programmed death  ligand 1 (PD-L1) has shown impressive antitumor efficacy in several solid cancers, including  advanced hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/57/1e/jhc-4-011.PMC5221808.pdf
"To extend this finding, we  examined eleven Correspondence: Le-Qun Li  Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi medical University, He Di road, #71, nanning 530021, People’s republic of Chinatel +86 771 5330 855Fax +86 771 5312 000 email xitongpingjia@163.comJournal name: Journal of Hepatocellular Carcinoma Article Designation: CommentaryY ear: 2017V olume: 4Running head verso: Zhong et alRunning head recto: Associations of PD-L1 with HCC patientsDOI: http://dx.doi.org/10.2147/JHC.S122807",Non-OADS,/arxiv_data1/oa_pdf/57/1e/jhc-4-011.PMC5221808.pdf
"Journal of Hepatocellular Carcinoma 2017:4submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journalThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina-tion and study of clinical, translational and basic research findings in this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/57/1e/jhc-4-011.PMC5221808.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 13 associations of PD-L1 with HCC patients  2.,Non-OADS,/arxiv_data1/oa_pdf/57/1e/jhc-4-011.PMC5221808.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2017:10 1–9International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 1 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S104208 Continuous ambulatory peritoneal dialysis:  perspectives on patient selection in low- to  middle-income countries Nicola Wearne1 Kajiru Kilonzo2 Emmanuel Effa3 Bianca Davidson1 Peter Nourse4 Udeme Ekrikpo1,5 Ikechi G Okpechi1 1Division of Nephrology and  Hypertension, University of Cape  T own, Cape T own, South Africa;   2Department of Medicine, Kilimanjaro  Christian Medical College, Moshi,  Tanzania;  3Department of Medicine,   University of Calabar, Calabar, Nigeria;   4Division of Paediatric Nephrology,   Red Cross War Memorial Children’s Hospital, Cape T own, South Africa;   5Department of Internal Medicine,   University of Uyo, Uyo, NigeriaAbstract:  Chronic kidney disease is a major public health problem that continues to show an  unrelenting global increase in prevalence.",Non-OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
"Apart from fewer hospital visits, CAPD allows for greater flexibility with  employment Correspondence: Ikechi G Okpechi E13 Renal Unit, Groote Schuur Hospital and University of Cape Town, Observatory, 7925 Cape Town, South AfricaTel +27 21 404 3321Email Ikechi.okpechi@uct.ac.za Journal name: International Journal of Nephrology and Renovascular Disease Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Wearne et alRunning head recto: PD patient selection in LMICsDOI: http://dx.doi.org/10.2147/IJNRD.S104208",Non-OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
Available from: https://www.usrds.,Non-OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
Available from: https://www.usrds.org/2014/view/.,Non-OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
Available from: http://www.who.int/hrh/statistics/hwfstats/en/.,OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
Available from: http://www.fao.org/3/a-y5650e.,Non-OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
"International Journal of Nephrology and Renovascular Disease 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 9 PD patient selection in LMICs  81.,Non-OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
"USRDS 2012 Annual Data Report: Atlas of Chronic Kidney  Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2012. https://www.usrds.org/atlas12.aspx.",Non-OADS,/arxiv_data1/oa_pdf/79/1c/ijnrd-10-001.PMC5221809.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/b4/ijn-12-279.PMC5221810.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 279–294International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  279OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11475 4 Preparation of arginine–glycine–aspartic acid- modified biopolymeric nanoparticles containing  epigalloccatechin-3-gallate for targeting  vascular endothelial cells to inhibit corneal  neovascularization che-Yi chang,1,2,* Ming- chen Wang,2,* Takuya  Miyagawa,1 Zhi-Yu chen,1  Feng-huei lin,3,4 Ko-hua  chen,5,6 guei-sheung liu,7  ching-li Tseng1 1graduate Institute of Biomedical  Materials and Tissue engineering,  college of Biomedical engineering,  Taipei Medical University, Taipei,  2Department of Biomedical engineering,  chung Yuan christian University,  Taoyuan, 3Institute of Biomedical  engineering and Nanomedicine,  National health research Institutes,  Zhunan, 4Institute of Biomedical  engineering, National Taiwan University,  5Department of Ophthalmology,  Taipei Veterans general hospital,  6Department of Ophthalmology, school  of Medicine, college of Medicine,  Taipei Medical University, Taipei, Taiwan;  7centre for eye research australia,  University of Melbourne, Royal  Victorian eye and ear hospital, east  Melbourne, VIC, Australia *These authors contributed equally  to this workAbstract:  Neovascularization (NV) of the cornea can disrupt visual function, causing ocular  diseases, including blindness.",Non-OADS,/arxiv_data1/oa_pdf/a9/b4/ijn-12-279.PMC5221810.pdf
"In general, patients who sustain correspondence: ching-li Tseng graduate Institute of Biomedical  Materials and Tissue engineering, college  of Biomedical engineering, Taipei Medical  University, 250, Wu-hsing street,  Taipei 110, Taiwan Tel +886 2 2736 1661 ext 5214 Fax +886 2 2739 7059 email chingli@tmu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Chang et al Running head recto: Preparation of RGD-HA gelatin–EGCG NPs for corneal NV DOI: http://dx.doi.org/10.2147/IJN.S114754",Non-OADS,/arxiv_data1/oa_pdf/a9/b4/ijn-12-279.PMC5221810.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a9/b4/ijn-12-279.PMC5221810.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/b4/ijn-12-279.PMC5221810.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bc/8a/imcrj-10-001.PMC5221811.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bc/8a/imcrj-10-001.PMC5221811.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 1–5International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 1 Case Repo Rt open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S113217optic neuritis and acute anterior uveitis  associated with influenza A infection: a  case report Hayate Nakagawa Hidetaka Noma osamu Kotake Ryosuke MotohashiKanako YasudaMasahiko shimura Department of Ophthalmology, T okyo  Medical University Hachioji Medical Center, T okyo, JapanBackground: A few reports have described ocular complications of influenza A infection,  such as impaired ocular movement, parasympathetic ocular nerve, keratitis, macular lesion, and  frosted branch angiitis.",Non-OADS,/arxiv_data1/oa_pdf/bc/8a/imcrj-10-001.PMC5221811.pdf
"Case presentation Informed consent was obtained from this patient and this study was approved by the institutional review board of Tokyo Medical University Hachioji Medical Center.Correspondence: Hayate Nakagawa Department of Ophthalmology, Tokyo Medical University Hachioji Medical Center, 1163 Tatemachi, Hachiouji-shi, Tokyo 1930944, Japantel +81 42 665 5611Fax +81 42 665 5639Email rocklife1031@yahoo.co.jpJournal name: International Medical Case Reports Journal Article Designation: Case ReportY ear: 2017V olume: 10Running head verso: Nakagawa et alRunning head recto: Acute anterior uveitis and optic neuritis associated with influenza A infectionDOI: http://dx.doi.org/10.2147/IMCRJ.S113217",Non-OADS,/arxiv_data1/oa_pdf/bc/8a/imcrj-10-001.PMC5221811.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/bc/8a/imcrj-10-001.PMC5221811.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 5 Acute anterior uveitis and optic neuritis associated with influenza A infection neuritis in the left eye, the patient was prescribed topical  prednisolone acetate ophthalmic suspension every 5 hours and high-dose intravenous methylprednisolone 1,000 mg daily for 3 days.",Non-OADS,/arxiv_data1/oa_pdf/bc/8a/imcrj-10-001.PMC5221811.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/16/ijn-12-327.PMC5221813.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 327–345International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  327OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11601 0 gold-quercetin nanoparticles prevent metabolic  endotoxemia-induced kidney injury by regulating  Tlr4/NF- kB signaling and Nrf2 pathway in high  fat diet fed mice Min-Xuan Xu1,2,* Ming Wang3,* Wei-Wei Yang4 1chongqing Key laboratory of  Medicinal resources in the Three  gorges reservoir region, school of  Biological and chemical engineering,   chongqing University of education,   chongqing, 2college of engineering  and applied sciences, Nanjing  University, Nanjing, 3Department  of Urology, The second affiliated  hospital, school of Medicine, Zhejiang  University, hangzhou, Zhejiang,   4Department of Nephrology, huai’an  First People’s hospital, Nanjing  Medical University, Jiangsu, People’s  republic of china *These authors contributed equally  to this workAbstract:  High-fat diet-induced metabolic syndrome followed by chronic kidney disease  caused by intestinal endotoxemia have received extensive attention.",Non-OADS,/arxiv_data1/oa_pdf/0d/16/ijn-12-327.PMC5221813.pdf
"Keywords:  gold-quercetin nanoparticles, kidney injury, podocytes, TLR4/NF- kB, Nrf2 Introduction Accumulating evidence has demonstrated that excess intake of fat may result in  metabolic symptoms, including hyperleptinemia, insulin resistance, and neuroinflam - mation, thus becoming a high risk factor of developing chronic kidney disease (CKD)  in humans and animals.1–3 Lately, high-fat diet (HFD)-induced inflammatory responses  in the peripheral tissues, especially in liver, cardiac muscle, and kidney, have been  well characterized.4–6 In a previous research, HFD was found to be capable of causing correspondence: Wei-Wei Yang Department of Nephrology, huai’an  First People’s hospital, Nanjing Medical  University, 6 Beijing road West, Jiangsu  223300, People’s republic of china email yangweiweihuaian@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Xu et al Running head recto: GQ nanoparticles prevent metabolic endotoxemia-induced kidney injury DOI: http://dx.doi.org/10.2147/IJN.S116010",Non-OADS,/arxiv_data1/oa_pdf/0d/16/ijn-12-327.PMC5221813.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0d/16/ijn-12-327.PMC5221813.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/16/ijn-12-327.PMC5221813.pdf
"Regarding prior  radiation, the authors mention that the late effects of radiation   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Ji Bong Jeong Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University  College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea Tel: +82-2-870-2222, Fax: +82-2-870-3863, E-mail: jibjeong@snu.ac.kr pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16548Investigation of Factors Affecting Clinical Outcomes after Stent Placement  in Malignant Obstruction of the Esophagus or the Gastric Cardia Ji Bong Jeong and Dong-Won Ahn Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National  University College of Medicine, Seoul, Korea  See “Factors That Affect Stent-Related Complications in Patients with Malignant Obstruction of the Esophagus or Gastric  Cardia” by Hiroyasu Iwasaki, et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/7b/gnl-11-001.PMC5221851.pdf
"In this issue of Gut and Liver , Choi et al.9 investigated the   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Chang Soo Eun Department of Internal Medicine, Hanyang University Guri Hospital, 153 Gyeongchun-ro, Guri 11923, Korea  Tel: +82-31-560-2228, Fax: +82-31-555-2998, E-mail: cseun@hanyang.ac.kr pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16574Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean  Inflammatory Bowel Disease Patients?",Non-OADS,/arxiv_data1/oa_pdf/a8/ea/gnl-11-003.PMC5221852.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Byung Ik Jang Department of Internal Medicine, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea  Tel: +82-53-620-3830, Fax: +82-53-654-8386, E-mail: jbi@med.yu.ac.kr pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16549Is Effective of Capsule Endoscopy Compared to Other Diagnostic Modalities  in Patients with Small Bowel Crohn’s Disease?",Non-OADS,/arxiv_data1/oa_pdf/97/1b/gnl-11-005.PMC5221853.pdf
"In this issue of Gut and Liver , Hwang et al.10 made a new at- tempt to re-evaluate the smoking of 1,437 Korean CD patients   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Yoon Tae Jeen Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medi- cine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea Tel: +82-2-920-6555, Fax: +82-2-953-1943, E-mail: ytjeen@korea.ac.kr  pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16534Role of Smoking as a Risk Factor in East Asian Patients with Crohn's Disease  Sung Chul Park1 and Yoon Tae Jeen2 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon,  and 2Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University  College of Medicine, Seoul, Korea  See “Underestimation of Smoking Rates in an East Asian Population with Crohn’s Disease” by Sung Wook Hwang, et al.",Non-OADS,/arxiv_data1/oa_pdf/3c/d5/gnl-11-007.PMC5221854.pdf
Avail- able from: http://www.cdc.go.kr/CDC/contents/CdcKrContentLink.,Non-OADS,/arxiv_data1/oa_pdf/3c/d5/gnl-11-007.PMC5221854.pdf
"As the HVAT is influ- enced by the microbubble extraction rate due to phagocytosis,  Sonazoid with higher extraction rate by Kupffer cells showed   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Soung Won Jeong Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, 59 Daesagwan-ro,  Yongsan-gu, Seoul 04401, Korea Tel: +82-2-710-3076, Fax: +82-2-709-9696, E-mail: jeongsw@schmc.ac.kr pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16563Another Face of Contrast-Enhanced Ultrasonography: A Diagnostic Tool for  Cirrhosis Soung Won Jeong Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea  See “Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis:   A Systematic Review and Meta-Analysis” by Gaeun Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/2a/0d/gnl-11-009.PMC5221855.pdf
"They demonstrated  that the expression levels of Elk-3 and early growth response-1  (Egr-1) were significantly increased during the TGF- β1-induced   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: In Hee Kim Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medi- cal School, 20 Geonji-ro, Deokjin-gu, Jeonju 54907, Korea  Tel: +82-63-250-1677, Fax: +82-63-254-1609, E-mail: ihkimmd@jbnu.ac.kr pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16564The Potential Role of Elk-3/Egr-1 Signaling Pathway in the Epithelial- Mesenchymal Transition during Liver Fibrosis In Hee Kim Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University  Medical School, Jeonju, Korea  See “Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition” by Tian Zhu  Li, et al.",Non-OADS,/arxiv_data1/oa_pdf/80/5e/gnl-11-011.PMC5221856.pdf
"EPIDEMIOLOGY Hepatobiliary malignancies account globally for 13%, and   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Boris Blechacz Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1466,  Houston, TX 77030, USA Tel: +1-713-792-3034, Fax: +1-713-745-9295, E-mail: bblechacz@mdanderson.org Received on November 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/41/7f/gnl-11-013.PMC5221857.pdf
"Published online December 8, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15568Cholangiocarcinoma: Current Knowledge and New Developments Boris Blechacz Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA  Fig.",Non-OADS,/arxiv_data1/oa_pdf/41/7f/gnl-11-013.PMC5221857.pdf
Available  from: http://www.nccn.org/professionals/physician_gls/pdf/hepa-tobiliary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/7f/gnl-11-013.PMC5221857.pdf
"These include enteric-coated tablets, gelatin capsules,   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.25 Years of Proton Pump Inhibitors: A Comprehensive Review Daniel S. Strand1, Daejin Kim2, and David A. Peura1 1Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA, and 2Division of Gastroenterology, Daegu  Fatima Hospital, Daegu, Korea  Correspondence to: Daniel S. Strand Division of Gastroenterology and Hepatology, University of Virginia, PO Box 800708, Charlottesville, VA 22908, USA  Tel: +1-434-297-7207, Fax: +1-434-244-7590, E-mail: DSS7A@Virginia.edu Received on October 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d3/3b/gnl-11-027.PMC5221858.pdf
"Published online November 14, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15502",Non-OADS,/arxiv_data1/oa_pdf/d3/3b/gnl-11-027.PMC5221858.pdf
Available from: http://www.fda.gov/drugs.,Non-OADS,/arxiv_data1/oa_pdf/d3/3b/gnl-11-027.PMC5221858.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ ucm245011.htm.,Non-OADS,/arxiv_data1/oa_pdf/d3/3b/gnl-11-027.PMC5221858.pdf
"Akin to microsatellite instability (MSI), CIMP  is now recognized as one of the most important molecular car-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.CpG Island Methylator Phenotype-High Colorectal Cancers and Their  Prognostic Implications and Relationships with the Serrated Neoplasia Pathway  Ye-Young Rhee, Kyung-Ju Kim, and Gyeong Hoon Kang Department of Pathology, Seoul National University College of Medicine, Seoul, Korea  Correspondence to: Gyeong Hoon Kang Department of Pathology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea  Tel: +82-2-740-8263, Fax: +82-2-743-5530, E-mail: ghkang@snu.ac.kr Received on October 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e3/b8/gnl-11-038.PMC5221859.pdf
"Published online November 28, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15535",Non-OADS,/arxiv_data1/oa_pdf/e3/b8/gnl-11-038.PMC5221859.pdf
"Siersema  et al.13 reported that  procedure-related complications were more common with the covered Gianturco-Z stent (Cook Medical, Bloomington, IN,  USA) than with the covered Flamingo Wallstent or the covered  Ultraflex stent (Boston Scientific, Natick, MA, USA), although  May  et al.14 found no differences in the occurrence of complica- tions and recurrence of dysphagia among patients who received   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Factors That Affect Stent-Related Complications in Patients with Malignant  Obstruction of the Esophagus or Gastric Cardia Hiroyasu Iwasaki1, Takashi Mizushima1, Yuta Suzuki1, Shigeki Fukusada1, Kenta Kachi1, Takanori Ozeki1, Kaiki Anbe1,  Hironobu Tsukamoto1, Fumihiro Okumura1, Takashi Joh2, and Hitoshi Sano1 1Department of Gastroenterology, Gifu Prefectural Tajimi Hospital, Tajimi, and 2Department of Gastroenterology and Metabolism, Nagoya City  University Graduate School of Medical Sciences, Nagoya, Japan  Correspondence to: Hiroyasu Iwasaki Department of Gastroenterology, Gifu Prefectural Tajimi Hospital, 161-5 Maehata-cho, Tajimi 507-8522, Japan  Tel: +81-572-22-5311, Fax: +81-572-25-1246, E-mail: iwasaki-hiroyasu@tajimi-hospital.jp Received on March 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/6c/f9/gnl-11-047.PMC5221860.pdf
"Published online October 13, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16172See editorial on page 1.",Non-OADS,/arxiv_data1/oa_pdf/6c/f9/gnl-11-047.PMC5221860.pdf
"Measuring serum IFX TLs and ATIs may predict the  course of IFX treatment in individual patients and optimize the   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical Use of Measuring Trough Levels and Antibodies against Infliximab  in Patients with Pediatric Inflammatory Bowel Disease So Yoon Choi1, Ben Kang1, Jee Hyun Lee2, and Yon Ho Choe1 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, and 2Department of Pediatrics,  Korea University Ansan Hospital, Korea University School of Medicine, Ansan, Korea  Correspondence to: Yon Ho Choea and Jee Hyun Leeb  aDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea   Tel: +82-2-3410-3527, Fax: +82-2-3410-0043, E-mail: yonho.choe@samsung.com bDepartment of Pediatrics, Korea University Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea  Tel: +82-31-412-7619, Fax: +82-31-405-8591, E-mail: izzihn@gmail.com Received on January 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/7c/4b/gnl-11-055.PMC5221861.pdf
"Published online September 9, 2016 pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16041See editorial on page 3.",Non-OADS,/arxiv_data1/oa_pdf/7c/4b/gnl-11-055.PMC5221861.pdf
"In the present study, we aimed to evaluate the diagnostic yield  of CE, compared with other diagnostic modalities, in patients  with suspected and established CD, using previous and newly   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effectiveness of Capsule Endoscopy Compared with Other Diagnostic  Modalities in Patients with Small Bowel Crohn’s Disease: A Meta-Analysis Miyoung Choi1, Sungwon Lim1, Myung-Gyu Choi2, Ki-Nam Shim3, and Seon Heui Lee4 1National Evidence-based Healthcare Collaborating Agency, 2Department of Internal Medicine, The Catholic University of Korea College of  Medicine, 3Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, and 4Department of Nursing Science, College  of Nursing, Gachon University, Incheon, Korea  Correspondence to: Ki-Nam Shima and Seon Heui Leeb aDepartment of Internal Medicine, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea Tel: +82-2-2650-2632, Fax: +82-2-2655-2076, E-mail: shimkn@ewha.ac.kr  bDepartment of Nursing Science, College of Nursing, Gachon University, 191 Hambangmoe-ro, Yeonsu-gu, Incheon 21936, Korea  Tel: +82-32-820-4235, Fax: +82-32-820-4201, E-mail: sunarea87@gachon.ac.kr  Received on January 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/50/4c/gnl-11-062.PMC5221862.pdf
"Published online October 13, 2016 pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16015See editorial on page 5.",Non-OADS,/arxiv_data1/oa_pdf/50/4c/gnl-11-062.PMC5221862.pdf
"Study population We prospectively re-evaluated smoking status at CD diagnosis   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Underestimation of Smoking Rates in an East Asian Population with Crohn’s  Disease Sung Wook Hwang1, Hyungil Seo1, Gwang-Un Kim1, Eun Mi Song1, Myeongsook Seo1, Sang Hyoung Park1, Eunja Kwon1,  Ho-Su Lee2, Dong-Hoon Yang1, Kyung-Jo Kim1, Byong Duk Ye1, Jeong-Sik Byeon1, Seung-Jae Myung1, Jin-Ho Kim1, and  Suk-Kyun Yang1 1Department of Gastroenterology and 2Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine,  Seoul, Korea   Correspondence to: Suk-Kyun Yang Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505,  Korea Tel: +82-2-3010-3901, Fax: +82-2-476-0824, E-mail: sky@amc.seoul.kr Received on April 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e7/71/gnl-11-073.PMC5221863.pdf
"Published online October 13, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16194See editorial on page 7.",Non-OADS,/arxiv_data1/oa_pdf/e7/71/gnl-11-073.PMC5221863.pdf
Available from: http://www.cdc.go.kr/CDC/notice/ CdcKrIntro0504.jsp?menuIds=HOME001-MNU1154-MNU0004- MNU0110 &cid=65024.,OADS,/arxiv_data1/oa_pdf/e7/71/gnl-11-073.PMC5221863.pdf
Available from: http://www.cdc.go.kr/CDC/intro/CdcKrIntro0201.jsp?menuIds=HOME001-MNU1154- MNU0005-MNU0011 &cid=66275.,OADS,/arxiv_data1/oa_pdf/e7/71/gnl-11-073.PMC5221863.pdf
"It is known that H.  pylori  activates NF- κB in a Cag pathogenicity island-dependent  manner and subsequently induces the up-regulation of cIAP2   expression.7,12 Expression of both NF- κB and cIAP2  increased  when gastric cancer cell lines were cocultured with CagA - positive H. pylori .12 Conversely, knockdown of cIAP2  in gastric  cancer cell lines resulted in increased apoptosis, decreased cell  proliferation, and delayed cell migration.13 In mouse models, H.   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Helicobacter pylori  Eradication Downregulates Cellular Inhibitor of  Apoptosis Protein 2 in Gastric Carcinogenesis Hyuk Yoon1, Sang Gyun Kim2, Bo Kyoung Kim2, Eun Shin3, Nayoung Kim1,2, Hyuk-Joon Lee4, Gyeong Hoon Kang5, and  Hyun Chae Jung2 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 2Department of Internal Medicine and Liver Research  Institute, Seoul National University College of Medicine, Seoul, 3Department of Pathology, Seoul National University Bundang Hospital,  Seongnam, Departments of 4Surgery and 5Pathology, Seoul National University College of Medicine, Seoul, Korea  Correspondence to: Sang Gyun Kim Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul  03080, Korea Tel: +82-2-740-8112, Fax: +82-2-743-6701, E-mail: harley1333@hanmail.net Received on November 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f6/77/gnl-11-079.PMC5221864.pdf
"Published online June 13, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15585",Non-OADS,/arxiv_data1/oa_pdf/f6/77/gnl-11-079.PMC5221864.pdf
"For analysis  using the ∆∆Ct method, we used the PCR Array Data Analysis  Software (SaBiosciences; http://pcrdataanalysis.sabiosciences.",OADS,/arxiv_data1/oa_pdf/f6/77/gnl-11-079.PMC5221864.pdf
"Since the European   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Quality of Life after Endoscopic Submucosal Dissection for Early Gastric  Cancer: A Prospective Multicenter Cohort Study Sang Gyun Kim1, Seon Mi Ji2,3, Na Rae Lee2, Seung-Hee Park2, Ji Hye You2, Il Ju Choi4, Wan Sik Lee5, Seun Ja Park6, Jun  Haeng Lee7, Sang-Yong Seol8, Ji Hyun Kim8, Chul-Hyun Lim9, Joo Young Cho10,11, Gwang Ha Kim12, Hoon Jai Chun13, Yong  Chan Lee14, Hwoon-Yong Jung15, and Jae J. Kim7 1Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 2National Evidence-Based  Healthcare Collaborating Agency, 3National Health Insurance Service, Seoul, 4Center for Gastric Cancer, National Cancer Center, Goyang,  5Department of Internal Medicine, Chonnam National University Medical School, Gwangju, 6Department of Internal Medicine, Kosin University  College of Medicine, Busan, 7Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  8Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, 9Department of Internal Medicine, The Catholic University of  Korea College of Medicine, 10Digestive Disease Center, Soonchunhyang University Hospital, Seoul, 11Digestive Disease Center, CHA Bundang  Medical Center, CHA University, Seongnam, 12Department of Internal Medicine, Pusan National University School of Medicine, Busan,  13Department of Internal Medicine, Institute of Digestive Diseases and Nutrition, Korea University College of Medicine, 14Department of Internal  Medicine, Yonsei University College of Medicine, and 15Department of Gastroenterology, Asan Medical Center, University of Ulsan College of  Medicine, Seoul, Korea   Correspondence to: Jae J. Kim Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul  06351, Korea Tel: +82-2-3410-3404, Fax: +82-2-3410-6983, E-mail: jjkim@skku.edu Received on October 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3d/50/gnl-11-087.PMC5221865.pdf
"Published online June 13, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15549Sang Gyun Kim and Seon Mi Ji contributed equally to this work as first author.",Non-OADS,/arxiv_data1/oa_pdf/3d/50/gnl-11-087.PMC5221865.pdf
"The technique   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with   Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis Gaeun Kim1, Kwang Yong Shim2, and Soon Koo Baik2 1Department of Nursing, Keimyung University College of Nursing, Daegu, and 2Department of Internal Medicine, Wonju Severance Christian  Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea  Correspondence to: Soon Koo Baika and Kwang Yong Shimb aDepartment of Internal Medicine, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Korea  Tel: +82-33-741-1223, Fax: +82-33-745-6782, E-mail: baiksk@yonsei.ac.kr bDepartment of Internal Medicine, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Korea  Tel: +82-33-741-1202, Fax: +82-33-745-6782, E-mail: kyshim@yonsei.ac.kr Received on January 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d8/08/gnl-11-093.PMC5221866.pdf
"Published online August 19, 2016 pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16031See editorial on page 9.",Non-OADS,/arxiv_data1/oa_pdf/d8/08/gnl-11-093.PMC5221866.pdf
"5 Recent study has demonstrated that hepatocytes  can contribute to the accumulation of activated fibroblasts via  EMT.6 In addition, EMT plays an important role in wound heal- ing and cancer metastasis as well as organ fibrosis.7 Among  many cytokines involved in the process of EMT, transforming growth factor (TGF)- β1 plays a key role in the initiation of   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the  Epithelial-Mesenchymal Transition Tian Zhu Li1,2, Sung Min Kim1, Wonhee Hur1, Jung Eun Choi1, Jung-Hee Kim1, Sung Woo Hong1, Eun Byul Lee1, Joon Ho  Lee1, and Seung Kew Yoon1 1The Catholic University Liver Research Center & WHO Collaborating Center of Viral Hepatitis, The Catholic University of Korea College of  Medicine, Seoul, Korea, and 2Molecular Medicine Research Center, Chifeng University School of Medical Science, Chifeng, China  Correspondence to: Seung Kew Yoon Department of Internal Medicine, Seoul St. Mary’s Hospital, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea  Tel: +82-2-2258-7534, Fax: +82-2-536-9559, E-mail: yoonsk@catholic.ac.kr Received on November 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/57/3b/gnl-11-102.PMC5221867.pdf
"Published online August 19, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15566See editorial on page 11.",Non-OADS,/arxiv_data1/oa_pdf/57/3b/gnl-11-102.PMC5221867.pdf
"Actually, combi- nation of more than one biomarker may improve the accuracy  of HCC diagnoses.16   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the  Pathogenesis of Hepatocellular Carcinoma  Juan Chen1, Zhenwen Qian2, Fengling Li3, Jinzhi Li4, and Yi Lu5 1Four Ward, Taian Disabled Soldiers Hospital of Shandong Province, Taian, 2Department of Inspection, Affiliated Hospital of Jining Medical  College of Shandong Province, Jining, 3Nursing Department, Taian Disabled Soldiers Hospital of Shandong Province, Taian, Departments of  4Pathology and 5Orthopedics, People’s Hospital of Zhangqiu City, Zhangqiu, China  Correspondence to: Zhenwen Qian Department of Inspection, Affiliated Hospital of Jining Medical College of Shandong Province, No.79 Guhuai Road, Rencheng District, Jining  272029, China Tel: +86-186-5371-9678, Fax: +86-0537-2903223, E-mail: qian_zhenwen@126.com Received on February 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/87/f3/gnl-11-112.PMC5221868.pdf
"Published online July 27, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16063Juan Chen and Zhenwen Qian contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/87/f3/gnl-11-112.PMC5221868.pdf
"Eligible datasets of HCC GEO database is a public functional genomics data reposi- tory (http://www.ncbi.nlm.nih.gov/geo/).17 By online search, the  gene expression profiles of HCC were obtained from the GEO  database.",OADS,/arxiv_data1/oa_pdf/87/f3/gnl-11-112.PMC5221868.pdf
"In order to better understand disease  mechanisms and obtain cells for disease modelling and drug  screening, three-dimensional (3D) structures are desirable 15,16   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Generation of Multilayered 3D Structures of HepG2 Cells Using a Bio-printing  Technique Hyeryeon Jeon1, Kyojin Kang1, Su A Park2, Wan Doo Kim2, Seung Sam Paik3, Sang-Hun Lee4, Jaemin Jeong1, and Dongho  Choi1 1Department of Surgery, Hanyang University College of Medicine, Seoul, 2Department of Nature-Inspired Nano Convergence Systems, Korea  Institute of Machinery and Materials, Daejeon, 3Department of Pathology, Hanyang University College of Medicine, Seoul, and 4Department of  Biomedical Science, Graduate School of Biomedical Science Engineering, Hanyang University, Seoul, Korea  Correspondence to: Dongho Choia and Jaemin Jeongb aDepartment of Surgery, Hanyang University College of Medicine, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea   Tel: +82-2-2290-8449, Fax: +82-2-2281-0224, E-mail: crane87@hanyang.ac.kr bDepartment of Surgery, Hanyang University College of Medicine, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea Tel: +82-2-2220-0647, Fax: +82-2-2281-0224, E-mail: jmj1103@gmail.com Received on January 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/gnl-11-121.PMC5221869.pdf
"Published online August 25, 2016 pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16010",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/gnl-11-121.PMC5221869.pdf
"Various rescue therapies have been used for CLV-resistant   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter  Cohort Study Eun Young Cho1, Hyung Joon Yim2, Young Kul Jung2, Sang Jun Suh2, Yeon Seok Seo3, Ji Hoon Kim3, Hong Soo Kim4, Sae  Hwan Lee4, Sang Hoon Ahn5, Jeong Il Lee5, Sook-Hyang Jeong6, Jin-Wook Kim6, Jin-Woo Lee7, In Hee Kim8, Hyoung Su  Kim9, Sang Jong Park10, Jeong Mi Lee11, and Seong Gyu Hwang12; on behalf of Antiviral Resistance Study Group 1Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, 2Department of Internal Medicine, Korea University  Ansan Hospital, Korea University College of Medicine, Ansan, 3Department of Internal Medicine, Korea University College of Medicine,  Seoul, 4Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, 5Department of Internal Medicine,  Yonsei University College of Medicine, Seoul, 6Department of Internal Medicine, Seoul National University College of Medicine, Seongnam,  7Department of Internal Medicine, Inha University School of Medicine, Incheon, 8Department of Internal Medicine, Chonbuk National  University Medical School, Jeonju, 9Department of Internal Medicine, Hallym University College of Medicine, Seoul, 10Bundang Jesaeng  Hospital, Seongnam, 11Department of Public Health, Wonkwang University Graduate School, Iksan, and 12Department of Internal Medicine,  CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea  Correspondence to: Hyung Joon Yima and Seong Gyu Hwangb aDepartment of Internal Medicine, Korea University Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea  Tel: +82-31-412-6565, Fax: +82-31-412-5582, E-mail: gudwns21@korea.ac.kr bDepartment of Internal Medicine, CHA Bundang Medical Center, 59 Yatap-ro, Bundang-gu, Seongnam 13496, Korea  Tel: +82-31-780-5213, Fax: +82-2-780-5246, E-mail: gudwns21@korea.ac.kr Received on November 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/90/ed/gnl-11-129.PMC5221870.pdf
"Published online August 19, 2016 pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15597",Non-OADS,/arxiv_data1/oa_pdf/90/ed/gnl-11-129.PMC5221870.pdf
"Thus, in this study, we de- scribed hereditary and nonhereditary cases of persistent AFP  elevation in healthy adults from South Korea and broadened the   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Persistent	α-Fetoprotein	Elevation	in	Healthy	Adults	and	Mutational	 Analysis	of	α-Fetoprotein	Promoter,	Enhancer,	and	Silencer	Regions	 Yejoo Jeon, Yun Suk Choi, Eun Sun Jang, Jin Wook Kim, and Sook-Hyang Jeong Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam,  Korea Correspondence to: Sook-Hyang Jeong Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173  beon-gil, Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7029, Fax: +82-31-787-4052, E-mail: jsh@snubh.org Received on February 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/6e/2b/gnl-11-136.PMC5221871.pdf
"Published online September 9, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16069",Non-OADS,/arxiv_data1/oa_pdf/6e/2b/gnl-11-136.PMC5221871.pdf
"We have used an ARMS with a funnel-shaped antireflux valve  and have sought the effectiveness of the ARMS on patients who  experienced covered SEMS occlusion due to the duodenobili- ary reflux,15 and thus, were considered to be at a higher risk for  recurrent occlusion of a subsequent SEMS.17-19 In our pilot study  of 13 patients, we demonstrated that the ARMS provided a safe  reintervention for covered SEMS occlusion due to sludge or  food impaction and significantly longer patency time compared  with the occluded SEMS in the same cohort.15 Based on the promising results of ARMS as a reintervention   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Antireflux Metal Stent as a First-Line Metal Stent for Distal Malignant  Biliary Obstruction: A Pilot Study Tsuyoshi Hamada1, Hiroyuki Isayama1,2, Yousuke Nakai1, Osamu Togawa1, Naminatsu Takahara1, Rie Uchino1, Suguru  Mizuno1, Dai Mohri1, Hiroshi Yagioka2, Hirofumi Kogure1, Saburo Matsubara1, Natsuyo Yamamoto1, Yukiko Ito3, Minoru  Tada1, and Kazuhiko Koike1 1Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 2Department of Gastroenterology, Tokyo Metropolitan  Police Hospital, and 3Department of Gastroenterology, Japanese Red Cross Medical Center, Tokyo, Japan  Correspondence to: Hiroyuki Isayama Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan  Tel: +81-3-3815-5411, Fax: +81-3-3814-0021, E-mail: isayama-tky@umin.ac.jp Received on November 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d4/c2/gnl-11-142.PMC5221872.pdf
"Published online June 13, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15579",Non-OADS,/arxiv_data1/oa_pdf/d4/c2/gnl-11-142.PMC5221872.pdf
"The aim of this study was to verify the technical feasibil-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Feasibility of Endoscopic Papillary Large Balloon Dilation in Patients  with Difficult Bile Duct Stones without Dilatation of the Lower Part of the Extrahepatic Bile Duct Yuji Fujita1, Akito Iwasaki1, Takamitsu Sato1, Toshio Fujisawa2, Yusuke Sekino1, Kunihiro Hosono1, Nobuyuki Matsuhashi2,  Kentaro Sakamaki3, Atsushi Nakajima1, and Kensuke Kubota1 1Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, 2Department of Gastroenterology,  NTT Tokyo Medical Center, Tokyo, and 3Department of Medical Statistic, Yokohama City University School of Medicine, Yokohama, Japan  Correspondence to: Kensuke Kubota Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura Kanazawa-ku, Yokohama 236-0004,  Japan Tel: +81-45-787-2800, Fax: +81-45-787-2866, E-mail: kubotak@yokohama-cu.ac.jp Received on December 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d2/5c/gnl-11-149.PMC5221873.pdf
"Published online August 19, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15634",Non-OADS,/arxiv_data1/oa_pdf/d2/5c/gnl-11-149.PMC5221873.pdf
"Therefore, present studies increasingly focus  on how to raise the concentration of anti-proteases in pancre-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Protection Provided by a Gabexate Mesylate Thermo-Sensitive In Situ Gel  for Rats with Grade III Pancreatic Trauma Hanjing Gao1,2, Qing Song3, Faqin Lv1, Shan Wang4, Yiru Wang1, Xiaoyan Li1, Yukun Luo1, Xingguo Mei4, and Jie Tang1 1Department of Ultrasound, Chinese PLA General Hospital, Beijing, 2Department of Ultrasound, 161th Hospital of Chinese PLA, Wuhan,  3Department of Radiology, General Hospital of Beijing Military Region, Beijing, and 4Department of Pharmaceutics, Beijing Institute of  Pharmacology and Toxicology, Beijing, China  Correspondence to: Jie Tang  Department of Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China  Tel: +86-1068282055, Fax: +86-1068282055, E-mail: txiner@vip.sina.com Received on June 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/67/1f/gnl-11-156.PMC5221874.pdf
"Published online September 20, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15281Hanjing Gao and Qing Song contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/67/1f/gnl-11-156.PMC5221874.pdf
"The total volume was calculated, and analysis was  performed using Origin 9.5 software (OriginLab, Northampton,  MA, USA; http://www.originlab.com/).",OADS,/arxiv_data1/oa_pdf/67/1f/gnl-11-156.PMC5221874.pdf
"EMR was performed and included the clip   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Colored Ring-Shaped Thread Tag Clippings to Identify the Accurate Location  of Multiple Polyps Resected via Endoscopic Mucosal Resection Hirohito Mori, Hideki Kobara, and Tsutomu Masaki Department of Gastroenterology and Neurology, Kagawa University, Kagawa, Japan  Correspondence to: Hirohito Mori Department of Gastroenterology and Neurology, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita, Kagawa 761-0793, Japan  Tel: +81-87-891-2156, Fax: +81-87-891-2158, E-mail: hiro4884@med.kagawa-u.ac.jp Received on April 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/37/47/gnl-11-164.PMC5221875.pdf
"Published online October 13, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16197Fig.",Non-OADS,/arxiv_data1/oa_pdf/37/47/gnl-11-164.PMC5221875.pdf
"The current  literature is divided with many studies that support, to some  extent, the findings within this paper, 5,6 whereas other studies  have not supported all the authors’ conclusions.7 According to  Hill’s criteria for causation, the strength of the association for   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Critical Appraisal of “Association between Diet and Lifestyle Habits and  Irritable Bowel Syndrome: A Case-Control Study” Samantha Noseworthy Memorial University of Newfoundland, St. John's, Newfoundland, Canada  Correspondence to: Samantha Noseworthy Memorial University of Newfoundland, 230 Elizabeth Avenue, St. John’s, Newfoundland, Canada  Tel: +1-709-728-2529, Fax: +1-709-864-2337, E-mail: skno57@mun.ca Received on April 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/77/f0/gnl-11-166.PMC5221876.pdf
"Published online November 24, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16196",Non-OADS,/arxiv_data1/oa_pdf/77/f0/gnl-11-166.PMC5221876.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Reply: The Characteristics about Our Study in Irritable Bowel Syndrome Kang-Min Zhuang, Yu-Bin Guo, and Si-De Liu Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University,  Guangzhou, China  Correspondence to: Si-De Liu Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University,  Guangzhou, Guangdong Province, China Tel: +86-13265036054, Fax: +86-2061641114, E-mail: liuside2013@163.com.",Non-OADS,/arxiv_data1/oa_pdf/a3/81/gnl-11-168.PMC5221877.pdf
"Published online November 24, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16346",Non-OADS,/arxiv_data1/oa_pdf/a3/81/gnl-11-168.PMC5221877.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/78/nihms793483.PMC5222523.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f2/89/jpr-10-073.PMC5222567.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f2/89/jpr-10-073.PMC5222567.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 73–77Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  73 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S121441Serratus anterior plane block for hybrid  transthoracic esophagectomy: a pilot study Cinzia Barbera1 Pamela Milito2 Michele Punturieri1 Emanuele Asti2 Luigi Bonavina2 1Anesthesiology Unit, 2Department  of General Surgery, IRCCS Policlinico  San Donato, University of Milan Medical School, Milano, ItalyBackground: Pain is a major limiting factor in patient’ s recovery from major thoracic surgi- cal procedures.",Non-OADS,/arxiv_data1/oa_pdf/f2/89/jpr-10-073.PMC5222567.pdf
"The serratus anterior plane (SAP) block provides a prolonged anesthesia of the  Correspondence: Luigi Bonavina Department of Surgery, IRCCS Policlinico San Donato, Piazza Malan 1, 20097 San Donato Milanese, Milano, Italy   Email luigi.bonavina@unimi.itJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Barbera et alRunning head recto: SAP block for hybrid transthoracic esophagectomyDOI: http://dx.doi.org/10.2147/JPR.S121441",Non-OADS,/arxiv_data1/oa_pdf/f2/89/jpr-10-073.PMC5222567.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/f2/89/jpr-10-073.PMC5222567.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 77 SAP block for hybrid transthoracic esophagectomy block in a series of patients undergoing hybrid transthoracic  esophagectomy.,Non-OADS,/arxiv_data1/oa_pdf/f2/89/jpr-10-073.PMC5222567.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2d/0c/jpr-10-101.PMC5222568.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2d/0c/jpr-10-101.PMC5222568.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 101–103Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  101 EDITORIAL open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S125715The burden of chronic pain and the role of  neurorehabilitation: consensus matters where  evidence is lacking Stefano Tamburin1 Stefano Paolucci2 Nicola Smania1,3 Giorgio Sandrini4,5 1Department of Neurosciences,   Biomedicine and Movement  Sciences, University of Verona,  Verona,  2Santa Lucia Foundation,   IRCCS, Rome, 3Neuromotor and  Cognitive Rehabilitation Research Centre, University of Verona, Verona,   4C.",Non-OADS,/arxiv_data1/oa_pdf/2d/0c/jpr-10-101.PMC5222568.pdf
"Among the medical conditions requiring rehabilitation in the US, for example, low back pain and arthritis carry the highest Correspondence: Stefano Tamburin Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Piazzale Scuro 10, I-37134 Verona, ItalyTel +39 045 812 4285Fax +39 045 802 7276Email stefano.tamburin@univr.itJournal name: Journal of Pain Research  Article Designation: EDITORIALY ear: 2017V olume: 10Running head verso: Tamburin et alRunning head recto: Pain and neurorehabilitation: consensus mattersDOI: http://dx.doi.org/10.2147/JPR.S125715",Non-OADS,/arxiv_data1/oa_pdf/2d/0c/jpr-10-101.PMC5222568.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/2d/0c/jpr-10-101.PMC5222568.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 103 Pain and neurorehabilitation: consensus matters  7.,Non-OADS,/arxiv_data1/oa_pdf/2d/0c/jpr-10-101.PMC5222568.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601605/DC1text S1.,Non-OADS,/arxiv_data1/oa_pdf/12/41/1601605.PMC5222578.pdf
Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.str.2016.11.008,Non-OADS,/arxiv_data1/oa_pdf/03/ef/main.PMC5222590.pdf
"Structure Article Structural Basis for Regulation and Speciﬁcity of Fructooligosaccharide ImportinStreptococcus pneumoniae Simone Culurgioni,1,2Gemma Harris,2Anirudh K. Singh,3Samantha J. King,3,4and Martin A. Walsh1,2,5,* 1Diamond House, Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, UK 2Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK 3Center for Microbial Pathogenesis, The Research Institute at Nationwide Children’s Hospital, Columbus, OH 43205, USA 4Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43210, USA 5Lead Contact *Correspondence: martin.walsh@diamond.ac.uk http://dx.doi.org/10.1016/j.str.2016.11.008 SUMMARY Streptococcus pneumoniae is dependent on carbo- hydrate uptake for colonization and pathogenesis,and dedicates over a third of its transport systemsto their uptake.",Non-OADS,/arxiv_data1/oa_pdf/03/ef/main.PMC5222590.pdf
Published by Elsevier Ltd. 79 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/ef/main.PMC5222590.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, two ﬁgures, three tables, and one movie and can be found with this articleonline at http://dx.doi.org/10.1016/j.str.2016.11.008 .",Non-OADS,/arxiv_data1/oa_pdf/03/ef/main.PMC5222590.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e7/c5/jpr-10-089.PMC5222600.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e7/c5/jpr-10-089.PMC5222600.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research Journal of Pain Research 2017:10 89–99Dovepress submit your manuscript | www.dovepress.com Dovepress  89 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S121328Depression, social factors, and pain perception  before and after surgery for lumbar and cervical  degenerative vertebral disc disease Renata Jabłońska1 Robert Ślusarz1 Agnieszka Królikowska1 Beata Haor1 Anna Antczak1 Maria Szewczyk2 1Neurological and Neurosurgical  Nursing Department; 2Department  of Surgery Nursing, Faculty of  Health Science, The Ludwik Rydygier Collegium Medicum in Bydgoszcz, The Nicolaus Copernicus University,T oruń,  Bydgoszcz, PolandObjectives:  The purpose of this study was to evaluate the effects of psychosocial factors on  pain levels and depression, before and after surgical treatment, in patients with degenerative  lumbar and cervical vertebral disc disease.",Non-OADS,/arxiv_data1/oa_pdf/e7/c5/jpr-10-089.PMC5222600.pdf
"The approach to surgical intervention is Correspondence: Renata Jabłońska  Neurological and Neurosurgical Nursing Department, Faculty of Health Science, The Ludwik Rydygier Collegium Medicum in Bydgoszcz, The Nicolaus Copernicus University, Toruń, 1 Łukasiewicza St, 85–821 Bydgoszcz, PolandTel +48 52 585 5831Fax +48 52 585 5809Email renjab_1@wp.pl Journal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Jabłońska et alRunning head recto: Assessment of depressive disorders before and after disc surgeryDOI: http://dx.doi.org/10.2147/JPR.S121328",Non-OADS,/arxiv_data1/oa_pdf/e7/c5/jpr-10-089.PMC5222600.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e7/c5/jpr-10-089.PMC5222600.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 99 Assessment of depressive disorders before and after disc surgery,Non-OADS,/arxiv_data1/oa_pdf/e7/c5/jpr-10-089.PMC5222600.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b1/5c/jpr-10-079.PMC5222601.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b1/5c/jpr-10-079.PMC5222601.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 79–88Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  79 PeRsPectives open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S123828sonographic tracking of trunk nerves: essential for  ultrasound-guided pain management and research Ke-vin chang1,2 chih-Peng Lin2,3 chia-shiang Lin4,5  Wei-ting Wu1 Manoj K Karmakar6 Levent Özçakar7 1Department of Physical Medicine  and Rehabilitation, National taiwan  University Hospital, Bei-Hu Branch,   taipei, taiwan; 2National taiwan  University college of Medicine,   taipei, taiwan; 3Department of  Anesthesiology, National taiwan  University Hospital, taipei, taiwan;   4Department of Anesthesiology,   Mackay Memorial Hospital, taipei,   taiwan; 5Mackay Medicine, Nursing  and Management college, Mackay Medical college, taipei, taiwan;   6Department of Anesthesia and  intensive care, chinese University  of Hong Kong, Prince of Wales Hospital, New territories, Hong  Kong;  7Department of Physical and  Rehabilitation Medicine, Hacettepe University Medical school, Ankara,   turkeyAbstract:  Delineation of architecture of peripheral nerves can be successfully achieved by  high-resolution ultrasound (US), which is essential for US-guided pain management.",Non-OADS,/arxiv_data1/oa_pdf/b1/5c/jpr-10-079.PMC5222601.pdf
"7, chung shan s Rd, Zhongzheng Dist, taipei city 10002, taiwanemail cplin0123@gmail.comJournal name: Journal of Pain Research  Article Designation: PerspectivesY ear: 2017V olume: 10Running head verso: Chang et alRunning head recto: Sonographic tracking of trunk nerveDOI: http://dx.doi.org/10.2147/JPR.S123828",Non-OADS,/arxiv_data1/oa_pdf/b1/5c/jpr-10-079.PMC5222601.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/b1/5c/jpr-10-079.PMC5222601.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 88 chang et al  4.,Non-OADS,/arxiv_data1/oa_pdf/b1/5c/jpr-10-079.PMC5222601.pdf
Available at: http://www.agreetrust.org.,Non-OADS,/arxiv_data1/oa_pdf/80/4b/gox-4-0e872.PMC5222633.pdf
This video is available  in the “related videos” section of the full-text article on  PRSGlobalOpen.com or available at http://links.lww.com/ PRSGO/A348).,Non-OADS,/arxiv_data1/oa_pdf/9f/4e/gox-4-e1031.PMC5222634.pdf
t his  video is available in the “related videos” section of the full-text   article on pRsGlobalopen.com or available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/9f/4e/gox-4-e1031.PMC5222634.pdf
"The former mouse model  has been shown to faithfully report NF-κ B transcriptional ac- tivity in a number of tissues including adipose tissue.11 MATERIALS	AND	METHODS Cells	and	Transgenic	Mice Transgenic mice with luciferase driven by NF-κB have  been described.12 ATMSCs were isolated from wild-type  C57BL/6 mice or transgenic mice for luciferase in the  same genetic background driven by a constitutive promot- er (see	 Document,	 Supplemental	 Digital	 Content	 1, which  displays generation of transgenic mice, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/dd/38/gox-4-e1110.PMC5222639.pdf
"For the comput-erized quantitative analyses, the open source software Im-ageJ (http://rsbweb.nih.gov/ij/) and Adobe Photoshop (CS5 or CC) were used.",OADS,/arxiv_data1/oa_pdf/dd/38/gox-4-e1110.PMC5222639.pdf
"Statistical	Analysis Benjamini–Hochberg correction was used for correc- tion of multiple testing (R software), and the power of 2-sample comparison was calculated with Sampsize soft-ware (http://sampsize.sourceforge.net/).",OADS,/arxiv_data1/oa_pdf/dd/38/gox-4-e1110.PMC5222639.pdf
"With only a  single pedicle (right side), the circulation of the adipose  flap of the contralateral side was poor, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/b3/93/gox-4-e1123.PMC5222642.pdf
"With only a single pedicle (right side), the circulation of the adipose flap of the contralateral side was poor, http://links.lww.com/PRSGO/A287) (Blue spot: perforator, blue line: boundary line of adequate flap circulation with single pedicle.)",Non-OADS,/arxiv_data1/oa_pdf/b3/93/gox-4-e1123.PMC5222642.pdf
"(See video, Supplemental  Digital Content 2, which displays adding blood flow from a con-tralateral pedicle (left side), entire part of the adipose flap became viable, http://links.lww.com/PRSGO/A288).",Non-OADS,/arxiv_data1/oa_pdf/b3/93/gox-4-e1123.PMC5222642.pdf
"With only a single pedicle (right side), the circula-tion of the adipose flap of the contralateral side was poor, http://links.lww.com/PRSGO/A287.",Non-OADS,/arxiv_data1/oa_pdf/b3/93/gox-4-e1123.PMC5222642.pdf
"See video, Supplemental Digital c ontent 2, which  displays adding blood flow from a contralateral pedicle (left side), entire part of the adipose flap became viable, http://links.lww.com/ PRSGO/A288.",Non-OADS,/arxiv_data1/oa_pdf/b3/93/gox-4-e1123.PMC5222642.pdf
DOI: http://dx.doi.org/10.1787/ trends_edu-2013-graph23-en  14.,OADS,/arxiv_data1/oa_pdf/b3/93/gox-4-e1123.PMC5222642.pdf
"3) (See  video,	 Supplemental	 Digital	 	 Content	 1, which displays  the “wrap technique.” The fascial flap before the vascular  anastomosis is wrapped around the bone graft and bone  stumps, http://links.lww.com/PRSGO/A303).",Non-OADS,/arxiv_data1/oa_pdf/51/31/gox-4-e1149.PMC5222651.pdf
"” the fascial flap before the  vascular anastomosis is wrapped around the bone graft and bone  stumps, http://links.lww.com/PRSGO/A303.",Non-OADS,/arxiv_data1/oa_pdf/51/31/gox-4-e1149.PMC5222651.pdf
"RESULTS At 2 weeks after transplantation to immunodeficient  mice, engineered skin grafts were healed and adhered to  wound beds and wound margins, with no gross differences  observed among groups (See figure, Supplemental	 Digital 	 Content	 1, http://links.lww.com/PRSGO/A328).",Non-OADS,/arxiv_data1/oa_pdf/c2/72/gox-4-e1151.PMC5222652.pdf
"TPPU was detected in TPPU- and TPPU + EET–treated  mice, with significantly elevated levels in blood and graft tis-sue compared with controls (See figure, Supplemental	 Digi- tal		Content	 2, http://links.lww.com/PRSGO/A329).",Non-OADS,/arxiv_data1/oa_pdf/c2/72/gox-4-e1151.PMC5222652.pdf
"Similarly, 12,13-EpOME, which  was significantly  elevated in plasma of TPPU and TPPU +  EET–treated mice,  constituted the majority of total EpOMEs measured in plasma of these mice (See figure,	 Supplemental 	 Digital	Content	3,  http://links.lww.com/PRSGO/A330).",Non-OADS,/arxiv_data1/oa_pdf/c2/72/gox-4-e1151.PMC5222652.pdf
"32 No significant differences  were observed in plasma DiHETEs; however, significant- ly higher levels were detected in tissue biopsies of mice treated with TPPU + EET compared with TPPU-treated mice and controls (See figure,	 Supplemental	 Digital 	 Content	 4, http://links.lww.com/PRSGO/A331).",Non-OADS,/arxiv_data1/oa_pdf/c2/72/gox-4-e1151.PMC5222652.pdf
"At the histological level, grafts in all groups displayed a  differentiated epidermis with a well-cornified surface (See  figure, Supplemental	 Digital	 Content	 5, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/c2/72/gox-4-e1151.PMC5222652.pdf
"Surrounding muscles  were reattached (See	 figure,	 Supplemental	 Digital	 Con- tent	1, http://links.lww.com/PRSGO/A313).",Non-OADS,/arxiv_data1/oa_pdf/44/bc/gox-4-e1159.PMC5222656.pdf
"2 and See	figure, 	 Supplemental	 Digital	 Content	 2, http://links.lww.com/PRS- GO/A314).",Non-OADS,/arxiv_data1/oa_pdf/44/bc/gox-4-e1159.PMC5222656.pdf
"Radiological follow-up shows good healing of the hybrid flap to the ten- don and vital scapular bone surrounding the socket with- out resorption (See	 figure,	 Supplemental	 Digital	 Content	 3,  http://links.lww.com/PRSGO/A315; See figure,	 Supplemental 	 Digital	Content	4, http://links.lww.com/PRSGO/A316).",Non-OADS,/arxiv_data1/oa_pdf/44/bc/gox-4-e1159.PMC5222656.pdf
Available at: http://www.zimmer.com/content/dam/zimmer-web/documents/en-US/pdf/surgical-techniques/knee/ NexGen-Trabecular-Metal-Augmentation-Patella-Surgical- Technique-97-7255-004-00-Rev-24-2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/bc/gox-4-e1159.PMC5222656.pdf
"A rectangular-type tissue ex- pander (8 × 4 cm, 100 mL: Koken Co., Ltd., Tokyo, Japan)  was inserted (See	 figure,	 Supplemental	 Digital	 Content	 1,  which displays the flap design, http://links.lww.com/PRS-GO/A325).",Non-OADS,/arxiv_data1/oa_pdf/1c/1f/gox-4-e1160.PMC5222657.pdf
"3), and the upper and lower eyelids  were covered by the divided flap (See	 figure,	 Supplemental	 Digital	 Content	 2, which displays the immediate postop- erative view, http://links.lww.com/PRSGO/A326).",Non-OADS,/arxiv_data1/oa_pdf/1c/1f/gox-4-e1160.PMC5222657.pdf
"4 and See	figure,	 Supplemental	 Digital	 Content	 3, which displays the post- operative lateral view, http://links.lww.com/PRSGO/A327).",Non-OADS,/arxiv_data1/oa_pdf/1c/1f/gox-4-e1160.PMC5222657.pdf
"Showcase is on white,  African, and Asian noses, http://links.lww.com/PRSGO/ A306; See video,	 Supplemental	 Digital	 Content	 2, which  displays a blonde white patient being injected on the nasal spine, columella, tip, and dorsum, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
"com/PRSGO/A307; and See video,	 Supplemental	 Digital 	 Content	 3, which displays a brunette white patient being  injected on the nasal spine, dorsum aesthetic lines, and supratip, http://links.lww.com/PRSGO/A308) (i) Step 1: deep preperiosteal nasal spine injection 5  (0.5 to 0.8 mL) to open nasolabial angle (NLA)  using a highly cross-linked hyaluronic acid gel4 (ii) Step 2 (for Asian or African skull)3 (See	video,  http://links.lww.com/PRSGO/A306): premaxilla  piriform fossa (0.5 to 1 mL) (iii) Step 3: bending the needle gently, form a mid- line columellar strut between the alar cartilages  to achieve tip rotation (0.2 to 0.5 mL) *Stay strictly midline for safety to avoid vessels and anastomoses (iv) Step 4: one at times continues superiorly to inject be- tween the 2 domes for tip enhancement/projection *NB: 1 to 4 steps, according to NLA From the Medical University of Nice, Nice, France.",Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A306.,Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
This video is available in the “related videos” section of the  full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A307.,Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
"Profile complex: (See	 videos, http://links.lww.com/ PRSGO/A306, http://links.lww.com/PRSGO/A307, and  http://links.lww.com/PRSGO/A308)Dorsum is injected 1 in a rectangular shape, creat- ing ideal double aesthetic light reflex lines along the dorsum edges (0.5 to 1 mL severe saddle nose;  step 5)Aim: to reproduce 2 parallel lines (described by Leonardo DaVinci) from an optimized point for the nasofrontal angle (NFA; 0.1 to 0.4 mL) superiorly  and to blend to the projected tip while maintaining a subtle supratip break inferiorly*Tip: safer to inject those lines more superficially  (compared with the dorsum and columella) sub- dermally (instead of deeply to periosteum and peri-chondrium), away from the major vessels (See	 video,  http://links.lww.com/PRSGO/A308)  3.",Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
"Tip support (step 6): (i) Heart-shape tip graft (0.1 to 0.3 ml) for a subtle  refinement with a cohesive softer gel (See	 video,  http://links.lww.com/PRSGO/A307) (ii) Alar batten grafts underlying the supraalar  crease in the space between the internal and  external valves if support to lateral wall is re-quired (0.1 to 0.2 ml; See video,	 Supplemental 	 Digital	 Content	 4, which displays a secondary  rhinoplasty patient injected on tip, nostril, and dorsum aesthetic lines, http://links.lww.com/ PRSGO/A309)  4.",Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
"Nostril refinement: See	 videos, http://links.lww.com/ PRSGO/A306, http://links.lww.com/PRSGO/A307, http:// links.lww.com/PRSGO/A308, and http://links.lww.com/ PRSGO/A309) (i) Nostril rim graft using cohesive softer gel for cor - rection of a retracted nostril or lowering (0.1 to 0.2 ml)RESULTS For results, See	videos, http://links.lww.com/PRSGO/ A306, http://links.lww.com/PRSGO/A307, http://links.",Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
"lww.com/PRSGO/A308, and http://links.lww.com/PRS- GO/A309).",Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
"The patient has been injected with a hyal-uronic acid following Eiffel Tower nose-lift steps 1,3,4,5 & 6, http://links.lww.com/PRSGO/A304; See	 figures, 	 Supplemental	 Digital	 Content	 6, which show results of  patient from video 2 at 6, 12 and 18 months.",Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
"The pa-tient has been injected with a hyaluronic acid following Eiffel Tower nose-lift steps 1,3,4,5 & 6, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
"See	also,	 video,	 http://links.lww.com/ PRSGO/A305.)",Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A308.,Non-OADS,/arxiv_data1/oa_pdf/d2/64/gox-4-e1167.PMC5222661.pdf
This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A317).,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
"This video is available in the “related videos” section of the full-text article on PRSGlo-balOpen.com or available at http://links.lww.com/PRSGO/ A318; See video,	 Supplemental	 Digital	 Content	 3, which  demonstrates the vertical mastopexy dissection.",Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
"This video is avail-able in the “related videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/ PRSGO/A320; See video,	 Supplemental	 Digital	 Content	 5,  depicting the wound closure.",Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
This video is available in the  “related videos” section of the full-text article on PRSGlo- balOpen.com or available at http://links.lww.com/PRSGO/ A321).,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
com or available at http://links.lww.com/PRSGO/A317.,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
this video is  available in the  “related videos” section of the full-text article on  PrSglobalOpen.com  or available at http://links.lww.com/PRSGO/A318.,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
this video is  available in the  “related videos” section of the full-text article on  PrSglobalOpen.com  or available at http://links.lww.com/PRSGO/A319.,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
this video is available in the  “related videos” section of the full-text article on  PrSglobalOpen.com  or available at http://links.lww.com/PRSGO/A320.,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
this video is available in the “  related  videos” section of the full-text article on PrSglobalOpen.com or  available at http://links.lww.com/PRSGO/A321.,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
This video is available in the “re-lated videos” section of the full-text article on PRSGlo- balOpen.com or available at http://links.lww.com/PRSGO/ A322).,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
this video is available in the “related  videos” section of the full-text article on PrSglobalOpen.com or available at http://links.lww.com/PRSGO/A322.Table 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
com or available at http://links.lww.com/PRSGO/A323).,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
"this is the same patient de - picted in the videos (Supplemental Digital Contents 1–7, http://links.lww.com/PRSGO/ A317, http://links.lww.com/PRSGO/A318, http://links.lww.com/PRSGO/A319, http:// links.lww.com/PRSGO/A320, http://links.lww.com/PRSGO/A321, and http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A323).,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
this video is  available in the “related videos” section of the full-text article on PrSglo - balOpen.com or available at http://links.lww.com/PRSGO/A323.,Non-OADS,/arxiv_data1/oa_pdf/4e/8a/gox-4-e1170.PMC5222662.pdf
Video 1. a video detailing the patient’s journey can be found here:  https://youtu.be/HeMD6zfJBu0.,Non-OADS,/arxiv_data1/oa_pdf/e9/e9/gox-4-e1174.PMC5222667.pdf
The video detailing the patient’s journey can be found here: https://youtu.be/HeMD6zfJBu0.,Non-OADS,/arxiv_data1/oa_pdf/e9/e9/gox-4-e1174.PMC5222667.pdf
http://www.skincancer.org/skin-can- cer-information/skin-cancer-facts.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/gox-4-e1182.PMC5222671.pdf
This video is available in the “Related  Videos” section of the Full-Text article on PRSGlobalOpen.com or available at http://links.lww.com/PRSGO/A345.),Non-OADS,/arxiv_data1/oa_pdf/84/57/gox-4-e1194.PMC5222677.pdf
This video is available in the “Related Videos” section  of the Full-Text article on PRSGlobalOpen.com or available  at http://links.lww.com/PRSGO/A346.),Non-OADS,/arxiv_data1/oa_pdf/84/57/gox-4-e1194.PMC5222677.pdf
com or available at http://links.lww.com/PRSGO/A345.,Non-OADS,/arxiv_data1/oa_pdf/84/57/gox-4-e1194.PMC5222677.pdf
This video is available in the “Related Videos” section of  the Full-Text article on PRSGlobalOpen.com or available at  http://links.lww.com/PRSGO/A347.,Non-OADS,/arxiv_data1/oa_pdf/84/57/gox-4-e1194.PMC5222677.pdf
this video is available in  the “Related videos” section of the Full- text article on PRsGlobalo - pen.com or available at http://links.lww.com/PRSGO/A346.,Non-OADS,/arxiv_data1/oa_pdf/84/57/gox-4-e1194.PMC5222677.pdf
this video is avail- able in the “Related videos” section of the Full- text article on PRsGlo - balopen.com or available at http://links.lww.com/PRSGO/A347.,Non-OADS,/arxiv_data1/oa_pdf/84/57/gox-4-e1194.PMC5222677.pdf
This video is available in the “Related Videos” section  of the Full-Text article on PRSGlobalOpen.com or available  at http://links.lww.com/PRSGO/A349.),Non-OADS,/arxiv_data1/oa_pdf/84/57/gox-4-e1194.PMC5222677.pdf
this video is available  in the “Related videos” section of the Full- text article on PRsGlobalo - pen.com or available at http://links.lww.com/PRSGO/A349.,Non-OADS,/arxiv_data1/oa_pdf/84/57/gox-4-e1194.PMC5222677.pdf
"Brain regions were identified using the Mouse Brain in Stereotaxic Coordinates (Paxinos and Franklin, 2004) and the Allen Brain Atlas (http://mouse.brain.-map.org).",OADS,/arxiv_data1/oa_pdf/1a/a2/CNE-525-955.PMC5222728.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://oig.hhs.gov/oei/reports/oei-07-08-00150.pdf .,OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://www.parl.gc.ca/Content/SEN/ Committee/412/soci/rep/rep05jan14-e.pdf .,Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://www.hc-sc.gc.ca/ dhp-mps/prodpharma/databasdon/index-eng.php .,OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://www.canhr.org/ newsroom/newdev_archive/2009/FDA-Alert-on-Antipsychotics.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/ 2005/14307a-eng.php .,OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://www.choosing wiselycanada.org/wp-content/uploads/2014/04/Antipsychotic-EN- web.pdf .,Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Availablefrom: http://www.cfhi-fcass.ca/WhatWeDo/reducing-antipsy chotic-medication-use-collaborative .,Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://www.health.alberta.ca/documents/ Continuing-Care-Strategy-2008.pdf .,Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from:http://www.bcli.org/publication/discussion-paper-assisted-living- past-present-and-future-legal-trends-canada-0 .,Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://hdl.handle.,Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://hdl.handle.net/10402/era.23788 .,OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Available from: http://yourhealthsystem.cihi.ca/enbref/ ?lang=en#!/indicators/008/potentially-inappropriate-use-of-antipsychotics-in-long-term-care/;mapC1;mapLevel2/ .A c c e s s e dA p r i l 2016.,Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
Availablefrom: http://www.albertahealthservices.ca/assets/about/scn/ahs- scn-sb-seniors-aua.pdf .,Non-OADS,/arxiv_data1/oa_pdf/76/d2/40266_2016_Article_411.PMC5222893.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f5/6e/40266_2016_Article_425.PMC5222894.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/73/73/40266_2016_Article_418.PMC5222895.pdf
http://www.accessdata.fda.gov/scripts/ cder/iig/index.cfm .,OADS,/arxiv_data1/oa_pdf/73/73/40266_2016_Article_418.PMC5222895.pdf
24 June 1993. http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Products/Guidelines/Efﬁcacy/E7/Step4/E7_Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/73/73/40266_2016_Article_418.PMC5222895.pdf
6 July 2010. http://www.ich.org/ﬁleadmin/ Public_Web_Site/ICH_Products/Guidelines/Efﬁcacy/E7/Q_As/ E7_Q_As_step4.pdf .,Non-OADS,/arxiv_data1/oa_pdf/73/73/40266_2016_Article_418.PMC5222895.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/be/df/40262_2016_Article_442.PMC5222896.pdf
Available from URL: http://www.justice.gc.ca/eng/rp-pr/cj-jp/fv-vf/aiw-mei/pdf/Abuse_is_ Wrong.pdf (accessed May 2016).,Non-OADS,/arxiv_data1/oa_pdf/bd/c4/12630_2016_Article_777.PMC5222897.pdf
Available from URL: http://www.justice.gc.ca/eng/cj-jp/fv-vf/about- apropos.html (accessed May 2016).,OADS,/arxiv_data1/oa_pdf/bd/c4/12630_2016_Article_777.PMC5222897.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), whichpermits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bd/c4/12630_2016_Article_777.PMC5222897.pdf
Clinical Trial Registration http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/23/fb/40262_2016_Article_417.PMC5222901.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/23/fb/40262_2016_Article_417.PMC5222901.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction inany medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available from URL: http://www.npsf.org/ ?page=throughtheeyes (accessed November 2016).,Non-OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available from URL:https://www.jointcommission.org/sentinel_event_alert_issue_40_behaviors_that_undermine_a_culture_of_safety/ (accessed November 2016).,OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available from URL: http://media.proquest.com/ media/pq/classic/doc/2524265761/fm t/ai/rep/NPDF?_s=aI7DcQq3% 2FaFOMFpHWFqCeq7tVdo%3D (accessed November 2016).,Non-OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available from URL: http://www.healthline.,Non-OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available from URL: https://www.cpp.com/Pdfs/TKI_Technical_Brief.pdf (accessed November 2016).,Non-OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available from URL: http://www.jointcommission.org/assets/1/18/2004_4Q_ 2012_SE_Stats_Summary.pdf (accessed November 2016).,OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Sentinel Event Statistics Released for 2014 - 2015; Available from URL: http://www.jointcommission.,OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available from URL:https://ismp.org/Survey/surveyresults/Survey0311.asp (accessed November 2016).,OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available from URL: https://www.cmpa-acpm.ca/ serve/docs/ela/goodpracticesguide/pages/professionalism/Behaviour/disruptive_behaviour-e.html (accessed November 2016).,Non-OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available from URL: http://www.ama- assn.org/resources/images/omss/cejae-9.045.pdf (accessed November 2016).,OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
Available fromURL: https://www.cma.ca/En/Pages/canadian-physician-health- expert-tells-colleagues-be-civil.aspx (accessed November 2016).140 A. Villafranca et al.,Non-OADS,/arxiv_data1/oa_pdf/fa/cc/12630_2016_Article_784.PMC5222921.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/56/main.PMC5222944.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.12.011 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/62/56/main.PMC5222944.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/47/main.PMC5222945.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.12.012 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/93/47/main.PMC5222945.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Functional magnetic resonance imagingFunctional connectivityEpilepsyNetwork analysisPartial least square analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/10.1016/j.nicl.2016.12.014 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/10.1016/j.clinph.2014.04.004 .,OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/10.1016/j.eplepsyres.2014.09.023 .,OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
Brain http://dx.doi.org/10.1093/brain/awv130 .,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
PLoS One 6. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
"Exp., e51442 http://dx.doi.org/10.3791/51442 .",Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/10.1111/epi.12476 .,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
PLoS One 5:27 –29.http://dx.doi.org/10.1371/journal.pone.0008525 .,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/ 10.1111/epi.12581 .,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
Psychiatry:1238 –1248 http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/10.1006/nimg.2001.0978 .,OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
http://dx.doi.org/10.1111/epi.12350 .,Non-OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC5222946.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/b5/main.PMC5222950.pdf
"In  order  not  to  compromise  the  blood  supply  of  the overlying  skin, the volar  lobe  of  the  tumor  was  resected  ﬁrst  via  a volar  lazy  “S”  incision;  and  one  month  later  the  dorsal  lobe  of  the http://dx.doi.org/10.1016/j.ijscr.2016.12.015 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/8d/b5/main.PMC5222950.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: BMI Critical thinking skillsObesityLarge lecture class 1.,Non-OADS,/arxiv_data1/oa_pdf/f0/e6/main.PMC5222954.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.12.020 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/e6/main.PMC5222954.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/e6/main.PMC5222954.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/f0/e6/main.PMC5222954.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/30/main.PMC5222955.pdf
"In  contrast, dorsal displacement  of  the  epiphysis  (without  rotation)  is  a  well http://dx.doi.org/10.1016/j.ijscr.2016.12.016 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/e3/30/main.PMC5222955.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Traumatic brain injuryEmotion recognition Facial affect Emotion labelingResting stateNetwork-based statistics 1.,Non-OADS,/arxiv_data1/oa_pdf/b4/e0/main.PMC5222957.pdf
http://dx.doi.org/10.1016/j.nicl.2016.12.010 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/e0/main.PMC5222957.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/e0/main.PMC5222957.pdf
"Here, the NBS Connectome toolbox (version 1.2) was used to per- form all NBS and FDR analysis ( https://www.nitrc.org/projects/nbs/ ).",OADS,/arxiv_data1/oa_pdf/b4/e0/main.PMC5222957.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/e0/main.PMC5222957.pdf
"Thelifestyle questionnaire is a short version of the questionnaire used in the EAGLE study (environment and genetics in lung cancer etiology, a population-based case –control study, http://eagle.cancer.gov) and details about information collected in it can be found in our previous article.",Non-OADS,/arxiv_data1/oa_pdf/6f/24/ejcn2016197a.PMC5222989.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)Urinary chromium and circulating miRNAs in obesity L Dioni et al 148 European Journal of Clinical Nutrition (2017) 142 –148",Non-OADS,/arxiv_data1/oa_pdf/6f/24/ejcn2016197a.PMC5222989.pdf
"NICE Clinical Guideline 127 .N I C E : London, 2011. https://www.nice.org.uk/guidance/cg127.",Non-OADS,/arxiv_data1/oa_pdf/44/a1/hr201687a.PMC5222992.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2017CV risk of white coat/masked hypertension in DM/CKD TK u s h i r o et al 95 Hypertension Research",Non-OADS,/arxiv_data1/oa_pdf/44/a1/hr201687a.PMC5222992.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies the paper on Hyp ertension Research website (http://www.nature.com/hr)T80/A5/H12.5 therapy for hypertension JH i g a k i et al 60 Hypertension Research",Non-OADS,/arxiv_data1/oa_pdf/60/c6/hr2016100a.PMC5222993.pdf
SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2017; 112:163–171; doi: 10.1038/ajg.2016.478; published online 25 October 2016  (number UMIN000002097).,Non-OADS,/arxiv_data1/oa_pdf/26/ca/ajg2016478a.PMC5223061.pdf
"” In Health at a Glance 2011: OECD Indica- tors     OECD Publishing  :   2011  ,   http://dx.doi.org/10.1787/health_glance-2011-30-en     (accessed 14 October 2013)  .",Non-OADS,/arxiv_data1/oa_pdf/26/ca/ajg2016478a.PMC5223061.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/4.0/      © Th e Author(s) 2017                   Study Highlights    WHAT IS CURRENT KNOWLEDGE       ✓     Computed tomographic colonography (CTC) is an estab- lished and widely used imaging technique for preoperative evaluation of colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/26/ca/ajg2016478a.PMC5223061.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/fa/main.PMC5223064.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/9e/fa/main.PMC5223064.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/fa/main.PMC5223064.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.005J Ginseng Res 41 (2017) 23 e30,OADS,/arxiv_data1/oa_pdf/9e/fa/main.PMC5223064.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7f/ed/main.PMC5223065.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/7f/ed/main.PMC5223065.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7f/ed/main.PMC5223065.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.007J Ginseng Res 41 (2017) 31 e35,Non-OADS,/arxiv_data1/oa_pdf/7f/ed/main.PMC5223065.pdf
"A similar method was followed to develop the K-1, a new cultivar G-1 and registered with the Korea Seed & Variety Service ( http://www.seed.",Non-OADS,/arxiv_data1/oa_pdf/7f/ed/main.PMC5223065.pdf
Multiple sequence alignments were performed using the online ClustalW2 program ( http://www.ebi.,OADS,/arxiv_data1/oa_pdf/7f/ed/main.PMC5223065.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/5d/main.PMC5223066.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/d8/5d/main.PMC5223066.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/5d/main.PMC5223066.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.008J Ginseng Res 41 (2017) 36 e42,OADS,/arxiv_data1/oa_pdf/d8/5d/main.PMC5223066.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f4/e1/main.PMC5223067.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/f4/e1/main.PMC5223067.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f4/e1/main.PMC5223067.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.006J Ginseng Res 41 (2017) 1 e9,OADS,/arxiv_data1/oa_pdf/f4/e1/main.PMC5223067.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/01/main.PMC5223068.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/f8/01/main.PMC5223068.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/01/main.PMC5223068.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.004J Ginseng Res 41 (2017) 10 e22,OADS,/arxiv_data1/oa_pdf/f8/01/main.PMC5223068.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/82/main.PMC5223069.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/78/82/main.PMC5223069.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/82/main.PMC5223069.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.009J Ginseng Res 41 (2017) 43 e51,OADS,/arxiv_data1/oa_pdf/78/82/main.PMC5223069.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/68/main.PMC5223077.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/50/68/main.PMC5223077.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/68/main.PMC5223077.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.011J Ginseng Res 41 (2017) 52 e59,OADS,/arxiv_data1/oa_pdf/50/68/main.PMC5223077.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/8a/main.PMC5223078.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/2f/8a/main.PMC5223078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/8a/main.PMC5223078.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.010J Ginseng Res 41 (2017) 78 e84,OADS,/arxiv_data1/oa_pdf/2f/8a/main.PMC5223078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/1b/main.PMC5223079.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/a1/1b/main.PMC5223079.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/1b/main.PMC5223079.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.012J Ginseng Res 41 (2017) 60 e68,OADS,/arxiv_data1/oa_pdf/a1/1b/main.PMC5223079.pdf
"Seven path- ways were identi ﬁed in the Kyoto Encyclopedia of Genes andGenomes (KEGG) database ( http://www.genome.jp/kegg/ ), including the glycolysis pathway (ko00010), valine, leucine, and isoleucine biosynthesis pathway (ko00290), glycine, serine, and threonine biosynthesis pathway (ko00260), citrate cycle [tricar- boxylic acid (TCA) cycle] (ko00020), fructose and mannose biosynthesis pathway (ko00051), and arginine and proline pathway (ko00330) ( Table 3 ).",OADS,/arxiv_data1/oa_pdf/a1/1b/main.PMC5223079.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/73/main.PMC5223080.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/2c/73/main.PMC5223080.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/73/main.PMC5223080.pdf
http://dx.doi.org/10.1016/j.jgr.2016.01.001J Ginseng Res 41 (2017) 69 e77,OADS,/arxiv_data1/oa_pdf/2c/73/main.PMC5223080.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/8f/main.PMC5223081.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/38/8f/main.PMC5223081.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/8f/main.PMC5223081.pdf
http://dx.doi.org/10.1016/j.jgr.2016.01.002J Ginseng Res 41 (2017) 85 e95,OADS,/arxiv_data1/oa_pdf/38/8f/main.PMC5223081.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/24/main.PMC5223082.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/1b/24/main.PMC5223082.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/24/main.PMC5223082.pdf
http://dx.doi.org/10.1016/j.jgr.2016.01.003J Ginseng Res 41 (2017) 96 e102,OADS,/arxiv_data1/oa_pdf/1b/24/main.PMC5223082.pdf
"The source of cytokine gene polymorphisms for Indonesians living in West Java were derived from Malays population in Singapore VariationGenome Project database (http://www.statgen.nus.edu.sg/ ~ SGVP), 22with some additional SNPs, which were not found in the database but were associated with phenotypes in Asian or other populations.",OADS,/arxiv_data1/oa_pdf/7c/27/gene201635a.PMC5223084.pdf
"Minor allele frequency, deviations from Hardy –Weinberg equilibrium and pairwise LD were calculated for each mother or child ’s SNP using Haploview software (http://www.broadinstitute.org).",OADS,/arxiv_data1/oa_pdf/7c/27/gene201635a.PMC5223084.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on Genes and Immunity website (http://www.nature.com/gene)Maternal and child cytokine gene polymorphisms Y Djuardi et al 385 Genes and Immunity (2016) 380 –385",Non-OADS,/arxiv_data1/oa_pdf/7c/27/gene201635a.PMC5223084.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj)Effect of genetic background and latitude on growth C De Leonibus et al 550 The Pharmacogenomics Journal (2016), 540 –550",Non-OADS,/arxiv_data1/oa_pdf/ac/0d/tpj201567a.PMC5223086.pdf
"1Department of Pulmonary Diseases, VU University Medical Center, 1007 MB Amsterdam, the Netherlands;2Department of Paediatric Pulmonology, VU University Medical Center, 1007 MB Amsterdam, the Netherlands;3Department of Clinical Genetics, VU University Medical Center, 1007 MB Amster- dam, the Netherlands;4Department of General Pediatrics, University Children’s Hospital Muenster, 48149 Muenster, Germany;5Department of Human Genetics, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, the Netherlands;6Department of Surgery and Physiology, Amsterdam Car- diovascular Sciences, VU University Medical Center, 1007 MB Amsterdam, the Netherlands;7Pediatric Genetics Division, Center for Pediatrics and Adoles- cent Medicine, University Hospital Freiburg, 79110 Freiburg, Germany 8These authors contributed equally to this work *Correspondence: d.micha@vumc.nl http://dx.doi.org/10.1016/j.ajhg.2016.11.019 .",Non-OADS,/arxiv_data1/oa_pdf/fd/a9/main.PMC5223094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/main.PMC5223094.pdf
A full list of contrib- uting groups can be found at http://exac.broadinstitute.org/about .,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/main.PMC5223094.pdf
"Received: September 4, 2016 Accepted: November 21, 2016 Published: December 29, 2016 Web Resources ExAC Browser, http://exac.broadinstitute.org/ Expression Atlas, http://www.ebi.ac.uk/gxa/home GenBank, http://www.ncbi.nlm.nih.gov/genbank/ OMIM, http://www.omim.org/ The Human Protein Atlas, http://www.proteinatlas.org/ varbank, https://varbank.ccg.uni-koeln.de References 1.Fliegauf, M., Benzing, T., and Omran, H. (2007).",OADS,/arxiv_data1/oa_pdf/fd/a9/main.PMC5223094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/dd/main.PMC5223095.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org http://dx.doi.org/10.1016/j.jgr.2016.08.007 p1226-8453 e2093-4947/$ esee front matter Copyright /C2112016, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/3e/dd/main.PMC5223095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).J Ginseng Res 41 (2017) 103 e112,Non-OADS,/arxiv_data1/oa_pdf/3e/dd/main.PMC5223095.pdf
"Cells 2016; 39(12): 841-846  http://dx.doi.org/10.14348/molcells.2016.0277                  Imaging Single-mRNA Localization and Translation  in Live Neurons    Byung Hun Lee1, Seong-Woo Bae1, Jaeyoun Jay Shim1, Sung Young Park2, and Hye Yoon Park1,3,*      Local protein synthesis mediates precise spatio-temporal regulation of gene expression for neuronal functions such  as long-term plasticity, axon guidance and regeneration.",OADS,/arxiv_data1/oa_pdf/2c/be/molce-39-12-841.PMC5223100.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/2c/be/molce-39-12-841.PMC5223100.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/2c/be/molce-39-12-841.PMC5223100.pdf
Cells http://molcells.org      A                   B                                    C                    Fig.,Non-OADS,/arxiv_data1/oa_pdf/2c/be/molce-39-12-841.PMC5223100.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/2c/be/molce-39-12-841.PMC5223100.pdf
Cells http://molcells.org      A               B                 Fig.,Non-OADS,/arxiv_data1/oa_pdf/2c/be/molce-39-12-841.PMC5223100.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/2c/be/molce-39-12-841.PMC5223100.pdf
Cells http://molcells.org     neurons: visualization by GFP linkage.,OADS,/arxiv_data1/oa_pdf/2c/be/molce-39-12-841.PMC5223100.pdf
"Cells 2016; 39(12): 847-854  http://dx.doi.org/10.14348/molcells.2016.0310                 Cancer Metabolism: Fueling More than Just Growth    Namgyu Lee1, and Dohoon Kim1,*      The early landmark discoveries in cancer metabolism re-search have uncovered metabolic processes that support  rapid proliferation, such as aerobic glycolysis (Warburg  effect), glutaminolysis, and increased nucleotide biosyn-thesis.",Non-OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
"In particular, a central cancer cell metabolism that aids their survival within  such an environment is a feature referred to as aerobic glycoly- sis: regardless of oxygen tension, cancer cells have a high rate Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
Functions of Cancer Metabolism beyond Proliferation  Namgyu Lee & Dohoon Kim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
Functions of Cancer Metabolism beyond Proliferation  Namgyu Lee & Dohoon Kim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
Cells http://molcells.org     ACKNOWLEDGMENTS  We thank Ohseop Kwon for designing the images in our figure  sets.,Non-OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
Functions of Cancer Metabolism beyond Proliferation  Namgyu Lee & Dohoon Kim      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
"Cells http://molcells.org     J.D., et al.",OADS,/arxiv_data1/oa_pdf/06/0c/molce-39-12-847.PMC5223101.pdf
"Cells 2016; 39(12): 855-861  http://dx.doi.org/10.14348/molcells.2016.0111                 Ginsenoside Re Inhibits Osteoclast Differentiation  in Mouse Bone Marrow-Derived Macrophages and Zebrafish Scale Model    Chan-Mi Park1,3,9, Hye-Min Kim1,4,9, Dong Hyun Kim1,4, Ho-Jin Han1,4, Haneul Noh1, Jae-Hyuk Jang1,4, Soo- Hyun Park2, Han-Jung Chae2, Soo-Wan Chae2, Eun Kyoung Ryu5, Sangku Lee1, Kangdong Liu1,7, Haidan  Liu1,8, Jong-Seog Ahn1,4, Young Ock Kim6, Bo-Yeon Kim1,4,*, and Nak-Kyun Soung1,4,*      Ginsenosides, which are the active materials of ginseng ,  have biological functions that include anti-osteoporotic effects.",Non-OADS,/arxiv_data1/oa_pdf/5d/6c/molce-39-12-855.PMC5223102.pdf
The effects of  herbal products and traditional foods on enhanced mineral Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/5d/6c/molce-39-12-855.PMC5223102.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/5d/6c/molce-39-12-855.PMC5223102.pdf
Cells http://molcells.org     accumulation in bones and maximization of bone mass in  premenopausal and postmenopausal women have been stud-ied.,Non-OADS,/arxiv_data1/oa_pdf/5d/6c/molce-39-12-855.PMC5223102.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5d/6c/molce-39-12-855.PMC5223102.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/6c/molce-39-12-855.PMC5223102.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5d/6c/molce-39-12-855.PMC5223102.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/6c/molce-39-12-855.PMC5223102.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/5d/6c/molce-39-12-855.PMC5223102.pdf
"Cells 2016; 39(12): 862-868  http://dx.doi.org/10.14348/molcells.2016.0219                  Detecting Positive Selection of Korean Native Goat  Populations Using Next-Generation Sequencing     Wonseok Lee1, Sojin Ahn2, Mengistie Taye1,3, Samsun Sung4, Hyun-Jeong Lee5, Seoae Cho4,  and Heebal Kim1,6,*     Goats ( Capra hircus ) are one of the oldest species of do- mesticated animals.",Non-OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
Blood samples from the Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
"Sequencing alignment and variant calling  Approximately 220,000,000-230,000,000 paired-end reads  were mapped to the reference goat genome (Dong et al., 2013) from the Goat Genome Databa se Web site (http://goat.kiz.",OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
"Open-source packages were used for downstream processing and variant calling for SNPs and IN- DELs, including Picard tools 1.94  (http://picard.sourceforge.net),  SAMtools 0.1.19 (Li  et al., 2009), VCFtools 4.0 (Danecek  et al.,  2011), and the Genome Analysis T oolkit (GATK) 2.6.4 (McKenna   et al., 2010).",OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
"Variant regions were then  annotated using SNPEff (Cingolani et al., 2012) with a GFF  format file (Dong et al., 2013) from the Goat Genome Database website (http://goat.kiz.ac.cn/).",OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
"To identify genes that have distinct allele types (between Korean native goats and cross- bred goats), we used the protein IDs of the Ensembl Genome  Browser [http://www.ensembl.org; (Hubbard et al., 2002)] in an annotated file.",OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
"Cells http://molcells.org     Dong, Y., Xie, M., Jiang, Y., Xiao, N., Du, X., Zhang, W., Tosser- Klopp, G., Wang, J., Yang, S., and Liang, J.",OADS,/arxiv_data1/oa_pdf/f6/b5/molce-39-12-862.PMC5223103.pdf
"Cells 2016; 39(12): 869-876  http://dx.doi.org/10.14348/molcells.2016.0023                 Cantharidin Overcomes Imatinib Resistance by  Depleting BCR-ABL in Chronic Myeloid Leukemia     Xiaoyan Sun1,2, Xueting Cai1,2, Jie Yang1,2, Jiao Chen1,2, Caixia Guo3,*, and Peng Cao1,2,*      Cantharidin (CTD) is an active compound isolated from the traditional Chinese medicine blister beetle and displayed  anticancer properties against various types of cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
"Primary antibodies against pCdc2, Cdc2, Cdc25c, cy-clin B1, cyclin D1, pSTAT5, STAT5, pAKT, AKT, pERK1/2, Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
"Cells http://molcells.org     ERK1/2, PARP1, cPARP, and pH3 (Ser10) were purchased  from Cell Signal Technology, Inc. (USA).",OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
Cells http://molcells.org      A               B                   C                  Fig.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
Cells http://molcells.org     suppression of PP2A alpha.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/molce-39-12-869.PMC5223104.pdf
"Cells 2016; 39(12): 877-887  http://dx.doi.org/10.14348/molcells.2016.0161                 Tazarotene-Induced Gene 1 Enhanced Cervical Cell  Autophagy through Transmembrane Protein 192    Rong-Yaun Shyu1, Chun-Hua Wang2, Chang-Chieh Wu3, Mao-Liang Chen4, Ming-Cheng Lee4, Lu-Kai  Wang5, Shun-Yuan Jiang4,*, and Fu-Ming Tsai4,*     Tazarotene-induced gene 1 (TIG1) is a retinoic acid- inducible protein that is considered a putative tumor sup- pressor.",Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
Autopha- Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
"Cells http://molcells.org     gosomes subsequently fuse with lysosomes to form autolyso- somes and then digest the contents with acid hydrolases pro-vided by the lysosome (Lamb et al., 2013; Mizushima et al.,  2011).",Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
Cells http://molcells.org      treated HtTA cells co-expressing TIG1B and TMEM192 (Sup- plementary Figs.,Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
"Cells http://molcells.org      siRNAs specific for TIG1 or TMEM192 for 48 h. No TIG1A or  TIG1B protein was detected in TIG1A or TIG1B-expressing cells transfected with each TIG1 siRNA, while TMEM192 pro- tein levels were reduced by 87% or were barely detectable in  TMEM192-expressing cells transfected with each TMEM192 siRNA (Figs.",Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
"Cells http://molcells.org     In conclusion, our present results demonstrate that TIG1  isoforms can interact with TMEM192.",OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/31/a5/molce-39-12-877.PMC5223105.pdf
"Cells 2016; 39(12): 888-897  http://dx.doi.org/10.14348/molcells.2016.0276                  DNA Demethylation of the Foxp3 Enhancer Is  Maintained through Modulation of Ten-Eleven- Translocation and DNA Methyltransferases    Varun Sasidharan Nair1, Mi Hye Song1, Myunggon Ko2, and Kwon Ik Oh1,*      Stable expression of Foxp3 is ensured by demethylation of CpG motifs in the Foxp3  intronic element, the conserved  non-coding sequence 2 (CNS2), which persists throughout  the lifespan of regulatory T cells (Tregs).",Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
"CD45.1 congenic  (B6.SJL- Ptprc a Pepcb/BoyJ), Foxp3-GFP transgenic (Foxp3  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
"Cells http://molcells.org     Actin forward, 5 -CAT CCG TAA AGA CCT CTA TGC CAA C-3   Actin  reverse, 5 -ATG GAG CCA CCG ATC CAC A-3     Transfection Plasmids transfection experiments were performed using  FACS-sorted Tet2 −/− Tregs.",OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
Cells http://molcells.org     inflammatory cytokine IL6 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8f/d2/molce-39-12-888.PMC5223106.pdf
"Cells 2016; 39(12): 898-908  http://dx.doi.org/10.14348/molcells.2016.0210                 Highly Expressed Integrin- 8 Induces Epithelial to  Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse    Jiyeon Ryu1, Youngil Koh2, Hyejoo Park1, Dae Yoon Kim1, Dong Chan Kim1, Ja Min Byun2, Hyun Jung  Lee3, and Sung-Soo Yoon1,2,*     Despite recent groundbreaking advances in multiple mye- loma (MM) treatment, most MM patients ultimately experi- ence relapse, and the relapse biology is not entirely un-derstood.",Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
"To investigate the biologically relevant pathways most  impacted by the gene input list, the online program Pathway- Express (Onto-Tools, Wayne State University, Detroit, MI, USA; http://vortex.cs.wayne.edu/Projects.html) was used (Draghici  et  al., 2007).",OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
"Specific biological pathways were defined using the  Kyoto Encyclopedia of Genes and Genomes (KEGG) database (Kanehisa Laboratories, Kyoto, Japan; http://www.genome.jp/  kegg/pathway.html).",OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
Genomic data   Genetic and expression alterations data were obtained from the cBioPortal cancer genomics platfo rm (http://www.cbi oportal.org).,OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
Cells http://molcells.org     Table 3.,OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
Cells http://molcells.org     has never previously been reported in MM.,OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
"The PDGFR inhibitor, sunitinib, is currently in a  phase II trial to test its effects on MM relapse; specifically, to  determine if it can inhibit growth of cancer cells by blocking  enzymes related to cancer cell proliferation and blood flow to  cancer (https://clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
Cells http://molcells.org     TNF-alpha induced expression in vitro .,Non-OADS,/arxiv_data1/oa_pdf/e8/47/molce-39-12-898.PMC5223107.pdf
"Cells 2016; 39(12): 909-914  http://dx.doi.org/10.14348/molcells.2016.0243                  Baicalein Inhibits Epithelial to Mesenchymal  Transition via Downregulation of Cyr61 and LOXL-2 in MDA-MB231 Breast Cancer Cells    Linh Thi Thao Nguyen1,3, Yeon Woo Song1,3, and Somi Kim Cho1,2,*     Epithelial-mesenchymal transition (EMT) is a critical step  in the acquisition of the migr atory and invasive capabilities  associated with metastatic competence.",Non-OADS,/arxiv_data1/oa_pdf/43/62/molce-39-12-909.PMC5223108.pdf
"Previous investigations have showed that baicalein causes cell cycle arrest and suppresses the proliferation of cancer cells,  and induces apoptosis in a variety of human cancer cell lines  (Chen et al., 2000; Fox et al., 2012; Kuo et al., 2009; Li-Weber, Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/43/62/molce-39-12-909.PMC5223108.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/43/62/molce-39-12-909.PMC5223108.pdf
"Cells http://molcells.org     2009; Po et al., 2002).",OADS,/arxiv_data1/oa_pdf/43/62/molce-39-12-909.PMC5223108.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/43/62/molce-39-12-909.PMC5223108.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/43/62/molce-39-12-909.PMC5223108.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/43/62/molce-39-12-909.PMC5223108.pdf
Cells http://molcells.org     epithelial cells.,Non-OADS,/arxiv_data1/oa_pdf/43/62/molce-39-12-909.PMC5223108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/da/main.PMC5223109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/da/main.PMC5223109.pdf
http://dx.doi.org/10.1016/j.eucr.2016.10.012Urology Case Reports 10 (2017) 16 e18,Non-OADS,/arxiv_data1/oa_pdf/65/da/main.PMC5223109.pdf
Available from: http://emedicine.medscape.com/article/1372132-overview .,Non-OADS,/arxiv_data1/oa_pdf/65/da/main.PMC5223109.pdf
Available from: http://www.surgwiki.com/wiki/About_SurgWiki .,Non-OADS,/arxiv_data1/oa_pdf/65/da/main.PMC5223109.pdf
Available from http://ispub.com/IJS/15/1/6898 .,Non-OADS,/arxiv_data1/oa_pdf/65/da/main.PMC5223109.pdf
2015;7(1):94 e96.http://dx.doi.org/10.4103/0974-7796.148632 .,Non-OADS,/arxiv_data1/oa_pdf/65/da/main.PMC5223109.pdf
Please read the full license for further details at - http://creativecommons.org/ licenses/by-nc-sa/4.0/ © The Author(s) 2016,Non-OADS,/arxiv_data1/oa_pdf/47/99/cr201677a.PMC5223238.pdf
6(3): 242-246  ISSN: 2226 -4485 (Print)  Case Report   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v6i3.14     _____________________________________________________________________________________________________ ___  *Corresponding Author: Simone Bergmann .,Non-OADS,/arxiv_data1/oa_pdf/28/b3/OpenVetJ-6-242.PMC5223282.pdf
http://www.openveterinaryjournal.com   H. Beims  et al.,Non-OADS,/arxiv_data1/oa_pdf/28/b3/OpenVetJ-6-242.PMC5223282.pdf
http://www.openveterinaryjournal.com   H. Beims  et al.,Non-OADS,/arxiv_data1/oa_pdf/28/b3/OpenVetJ-6-242.PMC5223282.pdf
http://www.openveterinaryjournal.com   H. Beims  et al.,Non-OADS,/arxiv_data1/oa_pdf/28/b3/OpenVetJ-6-242.PMC5223282.pdf
http://www.openveterinaryjournal.com   H. Beims  et al.,Non-OADS,/arxiv_data1/oa_pdf/28/b3/OpenVetJ-6-242.PMC5223282.pdf
6(3): 247-254  ISSN: 2226 -4485 (Print)  Original Article   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v6i3.15     _____________________________________________________________________________________________________ ___  *Corresponding Author:  Dr. Paula Pessina.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/OpenVetJ-6-247.PMC5223283.pdf
http://www.openveterinaryjournal.com   P. Pessina  et al.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/OpenVetJ-6-247.PMC5223283.pdf
http://www.openveterinaryjournal.com   P. Pessina  et al.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/OpenVetJ-6-247.PMC5223283.pdf
http://www.openveterinaryjournal.com   P. Pessina  et al.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/OpenVetJ-6-247.PMC5223283.pdf
http://www.openveterinaryjournal.com   P. Pessina  et al.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/OpenVetJ-6-247.PMC5223283.pdf
http://www.openveterinaryjournal.com   P. Pessina  et al.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/OpenVetJ-6-247.PMC5223283.pdf
http://www.openveterinaryjournal.com   P. Pessina  et al.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/OpenVetJ-6-247.PMC5223283.pdf
http://www.openveterinaryjournal.com   P. Pessina  et al.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/OpenVetJ-6-247.PMC5223283.pdf
6(3): 255-258  ISSN: 2226 -4485 (Print)  Short Communication   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v6i3.16     _____________________________________________________________________________________________________ ___  *Corresponding Author: Francesco Di Dona .,Non-OADS,/arxiv_data1/oa_pdf/25/a1/OpenVetJ-6-255.PMC5223284.pdf
http://www.openveterinaryjournal.com   F. Di Dona  et al.,Non-OADS,/arxiv_data1/oa_pdf/25/a1/OpenVetJ-6-255.PMC5223284.pdf
http://www.openveterinaryjournal.com   F. Di Dona  et al.,Non-OADS,/arxiv_data1/oa_pdf/25/a1/OpenVetJ-6-255.PMC5223284.pdf
http://www.openveterinaryjournal.com   F. Di Dona  et al.,Non-OADS,/arxiv_data1/oa_pdf/25/a1/OpenVetJ-6-255.PMC5223284.pdf
6(3): 259-262  ISSN: 2226 -4485 (Print)  Case Report   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v6i3.17     ____________________________________________________________________________________________________ ___  *Corresponding Author:  Silvina  Díaz.,Non-OADS,/arxiv_data1/oa_pdf/87/cf/OpenVetJ-6-259.PMC5223285.pdf
http://www.openveterinaryjournal.com   S.A. Sadaba  et al.,Non-OADS,/arxiv_data1/oa_pdf/87/cf/OpenVetJ-6-259.PMC5223285.pdf
http://www.openveterinaryjournal.com   S.A. Sadaba  et al.,Non-OADS,/arxiv_data1/oa_pdf/87/cf/OpenVetJ-6-259.PMC5223285.pdf
http://www.openveterinaryjournal.com   S.A. Sadaba  et al.,Non-OADS,/arxiv_data1/oa_pdf/87/cf/OpenVetJ-6-259.PMC5223285.pdf
6(3 ): 263-267   ISSN: 2226 -4485 (Print)  Original Article   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v6i3.18     _____________________________________________________________________________________________________ ___  *Corresponding Author:  Teresa Rocha .,Non-OADS,/arxiv_data1/oa_pdf/8a/0e/OpenVetJ-6-263.PMC5223286.pdf
"http://www.openveterinaryjournal.com   T. Rocha    Open Veterinary Journal , (2016), Vol.",Non-OADS,/arxiv_data1/oa_pdf/8a/0e/OpenVetJ-6-263.PMC5223286.pdf
"http://www.openveterinaryjournal.com   T. Rocha    Open Veterinary Journal , (2016), Vol.",Non-OADS,/arxiv_data1/oa_pdf/8a/0e/OpenVetJ-6-263.PMC5223286.pdf
"http://www.openveterinaryjournal.com   T. Rocha    Open Veterinary Journal , (2016), Vol.",Non-OADS,/arxiv_data1/oa_pdf/8a/0e/OpenVetJ-6-263.PMC5223286.pdf
http://www.oie.int/fileadmin/Home/fr/Health_stan dards/tahm/2.05.02_CEM.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8a/0e/OpenVetJ-6-263.PMC5223286.pdf
"http://www.openveterinaryjournal.com   T. Rocha    Open Veterinary Journal , (2016), Vol.",Non-OADS,/arxiv_data1/oa_pdf/8a/0e/OpenVetJ-6-263.PMC5223286.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Concomitant depression and anxiety negatively affect pain  outcomes in surgically managed young patients with trigeminal  neuralgia: Long‑term clinical outcome Seyed H. Mousavi, Raymond F .",Non-OADS,/arxiv_data1/oa_pdf/02/72/SNI-7-98.PMC5223392.pdf
"Surg Neurol Int 2016;7:98. http://surgicalneurologyint.com/Concomitant-depression-and-anxiety-negatively- affect-pain-outcomes-in-surgically-managed-young-patients-with-trigeminal- neuralgia:-Long-term-clinical-outcome/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/02/72/SNI-7-98.PMC5223392.pdf
"Surgical Neurology International 2016, 7:98  http://www.surgicalneurologyint.com/content/7/1/98in the younger versus older patient population, a lower  efficacy for MVD in the younger population has been  reported, suggesting that vascular compression is not  the main etiology of pain in this group.",Non-OADS,/arxiv_data1/oa_pdf/02/72/SNI-7-98.PMC5223392.pdf
"Surgical Neurology International 2016, 7:98  http://www.surgicalneurologyint.com/content/7/1/98described previously.",Non-OADS,/arxiv_data1/oa_pdf/02/72/SNI-7-98.PMC5223392.pdf
"Surgical Neurology International 2016, 7:98  http://www.surgicalneurologyint.com/content/7/1/98Table 3: Patients clinical outcome Case No.",Non-OADS,/arxiv_data1/oa_pdf/02/72/SNI-7-98.PMC5223392.pdf
"Surgical Neurology International 2016, 7:98  http://www.surgicalneurologyint.com/content/7/1/98Table 5: Role of Depression and Anxiety in TN outcome Pt No.",Non-OADS,/arxiv_data1/oa_pdf/02/72/SNI-7-98.PMC5223392.pdf
"Surgical Neurology International 2016, 7:98  http://www.surgicalneurologyint.com/content/7/1/98repeated surgeries that fail to provide pain relief from TN  has severe consequences.",Non-OADS,/arxiv_data1/oa_pdf/02/72/SNI-7-98.PMC5223392.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comErratum Erratum: Exploring the Virchow–Robin spaces function: A  unified  theory of brain diseases In the article titled, “Exploring the Virchow–Robin spaces function: A unified theory of brain diseases” published in  pages S711‑S714, Supplementary issue 26, vol.",Non-OADS,/arxiv_data1/oa_pdf/a0/98/SNI-7-102.PMC5223393.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Hypothermia for severe traumatic brain injury in adults: Recent  lessons from randomized controlled trials Shahzad Shaefi, Aaron M. Mittel, Jonathan A. Hyam1, M. Dustin Boone, Clark C. Chen2,  Ekkehard M. Kasper3 Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA, 1Victor Horsley Department  of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK, 2Division of Neurosurgery, University of California, San Diego, California,  3Department of Surgery, Division of Neurosurgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA E‑mail: Shahzad Shaefi ‑ sshaefi@bidmc.harvard.edu; Aaron M. Mittel ‑ amittel@bidmc.harvard.edu; Jonathan A. Hyam ‑ j.hyam@ucl.ac.uk;   M. Dustin Boone ‑ mboone@bidmc.harvard.edu; §Clark C. Chen ‑ clarkchen@ucsd.edu; *§Ekkehard M. Kasper ‑ ekasper@bidmc.harvard.edu   *Corresponding author   §Co‑senior author Received: 31 July 16  Accepted: 26 August 16  Published: 28 November 16 Abstract Background:  Traumatic brain injury (TBI) is a worldwide health concern associated  with significant morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/02/f3/SNI-7-103.PMC5223395.pdf
"Surg Neurol Int 2016;7:103. http://surgicalneurologyint.com/Hypothermia-for-severe-traumatic-brain-injury-in- adults:-Recent-lessons-from-randomized-controlled-trials/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/02/f3/SNI-7-103.PMC5223395.pdf
"Surgical Neurology International 2016, 7:103  http://www.surgicalneurologyint.com/content/7/1/103as a result of motor vehicle collisions, most frequently  involving males and people aged 15–24 years old.",Non-OADS,/arxiv_data1/oa_pdf/02/f3/SNI-7-103.PMC5223395.pdf
"Surgical Neurology International 2016, 7:103  http://www.surgicalneurologyint.com/content/7/1/103The paucity of high quality studies and the observation  that hypothermia may be associated with improved  outcomes depending on duration, target temperature,  rewarming rate, and time to initiation as well as center  of the respective study, led to uncertainty regarding the  significance of the 2007 guidelines.",Non-OADS,/arxiv_data1/oa_pdf/02/f3/SNI-7-103.PMC5223395.pdf
"Surgical Neurology International 2016, 7:103  http://www.surgicalneurologyint.com/content/7/1/103other hand, patients with more diffuse injury who were  treated with hypothermia had worse outcomes than those  in the normothermic group, even though this was not  significant.",Non-OADS,/arxiv_data1/oa_pdf/02/f3/SNI-7-103.PMC5223395.pdf
"Surgical Neurology International 2016, 7:103  http://www.surgicalneurologyint.com/content/7/1/103proper duration of therapeutic hypothermia for patients  with severe TBI.",Non-OADS,/arxiv_data1/oa_pdf/02/f3/SNI-7-103.PMC5223395.pdf
"Surgical Neurology International 2016, 7:103  http://www.surgicalneurologyint.com/content/7/1/103occurred, but rather implemented early if it is going to  be used, especially with patients who are undergoing (or  have undergone) surgical intervention.",Non-OADS,/arxiv_data1/oa_pdf/02/f3/SNI-7-103.PMC5223395.pdf
"Surgical Neurology International 2016, 7:103  http://www.surgicalneurologyint.com/content/7/1/103aggressive therapies such as decompressive craniectomy  and the risk of the significant adverse effects associated  with this intervention.",Non-OADS,/arxiv_data1/oa_pdf/02/f3/SNI-7-103.PMC5223395.pdf
Details available at https://clinicaltrials.gov/ct2/show/NCT01231139.,Non-OADS,/arxiv_data1/oa_pdf/02/f3/SNI-7-103.PMC5223395.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Treatment of iatrogenic V2 segment vertebral artery  pseudoaneurysm using Pipeline flow‑diverting stent Hakeem J. Shakir1,3, Patrick J. Rooney1,3, Leonardo Rangel‑Castilla1,3, Parham Yashar5, Elad I. Levy1,2,3,4 Departments of 1Neurosurgery, 2Radiology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo,  3Department of Neurosurgery, Gates Vascular Institute at Kaleida Health, 4T oshiba Stroke and Vascular Research Center, University at Buffalo, State University of  New York, Buffalo, New York, 5California Neurosurgical Institute, Valencia, California, USA E‑mail:  Hakeem J. Shakir ‑ hshakir@ubns.com; Patrick J. Rooney ‑ prooney@buffalo.edu; Leonardo Rangel‑Castilla ‑ leonardo.rangel‑castilla@wayne.edu;   Parham Yashar ‑ Yasharpmd@gmail.com; *Elad I.",Non-OADS,/arxiv_data1/oa_pdf/3b/e4/SNI-7-104.PMC5223396.pdf
"Surg Neurol Int 2016;7:104. http://surgicalneurologyint.com/Treatment-of-iatrogenic-V2-segment-vertebral- artery-pseudoaneurysm-using-Pipeline-flow-diverting-stent/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/3b/e4/SNI-7-104.PMC5223396.pdf
"Surgical Neurology International 2016, 7:104  http://www.surgicalneurologyint.com/content/7/1/104investigated in the context of cerebral aneurysms, most  commonly those stemming from the internal carotid  artery (ICA).",Non-OADS,/arxiv_data1/oa_pdf/3b/e4/SNI-7-104.PMC5223396.pdf
"Surgical Neurology International 2016, 7:104  http://www.surgicalneurologyint.com/content/7/1/104embolization in the V2 segment for a pseudoaneurysm  located at the level of C5‑C6.",Non-OADS,/arxiv_data1/oa_pdf/3b/e4/SNI-7-104.PMC5223396.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Access to health care in sub‑Saharan Africa Gilbert Dechambenoit Department of Neurosurgery, CMCO Côte d’Opale, Route de Desvres, 6236v0 Saint Matin Boulogne, France E‑mail: *Gilbert Dechambenoit ‑ gdechambenoit@neurochirurgie.fr   *Corresponding author Received: 27 October 16  Accepted: 27 October 16  Published: 23 December 16 The paper describing two cases of extradural hematoma  in Nigeria is a subject of concern and requires close  examination.",Non-OADS,/arxiv_data1/oa_pdf/7b/c9/SNI-7-108.PMC5223397.pdf
Surg Neurol Int 2016;7:108. http://surgicalneurologyint.com/Access-to-health-care-in-sub-Saharan-Africa/,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/SNI-7-108.PMC5223397.pdf
"Surgical Neurology International 2016, 7:108  http://www.surgicalneurologyint.com/content/7/1/108in these “young” countries, antagonistic social forces  at work, as well as external constraints and pressures  arising from great power politics and policies, which exert  conflicting pressures on weaker countries.",Non-OADS,/arxiv_data1/oa_pdf/7b/c9/SNI-7-108.PMC5223397.pdf
"Surgical Neurology International 2016, 7:108  http://www.surgicalneurologyint.com/content/7/1/108It is difficult to accept, from any conceptual, technical,  ethical, or human viewpoint, that a total population  equivalent to Europe’s including Russia has no access  to technical equipment, installations, and treatment  resources similar to those offered in a medium‑sized  French, German, American region or city.",Non-OADS,/arxiv_data1/oa_pdf/7b/c9/SNI-7-108.PMC5223397.pdf
"Sachs J. Macroeconomics and Health -.World Health Organization, 2001  Available at: http://www.who.int/macrohealth/infocentre/advocacy/en/ investinginhealth02052003.pdf.",Non-OADS,/arxiv_data1/oa_pdf/7b/c9/SNI-7-108.PMC5223397.pdf
The GDP increased to about 18.04 trillion U.S. dollars in 2015 Available  from: https://www.statista.com/statistics/188105/annual-gdp-of-the-united- states-since-1990/.,Non-OADS,/arxiv_data1/oa_pdf/7b/c9/SNI-7-108.PMC5223397.pdf
Available at: http://data.worldbank.org/indicator/SH.XPD.PCAP.,OADS,/arxiv_data1/oa_pdf/7b/c9/SNI-7-108.PMC5223397.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOriginal Article An algorithmic approach to the management of unrecognized  hydrocephalus in pediatric candidates for intrathecal baclofen  pump implantation Brian W .",Non-OADS,/arxiv_data1/oa_pdf/3b/f0/SNI-7-105.PMC5223398.pdf
"Surg Neurol Int 2016;7:105. http://surgicalneurologyint.com/An-algorithmic-approach-to-the-management-of-unrecognized-hydrocephalus-in-pediatric-candidates-for-intrathecal-baclofen-pump-implantation/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/3b/f0/SNI-7-105.PMC5223398.pdf
"Surgical Neurology International 2016, 7:105  http://www.surgicalneurologyint.com/content/7/1/105INTRODUCTION Intrathecal baclofen (ITB) delivery is one of the  most common and effective treatments for spasticity  and dystonia associated with cerebral palsy; however,  complications of ITB pump implantation continue to be  unacceptably high, with some reports citing a combined  risk of infection and malfunction exceeding 40%.",Non-OADS,/arxiv_data1/oa_pdf/3b/f0/SNI-7-105.PMC5223398.pdf
"Surgical Neurology International 2016, 7:105  http://www.surgicalneurologyint.com/content/7/1/105and con figuration.",Non-OADS,/arxiv_data1/oa_pdf/3b/f0/SNI-7-105.PMC5223398.pdf
"Surgical Neurology International 2016, 7:105  http://www.surgicalneurologyint.com/content/7/1/105Table 1: Overview of clinical data Patient Age/Sex Spasticity Etiology/Clinical  DetailsMotor  Function (GMFCS)Frontal and  Occipital  Horn RatioAdditional  Preoperative  Imaging FindingsPlanned  Procedure ICP(cmH2O)pCO2 (mmHg) Outcome 1 6/M Hypoxic/ ischemic (presumed  sudden infant death  syndrome)V 0.49 Diffuse cystic  encephalomalaciaTD 36 35 VP shunt placed  10 days later;  Baclofen pump  implanted  3 months  later without  complication 2 20/M Unknown V 0.38 Mild prominence  of extra‑axial CSF  spacesTD 14 20 Pump Implanted  1 month  later without  complication 3 7/M Lennox‑Gastaut  Syndrome,  cortical blindness,  pachygyria,  microcephalyV 0.48 Diffuse  pachygyria;  microcephalyTD 22 32 Family deferred  baclofen pump  implantation (tone  improved with test  dose but overall  clinical status/ comfort not felt to  be improved by  family) 4 4/M Kernicterus V 0.40 Mild prominence  of extra‑axial CSF  spacesTD 29 38 Minimal response  to test dose (pump  not implanted);  no papilledema  or optic nerve  atrophy by  fundoscopic  examination 5 11/M Anoxic brain injury  secondary to  attempted hangingV 0.38 Unremarkable PI 18 37 Pump implanted  without  complication 6 19/M Leukodystrophy of  unknown originV 0.44 Absence of  subcortical U  fiber myelination  evident by MRI  imagingTD 21 35 Pump implanted  2 weeks  later without  complication 7 13/F Cerebral palsy V 0.33 Unremarkable,  typical ventricular  anatomyPI 15 38 Pump implanted  without  complication 8 5/M Cerebral palsy IV 0.42 Periventricular  leukomalaciaTD 14 35 Family deferred  implant (ultimately  elected to  pursue selective  dorsal rhizotomy  for spasticity  management) 9 13/M Mitochondrial  cystopathy and  leukodystrophyV 0.37 Multifocal T2  signal abnormality  within white  matter of the  bilateral centrum  semiovale and  subcortical  frontoparietal  lobesTD 16 35 Pump implanted  2 weeks  later without  complication Contd...",Non-OADS,/arxiv_data1/oa_pdf/3b/f0/SNI-7-105.PMC5223398.pdf
"Surgical Neurology International 2016, 7:105  http://www.surgicalneurologyint.com/content/7/1/105Table 1: Contd...",Non-OADS,/arxiv_data1/oa_pdf/3b/f0/SNI-7-105.PMC5223398.pdf
"Surgical Neurology International 2016, 7:105  http://www.surgicalneurologyint.com/content/7/1/105Table 1: Contd...",Non-OADS,/arxiv_data1/oa_pdf/3b/f0/SNI-7-105.PMC5223398.pdf
"Surgical Neurology International 2016, 7:105  http://www.surgicalneurologyint.com/content/7/1/105interpreted with an understanding of the limitations  inherent in LP opening pressure measurements obtained  at a single time point, although the one patient in our  study who underwent a second LP to confirm the finding  of an elevated ICP of 23 cmH2O was found, on repeat  procedure, to have an ICP of 24 cmH2O.",Non-OADS,/arxiv_data1/oa_pdf/3b/f0/SNI-7-105.PMC5223398.pdf
"Surgical Neurology International 2016, 7:105  http://www.surgicalneurologyint.com/content/7/1/105we still advocate obtaining preoperative cranial imaging  to rule out mass lesions and/or Chiari malformations  that might increase the risk of CSF sampling via LP , our  data suggests that this preoperative imaging is of limited  value with respect to predicting intracranial pressure in  the cerebral palsy patient population.",Non-OADS,/arxiv_data1/oa_pdf/3b/f0/SNI-7-105.PMC5223398.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor Isolated intramedullary Rosai–Dorfman disease Kaichuang Yang, Manish Kolakshyapati1, Tejashwi Shrestha2, Lin Lou Department of Neurosurgery, ZheJiang Provincial People’s Hospital, Hangzhou, China, 1Department of Neurosurgery, Graduate School of Biomedical and Health  Sciences, Hiroshima University, 2Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences,   Hiroshima University, Hiroshima, Japan E‑mail:  Kaichuang Yang ‑ kaichuangyang@gmail.com; Manish Kolakshyapati ‑ manish.kola@gmail.com; T ejashwi Shrestha ‑ tejashwy@gmail.com;   *Lin Lou ‑ drloulin@gmail.com   *Corresponding author Received: 10 August 16  Accepted: 21 October 16  Published: 16 November 16 Sir, We read with great interest the case report by Jesús  Rocha‑Maguey et al .",Non-OADS,/arxiv_data1/oa_pdf/c2/78/SNI-7-100.PMC5223399.pdf
Surg Neurol Int 2016;7:100. http://surgicalneurologyint.com/Isolated‑intramedullary‑Rosai‑Dorfman‑disease/,Non-OADS,/arxiv_data1/oa_pdf/c2/78/SNI-7-100.PMC5223399.pdf
"Surgical Neurology International 2016, 7:100  http://www.surgicalneurologyint.com/content/7/1/1002.",Non-OADS,/arxiv_data1/oa_pdf/c2/78/SNI-7-100.PMC5223399.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comBook Review THIEME Atlas of Anatomy, Head and Neuroanatomy Seyed Ali Khonsary Department of Neurosurgery, Skull Base Laboratory, University of California, Los Angeles, California ‑ 90036, USA E‑mail: *Seyed Ali Khonsary ‑ akhon@ucla.edu   *Corresponding author Received: 10 October 16  Accepted: 14 October 16  Published: 16 November 16 This Neuroanatomy Atlas is one of the most concise  and fully updated texts of the central nervous system  anatomy, which is highly recommended for students,  residents, faculties, as well as those who are interested  in detailed and clear understanding of the structures of  the central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/dc/df/SNI-7-101.PMC5223400.pdf
"Surg Neurol Int 2016;7:101. http://surgicalneurologyint.com/THIEME-Atlas-of-Anatomy,-Head-and-Neuroanatomy/",Non-OADS,/arxiv_data1/oa_pdf/dc/df/SNI-7-101.PMC5223400.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comObituary Yucel Kanpolat, MD (1941–2016) Professor Kanpolat, one of the most prominent  neurosurgeons in the field of pain surgery, passed away on  September 17th, 2016.",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/SNI-7-107.PMC5223401.pdf
"Surg Neurol  Int 2016;7:107.  http://surgicalneurologyint.com/Yucel-Kanpolat,-MD-(1941-2016)/ Yucel Kanpolat (1941–2016)",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/SNI-7-107.PMC5223401.pdf
"Surgical Neurology International 2016, 7:107  http://www.surgicalneurologyint.com/content/7/1/107His legacy as a continuous contributor to scientific  education has been remarkable, especially  during his presidency in the T urkish Academy of  Sciences (TUBA).",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/SNI-7-107.PMC5223401.pdf
"Surgical Neurology International 2016, 7:107  http://www.surgicalneurologyint.com/content/7/1/107 world beyond neurosurgery and the state of humanity.",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/SNI-7-107.PMC5223401.pdf
"Surgical Neurology International 2016, 7:107  http://www.surgicalneurologyint.com/content/7/1/107what I always imagined a doctor should be – selfless and  fully dedicated to his patients and their well‑being.",Non-OADS,/arxiv_data1/oa_pdf/7d/d5/SNI-7-107.PMC5223401.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Paraneoplastic symptoms caused by extracranial meningioma  metastases?",Non-OADS,/arxiv_data1/oa_pdf/0b/cc/SNI-7-106.PMC5223464.pdf
"Surg Neurol Int 2016;7:106. http://surgicalneurologyint.com/Paraneoplastic-symptoms-caused-by-extracranial- meningioma-metastases?/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/0b/cc/SNI-7-106.PMC5223464.pdf
"Surgical Neurology International 2016, 7:106  http://www.surgicalneurologyint.com/content/7/1/106these symptoms and a neurological work up, the patient  was diagnosed with peripheral small fiber polyneuropathy.",Non-OADS,/arxiv_data1/oa_pdf/0b/cc/SNI-7-106.PMC5223464.pdf
"Surgical Neurology International 2016, 7:106  http://www.surgicalneurologyint.com/content/7/1/106the numerous liver and bone metastases, which are still  in place.",Non-OADS,/arxiv_data1/oa_pdf/0b/cc/SNI-7-106.PMC5223464.pdf
"Surgical Neurology International 2016, 7:106  http://www.surgicalneurologyint.com/content/7/1/106cranial meningioma should include screening for distant  metastases from the meningioma.",Non-OADS,/arxiv_data1/oa_pdf/0b/cc/SNI-7-106.PMC5223464.pdf
1  247–263 https://doi.org/10.1083/jcb.201511055Introduction Primary cilia coordinate several signaling cascades during em - bryonic development.,Non-OADS,/arxiv_data1/oa_pdf/c0/b4/JCB_201511055.PMC5223597.pdf
1  115–129 https://doi.org/10.1083/jcb.201511073Introduction It is now established that cells frequently reduce the rate of  translational initiation in response to stress as a protective  mechanism.,Non-OADS,/arxiv_data1/oa_pdf/c3/95/JCB_201511073.PMC5223598.pdf
1  231–246 https://doi.org/10.1083/jcb.201601098Introduction The strength of synaptic transmission is a critical determinant  of information processing in neural circuits.,Non-OADS,/arxiv_data1/oa_pdf/a7/53/JCB_201601098.PMC5223599.pdf
"1  199–215 https://doi.org/10.1083/jcb.201602002Introduction Semaphorins are a large family of secreted, transmembrane,  or glycosylphosphatidylinositol-linked proteins defined by a  semaphorin domain (Kolodkin et al., 1993; Luo et al., 1993).",Non-OADS,/arxiv_data1/oa_pdf/2d/4a/JCB_201602002.PMC5223600.pdf
1  101–113 https://doi.org/10.1083/jcb.201605001Introduction The centromere is a critical genomic region where the kine - tochore is assembled and mediates the interaction between  chromosome and spindle microtubules in the process of faith - ful chromosome segregation.,Non-OADS,/arxiv_data1/oa_pdf/ea/4f/JCB_201605001.PMC5223601.pdf
"1  93–100 https://doi.org/10.1083/jcb.201605097Introduction The movement of single cells through 3D material is essential  for normal wound healing, but can become lethal in metastatic  disease (Singer and Clark, 1999; Valastyan and Weinberg,  2011).",Non-OADS,/arxiv_data1/oa_pdf/a6/76/JCB_201605097.PMC5223602.pdf
1  181–197 https://doi.org/10.1083/jcb.201605104Introduction Podosomes are a distinctive form of integrin-mediated cell-   matrix adhesion typical of monocyte-derived cells but under  some circumstances produced by cells of other lineages.,Non-OADS,/arxiv_data1/oa_pdf/28/f7/JCB_201605104.PMC5223603.pdf
"1  131–147 https://doi.org/10.1083/jcb.201606059Introduction Several critical lipid intermediates, such as DAG and ceramide,  can be toxic when they accumulate in cellular membranes.",Non-OADS,/arxiv_data1/oa_pdf/ee/e5/JCB_201606059.PMC5223604.pdf
1  217–230 https://doi.org/10.1083/jcb.201607064Introduction Production of high-affinity antibodies against pathogens is an  effective mechanism of protection against a wide range of in - fections.,Non-OADS,/arxiv_data1/oa_pdf/cf/92/JCB_201607064.PMC5223605.pdf
"1  83–92 https://doi.org/10.1083/jcb.201607066Introduction About two thirds of mitochondrial precursor proteins use N-   terminal presequences as targeting signals (Vögtle et al., 2009).",Non-OADS,/arxiv_data1/oa_pdf/f5/ac/JCB_201607066.PMC5223606.pdf
1  149–165 https://doi.org/10.1083/jcb.201607110Introduction Mitochondrial function is critical for maintenance of local and  systemic metabolic homeostasis.,Non-OADS,/arxiv_data1/oa_pdf/ac/a0/JCB_201607110.PMC5223607.pdf
"1  167–179 https://doi.org/10.1083/jcb.201608071Introduction Clathrin-mediated endocytosis (CME) is the major pathway by  which receptors and their ligands are concentrated and taken  up into cells (Conner and Schmid, 2003; McMahon and Bou - crot, 2011).",Non-OADS,/arxiv_data1/oa_pdf/01/5b/JCB_201608071.PMC5223608.pdf
"1  265–277 https://doi.org/10.1083/jcb.201609094Introduction A central question in developmental biology is how overall  size and cell number in an organ are regulated during normal  development, particularly in tissues that display endogenous  size regulation.",Non-OADS,/arxiv_data1/oa_pdf/e8/6f/JCB_201609094.PMC5223609.pdf
"1  53–63 https://doi.org/10.1083/jcb.201610011Introduction Biologists eager to exploit the promises of a fast-moving field  are quickly adopting superresolution (SR) microscopy (SRM),  primarily using commercial SR microscopes.",Non-OADS,/arxiv_data1/oa_pdf/13/2e/JCB_201610011.PMC5223610.pdf
1  41–51 https://doi.org/10.1083/jcb.201610025Introduction Single-molecule approaches are transforming our understand - ing of cell biology.,Non-OADS,/arxiv_data1/oa_pdf/f5/3c/JCB_201610025.PMC5223611.pdf
1  65–71 https://doi.org/10.1083/jcb.201610026Introduction Microscopy assays enable the identification of cell biologi - cal phenotypes through the quantification of cell morphology.,Non-OADS,/arxiv_data1/oa_pdf/d2/18/JCB_201610026.PMC5223612.pdf
1  31–40 https://doi.org/10.1083/jcb.201610056How do we define organoids and  3D cultures?,Non-OADS,/arxiv_data1/oa_pdf/50/a9/JCB_201610056.PMC5223613.pdf
1  73–82 https://doi.org/10.1083/jcb.201611002Introduction Synthetic biology has pioneered transformative approaches that  are affecting how scientists tackle key questions in mammalian  cell biology.,Non-OADS,/arxiv_data1/oa_pdf/1f/37/JCB_201611002.PMC5223614.pdf
"1  13–15 https://doi.org/10.1083/jcb.201611097Cells constantly interact with their environment through contact  structures, and those traveling across tissues are equipped with  podosomes.",Non-OADS,/arxiv_data1/oa_pdf/e3/a2/JCB_201611097.PMC5223615.pdf
"1  9–11 https://doi.org/10.1083/jcb.201611115In eukaryotic cells, the majority of internalized transmembrane  protein receptors and ligands enter by clathrin-mediated endo - cytosis (CME).",Non-OADS,/arxiv_data1/oa_pdf/00/a6/JCB_201611115.PMC5223616.pdf
"1  21–24 https://doi.org/10.1083/jcb.201612010In the mid 1990s, MS fiercely entered the cell biology field, as  its potential in identifying and quantifying entire proteomes be - came clear.",OADS,/arxiv_data1/oa_pdf/69/bc/JCB_201612010.PMC5223617.pdf
"1  17–19 https://doi.org/10.1083/jcb.201612043Endocytosis requires deformation of cell membranes and cyto - skeleton remodeling (Doherty and McMahon, 2009; Johannes  et al., 2015).",Non-OADS,/arxiv_data1/oa_pdf/78/87/JCB_201612043.PMC5223618.pdf
1  25–28 https://doi.org/10.1083/jcb.201612094Recent years have seen a maturation in the application of op - togenetics in cell biology.,Non-OADS,/arxiv_data1/oa_pdf/de/14/JCB_201612094.PMC5223619.pdf
"1  29–30 https://doi.org/10.1083/jcb.201612098One morning over breakfast, my seven-year-old son suddenly  asked, “What is ER?” Confused and searching for context, I  walked over to where he was sitting at the kitchen table and  realized that he was looking through a recently acquired cell bi - ology coloring book, and was indeed asking about endoplasmic  reticulum.",Non-OADS,/arxiv_data1/oa_pdf/2f/6a/JCB_201612098.PMC5223620.pdf
1  5–8 https://doi.org/10.1083/jcb.201612112I still vividly remember the first time I met Sue as a prospective  graduate student at the University of Chicago—she was in her  office surrounded by artwork from her young children.,Non-OADS,/arxiv_data1/oa_pdf/c9/80/JCB_201612112.PMC5223621.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/43/ee/bmjqir.u210929.w4509.PMC5223624.pdf
Available from: https://www.cot.co.uk/standards-ethics/standards-ethics 7.,Non-OADS,/arxiv_data1/oa_pdf/43/ee/bmjqir.u210929.w4509.PMC5223624.pdf
Available from: https://www.cot.co.uk/uk-ot-research-foundation-ukotrf/funded-project-outputs-0 4 O’Reilly A. BMJ Quality Improvement Reports 2016; 5:u210929.w4509.,Non-OADS,/arxiv_data1/oa_pdf/43/ee/bmjqir.u210929.w4509.PMC5223624.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014194).,Non-OADS,/arxiv_data1/oa_pdf/b1/28/bmjopen-2016-014194.PMC5223626.pdf
Acknowledgements This research is part of Singapore Programme of Research Investigating New Approaches to Treatment of Tuberculosis (SPRINT-TB; http://www.sprinttb.org).,Non-OADS,/arxiv_data1/oa_pdf/b1/28/bmjopen-2016-014194.PMC5223626.pdf
"Global Tuberculosis Report 2015 : WHO, 2015. http://www.who.int/tb/publications/global_report/en/ (accessed16 Nov 2015).",Non-OADS,/arxiv_data1/oa_pdf/b1/28/bmjopen-2016-014194.PMC5223626.pdf
"The impact of direct observed therapy on daily living activities, quality of life and socioeconomicburden on patients with tuberculosis in primary care in Singapore.Proc Singapore Healthcare 2016 http://psh.sagepub.com/content/ early/2016/07/22/2010105816652148.full.pdf+html 4.",Non-OADS,/arxiv_data1/oa_pdf/b1/28/bmjopen-2016-014194.PMC5223626.pdf
https://www.ericsson.com/ res/docs/2016/ericsson-mobility-report-2016.pdf (accessed 11 Apr2016).,Non-OADS,/arxiv_data1/oa_pdf/b1/28/bmjopen-2016-014194.PMC5223626.pdf
https://www.statista.com/statistics/539395/smartphone-penetration-worldwide-by-country/ (accessed 11 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/b1/28/bmjopen-2016-014194.PMC5223626.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011054).,Non-OADS,/arxiv_data1/oa_pdf/98/99/bmjopen-2016-011054.PMC5223628.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012850).,Non-OADS,/arxiv_data1/oa_pdf/c4/fc/bmjopen-2016-012850.PMC5223629.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.2n6v4.,OADS,/arxiv_data1/oa_pdf/c4/fc/bmjopen-2016-012850.PMC5223629.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/fc/bmjopen-2016-012850.PMC5223629.pdf
doi:10.1136/bmjopen-2016- 013158 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013158).,Non-OADS,/arxiv_data1/oa_pdf/c6/87/bmjopen-2016-013158.PMC5223630.pdf
"STINMOD was developed (and is maintained) by the National Centre for Social andEconomic Modelling (NATSEM, University of Canberra) (http://www.natsem.canberra.edu.au) and is the princi- pal microsimulation model of Australia ’s income tax and transfer (welfare) system.",OADS,/arxiv_data1/oa_pdf/c6/87/bmjopen-2016-013158.PMC5223630.pdf
http://www.oecd.org/dataoecd/25/4/ 31743847.pdf 39.,Non-OADS,/arxiv_data1/oa_pdf/c6/87/bmjopen-2016-013158.PMC5223630.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013420).,Non-OADS,/arxiv_data1/oa_pdf/25/0e/bmjopen-2016-013420.PMC5223632.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.17tp1.,OADS,/arxiv_data1/oa_pdf/25/0e/bmjopen-2016-013420.PMC5223632.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/25/0e/bmjopen-2016-013420.PMC5223632.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013414).,Non-OADS,/arxiv_data1/oa_pdf/e7/a8/bmjopen-2016-013414.PMC5223633.pdf
2016. http://www.nrls.npsa.nhs.uk/resources/collections/quarterly-data-summaries/ (accessed 1 Jun 2016).,OADS,/arxiv_data1/oa_pdf/e7/a8/bmjopen-2016-013414.PMC5223633.pdf
2016. http://www.nrls.npsa.nhs.uk/resources/patient-safety-topics/patient-accidents-falls/ (accessed 6 Jun 2016).4.,Non-OADS,/arxiv_data1/oa_pdf/e7/a8/bmjopen-2016-013414.PMC5223633.pdf
2015. http://www.aihw.,Non-OADS,/arxiv_data1/oa_pdf/e7/a8/bmjopen-2016-013414.PMC5223633.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bf/06/bmjopen-2016-012246.PMC5223634.pdf
2006. http://www.ine.es/metodologia/t15/ens_adu06.pdf(accessed 26 Nov 2010).,OADS,/arxiv_data1/oa_pdf/bf/06/bmjopen-2016-012246.PMC5223634.pdf
2008. http://www.ine.es/daco/daco42/discapa/edad_ cui.pdf (accessed 26 Nov 2010).,OADS,/arxiv_data1/oa_pdf/bf/06/bmjopen-2016-012246.PMC5223634.pdf
METHODS DataData were drawn from a survey conducted in late 2014 as part of the Australian Child Wellbeing Project (ACWP — http://www.australianchildwellbeing.com.au).,OADS,/arxiv_data1/oa_pdf/39/05/bmjopen-2016-013946.PMC5223635.pdf
http://www.ada.edu.au/ada/01309.,Non-OADS,/arxiv_data1/oa_pdf/39/05/bmjopen-2016-013946.PMC5223635.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/39/05/bmjopen-2016-013946.PMC5223635.pdf
6) https://www.researchgate.net/profile/Oddrun_Samdal/publication/265034558_Social_determinants_of_health_and_well-being_among_young_people/links/548ae0310cf225bf669e135e.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/39/05/bmjopen-2016-013946.PMC5223635.pdf
2016. http://research.acer.edu.au/well_being/5/ 38.,Non-OADS,/arxiv_data1/oa_pdf/39/05/bmjopen-2016-013946.PMC5223635.pdf
2015. http://research.acer.edu.au/cgi/viewcontent.cgi?article=1001&context=well_being 39.,Non-OADS,/arxiv_data1/oa_pdf/39/05/bmjopen-2016-013946.PMC5223635.pdf
7)http://alkoholdialog.dk/wp-content/uploads/2016/08/HBSC-2016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/39/05/bmjopen-2016-013946.PMC5223635.pdf
http://dbc-zorgproducten-tarieven.nza.nl/nzaZpTarief/Welkom.aspx (accessed Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/2a/5e/bmjopen-2016-011537.PMC5223636.pdf
2009. http://www.whocc.no/atcddd/ 14.,Non-OADS,/arxiv_data1/oa_pdf/2a/5e/bmjopen-2016-011537.PMC5223636.pdf
http://epoc.cochrane.org/sites/epoc.cochrane.org/ files/uploads/inttime.pdf (accessed Jun 2015).,OADS,/arxiv_data1/oa_pdf/2a/5e/bmjopen-2016-011537.PMC5223636.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012379).,Non-OADS,/arxiv_data1/oa_pdf/ae/b3/bmjopen-2016-012379.PMC5223638.pdf
"The electronic search will be supplemented by search- ing study for unpublished and dif ﬁcult to locate studies through sources that may include GreyNet International (http://www.greylit.org), registries, conference abstractsand dissertations.",Non-OADS,/arxiv_data1/oa_pdf/b5/71/bmjopen-2016-013929.PMC5223640.pdf
"St. Michael ’s Hospital, 2012. http://www.breakthroughkt.ca/login.php) which will be used for study selection (ie, title/abstract screening andfull-text article screening) using the eligibility criteria outlined above.",Non-OADS,/arxiv_data1/oa_pdf/b5/71/bmjopen-2016-013929.PMC5223640.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/71/bmjopen-2016-013929.PMC5223640.pdf
2015. http://joannabriggs.org/assets/docs/sumari/Reviewers-Manual_Methodology-for-JBI-Scoping-Reviews_2015_v2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/71/bmjopen-2016-013929.PMC5223640.pdf
http://www.who.int/about/definition/en/print.html 21.,Non-OADS,/arxiv_data1/oa_pdf/b5/71/bmjopen-2016-013929.PMC5223640.pdf
2013.https://afmc.ca/pdf/AFMC-Primer-on-Population-Health-2013-08-14.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/b5/71/bmjopen-2016-013929.PMC5223640.pdf
"2016. http://epoc.cochrane.org/news/gesi 6 Tricco AC, et al.BMJ Open 2016; 6:e013929.",OADS,/arxiv_data1/oa_pdf/b5/71/bmjopen-2016-013929.PMC5223640.pdf
2009. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm071324.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/d5/6c/bmjopen-2016-011793.PMC5223641.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013927).,Non-OADS,/arxiv_data1/oa_pdf/19/96/bmjopen-2016-013927.PMC5223642.pdf
"The risk of bias (eg, selection bias, performancebias, detection bias, attrition bias and reporting bias) of the included trials was assessed by Cochrane risk-of-bias algorithm (http://www.cohchrane.org/training/cochrane-handbook).Data synthesis and analysis Since pre-diabetes and diabetes do not confer the same risk for the different entities of cardiovascular disease,patients with insulin resistance/pre-diabetes and dia- betes were analysed separately for cardiovascular out- comes.",OADS,/arxiv_data1/oa_pdf/19/96/bmjopen-2016-013927.PMC5223642.pdf
2011. https://www.nice.org.uk/guidance/cg127/chapter/1-Guidance#initiating-and-monitoring-antihypertensive-drug-treatment-including-blood-pressure-targets-2 (accessed 1 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/48/72/bmjopen-2016-012818.PMC5223644.pdf
2010. http://pathways.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/48/72/bmjopen-2016-012818.PMC5223644.pdf
2014. http://pathways.nice.org.uk/pathways/chronic-kidney-disease#path=view%3A/pathways/chronic-kidney-disease/management-of-chronic-kidney-disease.xml&content=view-node%3Anodes-blood-pressure-control-and-antihypertensive-treatment (accessed 1 Apr 2016.,Non-OADS,/arxiv_data1/oa_pdf/48/72/bmjopen-2016-012818.PMC5223644.pdf
2013. http://pathways.nice.org.uk/pathways/myocardial-infarction-secondary-prevention(accessed 1 Apl 2016).,Non-OADS,/arxiv_data1/oa_pdf/48/72/bmjopen-2016-012818.PMC5223644.pdf
http://www.hscic.gov.uk/hes (accessed 1 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/48/72/bmjopen-2016-012818.PMC5223644.pdf
http://www.renal.org/ information-resources/the-uk-eckd-guide/hypertension#sthash.QNqnBcyh.dpbs (accessed 1 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/48/72/bmjopen-2016-012818.PMC5223644.pdf
http://www.gpnotebook.co.uk (accessed 1 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/48/72/bmjopen-2016-012818.PMC5223644.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/93/bmjdrc-2016-000259.PMC5223646.pdf
"Systematic review of the non-specific effects of BCG, DTP and measles containing vaccines.http://www.who.int/immunization/sage/meetings/2014/april (accessed 1 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/bc/25/bmjopen-2016-011317.PMC5223649.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013457).,Non-OADS,/arxiv_data1/oa_pdf/47/0f/bmjopen-2016-013457.PMC5223651.pdf
6. http://stat.yangsan.go.kr (accessed 1 Feb 2016).7.,OADS,/arxiv_data1/oa_pdf/47/0f/bmjopen-2016-013457.PMC5223651.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:014082corr1.,Non-OADS,/arxiv_data1/oa_pdf/01/61/bmjopen-2016-014082corr1.PMC5223653.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b0/18/bmjopen-2016-012022.PMC5223655.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013663).,Non-OADS,/arxiv_data1/oa_pdf/d3/a7/bmjopen-2016-013663.PMC5223656.pdf
2014. https://accreditation.ca/sites/default/files/rop-handbook-2014-en.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/d3/a7/bmjopen-2016-013663.PMC5223656.pdf
"Ottawa, ON: Accreditation Canada, 2012. https://accreditation.ca/sites/ default/files/med-rec-en.pdf 4.",Non-OADS,/arxiv_data1/oa_pdf/d3/a7/bmjopen-2016-013663.PMC5223656.pdf
2012.https://www.cadth.ca/media/pdf/htis/april-2012/RC0339%20-%20Medication%20Reconciliation%20Final.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/d3/a7/bmjopen-2016-013663.PMC5223656.pdf
"METHODS AND ANALYSES Study designThis systematic review protocol will be reported in accord- ance with the Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) (seeResearch Checklist), 20 21and the results will be reportedfollowing the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement.22 23 Study registration On the basis of the PRISMA-P guidelines, this systematic review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO)on 14 April 2016 (registration number: CRD42016037750; http://www.crd.york.ac.uk/PROSPERO/).",Non-OADS,/arxiv_data1/oa_pdf/48/8a/bmjopen-2016-012479.PMC5223658.pdf
Risk of bias The quality of the included RCT will be assessed by extracting the PEDro scores from the PEDro database (http://www.pedro.org.au).,Non-OADS,/arxiv_data1/oa_pdf/48/8a/bmjopen-2016-012479.PMC5223658.pdf
"The scores on the individ-ual items of the PEDro scale of all included trial will be reported in a table .In an attempt to determine if reporting bias is present in the included trials, the trialregister ’s‘ClinicalTrials.gov ’,‘http://www.anzctr.org.au ’ and ‘http://www.clinicaltrialsregister.eu/ctr-search/search ’ will be screened to assess whether selective reporting ispresent.",Non-OADS,/arxiv_data1/oa_pdf/48/8a/bmjopen-2016-012479.PMC5223658.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org (accessed 14 Apr 2016).",OADS,/arxiv_data1/oa_pdf/48/8a/bmjopen-2016-012479.PMC5223658.pdf
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015024086 (accessed14 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/48/8a/bmjopen-2016-012479.PMC5223658.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013554).,Non-OADS,/arxiv_data1/oa_pdf/60/4c/bmjopen-2016-013554.PMC5223660.pdf
2011. http://www.dh.gov.uk/en/Healthcare/LiberatingtheNHS/index.htm 11.,Non-OADS,/arxiv_data1/oa_pdf/60/4c/bmjopen-2016-013554.PMC5223660.pdf
"National End of Life Care Programme/National Institute for Health and Clinical Excellence, 2010. http://www.endoflifecareforadults.nhs.uk/publications/eolc-for-people-with-dementia-commissioning-guide 13.",Non-OADS,/arxiv_data1/oa_pdf/60/4c/bmjopen-2016-013554.PMC5223660.pdf
"National Institute for Health and Clinical Excellence, 2006. https://www.nice.org.uk/guidance/cg42/resources/dementia-supporting-people-with-dementia-and-their-carers-in-health-and-social-care-975443665093 14.",Non-OADS,/arxiv_data1/oa_pdf/60/4c/bmjopen-2016-013554.PMC5223660.pdf
"National Institute for Health and Clinical Excellence, 2015. https://www.nice.org.uk/guidance/ng31/resources/care-of-dying-adults-in-the-last-days-of-life-183738732435715.",Non-OADS,/arxiv_data1/oa_pdf/60/4c/bmjopen-2016-013554.PMC5223660.pdf
"Department of Health, 2009. https://www.gov.uk/ government/uploads/system/uploads/attachment_data/file/168220/dh_094051.pdf 16.",Non-OADS,/arxiv_data1/oa_pdf/60/4c/bmjopen-2016-013554.PMC5223660.pdf
"Department of Health, 2015. https://www.gov.uk/government/uploads/system/uploads/ attachment_data/file/414344/pm-dementia2020.pdf 17.",Non-OADS,/arxiv_data1/oa_pdf/60/4c/bmjopen-2016-013554.PMC5223660.pdf
"Department of Health, 2011. https://www.gov.uk/government/publications/ dementia-commissioning-pack 18.",Non-OADS,/arxiv_data1/oa_pdf/60/4c/bmjopen-2016-013554.PMC5223660.pdf
http://www.ingesa.msc.es/estadEstudios/documPublica/CMBD-2001.htm (accessed 6 Oct 2015).,OADS,/arxiv_data1/oa_pdf/5f/3e/bmjopen-2016-013097.PMC5223662.pdf
http://www.msssi.gob.es/estadEstudios/estadisticas/encuestaNacional/ (accessed 1 Dec2015).,Non-OADS,/arxiv_data1/oa_pdf/5f/3e/bmjopen-2016-013097.PMC5223662.pdf
2010. http://www.ine.es (accessed 1 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/5f/3e/bmjopen-2016-013097.PMC5223662.pdf
http://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/Neumococo_Gruposriesgo.pdf (accessed 3 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/5f/3e/bmjopen-2016-013097.PMC5223662.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013995).,Non-OADS,/arxiv_data1/oa_pdf/0c/af/bmjopen-2016-013995.PMC5223667.pdf
2003. http://apps.who.int/medicinedocs/en/d/ Js4883e/ 30.,Non-OADS,/arxiv_data1/oa_pdf/0c/af/bmjopen-2016-013995.PMC5223667.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012287).,Non-OADS,/arxiv_data1/oa_pdf/98/64/bmjopen-2016-012287.PMC5223668.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/98/64/bmjopen-2016-012287.PMC5223668.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013096).,Non-OADS,/arxiv_data1/oa_pdf/0c/3c/bmjopen-2016-013096.PMC5223669.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013887).,Non-OADS,/arxiv_data1/oa_pdf/10/3e/bmjopen-2016-013887.PMC5223670.pdf
"We constructed a new site which cl osely resembled the design and features of the intervention yet was populated with the asthma self-management information taken from NHSChoices (http://www.nhs.uk), as the authoritative provider of online health information in the UK.",Non-OADS,/arxiv_data1/oa_pdf/65/19/bmjopen-2016-013401.PMC5223671.pdf
November 2013. http://www.pewinternet.org/2013/11/26/the-diagnosis-difference/ (accessed 29 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/65/19/bmjopen-2016-013401.PMC5223671.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/9d/bmjqir.u216506.w5621.PMC5223673.pdf
http://childrensnational.org/departments/asthma-impact-dc/resources-for-providers 18.,Non-OADS,/arxiv_data1/oa_pdf/01/9d/bmjqir.u216506.w5621.PMC5223673.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011924).,Non-OADS,/arxiv_data1/oa_pdf/6c/d4/bmjopen-2016-011924.PMC5223674.pdf
25 September 2014. http://www.stralsakerhetsmyndigheten.se/Yrkesverksam/Miljoovervakning/Sokbara-miljodata/Cesium/Cesium-Search-Page-New/ 8.,Non-OADS,/arxiv_data1/oa_pdf/6c/d4/bmjopen-2016-011924.PMC5223674.pdf
Provenance and peer review Not commissioned; externally peer reviewed.Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.v465c.,OADS,/arxiv_data1/oa_pdf/42/c8/bmjopen-2016-012063.PMC5223675.pdf
14. http://www.nhlbi.nih.gov/guidelines/cholesterol/risk_tbl.htm15.,Non-OADS,/arxiv_data1/oa_pdf/42/c8/bmjopen-2016-012063.PMC5223675.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/bmjopen-2016-013477.PMC5223677.pdf
23. http://www.phadia.com/PageFiles/29347/Product%20information% 20EliA%20Calprotectin.pdf 24.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/bmjopen-2016-013477.PMC5223677.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014014).,Non-OADS,/arxiv_data1/oa_pdf/55/e4/bmjopen-2016-014014.PMC5223678.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013668).,Non-OADS,/arxiv_data1/oa_pdf/f3/52/bmjopen-2016-013668.PMC5223679.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/52/bmjopen-2016-013668.PMC5223679.pdf
http://www.who.int/mediacentre/factsheets/fs317/en/ 4.,Non-OADS,/arxiv_data1/oa_pdf/f3/52/bmjopen-2016-013668.PMC5223679.pdf
(cited 2016 Jul 18).http://www.who.int/nmh/publications/essential_ncd_interventions_lr_settings.pdf?ua=1 8.,OADS,/arxiv_data1/oa_pdf/f3/52/bmjopen-2016-013668.PMC5223679.pdf
https://datahelpdesk.worldbank.org/knowledgebase/articles/906519.,Non-OADS,/arxiv_data1/oa_pdf/f3/52/bmjopen-2016-013668.PMC5223679.pdf
http://rayyan.qcri.org/.,Non-OADS,/arxiv_data1/oa_pdf/f3/52/bmjopen-2016-013668.PMC5223679.pdf
http://handbook.cochrane.org/chapter_15/figure_15_5_a_drummond_checklist_drummond_1996.htm 17.,OADS,/arxiv_data1/oa_pdf/f3/52/bmjopen-2016-013668.PMC5223679.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013634).,Non-OADS,/arxiv_data1/oa_pdf/79/ce/bmjopen-2016-013634.PMC5223682.pdf
"Stockholm:ECDC, 2013. http://ecdc.europa.eu/en/publications/surveillance_reports/Pages/index.aspx (accessed 08 Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/79/ce/bmjopen-2016-013634.PMC5223682.pdf
Review on Antimicrobial Resistance 2014. http://amr-review.org/Publications (accessed 15 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/79/ce/bmjopen-2016-013634.PMC5223682.pdf
Review on Antimicrobial Resistance 2016. http://amr-review.org/Publications (accessed 15 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/79/ce/bmjopen-2016-013634.PMC5223682.pdf
http://www.combacte.com/ COMBACTE-MAGNET/About (accessed 20 Jun 2016).,OADS,/arxiv_data1/oa_pdf/79/ce/bmjopen-2016-013634.PMC5223682.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013199).,Non-OADS,/arxiv_data1/oa_pdf/55/dc/bmjopen-2016-013199.PMC5223683.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012833).,Non-OADS,/arxiv_data1/oa_pdf/62/01/bmjopen-2016-012833.PMC5223686.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012812).,Non-OADS,/arxiv_data1/oa_pdf/04/23/bmjopen-2016-012812.PMC5223687.pdf
"20 –21, legislative decree 196/2003; http://www.garanteprivacy.it/web/guest/home/docweb/-/docweb-display/docweb/1115480) published in the Ofﬁcial Journal no.",Non-OADS,/arxiv_data1/oa_pdf/04/23/bmjopen-2016-012812.PMC5223687.pdf
467 of 28.12.2001) (http://www.privacy.it/legge675encoord.html).,Non-OADS,/arxiv_data1/oa_pdf/04/23/bmjopen-2016-012812.PMC5223687.pdf
"The Italian National Institute of Statistics (Istat) reported that, in 2012, multimorbidity affected 20.4% of the Italian population (49.4% in participants aged 54–74 years and 69.4% in participants aged ≥90 years) (http://www.istat.it/it/archivio/5471).",OADS,/arxiv_data1/oa_pdf/04/23/bmjopen-2016-012812.PMC5223687.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/7e/bmjqir.u211734.w4726.PMC5223689.pdf
"Alternatively, the filters can be evoked in PubMed by entering the following shortened Uniform Resource Locators (URLs) in the browser address box: http://tinyurl.com/pollution-specific forthe‘more specific ’filter; http://tinyurl.com/pollution-sensitive for the ‘more sensitive ’filter.",Non-OADS,/arxiv_data1/oa_pdf/61/ad/bmjopen-2016-013092.PMC5223690.pdf
http://www.ncbi.nlm.nih.gov/books/NBK3827/#pubmedhelp.Search_Field_Descrip (accessed 9 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/61/ad/bmjopen-2016-013092.PMC5223690.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012290).,Non-OADS,/arxiv_data1/oa_pdf/35/48/bmjopen-2016-012290.PMC5223691.pdf
"Sample size Forα=0.05 and a power of 90%, based on data from the Audipog database (a French national database: Audipog: http://www.audipog.net/interro-choices.php) thatwomen who deliver spontaneously, without any perineal lesion (ie, without episiotomy or spontaneous second- degree, third-degree or fourth-degree lacerations)account for 49.6% of all parturients, the investigators estimate that the use of a two-sided test to show an abso- lute difference between groups of 20% (or 49.6% vs69.6%, a relative difference of the order of 40%) would require 125 women per group.Recruitment Again using information from the Audipog database (n=413 888 women), we estimate that 63.4% of womengive birth without a planned caesarean to a singleton fetus at a term ≥37 weeks of gestation and have neither a uterine scar nor a utero fetal death.",Non-OADS,/arxiv_data1/oa_pdf/35/48/bmjopen-2016-012290.PMC5223691.pdf
"Moreover, the storage of data collected for this study must comply with Frenchguidelines issued by the competent agency (CNIL: National Data Protection Authority —http://www.cnil.fr).",Non-OADS,/arxiv_data1/oa_pdf/35/48/bmjopen-2016-012290.PMC5223691.pdf
"The authorship eligibility will follow the Recommendations for the Conduct, Reporting, Editing,and Publication of Scholarly Work in Medical Journals, 2015 (http://www.icmje.org).",Non-OADS,/arxiv_data1/oa_pdf/35/48/bmjopen-2016-012290.PMC5223691.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 014661).,Non-OADS,/arxiv_data1/oa_pdf/31/c9/bmjopen-2016-014661.PMC5223692.pdf
http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/31/c9/bmjopen-2016-014661.PMC5223692.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/51/87/bmjqir.u208344.w4094.PMC5223694.pdf
Care Quality Commission: 13th biennial report of Mental Health Act Commission 2009 https://www.cqc.org.uk/sites/default/files/documents/mhac_biennial_report_0709_final.pdf (accessed on 6thDecember 2015).,Non-OADS,/arxiv_data1/oa_pdf/51/87/bmjqir.u208344.w4094.PMC5223694.pdf
Care Quality Commission: Monitoring the Mental Health Act in 2010/ 11: The Care Quality Commission ’s annual report on the exercise of its functions in keeping under review the operation of the MentalHealth Act 1983;2011. http://www.cqc.org.uk/sites/default/files/documents/cqc_mha_report_2011_main_final.pdf (accessed on 6thDecember 2015).,Non-OADS,/arxiv_data1/oa_pdf/51/87/bmjqir.u208344.w4094.PMC5223694.pdf
Norwich: The Stationery Office;2008 http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_087309.pdf (accessed online on 6thDecember 2015).,Non-OADS,/arxiv_data1/oa_pdf/51/87/bmjqir.u208344.w4094.PMC5223694.pdf
P v Cheshire West and Chester; P and Q v Surrey County Council [2014] UKSC 19. https://www.supremecourt.uk/decided-cases/docs/UKSC_2012_0068_Judgment.pdf (accessed on 6th December 2015).,Non-OADS,/arxiv_data1/oa_pdf/51/87/bmjqir.u208344.w4094.PMC5223694.pdf
"Commission forHealthcare Audit and Inspection, http://image.guardian.co.uk/sys-files/Society/documents/2008/07/23/mentalhealthreview.pdf(accessed on 6th December 2015).",Non-OADS,/arxiv_data1/oa_pdf/51/87/bmjqir.u208344.w4094.PMC5223694.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:012819corr1.,Non-OADS,/arxiv_data1/oa_pdf/98/76/bmjopen-2016-012819corr1.PMC5223696.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014162).,Non-OADS,/arxiv_data1/oa_pdf/a5/83/bmjopen-2016-014162.PMC5223697.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012929).,Non-OADS,/arxiv_data1/oa_pdf/73/13/bmjopen-2016-012929.PMC5223698.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/73/13/bmjopen-2016-012929.PMC5223698.pdf
https://www.outcomes-umassmed.org/grace/files/GRACE_RiskModel_Coefficients.pdf (accessed 3 May2016).,Non-OADS,/arxiv_data1/oa_pdf/73/13/bmjopen-2016-012929.PMC5223698.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/18/c8/bmjopen-2016-012829.PMC5223700.pdf
2010. https://richtlijnendatabase.nl/richtlijn/cervicaal_radiculair_syndroom_tgv_chnp/conservatieve_therapie_bij_crs_tgv_chnp.html#verantwoording 3.,Non-OADS,/arxiv_data1/oa_pdf/18/c8/bmjopen-2016-012829.PMC5223700.pdf
"1994. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_Guideline.pdf Broekema AEH, et al.BMJ Open 2017; 7:e012829.",Non-OADS,/arxiv_data1/oa_pdf/18/c8/bmjopen-2016-012829.PMC5223700.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/29/bmjqir.u209522.w7251.PMC5223701.pdf
[cited 2016 Feb 23].Available from: https://www.qualitymeasures.ahrq.gov/content.aspx?id=49600.,OADS,/arxiv_data1/oa_pdf/c7/29/bmjqir.u209522.w7251.PMC5223701.pdf
http://www.ihi.org/engage/initiatives/tripleaim/pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/c7/29/bmjqir.u209522.w7251.PMC5223701.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013998).,Non-OADS,/arxiv_data1/oa_pdf/34/30/bmjopen-2016-013998.PMC5223702.pdf
"10 The Core Outcomes in Women ’s and Newborn Health (CROWN) initiative (http://www.crown-initiative.org)will support the dissemination and implementation of a core outcome set for endometriosis to increase the value of an initial research effort and ensure all future endo-metriosis trials report core outcomes and, therefore, rou- tinely contribute data to important research questions.",Non-OADS,/arxiv_data1/oa_pdf/34/30/bmjopen-2016-013998.PMC5223702.pdf
"METHODS AND ANALYSIS Prospective registration This study has been prospectively registered with theCore Outcome Measures in Effectiveness Trials(COMET) initiative, the registration number is 691 and is available online (http://www.comet-initiative.org/ studies/details/691).",Non-OADS,/arxiv_data1/oa_pdf/34/30/bmjopen-2016-013998.PMC5223702.pdf
"They warmly invite readers to participate in the modified Delphi survey by registeringtheir interest to participate here: http://www.eepurl.com/bNCo81 Hirsch M, et al.BMJ Open 2016; 6:e013998.",Non-OADS,/arxiv_data1/oa_pdf/34/30/bmjopen-2016-013998.PMC5223702.pdf
11. http://www.comet-initiative.org12.,Non-OADS,/arxiv_data1/oa_pdf/34/30/bmjopen-2016-013998.PMC5223702.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013285).,Non-OADS,/arxiv_data1/oa_pdf/65/04/bmjopen-2016-013285.PMC5223703.pdf
"Retrieved 8 June 2015, https://www.agreetrust.org.",Non-OADS,/arxiv_data1/oa_pdf/7c/d5/bmjopen-2016-013881.PMC5223704.pdf
http://www.agreetrust.org/resource-centre/agree-ii-training-tools/22.,Non-OADS,/arxiv_data1/oa_pdf/7c/d5/bmjopen-2016-013881.PMC5223704.pdf
2008. http://fhswedge.csu.mcmaster.ca/cepftp/qasite/AGREEIIRaterConcordanceCalculator.html 23.,Non-OADS,/arxiv_data1/oa_pdf/7c/d5/bmjopen-2016-013881.PMC5223704.pdf
"Retrieved 30 June 2015, http://www.acadmed.org.my.",Non-OADS,/arxiv_data1/oa_pdf/7c/d5/bmjopen-2016-013881.PMC5223704.pdf
"Retrieved 30 June 2015, http://www.moh.gov.sg.",Non-OADS,/arxiv_data1/oa_pdf/7c/d5/bmjopen-2016-013881.PMC5223704.pdf
"Retrieved 18 August 2015, http://www.nice.org.uk.",Non-OADS,/arxiv_data1/oa_pdf/7c/d5/bmjopen-2016-013881.PMC5223704.pdf
2004. http://www.iris-initiative.org.uk/silo/files/early-psychosis-declaration.pdf 47.,Non-OADS,/arxiv_data1/oa_pdf/7c/d5/bmjopen-2016-013881.PMC5223704.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012468).,Non-OADS,/arxiv_data1/oa_pdf/db/5f/bmjopen-2016-012468.PMC5223705.pdf
"National Institute for Health and Welfare (THL), Report 15/2013, 2013. http://urn.fi/URN: ISBN:978-952-245-931-2 31.",Non-OADS,/arxiv_data1/oa_pdf/db/5f/bmjopen-2016-012468.PMC5223705.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-014032).,Non-OADS,/arxiv_data1/oa_pdf/95/ce/bmjopen-2016-014032.PMC5223706.pdf
"London: British Society for Rheumatology, 2001 (http://www.rheumatology.org.uk).",Non-OADS,/arxiv_data1/oa_pdf/95/ce/bmjopen-2016-014032.PMC5223706.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013904).,Non-OADS,/arxiv_data1/oa_pdf/39/2b/bmjopen-2016-013904.PMC5223707.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/39/2b/bmjopen-2016-013904.PMC5223707.pdf
http://www.fda.gov/ downloads/food/ingredientspackaginglabeling/gras/noticeinventory/ucm287952.pdf (accessed 02 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/e6/47/bmjopen-2016-013928.PMC5223709.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012836).,Non-OADS,/arxiv_data1/oa_pdf/a6/dd/bmjopen-2016-012836.PMC5223712.pdf
2011:2016. http://www.whocc.no/atc/structure_and_principles/ (accessed online Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/a6/dd/bmjopen-2016-012836.PMC5223712.pdf
"Defined daily dose; ATC/DDD index, 2015. http://www.whocc.no/atc_ddd_index/ 20.",Non-OADS,/arxiv_data1/oa_pdf/a6/dd/bmjopen-2016-012836.PMC5223712.pdf
2016. http://www.dst.dk/ en (accessed online November 2016).,Non-OADS,/arxiv_data1/oa_pdf/a6/dd/bmjopen-2016-012836.PMC5223712.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e008247corr1.,Non-OADS,/arxiv_data1/oa_pdf/14/36/bmjopen-2015-008247corr1.PMC5223713.pdf
http://apps.who.int/iris/bitstream/10665/155002/1/WHO_HIS_ SDS_2015.6_eng.pdf?ua=1&ua=1 7.,OADS,/arxiv_data1/oa_pdf/f8/4e/bmjopen-2016-013632.PMC5223714.pdf
http://www.ncbi.nlm.nih.gov/books/NBK44008/(accessed Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/f8/4e/bmjopen-2016-013632.PMC5223714.pdf
http://www.qualityindicators.ahrq.gov/ (accessed 1 Oct 2016).,OADS,/arxiv_data1/oa_pdf/f8/4e/bmjopen-2016-013632.PMC5223714.pdf
http://www.patientscanada.ca/ (accessed Jun 2016).,OADS,/arxiv_data1/oa_pdf/f8/4e/bmjopen-2016-013632.PMC5223714.pdf
http://www.pcori.,Non-OADS,/arxiv_data1/oa_pdf/f8/4e/bmjopen-2016-013632.PMC5223714.pdf
http://synthesis.info/.,Non-OADS,/arxiv_data1/oa_pdf/f8/4e/bmjopen-2016-013632.PMC5223714.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012938).,Non-OADS,/arxiv_data1/oa_pdf/cf/46/bmjopen-2016-012938.PMC5223716.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/46/bmjopen-2016-012938.PMC5223716.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013335).,Non-OADS,/arxiv_data1/oa_pdf/03/a3/bmjopen-2016-013335.PMC5223718.pdf
"Systematic review of the non-specific effects of BCG, DTP and measles containing vaccines.http://www.who.int/immunization/sage/meetings/2014/april (accessed 1 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/a3/bmjopen-2016-013335.PMC5223718.pdf
"Feedback can be viewed on: http://wessexahsn.org.uk/programmes/show/5/mental-health A steering group was then set up, involving clinicians, commissioners, patient and carer representatives,general practitioners and other stakeholders who were essential to the development of the pathway.",Non-OADS,/arxiv_data1/oa_pdf/32/4f/bmjopen-2016-012751.PMC5223719.pdf
http://guidance.nice.org.uk/CG178.,Non-OADS,/arxiv_data1/oa_pdf/32/4f/bmjopen-2016-012751.PMC5223719.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012382).,Non-OADS,/arxiv_data1/oa_pdf/80/8e/bmjopen-2016-012382.PMC5223720.pdf
http://www.cdc.gov/injury/wisqars/index.html(accessed 11 Jul 2016).,OADS,/arxiv_data1/oa_pdf/53/27/bmjopen-2016-013466.PMC5223721.pdf
27 July 2009. http://www.sprc.org/bpr/section-III/kognito-risk-university-and-college-faculty-identifying-and-referring-students-menta (accessed 11 Feb 2011).,Non-OADS,/arxiv_data1/oa_pdf/53/27/bmjopen-2016-013466.PMC5223721.pdf
http://www.afsp.org/preventing-suicide/our-education-and-prevention-programs/programs-for-teens-and-young-adults/the-truth-about-suicide-real-stories-of-depression-in-college 11.,Non-OADS,/arxiv_data1/oa_pdf/53/27/bmjopen-2016-013466.PMC5223721.pdf
http://www.jmir.org/2014/3/e66/ (accessed 4 Mar).,Non-OADS,/arxiv_data1/oa_pdf/53/27/bmjopen-2016-013466.PMC5223721.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011177).,Non-OADS,/arxiv_data1/oa_pdf/04/f8/bmjopen-2016-011177.PMC5223722.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/bmjopen-2016-011177.PMC5223722.pdf
2013. http://www.nhsconfed.org/resources/ key-statistics-on-the-nhs (accessed Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/04/f8/bmjopen-2016-011177.PMC5223722.pdf
2014. http://www.nice.org.uk/guidance/sg1/resources (accessed Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/04/f8/bmjopen-2016-011177.PMC5223722.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012572).,Non-OADS,/arxiv_data1/oa_pdf/ce/1e/bmjopen-2016-012572.PMC5223723.pdf
Data entry will be performed by one of the researchers ( JCAN) and checked and cleaned according to thequality handbook of the EMGO+ institute for health and care research (http://www.emgo.nl/kc).,OADS,/arxiv_data1/oa_pdf/2f/77/bmjopen-2016-014381.PMC5223724.pdf
"Dutch Orthopeaedic Association, 2011. http://www.orthopeden.org 2.",Non-OADS,/arxiv_data1/oa_pdf/2f/77/bmjopen-2016-014381.PMC5223724.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010974).,Non-OADS,/arxiv_data1/oa_pdf/2e/2e/bmjopen-2015-010974.PMC5223725.pdf
2015. http://www.chess.su.se/research/data-materials/the-swedish-work-and-mortality-database-hsia-wmb 19.,Non-OADS,/arxiv_data1/oa_pdf/2e/2e/bmjopen-2015-010974.PMC5223725.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012961).,Non-OADS,/arxiv_data1/oa_pdf/31/6c/bmjopen-2016-012961.PMC5223728.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/31/6c/bmjopen-2016-012961.PMC5223728.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/be/81/bmjqir.u210590.w4267.PMC5223731.pdf
Venous thromboembolism: reducing the risk for patients in hospital NICE guidelines [CG92] Published date: January 2010 https://www.nice.org.uk/guidance/cg92 (accessed 24 January 2016) 2.,Non-OADS,/arxiv_data1/oa_pdf/be/81/bmjqir.u210590.w4267.PMC5223731.pdf
Safer Clinical Systems http://www.health.org.uk/programmes/ safer-clinical-systems (accessed 24th January 2016) 7.,Non-OADS,/arxiv_data1/oa_pdf/be/81/bmjqir.u210590.w4267.PMC5223731.pdf
"December2014 http://www.health.org.uk/publication/safer-clinical-systems-evaluation-findings#sthash.TXLeylCB.dpuf(accessed 24th January 2016) 6 Humphries A, et al.BMJ Quality Improvement Reports 2016; 5:u210590.w4267.",Non-OADS,/arxiv_data1/oa_pdf/be/81/bmjqir.u210590.w4267.PMC5223731.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/39/bmjopen-2016-013592.PMC5223732.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013522).,Non-OADS,/arxiv_data1/oa_pdf/9c/0f/bmjopen-2016-013522.PMC5223742.pdf
2013. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/9c/0f/bmjopen-2016-013522.PMC5223742.pdf
2012. https://www.nlsinfo.org/ content/cohorts/nlsy79 30.,Non-OADS,/arxiv_data1/oa_pdf/9c/0f/bmjopen-2016-013522.PMC5223742.pdf
"Copyright © 2017 The Korean Neurosurgical Society  30 Clinical Article J Korean Neurosurg Soc 60 (1) : 30-39, 2017 https://doi.org/10.3340/jkns.2015.0506.004 pISSN 2005-371 1   eISSN 1598-787 6Comparative Analysis between Total Disc Replacement  and Posterior Foraminotomy for Posterolateral Soft Disc  Herniation with Unilateral Radiculopathy : Clinical and  Biomechanical Results of a Minimum 5 Years Follow-up Kyoung-Tae Kim, M.D.,1 Dae-Chul Cho, M.D.,1 Joo-Kyung Sung, M.D.,1 Young-Baeg Kim, M.D.,2 Du Hwan Kim, M.D.3 Department of Neurosurgery,1  Kyungpook National University Hospital, Daegu, Korea Department of Neurosurgery,2  Chung-Ang University Hospital, Seoul, Korea Department of Rehabilitation Medicine,3  Keimyung University Hospital, Daegu, Korea Objective :  To compare the clinical outcomes and biomechanical effects of total disc replacement (TDR) and posterior cervical  foraminotomy (PCF) and to propose relative inclusion criteria.",Non-OADS,/arxiv_data1/oa_pdf/45/89/jkns-60-1-30.PMC5223749.pdf
"• Received: June 1, 2015   • Revised: October 13, 2015   • Accepted: October 14, 2015    •  Address for reprints : Kyoung-Tae Kim, M.D., Ph.D. Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Korea Tel : +82-53-200-5657, Fax : +82-53-423-0504, E-mail: nskimkt7@gmail.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/89/jkns-60-1-30.PMC5223749.pdf
J Korean Neurosurg Soc 60  | January 201732 https://doi.org/10.3340/jkns.2015.0506.004rial.,Non-OADS,/arxiv_data1/oa_pdf/45/89/jkns-60-1-30.PMC5223749.pdf
J Korean Neurosurg Soc 60  | January 201734 https://doi.org/10.3340/jkns.2015.0506.004coefficient and the Kendall-tau coefficient analyses to detect  associations between categorical variables.,OADS,/arxiv_data1/oa_pdf/45/89/jkns-60-1-30.PMC5223749.pdf
J Korean Neurosurg Soc 60  | January 201736 https://doi.org/10.3340/jkns.2015.0506.004ervation ” was given by 88.2% of group A patients.,Non-OADS,/arxiv_data1/oa_pdf/45/89/jkns-60-1-30.PMC5223749.pdf
"J Korean Neurosurg Soc 60  | January 201738 https://doi.org/10.3340/jkns.2015.0506.004facet, lamina, and soft tissue during surgery14).",Non-OADS,/arxiv_data1/oa_pdf/45/89/jkns-60-1-30.PMC5223749.pdf
"Copyright © 2017 The Korean Neurosurgical Society  8 Clinical Article J Korean Neurosurg Soc 60 (1) : 8-14, 2017 https://doi.org/10.3340/jkns.2016.0707.004 pISSN 2005-371 1   eISSN 1598-787 6Superficial Temporal Artery-Sparing Mini-Pterional  Approach for Cerebral Aneurysm Surgery Jun-Young Ahn, M.D., Sung-Tae Kim, M.D., Ki-Chang Yi, M.D., Won-Hee Lee, M.D., Ph.D., Sung Hwa Paeng M.D., Ph.D.,  Young-Gyun Jeong, M.D., Ph.D. Department of Neurosurgery, Busan Paik Hospital, Inje University, College of Medicine, Busan, Korea Objective :  The purposes of this study were to introduce a superficial temporal artery (STA)-sparing mini-pterional approach for  the treatment of cerebral aneurysms and review the surgical results of this approach.",Non-OADS,/arxiv_data1/oa_pdf/41/ea/jkns-60-1-8.PMC5223750.pdf
"• Received: July 7, 2016   • Accepted: August 22, 2016    •  Address for reprints : Young-Gyun Jeong, M.D., Ph.D. Department of Neurosurgery, Busan Paik Hospital, Inje University College of Medicine, 75 Bokji-ro, Busanjin-gu, Busan 47392,  Korea Tel : +82-51-890-6144, Fax : +82-51-898-4244, E-mail: jyk91@inje.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Ever since the classical pterional surgical approach was in - troduced by Yasagil, it has been adopted worldwide for the  clipping of intracerebral aneurysms19).",Non-OADS,/arxiv_data1/oa_pdf/41/ea/jkns-60-1-8.PMC5223750.pdf
J Korean Neurosurg Soc 60  | January 201710 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/41/ea/jkns-60-1-8.PMC5223750.pdf
J Korean Neurosurg Soc 60  | January 201712 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/41/ea/jkns-60-1-8.PMC5223750.pdf
J Korean Neurosurg Soc 60  | January 201714 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/41/ea/jkns-60-1-8.PMC5223750.pdf
"Copyright © 2017 The Korean Neurosurgical Society  102 Case Report J Korean Neurosurg Soc 60 (1) : 102-107, 2017 https://doi.org/10.3340/jkns.2015.0707.011 pISSN 2005-371 1   eISSN 1598-787 6Collision Tumor Composed of Meningioma and Cavernoma Jens Weigel, M.D.,1 Markus Neher, M.D.,1 Michael Schrey, M.D.,1 Peter H. Wünsch, M.D., Ph.D.,2 Hans-Herbert Steiner, M.D., Ph.D.1 Department of Neurosurgery,1 Institute of Pathology,2 Paracelsus Medical University, General Hospital Nuremberg, Nuremberg, Germany A true collision tumor is a rare entity composed of two histologically distinct neoplasms coinciding in the same organ.",Non-OADS,/arxiv_data1/oa_pdf/f4/b6/jkns-60-1-102.PMC5223751.pdf
"201 90471 Nuremberg, Germany Tel : +49-911-398 2318, Fax : +49-911-398 2981, E-mail : jens.weigel@klinikum-nuernberg.de  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION A true collision tumor represents a coexistence of two  adjacent but histologically different malignant neoplasm's  occurring in the same organ without histological admixture  or an intermediate cell population zone11).",Non-OADS,/arxiv_data1/oa_pdf/f4/b6/jkns-60-1-102.PMC5223751.pdf
"J Korean Neurosurg Soc 60  | January 2017104 https://doi.org/10.3340/jkns.2015.0707.011grade II: atypical meningioma, grade III: malignant (anaplas - tic) meningioma5).",Non-OADS,/arxiv_data1/oa_pdf/f4/b6/jkns-60-1-102.PMC5223751.pdf
"J Korean Neurosurg Soc 60  | January 2017106 https://doi.org/10.3340/jkns.2015.0707.011also reports of collision tumors consisting of two different  cerebral metastases2,8).",Non-OADS,/arxiv_data1/oa_pdf/f4/b6/jkns-60-1-102.PMC5223751.pdf
"Copyright © 2017 The Korean Neurosurgical Society  54 Clinical Article J Korean Neurosurg Soc 60 (1) : 54-59, 2017 https://doi.org/10.3340/jkns.2016.0707.007 pISSN 2005-371 1   eISSN 1598-787 6Comparison of the Effects of Sufentanil and Fentanyl   Intravenous Patient Controlled Analgesia after Lumbar  Fusion Do Keun Kim, M.D.,1 Seung Hwan Yoon, M.D., Ph.D.,1 Ji Yong Kim, M.D.,2 Chang Hyun Oh, M.D., Ph.D.,3 Jong Kwon Jung, M.D.,4  Jin Kim, M.D.4 Department of Neurosurgery,1 Inha University Hospital, Incheon, Korea Department of Neurosurgery,2 Na-Eun Hospital, Incheon, Korea Department of Neurosurgery,3 Guro Cham TeunTeun Hospital, Seoul, Korea Department of Anesthesiology,4 Inha university Hospital, Incheon, Korea Objective :  Postoperative pain is one of the major complaints of patients after lumbar fusion surgery.",Non-OADS,/arxiv_data1/oa_pdf/54/71/jkns-60-1-54.PMC5223752.pdf
"• Received: July 19, 2016   • Revised: September 19, 2016   • Accepted: September 22, 2016    •  Address for reprints : Seung Hwan Yoon, M.D., Ph.D. Department of Neurosurgery, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon 22332, Korea Tel : +82-32-890-2619, Fax : +82-32-890-2374, E-mail : nsyoon@gmail.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Intravenous patient controlled analgesia (IV-PCA)  is a  commonly used straightforward and effective method of pain control after surgery4,5,8,18).",Non-OADS,/arxiv_data1/oa_pdf/54/71/jkns-60-1-54.PMC5223752.pdf
J Korean Neurosurg Soc 60  | January 201756 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/54/71/jkns-60-1-54.PMC5223752.pdf
J Korean Neurosurg Soc 60  | January 201758 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/54/71/jkns-60-1-54.PMC5223752.pdf
"Copyright © 2017 The Korean Neurosurgical Society  114 Case Report J Korean Neurosurg Soc 60 (1) : 114-117, 2017 https://doi.org/10.3340/jkns.2014.1011.019 pISSN 2005-371 1   eISSN 1598-787 6Thermal-Induced Osteonecrosis of Adjacent Vertebra   after Intradiscal Electrothermal Therapy Soonjoon Kim, M.D.,1,2 Sun-Ho Lee, M.D., Ph.D.,1 Eun-Sang Kim, M.D., Ph.D.,1 Whan Eoh, M.D., Ph.D.1 Department of Neurosurgery,1 Spine Center, Samsung Medical Center Sungkyunkwan University, School of Medicine, Seoul, Korea   College of Medicine,2 Seonam University, Namwon, Korea A 42-year-old man was admitted to our hospital with complaints of low back pain and intermittent right thigh pain.",Non-OADS,/arxiv_data1/oa_pdf/36/92/jkns-60-1-114.PMC5223753.pdf
"• Received: November 13, 2014   • Revised: October 10, 2015   • Accepted: November 9, 2015     •  Address for reprints : Sun-Ho Lee, M.D., Ph.D. Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University, School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351,  Korea Tel : +82-2-3410-2457, Fax : +82-2-3410-0048, E-mail : sobotta72@hotmail.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Intradiscal electrothermal therapy (IDET) is a minimally  invasive procedure that is an intermediate, safe, and effective  intervention in the continuum of care for patients with disco - genic low back pain1,7,12).",Non-OADS,/arxiv_data1/oa_pdf/36/92/jkns-60-1-114.PMC5223753.pdf
J Korean Neurosurg Soc 60  | January 2017116 https://doi.org/10.3340/jkns.2014.1011.019from the L4 and L5 vertebral bodies and the L4–5 interverte - bral disc.,Non-OADS,/arxiv_data1/oa_pdf/36/92/jkns-60-1-114.PMC5223753.pdf
"89 Copyright © 2017 The Korean Neurosurgical Society  Case Report J Korean Neurosurg Soc 60 (1) : 89-93, 2017 https://doi.org/10.3340/jkns.2015.1206.001 pISSN 2005-371 1   eISSN 1598-787 6Cerebellar Hemorrhage due to a Direct Carotid–Cavernous  Fistula after Surgery for Maxillary Cancer Yoshinobu Kamio, M.D.,1 Hisaya Hiramatsu, M.D.,1 Mika Kamiya, M.D.,2 Shuhei Yamashita, M.D.,2 Hiroki Namba, M.D., Ph.D.1 Department of Neurosurgery,1 Department of Radiology,2 Hamamatsu University School of Medicine, Hamamatsu, Japan Infratentorial cerebral hemorrhage due to a direct carotid–cavernous fistula (CCF) is very rare.",Non-OADS,/arxiv_data1/oa_pdf/c9/d4/jkns-60-1-89.PMC5223754.pdf
"Department Neurosurgery, Hamamatsu University School of Medicine, Handayama 1-20-1 Higashi-ku, Hamamatsu,  Japan Tel : +81-53-435-2283, Fax : +81-53-435-2282, E-mail : kamio880@hotmail.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION A direct carotid–cavernous fistula (CCF) can result from  trauma, rupture of a cavernous carotid aneurysm, or a tear  in the wall of a cavernous internal carotid artery (ICA) weak - ened by collagen vascular disease.",Non-OADS,/arxiv_data1/oa_pdf/c9/d4/jkns-60-1-89.PMC5223754.pdf
"J Korean Neurosurg Soc 60  | January 201790 https://doi.org/10.3340/jkns.2015.1206.001maxillectomy and resection of the coronoid process of the  mandible, inferior wall of the orbit, and part of the pterygoid  process (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c9/d4/jkns-60-1-89.PMC5223754.pdf
"J Korean Neurosurg Soc 60  | January 201792 https://doi.org/10.3340/jkns.2015.1206.001CCF is life-threatening, but rare.",Non-OADS,/arxiv_data1/oa_pdf/c9/d4/jkns-60-1-89.PMC5223754.pdf
"47 Copyright © 2017 The Korean Neurosurgical Society  Clinical Article J Korean Neurosurg Soc 60 (1) : 47-53, 2017 https://doi.org/10.3340/jkns.2016.0405.003 pISSN 2005-371 1   eISSN 1598-787 6The Korean Spinal Neurosurgery Society ;  Are We Reimbursed Properly for Spinal Neurosurgical  Practices under the Korean Resource Based Relative  Value Scale Service?",Non-OADS,/arxiv_data1/oa_pdf/27/17/jkns-60-1-47.PMC5223755.pdf
"• Received: May 9, 2016   • Accepted: August 29, 2016    •  Address for reprints : Youn-Kwan Park, M.D., Ph.D.  Department of Neurosurgery, Korea University Guro Hospital, 148 Gurodongro, Guro-gu, Seoul 08308, Korea Tel : +82-2-2626-3095, Fax : +82-2-863-1684, E-mail : ykapa76@yahoo.co.kr  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Since it ’s introduction in 1977, the national health insur - ance program in Korea has paid health care providers on a fee-for-service basis, and the reimbursement for health care  providers has been regulated by the government.",Non-OADS,/arxiv_data1/oa_pdf/27/17/jkns-60-1-47.PMC5223755.pdf
J Korean Neurosurg Soc 60  | January 201748 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/27/17/jkns-60-1-47.PMC5223755.pdf
J Korean Neurosurg Soc 60  | January 201750 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/27/17/jkns-60-1-47.PMC5223755.pdf
J Korean Neurosurg Soc 60  | January 201752 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/27/17/jkns-60-1-47.PMC5223755.pdf
"15 Copyright © 2017 The Korean Neurosurgical Society  Clinical Article J Korean Neurosurg Soc 60 (1) : 15-20, 2017 https://doi.org/10.3340/jkns.2016.0102.001 pISSN 2005-371 1   eISSN 1598-787 6The Use of MR Perfusion Imaging in the Evaluation of  Tumor Progression in Gliomas Brian Snelling, M.D., Ashish H. Shah, M.D., Simon Buttrick, M.D., Ronald Benveniste, M.D., Ph.D.  Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL, USA Objective :  Diagnosing tumor progression and pseudoprogression remains challenging for many clinicians.",Non-OADS,/arxiv_data1/oa_pdf/c1/ca/jkns-60-1-15.PMC5223756.pdf
"• Received: February 1, 2016   • Revised: August 15, 2016   • Accepted: August 30, 2016    •  Address for reprints : Ronald J. Benveniste, M.D, Ph.D. Department of Neurological Surgery, University of Miami School of Medicine, 1095 NW Terrace Miami, FL   33136, USA Tel : +1-305-243-6946, Fax : +1-305-243-3337, E-mail : RBenveniste@med.miami.edu  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Differentiating post-treatment changes in high-grade glio - mas remains a challenging clinical task due to their radio - logical similarities (recurrent enhancing lesions).",Non-OADS,/arxiv_data1/oa_pdf/c1/ca/jkns-60-1-15.PMC5223756.pdf
"J Korean Neurosurg Soc 60  | January 201716 https://doi.org/10.3340/jkns.2016.0102.001criteria has replaced the McDonald criteria to help discrimi - nate these entities more clearly by dividing tumor response  into four sets (complete, partial, stable, and progression)25).",Non-OADS,/arxiv_data1/oa_pdf/c1/ca/jkns-60-1-15.PMC5223756.pdf
J Korean Neurosurg Soc 60  | January 201718 https://doi.org/10.3340/jkns.2016.0102.001dictive value of MRP to assess tumor progression within 90  days was 46.9% (sensitivity) and 85.0% (specificity).,Non-OADS,/arxiv_data1/oa_pdf/c1/ca/jkns-60-1-15.PMC5223756.pdf
J Korean Neurosurg Soc 60  | January 201720 https://doi.org/10.3340/jkns.2016.0102.001radiation necrosis after external beam radiation therapy with dynamic  susceptibility-weighted contrast-enhanced perfusion MR imaging.,Non-OADS,/arxiv_data1/oa_pdf/c1/ca/jkns-60-1-15.PMC5223756.pdf
"Copyright © 2017 The Korean Neurosurgical Society  60 Clinical Article J Korean Neurosurg Soc 60 (1) : 60-66, 2017 https://doi.org/10.3340/jkns.2016.0505.010 pISSN 2005-371 1   eISSN 1598-787 6Effects of Percutaneous Sacroplasty on Pain and Mobility  in Sacral Insufficiency Fracture Kyung-Chul Choi, M.D., Ph.D.,1 Seung-Ho Shin, M.D.,1 Dong Chan Lee, M.D.,1 Hyeong-Ki Shim, M.D.,1  Choon-Keun Park, M.D., Ph.D.2  Department of Neurosurgery,1 the Leon Wiltse Memorial Hospital, Anyang, Korea   Department of Neurosurgery,2 the Leon Wiltse Memorial Hospital, Suwon, Korea Objective :  Sacral insufficiency fracture (SIF) contributes to severe low back pain.",Non-OADS,/arxiv_data1/oa_pdf/6f/da/jkns-60-1-60.PMC5223757.pdf
"• Received: May 24, 2016   • Revised: August 22, 2016   • Accepted: September 27, 2016    •  Address for reprints : Choon-Keun Park, M.D., Ph.D. Department of Neurosurgery,  the Leon Wiltse Memorial Hospital, 437 Gyeongsu-daero, Paldal-gu, Suwon 16480, Korea Tel : +82-31-240-6280, Fax : +82-31-240-6281, E-mail : allspine@gmail.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Sacral insufficiency fracture (SIF) was first recognized by  Lourie24).",Non-OADS,/arxiv_data1/oa_pdf/6f/da/jkns-60-1-60.PMC5223757.pdf
J Korean Neurosurg Soc 60  | January 201762 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/6f/da/jkns-60-1-60.PMC5223757.pdf
J Korean Neurosurg Soc 60  | January 201764 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/6f/da/jkns-60-1-60.PMC5223757.pdf
J Korean Neurosurg Soc 60  | January 201766 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/6f/da/jkns-60-1-60.PMC5223757.pdf
"Copyright © 2017 The Korean Neurosurgical Society  118 Case Report J Korean Neurosurg Soc 60 (1) : 118-124, 2017 https://doi.org/10.3340/jkns.2015.0707.023 pISSN 2005-371 1   eISSN 1598-787 6Brain Abscesses Associated with Asymptomatic  Pulmonary Arteriovenous Fistulas Taek-Kyun Nam, M.D., Ph.D., Yong-sook Park, M.D., Ph.D., Jeong-taik Kwon, M.D., Ph.D.  Department of Neurosurgery, Chung-Ang University College of Medicine, Seoul, Korea Brain abscess commonly occurs secondary to an adjacent infection (mostly in the middle ear or paranasal sinuses) or due  to hematogenous spread from a distant infection or trauma.",Non-OADS,/arxiv_data1/oa_pdf/37/7e/jkns-60-1-118.PMC5223758.pdf
"• Received: July 14, 2015   • Revised: September 3, 2015   • Accepted: February 5, 2016     •  Address for reprints : Yong-sook Park, M.D., Ph.D. Department of Neurosurgery, Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea  Tel : +82-2-6299-1610, Fax : +82-2-6299-1597, E-mail : cuttage@cau.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/7e/jkns-60-1-118.PMC5223758.pdf
J Korean Neurosurg Soc 60  | January 2017120 https://doi.org/10.3340/jkns.2015.0707.023proved negative.,Non-OADS,/arxiv_data1/oa_pdf/37/7e/jkns-60-1-118.PMC5223758.pdf
J Korean Neurosurg Soc 60  | January 2017122 https://doi.org/10.3340/jkns.2015.0707.023 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/37/7e/jkns-60-1-118.PMC5223758.pdf
J Korean Neurosurg Soc 60  | January 2017124 https://doi.org/10.3340/jkns.2015.0707.0237.,Non-OADS,/arxiv_data1/oa_pdf/37/7e/jkns-60-1-118.PMC5223758.pdf
"21 Copyright © 2017 The Korean Neurosurgical Society  Clinical Article J Korean Neurosurg Soc 60 (1) : 21-29, 2017 https://doi.org/10.3340/jkns.2016.0404.005 pISSN 2005-371 1   eISSN 1598-787 6The Influence of Biomarker Mutations and Systemic  Treatment on Cerebral Metastases from NSCLC Treated  with Radiosurgery Min Ho Lee, M.D., Doo-Sik Kong, M.D., Ph.D., Ho Jun Seol, M.D., Ph.D., Do-Hyun Nam, M.D., Ph.D., Jung-Il Lee, M.D., Ph.D.  Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea  Objective : The purpose of this study was to analyze outcomes and identify prognostic factors in patients with cerebral metastases  from non-small cell lung cancer (NSCLC) treated with gamma knife radiosurgery (GKS) particularly, focusing on associations of  biomarkers and systemic treatments.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/jkns-60-1-21.PMC5223759.pdf
"• Received: April 11, 2016   • Revised: August 22, 2016   • Accepted: August 30, 2016    •  Address for reprints : Jung-Il Lee, M.D., Ph.D. Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel : +82-2-3410-3494, Fax : +82-2-3410-0048, E-mail : jilee@skku.edu  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/jkns-60-1-21.PMC5223759.pdf
"J Korean Neurosurg Soc 60  | January 201722 https://doi.org/10.3340/jkns.2016.0404.005 INTRODUCTION Brain metastases occur in 30% to 50% of patients with  non-small cell lung cancer (NSCLC) and are associated with  poor prognosis and reduced quality of life15,19,31,36,37).",Non-OADS,/arxiv_data1/oa_pdf/55/3f/jkns-60-1-21.PMC5223759.pdf
"J Korean Neurosurg Soc 60  | January 201724 https://doi.org/10.3340/jkns.2016.0404.005tween group A and C, group B and C showed significant dif - ferences ( p=0.001, p=0.012, respectively) (Fig.",OADS,/arxiv_data1/oa_pdf/55/3f/jkns-60-1-21.PMC5223759.pdf
J Korean Neurosurg Soc 60  | January 201726 https://doi.org/10.3340/jkns.2016.0404.005 Salvage treatment-free survival (Local recurrence) Duration (years)0 1 2Group A Group B Group C1.0 0.80.60.40.20.0 Salvage treatment-free survival (New lesion development) Duration (years)0 1 2 3 4Group A Group B Group C1.0 0.80.60.40.20.0 A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/55/3f/jkns-60-1-21.PMC5223759.pdf
"J Korean Neurosurg Soc 60  | January 201728 https://doi.org/10.3340/jkns.2016.0404.005static lesions, most previous studies that have compared  EGFR mutation status between primary tumors and corre - sponding brain metastases have reported a concordance rate  of 100%14,23,27,39).",Non-OADS,/arxiv_data1/oa_pdf/55/3f/jkns-60-1-21.PMC5223759.pdf
"75 Copyright © 2017 The Korean Neurosurgical Society  Clinical Article J Korean Neurosurg Soc 60 (1) : 75-81, 2017 https://doi.org/10.3340/jkns.2016.0505.004 pISSN 2005-371 1   eISSN 1598-787 6Effectiveness and Safety of Tranexamic Acid in Spinal  Deformity Surgery Ho Yong Choi, M.D., Seung-Jae Hyun, M.D., Ph.D., Ki-Jeong Kim, M.D., Ph.D., Tae-Ahn Jahng, M.D., Ph.D.,   Hyun-Jib Kim, M.D., Ph.D. Department of Neurosurgery, Spine Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea Objective :  Spinal deformity surgery has the potential risk of massive blood loss.",Non-OADS,/arxiv_data1/oa_pdf/eb/0d/jkns-60-1-75.PMC5223760.pdf
"• Received: May 16, 2016   • Revised: September 7, 2016   • Accepted: October 3, 2016    •  Address for reprints : Seung-Jae Hyun, M.D., Ph.D. Department of Neurosurgery, Spine Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 13620, Korea Tel : +82-31-787-7164, Fax : +82-31-787-4059, E-mail : hyunsj@snu.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Spinal deformity surgery has the potential for massive blood  loss15,19).",Non-OADS,/arxiv_data1/oa_pdf/eb/0d/jkns-60-1-75.PMC5223760.pdf
J Korean Neurosurg Soc 60  | January 201776 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/eb/0d/jkns-60-1-75.PMC5223760.pdf
J Korean Neurosurg Soc 60  | January 201778 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/eb/0d/jkns-60-1-75.PMC5223760.pdf
J Korean Neurosurg Soc 60  | January 201780 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/eb/0d/jkns-60-1-75.PMC5223760.pdf
"Copyright © 2017 The Korean Neurosurgical Society  94 Case Report J Korean Neurosurg Soc 60 (1) : 94-97, 2017 https://doi.org/10.3340/jkns.2014.0506.007 pISSN 2005-371 1   eISSN 1598-787 6Skull Metastasis of Gastric Gastrointestinal Stromal  Tumor Successfully Managed by Surgery Inkeun Park, M.D.,1 Dong Hae Chung, M.D., Ph.D,2 Chan Jong Yoo, M.D., Ph.D.,3 Dong Bok Shin, M.D., Ph.D.1 Division of Hematology-Oncology,1 Departments of Internal Medicine, Pathology,2 Neurosurgery,3 Gil Medical Center, Gachon University  College of Medicine, Incheon, Korea Gastrointestinal stromal tumors (GISTs) are rare, but are the most common mesenchymal neoplasm of the gastrointestinal  tract.",Non-OADS,/arxiv_data1/oa_pdf/60/f4/jkns-60-1-94.PMC5223761.pdf
"• Received: June 5, 2014   • Revised: July 31, 2014   • Accepted: August 6, 2014 •  Address for reprints : Dong Bok Shin, M.D., Ph.D. Division of Hematology-Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 21565, Korea Tel : +82-32-460-8371,  Fax : +82-32-460-1754,  E-mail : dbs@gilhospital.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Gastrointestinal stromal tumors (GISTs) are rare, but are  the most common mesenchymal neoplasm of the gastroin - testinal tract, with an incidence of 10–20 cases per million7).",Non-OADS,/arxiv_data1/oa_pdf/60/f4/jkns-60-1-94.PMC5223761.pdf
J Korean Neurosurg Soc 60  | January 201796 https://doi.org/10.3340/jkns.2014.0506.007trans formation was thought to result from drainage vein sac - rifice during the operation.,Non-OADS,/arxiv_data1/oa_pdf/60/f4/jkns-60-1-94.PMC5223761.pdf
"1 Copyright © 2017 The Korean Neurosurgical Society  Clinical Article J Korean Neurosurg Soc 60 (1) : 1-7, 2017 https://doi.org/10.3340/jkns.2016.0404.002 pISSN 2005-371 1   eISSN 1598-787 6Cerebrospinal Fluid Lumbar Tapping Utilization  for Suspected Ventriculoperitoneal Shunt  Under-Drainage Malfunctions Jong-Beom Lee, M.D., Ho-Young Ahn, M.D., Hong-Jae Lee, M.D., Ji-Ho Yang, M.D., Jin-Seok Yi, M.D., Il-Woo Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/4a/3f/jkns-60-1-1.PMC5223762.pdf
"Department of Neurosurgery, Daejeon St. Mary’s Hospital, The Catholic University of Korea, 64 Daeheung-ro, Jung-gu, Daejeon 34943, Korea   Tel : +82-42-220-9525,  Fax : +82-42-222-6601,  E-mail : yijinseok@hanmail.net  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION In communicating hydrocephalus, ventriculoperitoneal shunt (VPS) is the treatment of choice.",Non-OADS,/arxiv_data1/oa_pdf/4a/3f/jkns-60-1-1.PMC5223762.pdf
J Korean Neurosurg Soc 60  | January 20172 https://doi.org/10.3340/jkns.2016.0404.002lenging since neuroimaging evaluation is not always correlat - ed with clinical outcomes.,Non-OADS,/arxiv_data1/oa_pdf/4a/3f/jkns-60-1-1.PMC5223762.pdf
J Korean Neurosurg Soc 60  | January 20174 https://doi.org/10.3340/jkns.2016.0404.002tial valve opening pressure of the programmable valve was  set at 130 mmH 2O.,Non-OADS,/arxiv_data1/oa_pdf/4a/3f/jkns-60-1-1.PMC5223762.pdf
"J Korean Neurosurg Soc 60  | January 20176 https://doi.org/10.3340/jkns.2016.0404.002pressure was higher than the VPS valve opening pressure,  this result may be inferred VPS under-drainage due to VPS  malfunction, patients ’ positional effects or discordance be - tween the valve opening pressure and the CSF hydrodynam - ics.",Non-OADS,/arxiv_data1/oa_pdf/4a/3f/jkns-60-1-1.PMC5223762.pdf
"Copyright © 2017 The Korean Neurosurgical Society  82 Clinical Article J Korean Neurosurg Soc 60 (1) : 82-88, 2017 https://doi.org/10.3340/jkns.2016.0303.018 pISSN 2005-371 1   eISSN 1598-787 6Adult Patients with Congenital Muscular Torticollis  Treated with Bipolar Release : Report of 31 Cases Gun Sang Lee, M.D., Myung Ki Lee, M.D., Woo Jae Kim, M.D., Ho Sang Kim, M.D., Jeong Ho Kim, M.D., Yun-Suk Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ea/91/jkns-60-1-82.PMC5223763.pdf
"Department of Neurosurgery, Maryknoll Medical Center, 121 Jungguro, Jung-gu, Busan 48972, Korea Tel : +82-51-466-2456, Fax : +82-51-461-6164, E-mail : stereomk@naver.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Congenital muscular torticollis (CMT), caused by fibro - mastosis within the sternocleidomastoid muscle (SCM), re - fers to unilateral contracture of the SCM that restricts the  range of motion at the neck and causes a head tilt toward the  shortened SCM7,10).",Non-OADS,/arxiv_data1/oa_pdf/ea/91/jkns-60-1-82.PMC5223763.pdf
"J Korean Neurosurg Soc 60  | January 201784 https://doi.org/10.3340/jkns.2016.0303.018patient's neck was extended with a sandbag, and then the pa - tient's head was turned toward the shoulder on the opposite,  uninvolved side.",Non-OADS,/arxiv_data1/oa_pdf/ea/91/jkns-60-1-82.PMC5223763.pdf
"J Korean Neurosurg Soc 60  | January 201786 https://doi.org/10.3340/jkns.2016.0303.018exercise was effective in about 95% of patients who were first  seen before the age of 1 year4,5); however, CMT did not resolve  spontaneously after 1 year of age6,10).",Non-OADS,/arxiv_data1/oa_pdf/ea/91/jkns-60-1-82.PMC5223763.pdf
J Korean Neurosurg Soc 60  | January 201788 https://doi.org/10.3340/jkns.2016.0303.01813.,Non-OADS,/arxiv_data1/oa_pdf/ea/91/jkns-60-1-82.PMC5223763.pdf
"Copyright © 2017 The Korean Neurosurgical Society  98 Case Report J Korean Neurosurg Soc 60 (1) : 98-101, 2017 https://doi.org/10.3340/jkns.2015.0506.007 pISSN 2005-371 1   eISSN 1598-787 6Primary Intracranial Malignant Melanoma with Extracranial  Metastasis Kengo Hirota, M.D., Chika Yoshimura, M.D., Osami Kubo, M.D., Hidetoshi Kasuya, M.D.",Non-OADS,/arxiv_data1/oa_pdf/34/dd/jkns-60-1-98.PMC5223764.pdf
"Department of Neurosurgery, Tokyo Women’s Medical University Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo 116-8567, Japan  Tel : +81-3-3810-1111, Fax : +81-3-3819-8680, E-mail : k2bumps@gmail.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Primary intracranial malignant melanoma (PIMM) is a  rare tumor of the central nervous system (CNS)2).",Non-OADS,/arxiv_data1/oa_pdf/34/dd/jkns-60-1-98.PMC5223764.pdf
J Korean Neurosurg Soc 60  | January 2017100 https://doi.org/10.3340/jkns.2015.0506.007PET/CT.,Non-OADS,/arxiv_data1/oa_pdf/34/dd/jkns-60-1-98.PMC5223764.pdf
"Copyright © 2017 The Korean Neurosurgical Society  40 Clinical Article J Korean Neurosurg Soc 60 (1) : 40-46, 2017 https://doi.org/10.3340/jkns.2015.0911.002 pISSN 2005-371 1   eISSN 1598-787 6Role of Expression of Inflammatory Mediators in Primary  and Recurrent Lumbar Disc Herniation Yasar Dagistan, M.D.,1 Selma Cukur, M.D.,2 Emine Dagistan, M.D.,3 Ali Riza Gezici, M.D.1 Department of Neurosurgery,1 Pathology,2 Radiology,3 Abant Izzet Baysal University Medical School, Izzet Baysal Training and Research  Hospital, Bolu, Turkey Objective: To assess role of some inflammatory mediators in patients with primary and recurrent lumbar disc herniation.",Non-OADS,/arxiv_data1/oa_pdf/48/da/jkns-60-1-40.PMC5223765.pdf
"Department of Neurosurgery, Abant Izzet Baysal University Medical School, 14280 Gölköy, Bolu, Turkey Tel : +90-374-2534656-3280, Fax : +90-374-2534615, E-mail : dagistanyasar@hotmail.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Lumbar disc herniation (LDH) is the most frequent disor - der of the lumbar spine, and it is treated surgically at times5).",Non-OADS,/arxiv_data1/oa_pdf/48/da/jkns-60-1-40.PMC5223765.pdf
"J Korean Neurosurg Soc 60  | January 201742 https://doi.org/10.3340/jkns.2015.0911.002IGF-1, and BAX expressions examined immunohistochemi - cally using the biopsy tissues taken from the intervertebral  discs of patients of primary and recurrent lumbar disc herni - ation are summarized in Table 1.",OADS,/arxiv_data1/oa_pdf/48/da/jkns-60-1-40.PMC5223765.pdf
J Korean Neurosurg Soc 60  | January 201744 https://doi.org/10.3340/jkns.2015.0911.002and granulation tissues15).,Non-OADS,/arxiv_data1/oa_pdf/48/da/jkns-60-1-40.PMC5223765.pdf
"J Korean Neurosurg Soc 60  | January 201746 https://doi.org/10.3340/jkns.2015.0911.002297-305, 1983 27.",Non-OADS,/arxiv_data1/oa_pdf/48/da/jkns-60-1-40.PMC5223765.pdf
"Copyright © 2017 The Korean Neurosurgical Society  108 Case Report J Korean Neurosurg Soc 60 (1) : 108-113, 2017 https://doi.org/10.3340/jkns.2015.0707.022 pISSN 2005-371 1   eISSN 1598-787 6Malignant Transformation of Craniopharyngioma without  Radiation Therapy: Case Report and Review of the   Literature Tae Seok Jeong, M.D.,1 Gi Taek Yee, M.D., Ph.D.,1 Na Rae Kim, M.D., Ph.D.2 Departments of Neurosurgery,1 Pathology,2 Gil Medical Center, Gachon University, Incheon, Korea Craniopharyngiomas exhibiting histologic malignancy are extremely rare.",Non-OADS,/arxiv_data1/oa_pdf/0e/15/jkns-60-1-108.PMC5223766.pdf
"• Received: July 14, 2015   • Revised: December 4, 2015   • Accepted: January 1, 2016     •  Address for reprints : Gi Taek Yee, M.D., Ph.D. Department of Neurosurgery, Gil Medical Center, Gachon University, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565,  Korea Tel : +82-32-460-3304, Fax : +82-32-460-3899, E-mail : gtyee@gilhospital.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Craniopharyngioma is a type of benign tumor that arises  from Rathke ’s pouch, a derivative of the oral ectoderm, and  accounts for approximately 3–3.5% of all intracranial tu - mors3).",Non-OADS,/arxiv_data1/oa_pdf/0e/15/jkns-60-1-108.PMC5223766.pdf
"J Korean Neurosurg Soc 60  | January 2017110 https://doi.org/10.3340/jkns.2015.0707.022sion, and gross total resection of the tumor was performed.",Non-OADS,/arxiv_data1/oa_pdf/0e/15/jkns-60-1-108.PMC5223766.pdf
J Korean Neurosurg Soc 60  | January 2017112 https://doi.org/10.3340/jkns.2015.0707.022A case of malignant craniopharyngioma with spindle cell  proliferation that presented with sarcomatous transforma - tion has been reported11).,Non-OADS,/arxiv_data1/oa_pdf/0e/15/jkns-60-1-108.PMC5223766.pdf
"67 Copyright © 2017 The Korean Neurosurgical Society  Clinical Article J Korean Neurosurg Soc 60 (1) : 67-74, 2017 https://doi.org/10.3340/jkns.2016.0505.007 pISSN 2005-371 1   eISSN 1598-787 6Prevalence and Risk Factors for Lumbar Spondylosis and  Its Association with Low Back Pain among Rural Korean  Residents Sung Yeon Lee, M.D.,1,* Nam H. Cho, M.D., Ph.D.,2,* Young Ok Jung, M.D., Ph.D.,3 Young Il Seo, M.D., Ph.D.,1,†   Hyun Ah Kim, M.D., Ph.D.1,†  Division of Rheumatology,1 Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang,  Korea   Department of Preventive Medicine,2 Ajou University School of Medicine, Suwon , Korea   Division of Rheumatology,3 Department of Internal Medicine, Kangnam Sacred Heart Hospital, Seoul , Korea Objective :  The purpose of this study was to investigate the prevalence of and the relevant risk factors for lumbar spondylosis (LS)  among middle-aged and elderly rural Korean residents and to explore the association between radiographic LS and lower back pain  (LBP) in relation to age and gender.",Non-OADS,/arxiv_data1/oa_pdf/24/cd/jkns-60-1-67.PMC5223767.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/cd/jkns-60-1-67.PMC5223767.pdf
J Korean Neurosurg Soc 60  | January 201768 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/24/cd/jkns-60-1-67.PMC5223767.pdf
J Korean Neurosurg Soc 60  | January 201770 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/24/cd/jkns-60-1-67.PMC5223767.pdf
J Korean Neurosurg Soc 60  | January 201772 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/24/cd/jkns-60-1-67.PMC5223767.pdf
J Korean Neurosurg Soc 60  | January 201774 https://doi.org/10.3340/jkns.,Non-OADS,/arxiv_data1/oa_pdf/24/cd/jkns-60-1-67.PMC5223767.pdf
2016.0505.007•	Supplementary 	Materials The online-only Data Supplement is available with this ar - ticle at https://doi.org/10.3340/jkns.2016.0505.007.,OADS,/arxiv_data1/oa_pdf/24/cd/jkns-60-1-67.PMC5223767.pdf
"Copyright notice : This manuscript is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by- nc-nd/4.0/ Correspondence to : Leslie I. Boden, Department of Environmental Health, Boston University, School of Public Health, 715 Albany  St., Boston, Massachusetts 02118, lboden@bu.edu.",Non-OADS,/arxiv_data1/oa_pdf/5a/c3/nihms-819527.PMC5223776.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/c9/main.PMC5223778.pdf
Contents lists available at ScienceDirect American Journal of Ophthalmology Case Reports journal homepage: http://www.ajocasereports.com/ http://dx.doi.org/10.1016/j.ajoc.2016.07.004 2451-9936/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/c9/main.PMC5223778.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).American Journal of Ophthalmology Case Reports 4 (2016) 21 e23,Non-OADS,/arxiv_data1/oa_pdf/d1/c9/main.PMC5223778.pdf
Available  from: http://www.srs.org/professionals/glossary/SRS_revised_ glossary_of_terms.htm   7.,Non-OADS,/arxiv_data1/oa_pdf/b5/4e/Neurosciences-21-17.PMC5224406.pdf
Available from:  http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/b5/4e/Neurosciences-21-17.PMC5224406.pdf
Available from:  http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/b5/4e/Neurosciences-21-17.PMC5224406.pdf
A CNV was considered potentially pathologic  if it satisfied all of the following preliminary devised  criteria: 1) it was not reported in the Database of  Genomic Variants (DGV; http://dgv.tcag.ca/dgv/app/ home) among normal controls; 2) it was not present in  at least 215 healthy controls of similar ethnicity; 3) it  segregated with the phenotype and was not present in  unaffected family members; and 4) it included an area  of the genome encompassing one or more functional  gene(s).,Non-OADS,/arxiv_data1/oa_pdf/7d/eb/Neurosciences-21-72.PMC5224418.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK279088/   4.,Non-OADS,/arxiv_data1/oa_pdf/99/30/Neurosciences-21-75.PMC5224419.pdf
Sample references are available from:  http://www.nlm.nih.gov/bsd/uniform_requirements.html,Non-OADS,/arxiv_data1/oa_pdf/2a/40/Neurosciences-21-79.PMC5224421.pdf
Available from:  http://www.who.int/mediacentre/news/releases/2015/malaria-mdg-target/en/,Non-OADS,/arxiv_data1/oa_pdf/b6/86/Neurosciences-21-87.PMC5224425.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"24, 3442 –3453 http://dx.doi.org/10.1080/15384101.2016.1248006",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
ORCID Sivan Pearl Mizrahi http://orcid.org/0000-0001-5093-8361 Itamar Simon http://orcid.org/0000-0002-8517-1903 References [1] Aguirre-Ghiso JA.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Nature 2011;473:216-20; PMID:21562562; http://dx.doi.org/10.1038/nature10069 [3] Ayala F, Dewar R, Kieran M, Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Leukemia 2009; 23:2233-41; PMID:19727127; http://dx.doi.org/10.1038/leu.2009.175 [4] Balaban N. Persistence: mechanisms for triggering and enhancing phenotypic variability.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Curr Opin Genet Dev 2011; 21:768-75; PMID:22051606; http://dx.doi.org/10.1016/j.gde.2011.10.001 [5] Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. Bacterial Persistence as a Phenotypic Switch.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Science 2004; 305:1622-5; PMID:15308767; http://dx.doi.org/10.1126/science.1099390 [6] Bhuyan BK, Scheidt LG, Fraser TJ.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Oncogene 2002; 21:6249-54; PMID:12214265; http://dx.doi.org/10.1038/sj.onc.1205793 [10] Blagosklonny MV.,OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Leukemia 2006; 20:385-91; PMID:16357832; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Br J Haematol 2005; 130:469-79; PMID:16098060; http://dx.doi.org/10.1111/j.1365-2141.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Nat Rev Microbiol 2016; 14:320-30; PMID:27080241; http://dx.doi.org/10.1038/nrmicro.2016.34 [14] Brock A, Chang H, Huang S. Non-genetic heterogeneity —a muta- tion-independent driving force for the somatic evolution of tumours.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Nat Rev Genet 2009; 10:336-42; PMID:19337290; http://dx.doi.org/10.1038/nrg2556 [15] Cara S, Tannock IF.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Ann Oncol 2001; 12:23-7; PMID:11249045; http://dx.doi.org/10.1023/A:1008389706725 [16] Chen J, Li Y, Yu T-S, McKay RM, Burns DK, Kernie SG, Parada LF.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Nature 2012; 488:522-6; PMID:22854781; http://dx.doi.org/10.1038/nature11287 [17] Cipolleschi MG, Sbarba PD, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Dynamic proteomics of individual cancer cells in response to a drug.Science 2008; 322:1511-6; PMID:19023046; http://dx.doi.org/10.1126/science.1160165 [19] Cooper S. Rethinking synchronization of mammalian cells for cell cycle analysis.,OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Fems Microbiol Rev 2012; 36:306-39; PMID:21658086; http://dx.doi.org/10.1111/j.1574- 6976.2011.00287.x [22] Drewinko B, Yang LY, Barlogie B, Trujillo JM.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Cell Prolif 1984; 17:453-63; PMID:6467330; http://dx.doi.org/ 10.1111/j.1365-2184.1984.tb00604.x [23] Edelstein AD, Tsuchida MA, Amodaj N, Pinkard H, Vale RD, Stuur- man N. Advanced methods of microscope control using mManager software.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"J Biol Methods 2014; 1:e10; PMID:25606571; http://dx.doi.org/10.14440/jbm.2014.36 [24] Essers MAG, Trumpp A.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Cancer Cell 2008; 14:111-22; PMID:18656424; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Br J Cancer 2010; 103:1139-43; PMID:20877357; http://dx.doi.org/10.1038/sj.bjc.6605912 [28] Giuntoli S, Rovida E, Barbetti V, Cipolleschi MG, Olivotto M, Sbarba PD.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Leukemia2006; 20:1291-3; PMID:16710305; http://dx.doi.org/10.1038/sj.leu.2404224 [29] Graham FL, Whitmore GF.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Blood 2003; 101:3142-9;PMID:12468427; http://dx.doi.org/10.1182/blood-2002-10-3062 [31] He K, Xu T, Goldkorn A.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Mol Cancer Ther 2011; 10:938-48; PMID:21518726; http://dx.doi.org/10.1158/1535-7163.MCT-10-1120 [32] Heppner GH.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Br Med J 1975; 3:367-7; PMID:1156762; http://dx.doi.org/10.1136/ bmj.3.5979.367 [35] Hoffman RM.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"J Clin Lab Anal 1991; 5:133-43; PMID:2023059;http://dx.doi.org/10.1002/jcla.1860050211 [36] Holyoake T, Jiang X, Eaves C, Eaves A.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"N Engl J Med 2006; 355:1253-61; PMID:16990388; http://dx.doi.org/10.1056/NEJMra061808 [38] Jensen P, Mortensen BT, Hodgkiss RJ, Iversen PO, Christensen IJ, Helledie N, and Larsen JK.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Nat Rev Drug Discov 2011; 10:221-37; PMID:21358741; http://dx.doi.org/10.1038/nrd3373 [40] Kim JJ, Tannock IF.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Nat Rev Cancer 2005; 5:516-25; PMID:15965493; http://dx.doi.org/10.1038/nrc1650 [41] Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, Lerner SP, Chen F, Roh TT, Lay E, Ho PL, et al.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Nature 2015; 517:209-13; PMID:25470039; http://dx.doi.org/10.1038/ nature14034 [42] Laconi E. The evolving concept of tumor microenvironments.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"BioEssays 2007; 29:738-44; PMID:17621638; http://dx.doi.org/ 10.1002/bies.20606 [43] Laporte D, Lebaudy A, Sahin A, Pinson B, Ceschin J, Daignan-Fornier B, Sagot I. Metabolic status rather than cell cycle signals control quiescence entry and exit.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
J Cell Biol 2011; 192:949-57; PMID:21402786; http://dx.doi.org/10.1083/jcb.201009028 [44] van Leeuwen IMM.,OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Oncotarget 2012; 3:596-600; PMID:22711025; http://dx.doi.org/10.18632/oncotarget.524 [45] van Leeuwen IMM, Rao B, Sachweh MCC, La /C19ın S. An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Annu Rev Microbiol 2010; 64:357-72; PMID:20528688; http://dx.doi.org/10.1146/annurev.micro.112408.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"J Cell Physiol 1968; 72:185-95; PMID:5724569; http://dx.doi.org/10.1002/jcp.1040720306 [48] Miwa S, Yano S, Kimura H, Yamamoto M, Toneri M, Matsumoto Y, Uehara F, Hiroshima Y, Murakami T, Hayashi K, et al.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Cell Cycle 2014; 14:621-9; http://dx.doi.org/10.4161/15384101.2014.991604 [49] Miwa S, Yano S, Kimura H, Yamamoto M, Toneri M, Murakami T, Hayashi K, Yamamoto N, Fujiwara T, Tsuchiya H, et al.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Cell Cycle Georget Tex 2015; 14:1932-7; http://dx.doi.org/10.1080/15384101.2015.1033598 [50] Pardee AB.,OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
PLoS Biol 2008; 6:e120; PMID:18494559; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"J Cell Physiol 1973; 82:93-100; PMID:4354072; http://dx.doi.org/10.1002/jcp.1040820111 [55] Ravandi F, Estrov Z. Eradication of leukemia stem cells as a new goal of therapy in leukemia.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Clin Cancer Res 2006; 12:340-4;PMID:16428470; http://dx.doi.org/10.1158/1078-0432.CCR-05-1879 [56] Reya T, Morrison SJ, Clarke MF, Weissman IL.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Nature 2001; 414:105-11; PMID:11689955;http://dx.doi.org/10.1038/35102167 [57] Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M. A Temporarily distinct subpopulation of slow-cycling melanoma cellsis required for continuous tumor growth.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Cell 2010; 141:583-94;PMID:20478252; http://dx.doi.org/10.1016/j.cell.2010.04.020 [58] Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, et al.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
Cell 2008; 132:487-98; PMID:18267078; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"J Clin Invest 1999; 104:1645-3; PMID:10606615; http://dx.doi.org/10.1172/JCI9054 [62] Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA, et al.",Non-OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Cell 2010; 141:69-80; PMID:20371346; http://dx.doi.org/10.1016/j.cell.2010.02.027 [63] Son S, Tzur A, Weng Y, Jorgensen P, Kim J, Kirschner MW, Manalis SR.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Methods 2012; 9:910-2; PMID:22863882; http://dx.doi.org/10.1038/nmeth.2133 [64] Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"PLoSOne 2013; 8:e73801; PMID:24066072; http://dx.doi.org/10.1371/journal.pone.0073801 [67] Wang P, Robert L, Pelletier J, Dang WL, Taddei F, Wright A, Jun S. Robust growth of Escherichia coli.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
"Curr Biol CB 2010; 20:1099-103;http://dx.doi.org/10.1016/j.cub.2010.04.045 [68] Zetterberg A, Larsson O.",OADS,/arxiv_data1/oa_pdf/b6/6f/kccy-15-24-1248006.PMC5224467.pdf
http://dx.doi.org/10.1016/j.jbo.2016.12.002 Received 28 July 2016; Received in revised form 30 November 2016; Accepted 10 December 2016⁎Corresponding authors at: No.,Non-OADS,/arxiv_data1/oa_pdf/21/c8/main.PMC5224469.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/21/c8/main.PMC5224469.pdf
"cerevisiae strains and DNA se- quences reported here (Supplementary Tables S3 and S4), along with their associated information (including anno- tated sequence files), have been deposited in the public in-stanceoftheJBEIRegistry( 17)(https://public-registry.jbei.",OADS,/arxiv_data1/oa_pdf/d2/b7/gkw1023.PMC5224472.pdf
Experiment data availability All flow cytometry and gas chromatography mass spec- trometry data are available from the JBEI Experimental DataDepot( https://public-edd.jbei.org ).,OADS,/arxiv_data1/oa_pdf/d2/b7/gkw1023.PMC5224472.pdf
"CASdesigner implementation, licensing and availability CASdesigner is implemented in python 3.4 and third party libraries including biopython ( http://biopython.org ), pan- das (http://pandas.org ) and Intermine ( http://intermine.",OADS,/arxiv_data1/oa_pdf/d2/b7/gkw1023.PMC5224472.pdf
"CASdesigner is open-source software under the BSD license (https://opensource.org/licenses/BSD-2-Clause ), is freely available from GitHub ( https://github.com/JBEI/ CASdesigner )andisalsoavailablethroughitswebinterface on the public CASdesigner webserver ( http://casdesigner.",OADS,/arxiv_data1/oa_pdf/d2/b7/gkw1023.PMC5224472.pdf
"To aid users in cut site choice, annotated gene bank files of the 2.5 kb genomic region surrounding each cut site can be found as an attachment to each pCut plas- mid file on the JBEI Registry ( https://public-registry.jbei.",OADS,/arxiv_data1/oa_pdf/d2/b7/gkw1023.PMC5224472.pdf
"CASdesignerweb-basedsoftwarefacilitatescharacterization data visualization and semi-automated donor DNA design and construction To simplify the workflow of constructing integration cas- settes based on our characterization data, we developed a web tool, Computer-Aided Strain designer (CASdesigner, http://casdesigner.jbei.org ).",OADS,/arxiv_data1/oa_pdf/d2/b7/gkw1023.PMC5224472.pdf
"The authors also thank Leonard Katz forsuggestions while preparing this manuscript, Hector Pla- har, William Morrell and Jacob Coble for technical assis- tance,andPhilBaranforprovidingthetaxadienestandard.This work was part of the DOE Joint BioEnergy Institute (https://www.jbei.org )andtheDOEJointGenomeInstitute (https://jgi.doe.gov ) supported by the U.S. Department of Energy,OfficeofScience,OfficeofBiologicalandEnviron- mental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and theU.",Non-OADS,/arxiv_data1/oa_pdf/d2/b7/gkw1023.PMC5224472.pdf
"The United States Govern- ment retains and the publisher, by accepting the article for publication, acknowledges that the United States Govern-ment retains a non-exclusive, paid-up, irrevocable, world- wide license to publish or reproduce the published form of thismanuscript,orallow otherstodoso, forUnitedStatesGovernmentpurposes.TheDepartmentofEnergywillpro- vide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan(http://energy.gov/downloads/doe-public-access-plan ).",OADS,/arxiv_data1/oa_pdf/d2/b7/gkw1023.PMC5224472.pdf
The pro- cedure was conducted in accordance with the recom-mendedprotocolontheTaiwanNationalRNAiCoreFacil- ity website ( http://rnai.genmed.sinica.edu.tw/webContent/ web/protocols/wicket:pageMapName/wicket-0 ).,OADS,/arxiv_data1/oa_pdf/1d/b2/gkw1042.PMC5224474.pdf
"Thus, current largeepigenetic consortia such as Roadmap ( 9), Blueprint ( 10) andDEEP( http://www.deutsches-epigenom-programm.de/ ), do not generate TF-ChIP data.",Non-OADS,/arxiv_data1/oa_pdf/26/7c/gkw1061.PMC5224477.pdf
"NOMe peaks have been called using a HMMbased approach (Nordstr ¨omet al., unpublished, available athttps://github.com/karl616/gNOMePeaks ).",OADS,/arxiv_data1/oa_pdf/26/7c/gkw1061.PMC5224477.pdf
Se- quence alignments were calculated with ClustalW ( 32) and edited with GeneDoc ( http://www.psc.edu/biomed/ genedoc).,OADS,/arxiv_data1/oa_pdf/46/ae/gkw1111.PMC5224480.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org /licenses /by-nc-nd /4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided theoriginalworkisnotalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontactjournals.permis sions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/5c/8e/gkw1164.PMC5224488.pdf
"Hsmar1 andTdr1coordi- nates were filtered from their respective repeat masked genomes, downloaded from UCSC table browsers ( https:// genome.ucsc.edu/cgi-bin/hgTables ).Weemployedbedtools https://bedtools.readthedocs.io/en/latest/ to fetch their se- quencesfromHumanReferenceSequence(hg19 /GRCh37)",OADS,/arxiv_data1/oa_pdf/5c/8e/gkw1164.PMC5224488.pdf
The sequences were aligned using MUSCLE ( 28) sequence length and visualized by the jalview tool( http://www.jalview.org/ ).,OADS,/arxiv_data1/oa_pdf/5c/8e/gkw1164.PMC5224488.pdf
"We used BLAT (https://users.soe.ucsc.edu/ ~kent) to identify genomic se- quences on both strands that match a full-length element, soloterminalIRsandMITEsof Hsmar1andTdr1fromhu- man and zebrafish genomes, respectively.",OADS,/arxiv_data1/oa_pdf/5c/8e/gkw1164.PMC5224488.pdf
")Post-processingincludedacross-checkwithRepeatMasker (http://www.repeatmasker.org/ ) sequences of Hsmar1 and Tdr1.Upon identifying Hsmar1-derived sequences in the human genome, we noticed that most of solo IRs and MITEs are annotated as MADE1 repeat family as Hsmar1 dependent Tc1/mariner(http://www.repeatmasker.org/cgi- bin/ViewRepeat?id=MADE1 ).MADE1 is represented by ∼8000 copies in human genome, from which 660 are 100% identical to the Repbase sequence ( http://www.girinst.org/ repbase).",OADS,/arxiv_data1/oa_pdf/5c/8e/gkw1164.PMC5224488.pdf
stanford.edu/metacomparison andathttps://bitbucket.org/ khatrilab/meta-analysis-comparison-code/ .,OADS,/arxiv_data1/oa_pdf/f6/e8/gkw797.PMC5224496.pdf
The software im- plementation is available at https://github.com/lulab/ COME .,OADS,/arxiv_data1/oa_pdf/01/36/gkw798.PMC5224497.pdf
Sequencing reads were aligned against the human refer- ence genome hs37d5 ( http://www.1000genomes.org/home ) and the shmiRHCV318 as separate contig using the BWA- MEM (v0.7.8) software ( 39).,OADS,/arxiv_data1/oa_pdf/39/5d/gkw805.PMC5224498.pdf
Dataaccess AllmicroarraydataareavailableintheNCBIGeneExpres- sion Omnibus database (GEO; http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/39/5d/gkw805.PMC5224498.pdf
"The whole genome sequencing data have been deposited in the Euro- peanGenome-phenomeArchive(EGA, https://www.ebi.ac.",OADS,/arxiv_data1/oa_pdf/39/5d/gkw805.PMC5224498.pdf
ChIA-PET2 is available athttps://github.com/GuipengLi/ChIA-PET2 .,OADS,/arxiv_data1/oa_pdf/76/81/gkw809.PMC5224499.pdf
ChIA- PET2 is available at https://github.com/GuipengLi/ChIA- PET2.,Non-OADS,/arxiv_data1/oa_pdf/76/81/gkw809.PMC5224499.pdf
"NucleicAcidsResearch,2017,Vol.45,No.1 117 from the ENCODE database on the UCSC genome browser ( http://genome.ucsc.edu/ , Assembly February 2009 (GRCh37 /hg19)) (32).",OADS,/arxiv_data1/oa_pdf/91/e1/gkw820.PMC5224503.pdf
"Searches in the Allen Brain At- las (53)(http://human.brain-map.org ) revealed that NGB and GATA-2 co-express in parts of the brain includingthe dorsal and ventral thalamus, mesencephalon, pontine tegmentum and myelencephalon.",OADS,/arxiv_data1/oa_pdf/91/e1/gkw820.PMC5224503.pdf
Twenty independent clones for each sample were sequenced and analyzed using the online tool Cy- MATE (http://www.cymate.org/ )(34).,OADS,/arxiv_data1/oa_pdf/ab/8b/gkw850.PMC5224508.pdf
Differ- entially expressed genes were identified by edgeR ( 44) with cut-offasfoldchange >2andFDR <0.05.Thegeneontol- ogy(GO)enrichmentanalysiswasperformedbytheonlinetoolagriGO ( http://bioinfo.cau.edu.cn/agriGO/ )(45).,OADS,/arxiv_data1/oa_pdf/ab/8b/gkw850.PMC5224508.pdf
"net/sciencedownloads.html ) in Fiji ( http://fiji.sc/Fiji ), sub- tracted the background and normalised the mean intensityofrecruitmentareaoverthemeanintensityofthetotalcell.",OADS,/arxiv_data1/oa_pdf/fe/9d/gkw904.PMC5224513.pdf
"Color ﬁgure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/journal/10.10 02/ (ISSN)1552-4833.",Non-OADS,/arxiv_data1/oa_pdf/d2/7f/CCR3-5-5.PMC5224771.pdf
"Color ﬁgure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/journ al/ 10.1002/(ISSN)1552-4833. ª2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d2/7f/CCR3-5-5.PMC5224771.pdf
"Mediterr  J Hematol Infect Dis 201 6, 8(1): e201 7005, DOI: http://dx.doi.org/10.4084/MJHID.2017.005      This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/81/mjhid-9-1-e2017005.PMC5224801.pdf
"Hepatology (Baltimore, Md) 2015;61(1):77 -87.  https://doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d7/81/mjhid-9-1-e2017005.PMC5224801.pdf
Gut 2003;52(11):1644 - 1648. https://doi.org/10.1136/gut.52.11.1644     PMid:14570736       PMCid:PMC1773858   3.,Non-OADS,/arxiv_data1/oa_pdf/d7/81/mjhid-9-1-e2017005.PMC5224801.pdf
World Journal of Gastroenterology : WJG  2015;21(38):10790 -10810.  https://doi.org/10.3748/wjg.v21.i38.10790     PMid:26478671       PMCid:PMC4600581  5.,Non-OADS,/arxiv_data1/oa_pdf/d7/81/mjhid-9-1-e2017005.PMC5224801.pdf
Hepat Mon  2012;12(6):372 -381. https://doi.org/10.5812/hepatmon.6592      PMid:22879826      PMCid:PMC3412553   8.,Non-OADS,/arxiv_data1/oa_pdf/d7/81/mjhid-9-1-e2017005.PMC5224801.pdf
Case Reports in  Hematology 2016;2016:4. https://doi.org/10.1155/2016/7635128      PMid:27042368      PMCid:PMC4793097,Non-OADS,/arxiv_data1/oa_pdf/d7/81/mjhid-9-1-e2017005.PMC5224801.pdf
"Mediterr  J Hematol Infect Dis 201 7, 9(1): e201 7012, DOI: http://dx.doi.org/10.4084/MJHID.2017.012       This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/ce/mjhid-9-1-e2017012.PMC5224802.pdf
Annals of the New York Academy  of Sciences 2012:1272: 23 -30. http://dx.doi.org/10.1111/j.1749 - 6632.2012.06829.x    3.,Non-OADS,/arxiv_data1/oa_pdf/ed/ce/mjhid-9-1-e2017012.PMC5224802.pdf
Antimic robial Agents and Chemotherapy  201: 55: 1953 -1960.  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088208/    4.,Non-OADS,/arxiv_data1/oa_pdf/ed/ce/mjhid-9-1-e2017012.PMC5224802.pdf
European Journal of Haematology 2015: 94: 526 - 531. http://dx.doi.org/10.1111/ejh.1 2466    5.,Non-OADS,/arxiv_data1/oa_pdf/ed/ce/mjhid-9-1-e2017012.PMC5224802.pdf
Blood Reviews 2016.  http://www.sciencedirect.com/science/article/pii/S0268960X16300 753,Non-OADS,/arxiv_data1/oa_pdf/ed/ce/mjhid-9-1-e2017012.PMC5224802.pdf
"Mediterr  J  Hematol  Infect  Dis 2017,  9(1):  e2017008,  DOI: http://dx.doi.org/10.4084/MJHID.2017.008     Published:  January  1, 2017  Received:  October  4, 2016  Accepted:  December 5, 2016     This is an Open  Access  article  distributed  under  the terms  of the Creative  Commons  Attribution  License  (https://creativecommons.org/licenses/by -nc/4.0) ,  which permits  unrestricted use,  distribution,  and reproduction in any medium,  provided  the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2015;53:962 -1147.    https://doi.org/10.3109/15563650.2015.1102927   PMid:26624241   2.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2007;25:249 -81. https://doi.org/10.1016/j.emc.2007.02.004   PMid:17482020   3.,OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
1998;  131: 466-74.   https://doi.org/10.1016/S0022-2143(98)90148-2  7.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2005;  43:553 -70. https://doi.org/10.1081/CLT -  200068842   8.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2005;24:559 -62.   https://doi.org/10.1191/0960327105ht564oa     PMid:16323571   10.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
1996;199:13 -22  https://doi.org/10.1148/radiology.199.1.8633135     PMid:8633135   11.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2016;10:465 -81. https://doi.org/10.2147/DDDT.S79458   PMid:26893541       PMCid:PMC4745840   13.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2010;18:359 -81. https://doi.org/10.1016/j.mric.2010.08.014   PMid:21094445       PMCid:PMC3430384   14.,OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2014;71:2215 -2223.   https://doi.org/10.1002/mrm.24854  PMid:23821350   PMCid:PMC4238736   15.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2014   Jun 10;16:40.  doi: 10.1186/1532 -429X -16-40.   https://doi.org/10.1186/1532 -429X -16-40  16.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
1977;296:1422 -6.  https://doi.org/10.1056/NEJM197706232962501      PMid:194151   17.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2009;114:4632 -8.   https://doi.org/10.1182/blood -2009 -02-203323  PMid:19721013   PMCid:PMC2780299   18.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
J Toxicol  Clin Toxicol.1996;34:485 -489.   https://doi.org/10.3109/15563659609028005     PMid:8800185   19.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2000;18:36 -40.   https://doi.org/10.1016/S0735-6757(00)90045-7  20.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
2011; 58:69 -73.   https://doi.org/10.1016/j.annemergmed.2010.11.020  PMid:21288598,OADS,/arxiv_data1/oa_pdf/25/1b/mjhid-9-1-e2017008.PMC5224804.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7009, DOI: http://dx.doi.org/10.4084/MJHID.2017.009      Published:  January 1 , 201 7 Received:  November 2 , 201 6 Accepted:  December  7, 2016    This is  an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
2013;163:465 -77.   https://doi.org/10.1111/bjh.12562   PMid:24033296     3.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
2011;105:1684 -92.  https://doi.org/10.1038/bjc.2011.450   PMid:22045184 PMCid:PMC3242607   4.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Adv Immunol  111:1 -46, 2011. https://doi.or g/10.1016/B978 -0-12-385991 - 4.00001 -5  PMid:21970951      5.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Blood 201 6, Vol 127, n 20.   https://doi.org/10.1182/blood -2016 -01-643569   PMid:26980727      6.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
J Clin Oncol  2014;32:3059 -3068. https://doi.org/10.1200/JCO.2013.54.8800      PMid:25113753  PMCid:PMC4979083   7.,OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
2008;  46(2):213 -23. https://doi.org/10.1016/j.rcl.2008.03.003       PMid:18619377      8.,OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"104:1258 -1265, 2004. https://doi.org/10.1182/blood -2003 -12-4434      PMid:15126323      11.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"J Clin  Oncol 27:4555 -4562, 2009.   https://doi.org/10.1200/JCO.2008.21.3991   PMid:19652063      12.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
Lancet Oncol 2015 16:1111 -1122.  https://doi.org/10.1016/S1470 -2045(15)00169 -2    13.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
J Am Geriatr Soc 1993;  (41): 1245 -1254.   https://doi.org/10.1111/j.1532 -5415.1993.tb07310.x      PMid:7693787      15.,OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Clin Cancer Res 13:5784 -5789, 2007.   https://doi.org/10.1158/1078 -0432.CCR -07-0778      PMid:17908969     18.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Blood 106:2169 -  2174, 2005. https://doi.org/10.1182/blood -2005 -04-1565      PMid:15933054      19.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
Blood 2013 (122)23: 3759 -3766. https://doi.org/10.1182/blood - 2013 -06-507319     PMid:24085766      21.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
JAMA 1963(185): 914 -919.   https://doi.org/10.1001/jama.1963.0 3060120024016      PMid:14044222      24.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
Cancer 2009; 115: 4547 - 4553.  https://doi.org/10.1002/cncr.24490     PMid:19562776      28.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
J  Clin Oncol 2005; (23):8447 - 8452   https://doi.org/10.1200/JCO.2005.03.1674     PMid:16230674      30.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
https://doi.org/10.1002/cncr.25149     32.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
Lancet Oncol 2014; 15:  457-463. https://doi.org/10.1016/S1470 -2045(14)70036 -1    33.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
J Clin Oncol 2004;2 2(8):1454 -1459   https://doi.org/10.1200/JCO.2004.10.086     PMid:15024027      34.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
J Clin Oncol 2012; 30: 3848 -3853.  https://doi.org/10.1200/JCO.2010.33.4474   PMid:23008294     36.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
Blood 2016 127:2055 -2063.   https://doi.org/10.1182/blood -2015 -11-624288     37.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
Blood 2005;106(12):3725 -3732.  https://doi.org/10.1182/blood -2005 -01-0016    PMid:16123223      38.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
J Clin Oncol  2013;31(12):1506 -1513 https://doi.org/10.1200/JCO.2012.45.0866      PMid:2353 0110      40.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
Lancet  2013;381(9873):1203 -1210. https://doi.org/10.1016/S0140 - 6736(12)61763 -2    41.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Blood, 2014, 123.19: 2944 -2952.  https://doi.org/10.118 2/blood -2013 -11-531327     PMid:24591201       PMCid:PMC4260975   42.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"British journal of haematology, 2014, 164.5:  710-716. https://doi.org/10.1111/bjh.12695     PMid:24344981      43.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"J Clin Oncol 2013, 31:1977 -1983.  https://doi.org/10.1200/JCO.2012.45.6400     PMid:23547079      46.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Vitolo U, Ladetto M, Boccomini C et al: Rituximab maintenance  compared with observation after brief first -line R -FND  chemoimmunotherapy with rituximab consolidation in p atients age  older than 60 years with advanced follicular lymphoma: a phase III  randomized study by the Fondazione Italiana Linfomi, J Clin Oncol  2013; 31(27):3351 -9 https://doi.org/10.1200/JCO.2012.4 4.8290      PMid:23960180      48.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Haematologica 92:826 -833, 2007.  https://doi.org/10.3324/haematol.10894     PMid:17550856      50.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Blood 108:4003 -4008, 2006. https://doi.org/10.1182 /blood -2006 - 04-016725     PMid:16946304      51. van Oers MH, Klasa R, Marcus RE, et al.",OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Blood 108:3295 -3301, 2006.   https://doi.org/10.1182/blood -2006 -05-021113   PMid:16873669      52.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"J Clin Oncol 28:2853 -2858, 2010.  https://doi.org/10.1200/JCO.2009.26.5827       PMid:20439641 PMCid:PMC2903319   53.",OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Journal of Clinical Oncology, Vol 31, No  27 (September 20), 2013: pp 3307 -3308.   https://doi.org/10.1200/JCO.2013.50.0454   PMid:23960176     55.",Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
E xperimental Hematology & Oncology (2015) 4:17  https://doi.org/10.1186/s40164 -015-0012 -3 PMid:26120498       PMCid:PMC4482187   58.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
N Engl J Med 2014;  370: 1008 -1018. https://doi.org/10.1056/NEJMoa1314583      PMid:24450858  PMCid:PMC4039496   59.,OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
Lancet Oncol 2014; 15: 1311 -18.  https://doi.org/10.1016/S1470 -2045(14)70455 -3    60.,Non-OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
J Clin Oncol 2015; 33:3635 -3640.   https://doi.org/10.1200/JCO.2014.59.9258    PMid:26304886  PMCid:PMC4622102   61.,OADS,/arxiv_data1/oa_pdf/95/9b/mjhid-9-1-e2017009.PMC5224805.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7011, DOI: http://dx.doi.org/10.4084/MJHID.2017.011      Published: January 1 , 201 7 Received: October 3 , 2016  Accepted: November 18 , 2016     This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/d3/mjhid-9-1-e2017011.PMC5224807.pdf
2015;34:46 -50. https://doi.org/10.1016/j.ijid.2015.02.021      PMid:25743761      2.,OADS,/arxiv_data1/oa_pdf/e7/d3/mjhid-9-1-e2017011.PMC5224807.pdf
2016;9:118.    https://doi.org/10.1186/s13071 -016-1412 -x    PMid:26932389       PMCid:PMC4774109   3.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/mjhid-9-1-e2017011.PMC5224807.pdf
Sci Rep. 2015;5:12862.   https://doi.org/10.1038/srep12862     PMid:26249106       PMCid:PMC4528201   4.,OADS,/arxiv_data1/oa_pdf/e7/d3/mjhid-9-1-e2017011.PMC5224807.pdf
2004;165(6):2123 -33. https://doi.org/10.1016/S0002 - 9440(10)63262 -2    5.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/mjhid-9-1-e2017011.PMC5224807.pdf
2010;185(4):2416 -23. https://doi.or g/10.4049/jimmunol.1000483      PMid:20624946      PMCid:PMC2944829   6.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/mjhid-9-1-e2017011.PMC5224807.pdf
https://doi.org/10.1371/journal.ppat.1000158     PMid:18802456       PMCid:PMC2528938   7.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/mjhid-9-1-e2017011.PMC5224807.pdf
1999;7(2):73 -83.   https://doi.org/10.3109/15419069909034398     PMid:10427961      8.,Non-OADS,/arxiv_data1/oa_pdf/e7/d3/mjhid-9-1-e2017011.PMC5224807.pdf
2008;57(4):332 -7.   https://doi.org/10.1016/j.jinf.2008.07.005  PMid:18722018,OADS,/arxiv_data1/oa_pdf/e7/d3/mjhid-9-1-e2017011.PMC5224807.pdf
"Mediterr J Hematol Infect Dis  2017, 9(1): e201 7002, DOI: http://dx.doi.org/10.4084/MJHID.2017.00 2     Published:  January 1 , 201 7 Received:  July 27 , 201 6 Accepted:  November 11 , 201 6    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribu tion, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
An online website showing the  current drug resistance rates and antimicrobial use  worldwide is also a vailable at  ‘http://resistancemap.cddep.org ’.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Lymphoma  Myeloma 2007; 7 Suppl 3: S102 -4.  https://doi.org/10.3816/CLM.2007.s.009     PMid:17382018      2.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Leukemia 2007; 21: 12 -7.  https://doi.org/10.1038/sj.leu.2404441     PMid:17109028      3.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Br J Haematol 2007; 136:  549-64. https://doi.org/10.1111/j.1365 - 2141.2006.06461.x     PMid: 17214739      4.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Bone Marrow Transplant 2009; 44:  457-62. https://doi.org/10.1038/bmt.2009.255     PMid:19861978      5.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Transpl Infect Dis 2004; 6: 171 -8.  https://doi.org/10.1111/j.1399 - 3062.2004.00075.x     PMid:15762935      6.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Blood 2002; 99: 1978 -85.  https://doi.org/10.1182/blood.V99.6.1978     PMid:11877269      7.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Biol Blood Marrow Transplant 2002; 8: 512 -20.  https://doi.org/10.1053/bbmt.2002.v8.pm12374456     PMid:123744 56      8.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Leukemia 2006; 20: 1690 -700.  https://doi.org/10.1038/sj.leu.2404335     PMid:16871276      9.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Biol Blood  Marrow Transplant 2009; 15(1 Sup pl): 128 -133.  https://doi.org/10.1016/j.bbmt.2008.10.005     PMid:19147091      10.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Bone Marrow Transplant 2003; 31: 795 -801.  https://doi.org/10.1038/sj.bmt.1703920     PMid:12732887      11.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Ther Adv Infect Dis 2013; 1: 37 -43.  https://doi.org/10.1177/2049936113475610     PMid:25165543      P MCid:PMC4040719   13.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis  2001; 33: 1462 -1468. https://doi.org/10.1086/322677     PMid:11588690      14.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J  Chemother  2010; 22: 5 -12.  https://doi.org/10.1179/joc.2010.22.1.5     PMid:20227985      15.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Microbiol Infect  2014; 20: O7 -12. https://doi.org/10.1111/1469 - 0691.12294     PMid:2382 6912      16.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
BMC Infect Dis 2013; 13: 356. https://doi.org/10.1186/1471 -2334 - 13-356    PMid:23899356      PMCid:PMC3729823   17.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Mayo Clin Proc 2010; 85: 711 -8.  https://doi.org/10.4065/mcp.2010.0006     PMid:20675508      PMCi d:PMC2912731   18.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J Antimicrob Chemother 2013; 68: 1431 -8.  https://doi.org/10.1093/jac/dkt002     PMid:23396855      19.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J Antimicrob Chemother 2005; 55:  57-60. https://doi.org/10.1093/jac/dkh510     PMid:15574472      20.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin  Microbiol Infect 2005; 11: 505 -7. https://doi.org/10.1111/j.1469 - 0691.2005.01114.x     PMid:15882204      21.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Cancer 2010; 116: 967 -73.  https://doi.org/10.1002/cncr.24812     PMid:20052728      22.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2005; 41: 435 -440.  https://doi.org/10.1086/432056     PMid:16028149      23.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Infect  Control Hosp Epidemiol 2005; 26: 273 -280.  https://doi.org/10.1086/502539     PMid:15796280      24.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Microb Drug Resist 2012; 18: 518 -524.  https://doi.org/10.1089/mdr.2012.0067     PMid:22742454      25.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2005; 41:  1254 -1260. https://doi.org/10.1086/496986     PMid:16206099,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Br J Clin Pharmacol 2015; 79: 195 -207.  https://doi.org /10.1111/bcp.12310     PMid:24341410      PMCid:P MC4309626   27.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Haematologica 2013; 98:  1826 -35.  https://doi.org/10.3324/haematol.2013.091025     PMid:24323983       PMCid:PMC3856957   28.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Haematologica 2013; 98:  1836 -47.  https://doi.org/10.3324/haematol.2013.091330     PMid:24323984      PMCid:PMC3856958   29.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Curr Opin  Hematol 2014; 21: 451 -8.  https://doi.org/10.1097/MOH.0000000000000088     PMid:2529574 2      30.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Oncol 2014; 15: e606 -19.  https://doi.org/10.1016/S1470 -2045(14)70344 -4   31.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Virulence 2016; 7: 280 -97.  https://doi.org/1 0.1080/21505594.2016.1156821     PMid:27002635    32.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect  Dis 2011; 52: 427 -31.  https://doi.org/10.1093/cid/ciq147     PMid:21205990      33.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2004; 39(Suppl 1): S25 -31.  https://doi.org/10.1086/383048     PMid :15250017      34.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 1999; 29: 490 -494.  https://doi.org/10.108 6/598620     PMid:10530434      35.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin I nfect Dis 2003; 36: 1103 -1110.  https://doi.org/10.1086/374339     PMid:12715303      36.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Microb Drug Resist 2005; 11: 254 -259.  https://doi.org/10.1089/mdr.2005.11.254     PMid:16201928      37.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2005; 41: 848 -854.  https://doi.org/10.1086/432 803    PMid:16107985      40.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J Antimicrob Chemoth er 2011; 66: 657 -63.  https://doi.org/10.1093/jac/dkq494     PMid:21193475      41.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Microbiol Infect 2013; 19: 474 -9.  https://doi.org/10.1111/j.1469 - 0691.2012.03879.x     PMid:22524597      42.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Bone Marrow Transplant 2007; 39: 687 -693.  https://doi.org/10.1038/sj.bmt.1705653     PMid:17401395      43.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Bone Marrow Transplant.2015; 50: 282 -8.  https://doi.org/10.1038/bmt.2014.231     PMid:25310302      45.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J Antimicrob Chemother  2010; 65: 333 -41.  https://doi.org/10.1093/jac/dkp411     PMid:19959544      46.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Support Care Cancer  2008; 16:1085 -1088. https://doi.org/10.1007/s00520 -007-0398 - 5    PMid:18274787      47.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Biol Blood Marrow Transplant  2007; 13: 615 -621.   https://doi.org/10.1016/j.bbmt.2007.01.078     PMid:17448922      48.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Arch Intern Med 1998;  158: 868 -872.   https://doi.org/10.1001/archinte.158.8.868     PMid:9570172      49.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J Infect 2014; 68: 321 -31.  https://doi.org/10.1016/j.jinf.2013.1 2.006     PMid:24370562      50.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Future Microbiol 2016; 11:  767-80. https://doi.org/10.2217/fmb -2015 -0014   PMid:27196948      51.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
https://doi.org/10.4084/mjhid.2015.045     PMid:26185610      PMC id:PMC4500472   52.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Virulence 2016; 7: 252 -66.  https://doi.org/10.1080/21505594.2016.1159366     PMid:26984779    53.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Infect Dis (Lond) 2015; 47: 686 -93.  https://doi.org/1 0.3109/23744235.2015.1051105     PMid:26024284   54.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Korean J Intern Med 2012; 27: 128 -42.  https://doi.org/10.3904/kjim.2012.27.2.128     PMid:22707882      P MCid:PMC3372794   56.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Microbiol Infect 2008; 14 Suppl 1:  189-93. https://doi.org/10.1111/j.1469 - 0691.2007.01858.x     PMid:18154546      57.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
JAMA 2015; 314: 1479 -87.  https://doi.org/10.1001/jama.2015.12480     PMid:26436831      58.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Microbiol Infect 2014; 20: 821 -30.  https://doi.org/10.1111/1469 -0691.12719     PMid:24930781      59.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect Dis 2011; 11: 381 -93.  https://doi.org/10.1016/S1473 -3099(11)70056 -1   60.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
https://doi.org/10.2807/1560 - 7917.ES.2015.20.49.30085     PMid:26676364      62.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
2016 Mar;16(3):286 -7.  https://doi.org/10.1016/S1473 -3099(16)00014 -1   63.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect Dis 2016; 16: 283 -4.  https://doi.org/10.1016/S1473 -3099(16)00012 -8   64.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect Dis  2016; 16: 282 -3. https://doi.org/10.1016/S1473 -3099(16)00009 -8   65.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
https://doi.org/10.2807/1560 - 7917.ES.2016.21.6.3013 5    PMid:26898350      66.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect Dis 2016; 16: 132 -3.  https://doi.org/10.1016/S1473 -3099(15)00463 -6   67.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect Dis 2016; 16: 145 -6.  https://doi.org/10.1016/S1473 -3099(15)00532 -0   68.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect  Dis 2016; 16: 144 -5. https://doi.org/10.1016/S1473 - 3099(15)00538 -1   69.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect Dis  2016; 16: 285 -6. https://doi.org/10.1016/S1473 -3099(16)00010 -4  71.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin  Microbiol Infect 2012; 18: 413 -31. https://doi.org/1 0.1111/j.1469 - 0691.2012.03821.x     PMid:22507109      72.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Epidemiol Infect 2014; 142: 1972 -7.  https://doi.org/10.1017/S0950268813002975     PMid:24252194      73.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect Dis 2013;  13: 785 -96. https://doi.org/10.1016/S1473 -3099(13)70190 -7   74.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
https://doi.org/10.1371/journal.pone.0138471     PMid:26384242       PMCid:PMC4575059   75.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
https://doi.org/10.2807/1560 - 7917.ES2014.19.42.20939     PMid:25358041      76.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Microbiol Infect 2015; 21: 1106.e1 -8.  https://doi.org/10.1016/j.cmi.2015.08.001     PMid:26278669      77.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Available at:  http://ecdc.europa.eu/en/publications/Publications/antimicrobial - resistance -annual -epidemiological -report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Int J Antimicrob  Agents 2015; 45: 568 -85.  https://doi.org/10.1016/j.ijantimicag.2015.03.001    PMid:25857949   79.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Biomed Res  Int 2014; 2014: 249856.  https://doi.org/10.1155/2014/249856     PMid:24790993      PMCid: PMC3984790   81.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Intern Med 2011; 50: 1009 -13.  https://doi.org/10.2169/internalmedicine.50.4270    PMid:21532223   82.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Crit Care Med 2010;  38: 1773 -85.   https://doi.org/10.1097/CCM.0b013e3181eb3ccd    PMid:20639750   84.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect Dis 2004; 4: 519 -27.  https://doi.org/10.1016/S1473 -3099(04)01108 -9   85.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Antimicrob Agents Chemother 2010; 5 4: 3590 -6.  https://doi.org/10.1128/AAC.00115 -10  PMid:20585123      PMCid:PMC2934963   86.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin  Microbiol Infect 2005; 11: 682 -3. https://doi.org/10.1111/j.1469 - 0691.2005.01198.x     PMid:16008625      88.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2013; 57: 349 -58.  https://doi.org/10.1093/cid/cit253     PMid:23616495      89.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Antimicrob Agents Chemother 2012; 56: 2108 -13.  https://doi.org/10.1128/AAC.06268 -11      PMid:22252816      PMCid:PMC3318350   90.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2007; 44: 1208 -1215.  https://doi.org/10.1086/513203     PMid:17407040      91.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet Infect Dis 2013; 13: 698 -708.  https://doi.org/10.1016/S1473 -3099(13)70136 -1   92.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Microbiol Rev 2010; 23: 616 -87.  https://doi.org/10.1128/CMR.00081 -09      PMid:20610826      PMCid:PMC2901661   93.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Microbiol Inf ect 2013;  19: 465 -71. https://doi.org/10.1111/j.1469 - 0691.2012.03903.x     PMid:22616816      94.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J  Hosp Infect 2009; 73: 364 -70.  https://doi.org/10.1016/j.jhin.2009.07.004     PMid:19786313      95.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Infect Control Hosp Epidemiol 2015; 36: 1417 -22.  https://doi.org/10.1017/ice.2015.213     PMid:26372679      96.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2009; 49: 1 -45.  https://doi.org/10.1086/599376     PMid:19489710      PMCid:PMC 4039170   98.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Available from  http://ecdc.euro pa.eu/en/healthtopics/antimicrobial_resistance/data base/Pages/database.aspx .,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
https://doi.org/10.1371/journal.pone.0082665     PMid:24349331       PMCid:PMC3857279   101.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2003; 36: 149 -58.  https://doi.org/10.1086/345435     PMid:12522746      102.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Diagn Microbiol Infect Dis 1997;  29: 259 -63. https://doi.org/10.1016/S0732 -8893(97)00159 -4   103.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Diagn Microbiol Infect Dis  1997; 29: 273 -6. https://doi.org/10.1016/S0732 -8893(97)00139 -9   104.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Infect Control Hosp Epidemiol 2013; 34:  1-14. https://doi.org/10.1086/668770     PMid:23221186      105.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J  Antimicrob Chemother 2013; 68: 731 -42.  https://doi.org/10.1093/j ac/dks469     PMid:23208830      108.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect  Dis 2007; 45(Suppl 3): S184 -190.  https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Leuk  Lymphoma 2012; 53: 1610 -2.  https://doi.org/10.3109/10428194.2012.661051     PMid:22390617     110.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Support Care Cancer 2014; 22: 7 -14.  https://doi.org/10.1007/s00520 -013-1947 -8    PMid:23975231      111.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Pharmacotherapy 2007; 27: 927 -32.  https://doi.org/10.1592/phco.27.6.927     PMid:17542774      112.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J Antimicrob  Chemother 2011; 66: 1963 -71.  https://doi.org/10.1093/jac/dkr242     PMid:21685488      113.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin  Infect Dis 2012; 54: 1699 -709.  https://doi.org/10.1093/cid/cis270     PMid:22467668      PMCid:P MC3404716   114.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2012; 54: 1053 -63.  https://doi.org/10.1093/cid/cir1035     PMid:22412 059      PMCid:P MC3309884   115.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Biol Blood Marrow Transplant 2012; 18:  1295 -301.  https://doi.org/10.1016/j.bbmt.2012.02.010     PMid:22387347      116.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Biol  Blood Marrow Transplant 2013; 19: 405 -9.  https://doi.org/10.1016/j.bbmt.2012.10.030     PMid:23219779      117.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Bone Marrow Transplant 2000; 26: 871 -6.  https://doi.org/10.1038/sj.bmt.1702627     PMid:11081387      118.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Int J Antimicrob Agents 2000; 16: 521 -6.  https://doi.org/10.1016/S0924 -8579(00)00293 -4   119.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2002; 34: 346 -53.  https://doi.org/10.1086/338260     PMid:11774082      120.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
N Engl J Med  2005; 353: 2433 -41.  https://doi.org/10.1056/NEJMoa051590     PMid:16322603      121.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
N Engl J Med 2005; 353: 2442 -9.  https://doi.org/10.1056/NEJMoa051639     PMid:16322602      122.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet 1983; 2: 1043 -6.  https://doi.org/10.1016/S0140 -6736(83)91036 -X   123.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 1996; 22: 813 -8.  https://doi.org/10.1093/clinids/22 .5.813     PMid:8722937      124.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis  2005; 40: 1586 -90.  https://doi.org/10.1086/430311     PMid:15889354      125.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Lancet 2005; 366: 1079 -84.  https://doi.org/10.1016/S0140 -6736(05)67420 -X   126.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin Infect Dis 2008; 47: 56 -62.  https://doi.org/10.1086/588293     PMid:184 91964      127.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin  Infect Dis 2007; 45: 302 -7. https://doi.org/10.1086/519265     PMid:17599306      128.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin  Infect Dis 2001; 3 3: 786 -91.  https://doi.org/10.1086/322616     PMid:11512083      130.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J Oncol Pharm Pract 2014; 20: 172 -82.  https://doi.org/10.1177/1078155213490004     PMid:23804627      131.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Infect Control  Hosp Epidemiol 2010; 31: 431 -55.  https://doi.org/10.1086/651706     PMid:20307191      132.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Antimicrob Agents Chemother 2013; 57: 4501 -5.  https://doi.org/10.1128/AAC.01120 -13      PMid:23836168      PMCid:PMC3754298   133.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
N Engl J Med 2011; 364: 422 -31.  https://doi.org/10.1056/NEJMoa0910812     PMid:21288078      134.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J  Clin Oncol 2013; 31: 2493 -9.  https://doi.org/10.1200/JCO.2012.45.5899     PMid:23715579      135.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Scand J Infect Dis 2 010; 42: 324 -32.  https://doi.org/10.3109/00365540903496569     PMid:20100118      136.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Pediatr Infect Dis J 2013; 32: 723 -6.  https://doi.org/10.1097/INF.0b013e31828aebc8     PMid:23838774     137.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J Antimicrob Chemother 2009; 63:  568-74. https://doi.org/10.1093/jac/dkn514     PMid:19126669      138.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Available at:  http://www.ebmt.org/Contents/Resources/Library/ECIL/Document s/Forms/AllItems.aspx    139.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Expert Rev Anti Infect Ther 2014 ; 12: 1003 -16.  https://doi.org/10.1586/14787210.2014.920253   PMid:24834465      140.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Bone Marrow  Transplant 2009; 44: 467 -70.  https://doi.org/10.1038/bmt.2009.257     PMid:19861980      141.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Biol Blood Marrow Transplant 2009; 15: 1143 -1238.  https://doi.org/10.1016/j.bbmt.2009.06.019     PMid:19747629      P MCid:PMC3103296,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Bone Marro w  Transplant 2009; 44: 495 -507.  https://doi.org/10.1038/bmt.2009.261     PMid:19861984      144.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Infect Control Hosp Epidemiol  2005; 26: 161 -5.  https://doi.org/10.1086/502521     PMid:15756887      147.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
J Infect Dis 2002; 186: 1754 -60.  https://doi.org/10.1086/345921     PMid:12447761      149.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Am J  Infect Control 2007; 35(10 Suppl 2): S165 -93.  https://doi.org/10.1016/j.ajic.2007.10.006     PMid:18068814      150.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Microb Drug Resist 2004; 10: 177 -83.  https://doi.org/10.1089/1076629041310091     PMid:15256034      151.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Infect Control Hosp Epidemiol  2002; 23: 429 -35.  https://doi.org/10.1086/502080     PMid:12186207      152.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
JAMA 2008; 299: 1149 -57.  https://doi.org/10.1001/jama.299.10.1149     PMid:18334690      154.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Ann Intern Med 2008; 148: 409 -18. https://doi.org/10.7326/0003 - 4819 -148-6-200803180 -00003     PMid:18347349      155.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Clin  Infect Dis 2006; 43: 971 -8.  https://doi.org/10.1086/507636     PMid:16983607       156.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
2015; 100:  e373 -6.  https://doi.org/10.3324/haematol.2015.125484     PMid:25862702       PMCid:PMC4800687   157.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Curr Opin Infect Dis 2016; 29: 555 -60.  https://doi.org/10.1097/QCO.0000000000000313    PMid:27584588   158.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
2016: 357 -80.  https://doi.org/10.1007/978 -3-319-28797 -3_21    159.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
https://doi.org/10.1093/jac/dkw272    160.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Bone Marrow  Transplant 2011; 46: 1226 -30.  https://doi.org/10.1038/bmt.2010.279     PMid:21057549      161.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Infect Control Hosp Epidemiol 2012; 33: 14 - 9. https://doi.org/10.1086/663206     PMid:22173517      162.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Am J Infect Control 2013; 41: 1167 -72.  https://doi.org/10.1016/j.ajic.2013.04.018     PMid:24274912      163.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Int J Antimicrob Agents 2013; 42: 565 -70.  https://doi.org/10.1016/j.ijantimicag.20 13.08.008    PMid:24100228   165.,OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
JAMA 2014; 312:  1429 -37.  https://doi.org/10.1001/jama.2014.7247     PMid:25271544      166.,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
Antimicrob Agents Chemother 2014; 58: 1972 -6. https://doi.org/10.1128/AAC.02283 -13   PMid:24419337      PMCid:PMC4023775,Non-OADS,/arxiv_data1/oa_pdf/94/48/mjhid-9-1-e2017002.PMC5224809.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7001, DOI:  http://dx.doi.org/10.4084/MJHID.2017.001      Published:  January 1 , 201 7 Received:  August 20 , 201 6 Accepted:  November 14 , 201 6    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2016;20:451 -459  https://doi.org/10.4103/2230 -8210.183456     PMid:27366710       PMCid:PMC4911833   2.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
eCollection  2016. https://doi.org/10.4084/mjhid.2016.022    3.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2015;19:306 -307 https://doi.org/10.4103/2230 - 8210.149331   PMid:25729702      PMCid:PMC4319280   4.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2001;24:716 -723.  https://doi.org/10.1007/BF03343916     PMid:11716158     5.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
Menopause 2007;14:567 –571  https://doi.org/10.1097/gme.0b013e31804c793d   PMid:17476146     6.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
JAMA 2002; 288: 321 -333.  https://doi.org/10.1001/jama.288.3.321     PMid:12117397     7.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
Indian J Endocrinol Metab.2016 Nov - Dec;20(6):880 -881. https://doi.org/10.4103/2230 -8210.192905      PMid:27867897      PMCid:PMC5105578   8.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
https://doi.org/10.1089/jwh.2016.5942    10.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
https://doi.org/10.1093/humupd/dmw016    11.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2015;16: 2759 -2772.  https://doi.org/10.1517/14656566.2015.1100173     PMid:26512437     12.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2010;22:363 -368.  https://doi.org/10.1097/GCO.0b013e32833e4a35   PMid:20724926      13.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
https://doi.org/10.1210/jc.2012 -4243     PMid:23678038     14.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
1998; 99:76 -79. https://doi.org/10.1159/000040814      PMid:9554453     16.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
1992;87:71 -74. https://doi.org/10.1159/000204720    PMid:1585774     17.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2006; 96:488 -491. https://doi.org/10.1160/th06 -05-0267    18.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2012;23:212 -217.  https://doi.org/10.1097/MBC.0b013e3283502975      PMid:2 2322139     19.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2014;171:R221 -230. https://doi.org/10.1530/EJE -14- 0527     PMid:2 5012200     20.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
200 4;292:1573 -1580.  https://doi.org/10.1001/jama.292.13.1573     PMid:15467059     22.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2010;95(7 Suppl  1):s1 -s66 https://doi.org/10.1210/jc.2009 -2509     PMid:20566620     23.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
1997; 25:702 -704.  https://doi.org/10.1002/hep.510250335     PMid:904 9222     24.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2009; 82:22 - 25 https://doi.org/10.1111/j.1600 -0609.2008.01162.x      PMid:19021734     26.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
Blood 2004;104:34 -39  https://doi.org/10.1182/blood -2003 -09-3167     PMid:14988152     28.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2016;9:401 - 408 https://doi.org/10.1586/17474086.2016.1136209      PMid:266977 56     29.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2013;27:67 -76.  https://doi.org/10.1016/j.beem.2012.11.001   PMid:23384747     30.,OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
https://doi.org/10.1016/j.contraception.2003.08.014       PMid:14720615     31.,OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
1993;42:846 -853.  https://doi.org/10.1016/0026 -0495(93)90058 -V   32.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2006;46:174 -190.  https://doi.org/10.1159/000095726     PMid:17068402     33.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
Menopause 2016; 23:593 -599.  https://doi.org/10.1097/GME.0000000000000611      PMid:27023862     35.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
Menopause 2012; 1 9:257 -271.  https://doi.org/10.1097/gme.0b013e31824b970a     PMid:22367731       PMCid:PMC3443956   36.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
1993;46:660 -664.  https://doi.org/10.1136/jcp.46.7.660     PMid:8157756       PMCid:PMC501398   37.,OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2016;19:109 -150.  https://doi.org/10.3109/13697137.2015.1129166     PMid:26872610     38.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2015;31:345 -348.  https://doi.org/10.3109/09513590.2014.998646     PMid:25578420     39.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
"DOI: 10.14319/ijcto.41.13 https://doi.org/10.14319/ijcto.41.13    40. van Kasteren YM, Schoemaker J.",Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
1999 ;5 :483 -492. https://doi.org/10.1093/humupd/5.5.483      PMid:10582785     41.,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
2009;360:606 -614.  https://doi.org/10.1056/NEJMcp0808697     PMid:19196677       PMCid:PMC2762081,Non-OADS,/arxiv_data1/oa_pdf/37/07/mjhid-9-1-e2017001.PMC5224811.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7007, DOI: http://dx.doi.org/10.4084/MJHID.2017.007      Published:  January 1 , 201 7 Received:  October 1 , 201 6 Accepted:  December 12 , 201 6    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
1947 Oct;214(4):410 -5. https://doi.org/10.1097/00000441 - 194710000 -00009     PMid:20266939      3.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2010 Jan;47(Pt 1):8 -16  https://doi.org/10.1258/acb.2009.009180     PMid:20040797      5.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
1974 Nov;57(5):775 -88. https://doi.org/10.1016/0002 - 9343(74)90852 -3    6.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2012 Jan 28;379(9813):348 -60.  https://doi.org/10.1016/S0140 -6736(11)60242 -0    7.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2002 Jan;55(1):4 -13. https://doi.org/10.1 136/jcp.55.1.4      PMid:11825916      PMCid:PMC1769573   9.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2000  Jan;12(1):53 -60. https://doi.org/10.1097/00002281 -200001000 - 00009     PMid:10647955      10.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2011 Jun;86(6):500 -2.  https://doi.org/10.1002/ajh.22023     PMid:21594887      11.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
1997:35:287 -90. https://doi.org/10.1515/cclm.1997.35.4.287     14.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1097/0000579 2-200107000 -00004     18.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2008 Sep  16;3:25. https://doi.org/10.1186/1750 -1172 -3-25    PMid:18796155       PMCid:PMC2569912   19.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
1987; 15:  171-87. https://doi.org/10.1016/0161 -5890(78)90146 -3    20.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1182/blood.V97.11.3537      PMid:11369648      21.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
Lancet.1980 Feb;  1(8163):285 -7. https://doi.org/10.1016/S0140 -6736(80)90781 -3    22.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
1987; 24: 897 -905. https://doi.org/10.1016/0161 - 5890(87)90001 -0    23.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1016/S1473 -3099(05)70053 -0    25.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2007 May 7;13(17):2467 -78.  https://doi.org/10.3748/wjg.v13.i17.2467     PMid:17552031       PMCid:PMC4146766   26.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2008 Feb -Apr;29(1 -2):85 - 95. https://doi.org/10.1016/j.mam.2007.09.017   PMid:18177700   27.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
Lancet 1992; 339: 321 -3.  https://doi.org/10.1016/0140 -6736(92)91645 -O    28.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
Clin Exp Immunol 1997; 110: 9 - 14. https://doi.org/10.1111/j.1365 -2249.1997.475 -ce1383.x      PMid:9353142      PMCid:PMC1904798   29.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1016/j.dld.2014.09.010      PMid:25445409      31.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2015 Mar 27;7(3):327 -43.  https://doi.org/10.4254/wjh.v7.i3.327     PMid:25848462       PMCid:PMC4381161   32.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
Am J Med 1966;40:828 -36. https://doi.org/10.1016/0002 -9343(66)90199 -9    34.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2014 Dec;53(12):2209 -13.  https://doi.org/10.1093/rheuma tology/keu271     PMid:24994905      35.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2001  Sep;44(9):2118 -24. https://doi.org/10.1002/1529 - 0131(200109)44:9<2118::AID -ART364>3.0.CO;2 -X    36.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2002 Jan;59(1):31 -7.  https://doi.org/10.1034/j.1399 -0039.2002.590106.x      PMid:11972876      37.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2014 Oct;15(7):500 -5.  https://doi.org/10.1038/g ene.2014.41     PMid:25030430       PMCid:PMC4208981   38.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2015  Jan;11(1):15 -31.  https://doi.org/10.1586/1744666X.2015.997214     PMid:25534977     39.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2012  Jul;26(7):1654 -62. https://doi.org/10.1038/leu.2012.29      PMid:22307176      40.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1371/journal.pone.0062965     PMid:23650540       PMCid:PMC3641090   41.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1016/S0889 - 8588(05)70129 -5    42.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1136/ard.52.Suppl_1.S48      PMid:8481059      PMCid:PMC1035026   43.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2012  Nov;23(11):1869 -78. https://doi.org/10.1681/ASN.2012050477      PMid:23024299      PMCid:PMC3482736   44.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2016  Aug;48(8):927 -33. https://doi.org/10.1016/j.dld.2016.05.013      PMid:27289333      45.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2012 Oct;81(10):883 -7. https://doi.org/10.1002/cy to.a.22112      PMid:22961692      46.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2015; 2015:  783063. https://doi.org/10.1155/2015/783063     PMid:25692146       PMCid:PMC4321088   47.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
2016 Apr;54(4):e123 -6. https://doi.org/ 10.1515/cclm - 2015 -0404     PMid:26587742      49.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
Clin Chem Lab Med 2003;41:85 -9.  https://doi.org/10.1515/CCLM.2003.015     PMid:12636055      50.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
Eur J Clin Invest 2001;31:628 -38.  https://doi.org/10.1046/j.1365 -2362.2001.00824.x      PMid:11454019      52.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
Am J Kidney Dis 1996;27:476 -83.  https://doi.org/10 .1016/S0272 -6386(96)90156 -0   53.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1258/acb.2011.011158      PMid:22402916      55.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
Electrophoresis  1996;17:1607 -12. https://doi.org/10.1002/elps.1150171020      PMid:8957190      56.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
PubMed PMID: 22762140. https://doi.org/10.1111/j.1365 - 2893.2011.01576.x     57.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1016/j.tmaid.2016.05.020     58.,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.3109/23744235.2015.1113438     60.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
Liver International 2015  https://doi.org/10.1111/liv.12829     PMid:25800731     61.,Non-OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
https://doi.org/10.1016/j.autrev.2016.01.012     PMid:26827906,OADS,/arxiv_data1/oa_pdf/59/45/mjhid-9-1-e2017007.PMC5224812.pdf
"Mediterr J  Hematol Infect Dis 201 7, 9(1): e201 7006, DOI: http://dx.doi.org/10.4084/MJHID.2017.006      Published:  January 1 , 201 7 Received:  September 28 , 201 6 Accepted:  November 21 , 201 6    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribu tion, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Lancet Neurol 2005;  4: 827 -40. https://doi.org/10.1016/S1474 -4422(05)70247 -7    2.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Neuroimmunomodulation 2 009;16:134 -145  https://doi.org/10.1159/000180268     PMid:19212133      3.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Annals Trop Paedia 2004; 24: 17 -24.  https://doi.org/10.1179/027249304225013240     PMid:15005962    4.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Pharmacol Ther 1998; 79:1 -53  https://doi.org/10.1016/S0163 -7258(98)00008 -4    5.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
"Lancet 1990; 336:1039 -43  https://doi.org/10.1016/0140 -6736(90)92498 -7   6. van Hensbroek MB, Palmer A, Jaffar S, Schneider G, Kwiatkowski  D. Residual neurologic sequelae after childhood cerebral malaria.",Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
J  Pediatr 1997; 131:125 -129 https://doi.org/10.1016/S0022 - 3476(97)70135 -5    7. http://nvbdcp.gov.in/malaria3.html [accessed on 22.04.2016]   8.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Bangladesh Med Res Counc Bull 2009; 35: 15 -17  https://doi.org/10.3329/bmrcb.v35i1.2313     PMid:19637540     10.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
J Neurol  Neurosurg Psychiatry 2000 69: 433 -441.  https://doi.org/10.1136/jnnp.69.4.433     PMid:10990500       PMCid:PMC1737146   11.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Acta Tropica  2011; 117: 82 -85 https://doi.org/10.1016/j.actatropica.2010.10.001      PMid:20943199      13.,OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Trans R Soc Trop Med Hyg 1996;  90: 391 -4 https://doi.org/10.1016/S0035 -9203(96)90518 -0    14.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Epilepsia  2008; 49:19 -24 https://doi.org/10.1111/j.1528 -1167.2008.01752.x      PMid:18754957      15.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
J  Neurol Neurosurg Psychiatry 2005; 76:476 -81  https://doi.org/10.1136/jnnp.2004.043893     PMid:15774431       PMCid:PMC1739592   16.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Pediatrics 2008; 122:e92 -e99  https://doi.org/10.1542/ped s.2007 -3709     PMid:18541616       PMCid:PMC2607241   17.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
Paediat Res 2000; 68 (4): 267 -74.  https://doi.org/10.1203/PDR.0b013e3181eee738     PMid:20606600       PMCid:PMC3056312   18.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
N Engl  J Med 1983;309:61 -6.  https://doi.org/10.1056/NEJM198307143090201     PMid:6343877     19.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
N Engl J Med  1988;319:1040 -7. https://doi.org/10.10 56/NEJM198810203191602      PMid:3050516      20.,Non-OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
https://doi.org/10.1542/peds.2006 -3171      PMid:17766489      21.,OADS,/arxiv_data1/oa_pdf/f4/c5/mjhid-9-1-e2017006.PMC5224813.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7004, DOI:  http://dx.doi.org/10.4084/MJHID.2017.004      Published:  January 1 , 201 7 Received:  October 3 , 201 6 Accepted:  December 12  , 201 6    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
3(1s): p. 18.  https://doi.org/10.4081/thal.2013.s1.e18    2.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
38(1): p. 140 -149.  https://doi.org/10.2337/dc14 -2441     PMid:25538310     4.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
42(10): p. 999 -1024. https://doi.org/10.1111/1440 -1681.12455      PMid:26173919     5.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
9(2): p. 194 -205.  https://doi.org/10.1111/j.1463 -1326.2006.00704.x      PMid:17300595     6.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
64(5): p. 562 -76.  https://doi.org/10.1111/j.1742 -1241.2010.02353.x      PMid:20456211     7.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
7(8): p. 607 -612.  https://doi.org/10.14740/jo cmr2149w     PMid:26124906       PMCid:PMC4471747   8.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
58(12): p. 1648 -1655.  https://doi.org/10.1373/clinchem.2012 .188367     PMid:23019309       PMCid:PMC3652236   10.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
298(2): p. 194 -206.  https://doi.org/10.1001/jama.298.2.194     PMid:17622601     12.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
https://doi.org/10.1002/14651858.cd006739.pub2    13.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
14(12): p. 1061 -1072. https://doi.org/10.1111/j.1463 - 1326.2012.01610.x     PMid:22519906     14.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
"Diabetes, Obesity and  Metabolism, 2016. https://doi.org/10.1111/dom.12610    15.",Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
14(4): p. 505 -24.  https://doi.org/10.1517/14740338.2015.1006625      PMid:25630605     16.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
370( 9):  p. 794 -7. https://doi.org/10.1056/NEJMp1314078      PMid:24571751     17.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
https://doi.org/10.1111/jcpt.12373     PMid:26936090     18.,OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
176(10): p. 14 74-1481.  https://doi.org/10.1001/jamainternmed.2016.1531      PMid:27478902     19.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
32(4): p. 391 - 404. https://doi.org/10.1002/dmrr.2723     PMid:26417956     20.,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
https://doi.org/10.3803/EnM.2015.30.1.84      PMid:25325279      PMCid:PMC4384675,Non-OADS,/arxiv_data1/oa_pdf/66/c9/mjhid-9-1-e2017004.PMC5224814.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7010, DOI: http://dx.doi.org/10.4084/MJHID.2017.010      Published:  January 1 , 201 7 Received:  November 11 , 201 6 Accepted:  November 24, 201 6    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2016;127:2055 -2063.  https://doi.org/10.1182/blood -2015 -11-624288     PMid:26989204     2.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2013;122:981 - 987. https://doi.org/10.1182/blood -2013-03-491514      PMid:23777769      PMCid:PMC3739040   3.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2003;362:516 -522.  https://doi.org/10.1016/S0140 -6736(03)14110 -4   5.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2014;28:1388 -1395. https://doi.org/10.1038/leu.2014.91      PMid:24577532     7.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2011;377:42 -51.  https://doi.org/10.1016/S0140 -6736(10)62175 -7   8.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2016;122:2996 - 3004. https://doi.org/10.1002/cncr.30137     PMid:27351685     9.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
https://doi.org/10.1371/journal.pone.0106745     PMid:25255081       PMCid:PMC41778 39  10.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2007;25:579 -586.  https://doi.org/10.1200/JCO.2006.09.2403     PMid:17242396     12.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2000;27:85 -94.  https://doi.org/10.1002/(SICI)1098 -2264(200001)27:1<85::AID - GCC11>3.0.CO;2 -9   13.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2015;15:172 -184.  https://doi.org/10.1038/nri3814     PMid:2571215 2     15.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2007;9:530 -537.  https://doi.org/10.2353/jmoldx.2007.070038     PMid:17652637       PMCid:PMC1975105   16.,OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
1987;317:1185 -1189. https://doi.org/10.1056/NEJM19871105 3171904     PMid:3657890     17.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2010;24:521 -535.  https://doi.org/10.1038/leu.2009.268     PMid:20033054     20.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2008:44 -47.  https://doi.org/10.1093/jncimonographs/lgn 005    PMid:18648002     22.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2003;21:1398 -1403.  https://doi.org/10.1200/JCO.2003.07.070     PMid:12663733     23.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2014;20:6398 -6405.  https://doi.org/10.1158/1078 -0432.CCR -14-0407      PMid:25316810     24.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2013;122:3759 -3766. https://doi.org/10.1182/blood -2013 - 06-507319     PMid:24085766     25.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
"2008;111:4004 -4013. https://doi.org/10.1182/blood -2007 -10- 116749     PMid:18239086     26. van der Velden VH, Cazzaniga G, Schrauder A, et al.",Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2007;21:604 -611.  https://doi.org/10.1038/sj.leu.2404586    27.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2015;17:652 -660.  https://doi.org/10.1016/j.jmoldx.2015.05.007     PMid: 26319783     28.,OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2015;126:1045 -1047. https://doi.org/10.1182/blood -2015 -07- 655159     PMid:26294720      PMCid:PMC4551355   29.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2002;99:856 -862.  https://doi.org/10.1182/blood.V99.3.856     PMid:11806987,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2002;100:1559 -1565.  https://doi.org/10.1182/blood -2002 -02-0621     PMid :12176870     32.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2007;13:1057 - 1065. https://doi.org/10.1016/j.bbmt.2007.05.012      PMid:17697968      PMCid:PMC4147857   34.,OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2005; 106:3725 -3732.  https://doi.org/10.1182/blood -2005 -01-0016     PMid:16123223     35.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2005;105:1417 -1423.  https://doi.org/10.1182/blood -2004 -08-3175     PMid:15494430     36.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2004;15:1691 - 1698. https://doi.org/10.1093/annonc/ mdh425     PMid:15520073     37.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2012;23:2687 -2695.  https://doi.org/10.1093/annonc/mds202     PMid:22767588     38.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2008;141:631 -640. https://doi.org/10.1111/j.1365 - 2141.2008.07101.x     PMid:18422779     39.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2012;31:308 -313.  https://doi.org/10.1200/JCO.2011.41.1553     PMid:23 233718     41.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
"2009;27:6094 -6100.  https://doi.org/10.1200/JCO.2009.22.6258     PMid:19858392     42. van Oers MH, Tonnissen E, Van Glabbeke M, et al.",OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2010;28:2246 - 2252. https://doi.org/10.1200/JCO.2009.25.0852     PMid:20368567     43.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2001;29:183 -193.  https://doi.org/10.1016/S0301 -472X(00) 00651 -2   44.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2003;32:57 -63. https://doi.org/10.1038/sj.bmt.1704102      PMid:12815479     45.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2005;105:3428 -3433. https://doi.org/10.1182/blood -2004 - 06-2490     PMid:15637137     46.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2014;32:3059 -3068. https://doi.org/10.1200/JCO.2013.54.8800      PMid:25113753      PMCid:PMC4979083   47.,OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2010;37:2307 -2314.  https://doi.org/10.1007/s00259 -010-1539 -5    PMid:20717826     48.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2012;30:4317 -4322.  https://doi.org/10.1200/JCO.2012.43.0934     PMid:23109699     49.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2011;29:3194 -3200.  https://doi.org/10.1200/JCO.2011.35.0736     PMid:21747087     50.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2016;101:e66 -68.  https://doi.org/10.3324/haematol.2015.132811     PMid:26471485       PMCid:PMC4938338   51.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2015;33:2516 -2522.  https://doi.org/10.1200/JCO.2014.59.7534     PMid:26124482       PMCid:PMC4879714   52.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2015;16:1111 -1122.  https://doi.org/10.1016/S1470 -2045(15)00169 -2   53.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2016;128:1112 -1120.  https://doi.org/10.1182/blood -2016 -05-717355     PMid:27418643    54.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
2016;128:325 -330.  https://doi.org/10.1182/blood -2016 -04-709477   PMid:27222479     55.,Non-OADS,/arxiv_data1/oa_pdf/c1/cc/mjhid-9-1-e2017010.PMC5224815.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1):  e201 7003, DOI: http://dx.doi.org/10.4084/MJHID.2017.003      Published:  January 1 , 201 7 Received:  August 14 , 201 6 Accepted:  November 11 , 201 6    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
https://doi.org/10.1002/hep.26141      PMid:23172780     2.,OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
J Viral Hepat 2016;23  (Suppl 1):1 -12. https://doi.org/10.1111/jvh.12493      PMid:26809941     3.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
2010;1 16:2875 -83. https://doi.org/10.1182/blood -2009 -11-248724      PMid:20551378     4.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
2010;1202:1 -9.  https://doi.org/10.1111/j.1749 -6632.2010.05544.x      PMid:20712765     5.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
2002;100:17 -21.  https://doi.org/10.1182/blood .V100.1.17     PMid:12070002     6.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
2008;93:1243 -6.  https://doi.org/10.3324/haematol.12554     PMid:18556410     7.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
2015;63:199 -236.  https://doi.org/10.1016/j.jhep.2015.03.025     PMid:25911336     8.,OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
https://doi.org/10.1016/j.jhep.2011.02.023     PMid:21371579     9.,OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
1993;83:491 -497. https://doi.org/10.1111/j.1365 -2141.1993.tb04676.x     PMid:8387324     10.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
2016;144:1634 - 40. https://doi.org/10.1017/S0950268815003064     PMid:27125573     11.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
1997;98:850 -855.  https://doi.org/10.1046/j.1365 -2141.1997.2953112.x      PMid:9326177     12.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
2002;117:755 -8.  https://doi.org/10.1046/j.1365 -2141.2002.03491.x    14.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
Ann N Y Acad Sci 2005; 1054: 290 -299.  https://doi.org/10.1 196/annals.1345.038     PMid:16339677     15.,Non-OADS,/arxiv_data1/oa_pdf/c3/68/mjhid-9-1-e2017003.PMC5224816.pdf
